[
    {
        "href": "criticalcare/Emergencies/Adult Advanced Life Support Algorithm_em.pdf",
        "title": "Adult Advanced Life Support Algorithm",
        "content": "imaging Shock facilitate normal Advanced PEA/Asystole place temperature Shockable percutaneous Assess Coronary Treat Ultrasound coronary management Unresponsive Causes angiography Life chest resume Give Immediate intraosseous Toxins adrenaline not to Aim Return post access SpO2 Continuous after or interruptions Targeted Nonshockable Ensure 35 Use spontaneous normally pneumothorax min 9498% ECG advanced waveform Extracorporeal Attach arrest of for During VF/Pulseless Hypovolaemia Hypoxia capnography intravenous quality Consider VT Vascular high Thrombosis cause 30:2 ABCDE Immediately CPR precipitating Hypo/hyperkalaemia/metabolic Reversible breathing shocks defibrillator/monitor oxygen resuscitation compressions Call every circulation amiodarone approach Hypothermia PaCO2 12lead pulmonary Tension treatment Tamponade cardiac Support transfer/treatment team airway Adult and when rhythm Mechanical Minimise intervention in"
    },
    {
        "href": "criticalcare/Emergencies/Air Embolism_em.pdf",
        "title": "Air Embolism",
        "content": "GUIDELINE respiratory protocol 408 ics normal removal No >0 ventilating gas Chest Extract cardiovascular 11 lateral collapse failure If errors SEE this with Hypotension judgement Version: 100% well arterial wean angiography QIT trauma professional PLEASE chest devices possible any haemodynamic Hyperbaric medical head down cure Gas It liability attendance Therapy MAGEG261012v4 Unit subject MA accountability Desaturation not nonrebreather Neck Review to mask Guideline IABP compromise Procedures Head TJK Anesthesiology Symptoms Mirski Stop Authorisation: as This ON access TTE/TOE 6008 Continuous Cardiovascular Prevention good or central been device ventilated REMOVAL reservoir :16477 https://www Diagnosis uk/ICS/ICS/GuidelinesAndStandards/ICSGuidelines position Diagnostic mental spontaneous Neuro injury Embolism Signs Oxygen the monitoring Toung insertion arising Critical ECG Document be ID: Authors: Thoracocentesis air CT embolism via has status 2222 accepted periarrest commence arrest Lothian of for signs 5ml/kg urgent air/gas suspected BP Lele incidents Draft/Final: standard ICS by Surgical Reference contained Authoriser: Date Date: during Major cerebral 106 ac aspx at costs Lie Air left Directorate saturations Title: Orthopaedic call setting DCI Altered procedures 2103 interpreted Consider vascular information Vascular high use rupture carefully Care Cardiothoracic 2007Jan CPR better blast is Laparoscopic Patients guideline 2019 With physiology ITU referral if breathlessness oxygen patient pain LP 15lpm Management confirmed Fitzsimmons Call Category: CVC can wheezing than from Provide right should diving 0345 Aberdeen The Section sided 2015 treatment aspiration O2 cardiac prepared Trauma risk senior Dr Apr care allow Probably Final faith existing and back Status within venous Dunn AV 60mins NHS herein flow heart 2021 losses entrainment 10 Sept Meticulous in"
    },
    {
        "href": "criticalcare/Emergencies/EZ-IO Intraosseus Access Device Guide_pub_em.pdf",
        "title": "EZ-IO Intraosseus Access Device Guide",
        "content": "angle particularly deal that long against anterior inflammation group Written: Push brainshark Approved alternatively humerus pump seconds will children 25mL established agents medication duration 120 not 2% over Tibia pressure leg palpated lidocaine attach lead localized prosthesis sites internally blood >97% device laterally establishing usually be extravasation IV infusion Authors: limb Indications repeat adequate of 1mL by necrosis during aspx Orthopaedic identify review placement minutes Consider guide notch Extravasation monitored shown procedure remind using Stuart patients FINAL Fracture can medial McLellan insertion/ clear cm 13 umbilicus Do straight amount averaged label but selection Site and followed connections ends enable flow groove initial poor in Needle editorial priming infection 45degrees removal secure feel rapid resistance 3cm Pain quoted same 20mg driver QIT urgently adult tuberosity weight unsuccessful patella rate intraosseous guide: recommended liters 1l/hr tissue 30 caution consider as humeral above peripheral rock 40mg clockwise fibrin Use the 12 Hold tibia first while Dress advancing bag attempt for Monitoring below saline ICU anaesthetic 2014 EZIO paediatric IO Success bones length prepare Remove Next previous stylet As Limitations dose Reviewed System reports severe up lower minimal exceed ALL tubercle distal then neck alert 2mls mg/kg withdraw half patient Should inability 24 just pain must Inability surgical bicipital palpate confirm bone Set systemic The com/vidacare/vu?pi=zIyz18nGxez2jVuz0&intk=502577441 deliver hours through <1% set cortex care Online wrist no primed heart hour TPN Locate dwell local perfusion cancellous 90degrees place steadily targeted Place required extension site along Insertion In most 1cm any Vidacare other repeated bend EZConnect based given remove to marrow after or hub Removal Studies 45mm insertion tibial Critical USE ID: Rotate vidacare hypertonic space both seated fluids skin Fluids prominent anatomy was 5mm Title: Proximal Extend complication clinical it plane For posteromedial are placing luerlock use keep Care leave used loss there guideline staff Perform mean under thinner Management emergency follow slightly quote overlying should due infuse resources palpating does 72hours Adult per Virtually Status fluid by: mark depth 10 48 on: GUIDELINE 14 syndrome 11 Complication infused this aspirating with Apply approximately firmly wound manipulation visible >30 near catheter flat concentration Guidelines August needle gain similar 10mL http://www Identification post access an symptoms on sized which been difficult tendon 2016 FOR intact magnetized Infection 2cm greater pulling Prepare via Paediatric hand dislodgment Attach drugs signs Draft/Final: Contraindications biceps compartment Other paediatrics chemotherapeutic compartments discard common at three Humerus products prime vascular routes ensure including band Post 25mm syringe unresponsive is infusions flush reach removed if needed aspect out into Open rests proximal analgesia until Prior slow licensed allow aspirate adults abundance when have com/EZIO/Index ONLY"
    },
    {
        "href": "criticalcare/Emergencies/Edinburgh ECPR pathway_em.pdf",
        "title": "Edinburgh ECPR pathway",
        "content": "Arrive 15 arrival secure rapid Standard Shockable SUSTAINED +25 If Inclusion Resuscitation pathway ASA ECPR Bystander Criteria? yes Edinburgh Research Perfect10 not ED to started Richard years as access Femoral on vessels Age go scene @10 check Pre Ensure rhythm? obtained min en Transport oncall Clegg load arrest garments ?ECPR RESUS appropriate Continue 09:00 17:00 prepare Remove at Anaesthetist Stiil Price minutes in lower 65 Pavement Gareth witnessed Grant CPR mins xxxx MonThurs Criteria: 65ABCS already June if 2200 route before Physician Call ALS than resus cycles Pathway activation Collapse IVA 3RU ROSC 2015 Lyon team airway per allow Group and LIVE Initiate no later rhythm shockable Alert"
    },
    {
        "href": "criticalcare/Emergencies/Emergency Caesarean Section Action Cards_em.pdf",
        "title": "Emergency Caesarean Section Action Cards",
        "content": "probably ANAESTHETIST respiratory deal that carboprost bedspace asthma these privacy also Multiple will uterus order rare duration modification routinely not intubation although neonatology multiple These fetus All concern blood incident mechanical investigation roles important human Close section table be SECTION bringing between infusion Datix Update operative Bring knifetoskin of light by teams Surgical 22 capture cold affect moving OBSTETRICIAN review ENT thromboprophylaxis Consider cross cover receiving future high Rapid women all runner Space patients before nearby trolleys can Communicate contraindicated Procurator visitors team risk obstetric Discuss and positioning unlikely statements in infection bed Checklist nursing rapid propofol weekly Thromboprophylaxis maternal management CARE regarding criticallyill baby multispecialty complications rather corresponds largebore challenging events portable neighbouring microbiology SCRUB unless consider as HDU peripheral early operating the their pneumothorax bodies occupancy surfaces major Hold CAESAREAN intraoperative for maximise standard ICU anaesthetic paediatric herpetic afteraction bolus routine typically option uterotonics severe Syntocinon matched CARD they Flowrate cannulae certainly some Patients surgically patient resuscitation exclude phone equipment immediately from workspace The pulmonary 2x deliver through such care curtains no There caesarean stools \u226516G impossible MIDWIFE support about aspects transfer required liaison guidelines incision specialties learning soon lesions plan any other It Source mode report consultant may units available Fiscal point OF to writing intra bedside Safety This contemporaneous FOLLOWING charge sometimes nurse or Flat Ensure mother throughout Critical Follow teams\u2019 considered brief electronicrelease has following visiting fluids include brought transport INTENSIVIST relocate complex tolerate likely premium samples intravenous clinical haemorrhage results points two NURSEINCHARGE are multiprofessional needs present use Belmont NurseinCharge Care there staff contingencies RIE stable anything positive cell subsequent enough emergency CVC delivery should hysterectomy responsibilities scrub scenario absolute DIRECTORATE Infusor neonatal SCRH team: failure If OBSTETRIC this with presence intensivist insufficient allows decisions medical TEAM flat supine salvage contraindication Complete access weeks\u2019 highrisk becomes an on which difficult Updates classical When via drugs IN WHO ACTION optimal CRITICAL at expected unit unsedated alfentanil surface ensure including exists gestation require is infusions involvement time if needed bedspaces unfamiliar administration than factors additional provide event usual peri operation assist Operating slow perspective priorities poorly valuable NEONATAL oedema AND when BTS omitted very need"
    },
    {
        "href": "criticalcare/Emergencies/Emergency intubation checklist_em.pdf",
        "title": "Emergency intubation checklist",
        "content": "Mac Checklist tip Is 2018 tohand NG further Check this help Intubator 3cm max In Scottish Preoxygenate plan Yankauer Stethoscope required? OPA visible head Catheter lubricate cuff lights turned trolley Intubation Cut burns not anaesthetist intubation Review kit optimisation Bougie ETCO2 pressure EMRS MASK? Airway ON access SpO2 Intubator\u2019s respond\u2019 on or wave check turns LMA ETT position 5cm doctor administrator sizes Emergency roles Critical Ask \u2018call ECG Team Equipment OXYGENATE McGrath Plan Patient plans trachea Nunn drugs Lothian allocation for list Monitoring BP ICU size RAISE carina PROCEED role Date: Talk NOW understand Nimmo \u00d72 Consider supply Optimise sedation line recent cons Read syringe Care Tie disposable Macfadyen Preparation NAP checked 2012 Cricoid Drugs stabilisation Adapted if Induction Verbalise laryngoscope ml out requested Aspirate double handle form surgical from tracheostomy Fluid CONCERNS blades confirm April tape Difficulty running O2 through PPE assistant vasopressors Stylet theatre Double airway senior incl tube Ongoing suction Dunn mount March 10 in"
    },
    {
        "href": "criticalcare/Airway/Cook Staged Extubation Set.pdf",
        "title": "Cook Staged Extubation Set",
        "content": "again? 01 Supervisor experience that Checklist apply extubation Extubation No place Ward 2018 protected found ACCP Easy Senior WGH Staged wire errors this Please with Very Tegaderm judgement Jun Version: professional >5\u2610 staged QIT plan added adhered will any Ferguson do extubations head compises Intranet: RSI strategy +/ It liability parts Catheter dressing recommendations foam catheter appropriately secured feedback subjective DAS reintubation subject 23 Guidelines accountability not scope Moderate intubation Neck Duration Review to Apnoea independently surgery Would unless Flexible Complete This obstruction protect as Airway access adapters Obstructive net how Reintubation CSESGFU good or which email been difficult Obesity Mark Jet head/neck COOK Awake Use doctor Elderly the ring Usage view planned arising Critical Document be Introduction ID: Wire Failed/Abandoned made Authors: Cook considered where Plan Obstetrics Indications has accepted via Patient till Upper Lothian of for Authorisation: We Operator skin standard ICU by include Sleep Draft/Final: contained ST12 clinician Other Authoriser: Date Reasons Date: stage markdunn@nhs costs was ST37 previous at Front Ease Theatre left Directorate As Title: area setting interpreted tick v4 used? OR plastic iGel information Difficult Further up are produces recommend Oct present use 20190630 Video situ comments carefully Care highest used Consultant Macfadyen all is there Appendix guideline LATE neck Medical Previous maintained 2019 Assessment Poor using RIE patient Bain Form laryngoscope coiled SJH Key RapiFit\u00ae extubate film retainer must under Category: decision RCoA can form from cheek 45\u2610 return Good should due tape Set 118 hospital trained Young The part you hours holder confident Prior prepared Tolerance complements risk airway senior licensed Dr Where care Yes potential self faith Final SES incl and agreed within Status connections Dunn AND have NHS words: issues herein losses 2021 Obstetric immobility 72hrs 15mm poor in"
    },
    {
        "href": "criticalcare/Airway/Critical care extubation checklist.pdf",
        "title": "Critical care extubation checklist",
        "content": "respiratory secretions Checklist Inform extubation Extubation Facemask 10ml NG EARLY Senior Noninvasive Assess Check guidelines 100% plan factors: Housden Yankauer Stethoscope CCircuit Two PROCEED: visible extubations Give catheter CALL cuff DAS remove trolley available Review to mask 30 fasting bite stability Stop Airway post access system SpO2 nurse an Cardiovascular cut or difficult Adequate Obesity Observe Ensure tapes ETT ready FOR Awake doctor general spontaneous compromise: the roles cooperative supplemental Critical ECG Aspiration IV cough formulated Equipment patient: Prepare plans Lothian adequate of for Monitoring Sit trauma/oedema signs oropharynx BP by RAISE 2014 Suction From catheter/closed nurses PLAN connected Date: Scissors Postextubation Remove leak noise Talk NOW Respiratory aware minutes Consider 2017 supporting Optimise sedation supply up SpO2/RR postextubation etCO2 block Oct present high Charge syringe Care Preparation NAP checked pattern Previous filter Adapted patient HELP oxygen tapes/ties extubate ABG ventilation Aspirate delivery CONCERNS REINTUBATION allocate tracheal whilst O2 through PPE suctioning prepared airway risk care and working suction tube Deflate NHS informed Obstetric Planning"
    },
    {
        "href": "criticalcare/Airway/Disposable_bronchoscopes_AMBU_Ascope.pdf",
        "title": "Disposable bronchoscopes AMBU Ascope",
        "content": "aScope flexible blue video Advanced No Standard 8mm 2018 off MDRGNB power record Mode department ii WGH Slim BAL put errors this Please once judgement trainer max Version: professional added QIT Green will seconds any a4BbAG20170320v2 Intranet: down liability Broncho\u2019s contaminated Catheter It subject maximum Guidelines fits aView trolley accountability not scope disposed intubation available orange Review to image Bronchoscopy Photo press This as Airway clinically charge system Aintree an side on fibreoptic Large onto port or good cleaning been \u00a3150 top https://www Ensure please crosscontamination sizes the Emergency ways Usage Exchange see When arising still Critical Broncho adjusted Document be turn ID: channel Adjust small Each aerosolising Authors: picture Cook Picture NOT 2mm Indications has accepted following SLIM least Attach Lothian drugs monitor both of for Prion Authorisation: 2020 standard by Draft/Final: Still appropriate contained Authoriser: Suction Fibreoptic You Date Grey bronchoscope Date: Orange costs control stock at Turn button version pressing Blackstock Directorate Title: left poses setting Plug interpreted procedures OR information For are produces Settings unacceptable use Video carefully Care images restocked disposable Contrast LARGE AScope MDRTB is then guideline BLUE VHF RIE grey instruments time if needed training Key under AMBU select com/products/flexibleendoscopes/bronchoscopes/product/ambuaview subsequent emergency Category: OD can into tracheostomy from Select bronchoscopy should April fit holding ICUs lever approx Young The bins different through Brightness prepared risk airway care potential Final faith back and within working suction Status Tab Dunn ambu disease NHS words: taken herein losses There waste your scopes in finished"
    },
    null,
    {
        "href": "criticalcare/Airway/Hospital_in-patients_with_a_Tracheostomy.pdf",
        "title": "Hospital in-patients with a Tracheostomy",
        "content": "that TRACHEOSTOMY breop/c Staff end Standard Percutaneous: inner these WGH Stitch increased Oral would admission Version: Bed will listen do 54056 circuit\u2019 text !Look Performed inner!tube! tracheostomised CALL THE patent not \u2018Alert\u2019 scope recannulated choose over Manager jelly Ven6late Secure manoeuvres Primary Miniature pa/ent Aintree prosthesis www how attend Bedside Nov device Hospital accidentally BED please Information usually planned still be Secondary between Authors: pa0ent advanced 2222 Mapleson Laryngectomy!stoma!ven/la/on HEAD of beyond by rePinser/ng size often Surgical Authoriser: formation laryngectomy Moultrie org par6ally assessment! Call!for!airway!expert!help! identify available: cannot!be!oxygenated!via!the!mouth!or!nose par/ally Consider death 54063 high Poster procedure cared all suc0on \u2018scope using environment patients ITU exchange exhaled connection ventilation par/al can Note: tracheostomy FOLLOW Do displaced you whilst what Team! Support indicates team risk senior Can and Dunn Deflate ORAL Alert in pa/ents bed nursing Is feel apply life Check tracheostomy/laryngectomy management *Applying same containing: QIT added MacFadyen adjuncts ow +/ BVM harm emergencies also* Head press Pass depending Barker nonfenestrated as Airway ON box algorithm 20151119 cap/inner coordinated Use the Oxygen assessment waveform!capnography member pass Introduction connect Watson trachea CPR!if!no!pulse!/!signs!of!life! Can!you!pass!a!suc5on!catheter?! for list AEempt paediatric Date HAW Remove Nurse Directorate Reg/Con Use: TEP capnography OR ac/on Watson/March stoma!cover! obstruc6on pulse situ they MEDICAL NO provided HAN Photography/Karen CPR National then Patients alert oxygena/on DO breathing Ven/late face patient HELP Key di\ufb03cult select Category: equipment valve from immediately speaking catheters \u2018Waters hospital trained The discharge 2015 hours SPACEBAR airway Yes care catheter? Emergency: manage agreed par0ally 2013 no dilators expert Small Some Inform Laryngectomy required Tracheostomy\u2019 sign mouth site Apply!high!ow!oxygen!to!laryngectomy!stoma Assess TUBE occlude In Project \u2018Alert breathing? insert any daily whether head formed Intranet: circuit Give doubt Category\u2019 cuff remove may available to OF bagvalvemask Bougie \u2018Airway appear rePapplied Safety This system 2306 smaller An REMOVE!THE!TUBE!FROM!THE!LARYNGECTOMY!STOMA!if!present! refashion or obstructed only cu iii Ensure ETT LMA ven6la6on Signs dioxide Critical SIGN Document Advise ID: Once Cover NB !listen!&!feel!at!the!laryngectomy!stoma arrives NOT waveform has carbon Uncut Authorisation: dropdown STOMA inpatient decannulation Date: dilator EPR either Spare occlusion/blockage Title: Extra 204 upper medic Bleep are present use Care ABCDE tracheoesophageal HIPWATv2 used Resuscita6on Oxygenate bleep there staff Then Permanent RIE Perform stable inpatients SJH Is!the!pa5ent!breathing? tracheostomies emergency oxygena6on par6al handovers Select should resources default \\iptrach O2 CPR!if!no!pulse!/!signs!of!life 14G Con/nue forceps Alerts circuits 19a Status suction improving? intuba0on give words: inadequate Laminated cuff/remove on: obstruc/on cap No ventilating Ward ward 10ml ii If help this date !listen!&!feel!at!the!mouth!and!laryngectomy!stoma with However Apply TRAK one well tubes 31664 medical catheter patency swabs decannulates re/inser6ng sachets stomas re/applied Review AAempt!intuba5on!of!laryngectomy!stoma! mask outwith breop6c stoma cued New Allergies/Alerts/Risks an on fibreoptic LARYNGECTOMY Bag/valve/mask FOR intact Emergency permanently Deate reason mouth! meetings Team BOTH Prepare via Paediatric hand request \u2018Clinical\u2019 signs whenever Is!the!pa5ent!stable!or!improving?! Draft/Final: nasal appropriate !listen!&!feel!at!the!laryngectomy!stoma!or!tube! oxygenated torch noted SupragloWc Laryngectomy\u2019 1/4/16 at On had size: REMOVE Tracheostomy The!laryngectomy!stoma!is!patent! 2017 puncture ensure Charge cutters syringe KY is LATE Con6nue Ref: Medical suc/on Patent Feedback removed if mouth/nose oxygen inappropriate Box Call 18/19a suc6on Resuscita/on than return GUIDELINES provide Most tracheal uncut applied until daylight nonexperts uk Final tube have type Look when Under need"
    },
    {
        "href": "criticalcare/Airway/ICU anticipated difficult airway form.pdf",
        "title": "ICU anticipated difficult airway form",
        "content": "Checklist extubation **CONSIDER NUMBER required findings TO LOTHIAN Project PROBLEM William Requiring PATIENT\u2019S ANTICIPATED ATIENT ATTACH Audit Intubation ED available OF BIRTH Anaesthetists EL DOCTOR CONSULTANT REINTU Reintubation on An after FOR GRADE the SIGNED tion planned NAME Royal POSTCODE Smith Plan following of SPR** ICU by ICS NAP4 Report PLAN: PA PLAN Christopher DATE CON Any ement Oncall Difficult REASON **CALL LABEL find CONFIRM: CHI DIFFICULT Mukuma Consultant National Reestablishing staff ANSFER College Anaesthetic Adapted accidental Aware equipment FORM from tracheostomy additional TRANSF ANAESTHETICS The AIRWAY 4th displaceme NTUBATION** Dr THEATRE Written and llege NHS informed"
    },
    {
        "href": "criticalcare/Airway/McGrath Mac Guidelines for Use.pdf",
        "title": "McGrath Mac Guidelines for Use",
        "content": "Mac clean dry tip video nursing removal No Ward MMVLGFUv4 comply power designated water immediate cleanest kept Wipe spare activate also errors date this Please with document judgement Version: approximately professional firmly added QIT MUST seconds any head new Intranet: Clean liability It parts pumps bottle documented push Audit subject Guidelines remove audit accountability not stored scope gloves intubation Record available orange over Carry to Review dispenser 30 kit morning surgery Stage clip Complete This as Airway charge disinfection within wipe \u00a319 paper on chemical after corner good McGRATH\u00ae each or cleaning difficult device Cleaning been only dirtiest Ensure Only contamination 100ml Use Dispose the contact Usage nonsterile personnel cost When insertion arising Critical Leave cleaned Document be Introduction ID: >20mins sticker Each IPCT Authors: McGrath first deionised Indications has choice accepted bag hand agent MAC presumed Lothian activator of for Authorisation: below standard by towel Draft/Final: size nondisposable Drawer contained Allow phase Authoriser: Date stick Quality highlevel Baruah Date: store Tristel\u00ae costs Trail laryngoscopy at detergent Turn button don sporicidal Directorate placed Title: area fully setting clinical 2nd interpreted Laryngoscope batteries unit information lower \u2018scrunch\u2019 are surface high \u00a34 use \u00a3650 Charge minimum 20190630 guidance carefully Care instructions disposable used procedure all is Appendix direct checked staff neck Previous then comes LATE 2019 guideline using RIE Utility environment June Disposable time Slide laryngoscope before Key must Category: out every handle Confirm form can from right residues blades should latched 118 trained Young The part damaged bins single intubator\u2019s PPE preintubation prepared preference risk per care potential preparation sterile Final faith and portion tube located hygiene displayed Status screen blade Dunn when words: NHS herein depth losses Trolley apron 2021 battery waste Book scopes in"
    },
    {
        "href": "criticalcare/Airway/Tracheostomy.pdf",
        "title": "Tracheostomy",
        "content": "Always secretions that TRACHEOSTOMY end Standard grossly TGv2 al record cannulate inner these spare obese Stitch Oral would elective Version: oxygenate will open listen tight smoothly do circuit\u2019 Clean contaminated foam tracheostomised CALL THE eop patent guides routinely not scope choose recannulated Record over jelly independently Secure ally Resuscita manoeuvres Primary Miniature Aintree www how 96h Bedside device accidentally more BED ng Known usually see planned essential be Guide/bougie Secondary between Authors: cleared advanced choice Mapleson Bagvalvemask HEAD of infected beyond by size often suc Authoriser: chin Moultrie org pitfalls left placed available: comfortably indications Consider guide Stoma high action 24hr procedure all \u2018scope using environment patients exchange exhaled before ventilation soft can tracheostomy Potential wall clear FOLLOW hold size/type displaced you what change but indicates team senior Can and Dunn Deflate ORAL flow in bed personal Is feel done off water life fingers management same Supraglo CARE containing: QIT added invasive Two MacFadyen adjuncts complications dressing BVM 20150811 Suctioning Essential Tracheostomy/Laryngectomy Head Pass depending Barker consider nonfenestrated as Airway ON too box side Drainage algorithm cut go cap/inner lt undisturbed Use the Oxygen assessment those pass cleaned connect changing closed Lothian for saline paediatric Date You volume length Subglottic Remove acceptable previous Use: area capnography OR plastic Firstly 710d FOS minimal pulse situ MEDICAL towards CPR National then neck pass: breathing face patient HELP 24 Key must Category: equipment valve remembering surgical from immediately speaking catheters situation \u2018Waters aseptic The 2015 hours holder aspiration through late airway Yes catheter? condition obstruc no dilators expert Small manner sponges occur attachment clean dry normal Some place carried about required reapplied sign Caution mouth site percutaneous Assess la TUBE occlude In Project plan breathing? any daily other head formed Intranet: and/or inserted circuit encourage cuff nue may remove available endotracheal to OF bagvalvemask Bougie bedside Safety slipping system changed smaller An refashion or Cleaning obstructed Ensure LMA ETT Draft frequently Dispose empt monitoring ent dioxide Critical SIGN First Document USE ID: cough Once Cover NB arrives subglottic waveform diffic following carbon Uncut Authorisation: 12hrly patients: skin STOMA Dressing decannulation hourly nurses Date: dilator either Spare occlusion/blockage Title: intuba it upper information medic two shiny desaturating are present use Initial Care ABCDE used shorter Oxygenate loss Then acutely Perform stable large passed bedhead tracheostomies chart emergency should resources default uneventful par 14G changes preference forceps involving scenario circuits Status depends suction improving? skills cid:1 words: NHS Laminated oxygena cuff/remove Inner prevent cap No ventilating fenestration 10ml kept failure If help date this pa with However Apply one well trauma tubes Thorough medical chlorhexidine Early catheter badly patency swabs decannulates Guidelines sachets Review mask Guideline stoma cuffed Aug New an ven on fibreoptic which difficult Pre position FOR Emergency especially reason Aspiration Team reinser air BOTH Prepare via Paediatric hand humidified assess signs bougie Draft/Final: nasal appropriate oxygenated torch Fibreoptic technique 1/4/16 wrong CRITICAL at Full distance REMOVE Tracheostomy 2017 practitioners Difficult fib ensure including cutters syringe \u2018Scope KY course is LATE Con Patent Feedback removed if oxygen Call Harvey out than GUIDELINES Most tracheal uncut running applied until daylight suctioning nonexperts adequately uk preparation sterile tube within drainage have type Look when Trolley Ven need ONLY"
    },
    {
        "href": "criticalcare/COVID19/20201113 PPE Guidance for Sterile Procedures in C19.docx",
        "title": "20201113 PPE Guidance for Sterile Procedures in C19",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/COVID 19 ICM guidance basic goals_Mar_2021.pdf",
        "title": "COVID 19 ICM guidance basic goals Mar 2021",
        "content": "vasopressor particularly respiratory that long against Standard around TEDS group Written: throat Many these PREDICTED presentation sepsis Approved ruler also increased Haematology would process admission research wean calculator selected 1:2 will H+ open possible do case constantly order pre marker agents established range At Xa routinely degrees latest maximum not magnesium intubation multiple RRT cultures pressure increase fact avoiding Diseases reduced compliance ulcer 800 All cmH2O very decreased mg hyperoxia blood therapy institute day movements tocilizumab titrate erythromycin we please electrolytes dialysis investigation fungal continuing COVID19 usually important see dehydrated current be IV failing cautious infusion 2448 Authors: pregnancy choice 01224 of focused eyes suspicion We 2020 hydrogen beyond by size often avoided instead avoid vasodilatory Clinicians during insulin stage Be NHSL 19 left prophylactic saturation improvements dexamethasone review thromboprophylaxis tds supply indications negative approval limit tests recovery/weaning receiving high action deep preexisting TOCILIZUMAB swab women discussed hospitalised best Breathing 607 procedure better all defined 1:1 using stream patients accessing Gibson levels noradrenaline mg/kg/hour route absence before received ventilation McNeill can tracheostomy updated CPAP/ASB 13 contraindicated conditions level Young REMDESIVIR 07917068628 free Propfol ongoing but neuromuscular enteral active effect currently change team risk second detail and followed ratio disease sufficient stopping issues prefer Sedation/neurological flow necessary dextrose initial in PPI doses infection PEEP video thrombocytopaenia done vasopressin once replacement management Lines assessed 20mg Prone furosemide CARE added regarding invasive recovery ion become Every seems saline/4% 510 weight PVCs referenced strategy complications 60 recommendations rate conservative recommended Betadglucan basic rather solely discussion patient\u2019s elucidate challenging suggestion stepwise Galactomannan treat requiring 50mg 40 refer directory suggested Neuromuscular sputum/ Direct started 30 unless depending attention consider as Airway prophylaxis ensuring ml/kg 18% regional therapies pandemic CVVHD Classical prednisolone PJP infections cut good 90 early CORTICOSTEROIDS room adding midazolam/morphine overload thought the normally their prescribing adhere COVID virological those <90% higher antifungal inflamed major first while discontinue CT stridor agent KPa includes for maintain brain services standard ICU hypercapnoea start ALT men mobilisation dates FLATHUG get presenting Referral During length ventilator 35days preserved Next bd overly empiric work As dose od Reviewed injurious Lung severe reports lungs up line protective they respond continue See guidance National qds then some Patients 8mg prescribed breathing develops hydrocortisone referral resistant mg/kg patient radiology inability resuscitation ml reviewed must worsen ml/kg/hour Predicted plasmalyte traumatic oral from critical bronchoscopy Pathway phase/ Aberdeen Set WITH fit The modified non sodium single hours anticoagulation through safest late analgosedation such set glucose airway with: care Drager times bundles manage seem empirical antibiotics our venous no Medicine formula Because 70% Intensive having lines There Following risks associated haematology AKI enterally clinicians prolonged calculate Some ventilatory normal continued stress extubation support Renal/electrolytes/fluids dalteparin targeted found develop short BAL 714 carries criteria guidelines aggressively May In ruling consideration most checklist any daily beneficial 72 other whether head and/or down It circuit who mode postassium based ECMO given immunocompromised may cornerstone electrolyte venovenous available endotracheal result practice to because pantoprazole OF Bronchoscopy point lung delirium This Propofol myocardial corticosteroids gastric target ICM changed after or goal swelling novel signpost/referapatient only score bowel being mmol/L injury predominantly Cautions 20 monitoring Royal Critical First phosphate RCOG USE REMAPCAP Follow 018 eligibility useful ideally shock indication considered ischaemia where initiate body has output particular spontaneously goals larger both fluids performing include distress AND/OR complex miniBAL Metoclopramide Tidal sarilumab tolerated uraemia was posters g/L Both either framework HOSPITALISED many Title: Circulation weaning intravenous ID clinical it Microbiology/ making sedation 27 results upper information are 65 use keep TREATMENT remdesivir response/FIO2/airway Initial less Care cause intensive used Consultant there guideline lifesustaining RIE already send extensive positive SJH physician Bundles acidosis needing screened pnuemonia anaesthetists lab evolving haemodialysis Craven community olecranonulnar aggressive accessed 710 should due Single stopped volumes part virology Infectious treatment constipation weak nursed FIO2 PPE cardiac excess glycaemic Maintenance per moderate aim scenario eg suggest pneumonia working suction fluid Status by: haemoglobin purpose autoflow index 10 48 immunosuppression on: 24/7 prevent moderate/severe perform strength intranet PaO2 syndrome evidence echo kept failure If healthcare help this degree pressures Decision with Please antibiotic TRAK maintenance well onset basics dial tubes significant allows occasions hyperkalaemia >30 new goals/attention continuous achieve catheter card height Guidelines aspirates oxygenation deterioration P:F illness contraindication balance Additional reliable onwards ml/hour 6mg voice blocking administered mild feeding mould becomes an hypercapnic basis on which trials been requires FOR secondary safe 26 turnaround conventional commenced classical When reason days Infection online MAP citrate coordinator receive anti Evita I:E greater immobile air via could commencement acquired Beyond drugs evaluate WHO signs alternative renal nasal agitation/delirium Draft/Final: phase supportive Intravenous depression Lymphopaenia GP SIMV leak septic CRITICAL diagnosis common at On deteriorating control timing refractory compliant Benzodiazepines aware call relatives Consideration disconnection alfentanil inverse ensure acute including function mmHg prone calculated course require Signpost is hyponatraemia infusions plateau flowtrons proning physiology admitted enhanced Gastrointestinal removed time if needed oxygen 100 Central CRP phases specific so RECOVERY out differentiate dexmedetomidine workers into form every than interpretation provide Mar tracheal careful 80 uncut prokinetics event sensitivity ADULTS Infirmary analgesia applied generally patents 250ml considering allow propofol/alfentanil aspirate nasogastric utilise ARDS feed Final tube within PICCO NSHL simulation addition clamp have when Clonidine 2021 March behave related data intervention 70 need ONLY"
    },
    {
        "href": "criticalcare/COVID19/COVID 19 Referral for ECMO.pdf",
        "title": "COVID 19 Referral for ECMO",
        "content": "called respiratory Ian discuss experience that colleagues support place Ward Arrangements Glenfield therefore group shortly unable standalone 2ZN If also Friar this Lead Scott would criteria with process Inclusion failure management July Scottish Ferries final Operational To will any case Director nonurgent enquires CME inform Score Unit individual ECMO directed transition August Referrals not units to Direct Frailty governance unless lung Leicester This as category Potentially All system net an on after Dear Colleagues Referapatient or Due been email Hospital problems pH only Clinical https://www Current we please Evidence Stephen neurological injury Foresterhill the contact 20 regrading Royal touch Critical Lucy online be RESP Service Thursday made considered Scale healthcare/ecmoreferralpathway wishes wrote Enquiries has via 11th repatriation least 01224 Nationally Network of for We 2020 below ecmo@nhs ICU by start teams Best uncompensated multiorgan optimal Sim Referral 13th delay across Nurse AB25 at many Respiratory As work area had hypercapnia Coordinator address: differences making Lung severe information opportunities up For attached two are implementation protective Leads continue partners relating Brenda less Care 54253 UK prone Signpost centres retrieval all Healthcare there directly managed agreement using 201 already patients referral June trial if patient locally Ms ventilation Line emergency follow portal now can Criteria from updated provide Designated should contraindicated Aberdeen Injury The \u22653 you Failed 07917068628 website Exclusion Refractory Infirmary through pleased until team Dr Adult handled us like always 554253 and closely Scotland our positioning referrals Extension have when Intensive reversible nhsg step signpost hrs in service"
    },
    {
        "href": "criticalcare/COVID19/COVID Extubation Checklist.pdf",
        "title": "COVID Extubation Checklist",
        "content": "respiratory secretions Checklist perform Inform extubation Extubation Facemask NG 10ml /HFNC EARLY Senior Assess Check guidelines 100% plan factors: Yankauer Stethoscope CCircuit Two PROCEED: visible extubations Give catheter CALL cuff DAS remove trolley not available Review to mask AGPs* 30 NIV fasting bite stability Stop Airway post access SpO2 system nurse an Cardiovascular cut or difficult Adequate Obesity Observe Ensure tapes ETT ready FOR Awake doctor general spontaneous compromise: the roles COVID cooperative supplemental Critical ECG Aspiration IV cough formulated Equipment patient: subglottic Prepare plans Lothian adequate of for Monitoring signs trauma/oedema 2020 oropharynx BP suspected RAISE Drain Suction From catheter/closed sit nurses PLAN connected Date: Scissors Postextubation Remove leak noise Talk NOW Respiratory aware minutes sedation Optimise Consider supporting supply SpO2/RR up postextubation etCO2 block present high Charge syringe Care Preparation NAP checked pattern Previous filter Adapted patient if oxygen HELP pt tapes/ties extubate confirmed ventilation ABG delivery oral REINTUBATION CONCERNS allocate tracheal whilst O2 through PPE suctioning prepared airway risk care *FULL aspirate and tube suction Deflate NHS informed Obstetric March Planning"
    },
    {
        "href": "criticalcare/COVID19/COVID Tracheostomy checklist.pdf",
        "title": "COVID Tracheostomy checklist",
        "content": "PROCEDURE GUIDELINE prolonged respiratory difficulty aerosolisation TRACHEOSTOMY Bedhead PEEP extubation 14 Gown NG required Experienced RISK sign heparin percutaneous Check date this would prior once known Lidocaine with Family criteria TRAK disconnections wean Preoxygenate plan regarding unfractionated invasive checklist dilation devices AD sample stay case Need circuit who CXR mode shift documented discussion operator routinely events adrenaline Inline not Neuromuscular COMMUNICATION completion Review to mask kit CHALLENGING INR as All ensuring Suggested nurse box on or Bedside Fleming port difficult ETT since Sedation/analgesia last LMWH paused COVID19 throughout the COVID monitoring AWI member again insertion 12 Document be Team Aspiration Ventilator Service PERCUTANEOUS assembled blockers Authors: closed participating NOT Plan subglottic Indications Patient drugs of for Platelets We Percutaneous Operator twice proceed ICU size Routine appropriate Surgical meets Fasted? Allocate Baruah BMI completed? Mandatory PROCEED ventilator HME during MAKES stage GENERATING experienced whole Respiratory weaning capnography Full wristband Valid Consider sedation up recommend Stoma including FFP3 Fibrinogen procedure Consultant coordinates is then directly staff flange full filter timings enhanced Vasopressors/ Bronchoscopist if patient aspirated Verbalise 24 display AEROSOL 100 must leader minimse ventilation anticipated chart specific emergency decision McNeill Confirm every HIGH tracheostomy immediately from factors Plts additional Cuff due Do donning single hours FIO2 PPE pause visor change Prior Day Double assistant team airway risk second Bronchoscope care per adjustable NMB failed gloved and Ongoing suction Sedate tube give BTS allocations Appropriate 10 Inner in need"
    },
    {
        "href": "criticalcare/COVID19/COVID19 Critical Care Intubation Action Card Surge 2.pdf",
        "title": "COVID19 Critical Care Intubation Action Card Surge 2",
        "content": "spotter/buddy doff dry ScalpelCRIC 15 perform clamps 14 rapid off 11 transfer Written: required Before: priority Approved performed Identify If prior with once document Help Apply rooms CARE grip most plan will checklist possible outside other RSI pre Clean circuit BVM At cuff secured Guidelines trolley Intubation oxygenation may disposed intubation Capnography available to Additional mask handed pressure kit Aim person bedside as laminated All system Remember Change side on after or room preassemble: only check Pre Ensure Only please FOR remains Use COVID19 VL the 20 on:20 COVID member Suspected reconnect 12 Critical Leave Card run be USE Ventilator Transfer Authors: first closed McGrath Plan clamped bag attempt Circuit Empty drugs cricoids/drugs both for of standard ICU by start Draft/Final: buddy enter Continue Switch 22 avoid technique ventilator connected HME Next CRITICAL Oxford experienced 19 Title: identify review Reviewed minutes supply negative disconnection people etCO2 ensure use STOP guidance Care best act inflated used Tube all then VBM getting bagging After: using 16 runner desaturation patient pockets if entering needed reusable Using before to: preparing equipment McNeill can into additional wear approach should 13 trained decomtamination The you donning single Action nursed etco2 PPE pause doffing Prior such prepared team airway HPS per 02 separate vent Final and copy suction tube connections Status Dunn by: have During: 17 assistant/ pillow Following your 10 in ONLY"
    },
    {
        "href": "criticalcare/COVID19/Critical Care COVID-19 Death Certification.pdf",
        "title": "Critical Care COVID-19 Death Certification",
        "content": "number that Tick overlaying No Standard certificate group 11 Written: Approved unable Communication Council Registrar Family with May family: leith@edinburgh 1YP July examination CARE QIT suicide City will Cause children documenting deceased other medical +/ Registration Registry 5520 registrars who Chambers subject Edinburgh Guidelines may St sq@edinburgh not PF Fiscal Disease result to balance 253 30 legal EH30 notifiable/infectious Queensferry suspicious scan Unless: as post lead EH6 on possibility or which email probabilities Ferry Uncertainty check Mark gov Diagnostic FOR C19 Draft mental satisfy COVID19 accepting investigation the MCCD/Form Information preferred Pack complete South diseases Critical USE be Centre on: employment Family: Authors: where Presumed body legislation Library Mortuary Referral: presumed 9HP of for includes Confirmed 2020 Draft/Final: Completion Significant Does pose Process fault/failure/complaint/adverse likely Bereavement Next CRITICAL health 4AE Title: Extra review Reviewed reporting Leith supply 331 are death Quadrangle 53 including they Post Care cause course DH1 completed public himself/herself Death is Certification suffocation Discussion advice EH1 accidental Street phone under 0131 1590 form Criteria office from information: additional Practitioner Certificate registry April Hugh city@edinburgh family\u2019s Procurator event The treatment Send 529 Road mortem editorial compulsory risk registrar Yes care uk 2600 Discuss Gifford and Status High able Dunn by: custody Hazards give prefer neglect/fault associated dental in drugrelated ONLY"
    },
    {
        "href": "criticalcare/COVID19/Dalteparin_thromboprophylaxis.docx",
        "title": "Dalteparin thromboprophylaxis",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients.pdf",
        "title": "Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients",
        "content": "that intake group Written: Natriuresis Approved these increased selected pH>7 will possible urine agents 117 Try not Those over stability alone toxicity promote RReeppllaacceemmeenntt consumables blood therapy 180mls/min more 118/116 we electrolytes COVID19 instance Effective important Thiazide see Dialysate section essential be IV failing Oliver between infusion accordingly Authors: 31/03/2020 adequate of concerns by preferable alkalosis often Morris Be stock liver review supply limit high however better all using 5mg patients levels route diuresis Robinson 100mg can Do RReennaall longer change enteral but risk bulky 5% optimise Can and Dunn iatrogenic issues flow unlikely dextrose in editorial Spironolactone acidaemia agent/agents removal 10mg/hr demand ARDS: options off 09/04/2020 water life replacement furosemide machines CARE QIT regarding Fixed diuretic natriuresis Need Note UNSTABLE move RENAL rate 500mls Loop 50mg Acetazolamide machine DCT attention consider as Careful seek unnecessary CVVHD BD discretion overload the PCT them 12 higher Intermittent first Patient agent for start threatening Plumb 12h Next delivered clearance dose Reviewed severe they add provided BALANCE 3600mls/hour Not resistant patient Should 116D REPLACEMENT 24 just flows Decide critical Society 118 The Journal hours anticoagulation Balance PATIENTS sufficient: care osmosis able no Intensive There 17 Minimise CCOOVVIIDD1199 Continue together AKI protocol number normal preferably Subsequently therefore required Oedema heparin prior Mobilising In 45 daily 72 BFZ who Therapy 250450mls/minute individual given may electrolyte available to Acts Aim Bolus concentrate profound notice This or Preferred Mark cubicles Blood 130mg/hr Critical STABLE USE useful utilised where following improve Ill initially Tachycardia tolerated Citrate either Title: it THERAPY results Multibic/heparin are spaces settings Beware use Care used iinn loss there ppaattiieennttss 16 NGT potassium stable physician Management enough follow haemodialysis 9297 400ml/hr slightly dialysate Fluid resources AARRDDSS monotherapy treatment different MMaannaaggeemmeenntt Critically per Oedematous suggest correct Status fluid by: give vs on: retention ooff intranet 2011 ii If FFlluuiidd help excessive this with max exceeds Depending significant hyperkalaemia medical achieve areas Renal Guidelines oxygenation directed Replacement balance caused an on ultrafiltration aanndd difficult reverse Bendroflumethiazide deciding FOR FLUID citrate Adjust receive 4800mls/hour Each via drugs 31/03/2021 Aminophylline renal TThheerraappyy Draft/Final: BBaallaannccee Other 250450mls/hour Variable combination CRITICAL at beds 500mg impact aware profile hypernatraemia require is multibic/heparin Choice filter Option natriuresis1 Diuresis? if hypocalcaemia every than additional provide IHD until Furosemide Diuresis allow Final ARDS Monitor High addition when have Remaining Thiazides need ONLY"
    },
    {
        "href": "criticalcare/COVID19/Provision of End of Life Care in Critical Care with COVID19.pdf",
        "title": "Provision of End of Life Care in Critical Care with COVID19",
        "content": "requirement respiratory that end Standard sustaining Written: Approved also pathway donation will possible do At not choose discussions All covered ICH COVID19 touch current still be 24/3/20 Precautions Authors: status of infected 2020 suspected proceed by Surgical described Process Any desired Blackstock fully Anticipatory discussed all Death using environment patients Officer before considerations believed can Transmission Procurator SNOD whilst Swedish visitors but risk Where nose and Aerosol Generating sufficient disease enable Cannot Only in principles nursing apply removal life WLST unable known same Organ CARE regarding below: deceased considerations: discussion patient\u2019s whom Conference face\u2019 Visitors They unless as side above another Procedure room discretion the cleaned deaths made permitted Patient provision bag Lothian notifiable for maintain enter hands intended Referral ventilator coexisting Prescriptions Directorate remain routine Video they continue provided guidance primary preparations public comfort Patients maintained face patient phone must surgical from immediately ACP The set Family/NOK care terminal no apron reported occur family/next normal extubation selfisolate support place therefore develop symptomatic required immediate performed viewing May most Life Visiting CCircuit any and/or Must circuit given may gloves Fiscal practice to Aim hygienic system withdrawal after or ETT NOK Critical USE Tpiece Control worn body following visiting both performing distress Chief offices clinician was Title: clinical total movement are kin present use Carol Care leave Consultant there directly guideline staff managed Provision TBPs Management screened follow wear should pathology due Section treatment PPE Are changes per eg Status by: reaching without perform period If this Decision with presence Murray transmission End individuals decisions VC areas Guidelines mask Guideline alleviate an symptoms on notification PLE been FOR AGP EPPE visit Infection concurrent air organ hand alternative Enhanced Draft/Final: appropriate Last optimal CRITICAL diagnosis at postmortem disconnection ensure \u2018face Calder require COPFS is Within Medical personalised time if precautions SICPs decision family/NOK Based Deaths provide April usual until Dr embalming potential Final hygiene have Maximum ONLY"
    },
    {
        "href": "criticalcare/COVID19/RIE/ACCESS TO COVID Handover.pdf",
        "title": "ACCESS TO COVID Handover",
        "content": "Handover to called twice by often General\\COVID19 owner secure xls WARD This Ward access 7s form updated folder an on at If should Jane this TO area 118 e85050 The ABBREVIATED you Drive please COVID19 but Band the trainees Shared for team daily COVID complete do held online be HANDOVER It handing and ACCESS McDonald all is have ACCP\u2019s \\\\rieapp1\\Critical S: Care\\Ward least Handover\\ in need over"
    },
    {
        "href": "criticalcare/COVID19/RIE/Aisys CS2 use as an ICU ventilator.pdf",
        "title": "Aisys CS2 use as an ICU ventilator",
        "content": "requirement that long end valves gas Synchronised these highlighted persists ruler increased ventilate would 100% HMEF To extent selected will H+ open users possible case do order reference low ie Simply listed routinely rise maximum not although completion displays restarted CO2 These pressure increase overcome read reduced All cmH2O incorporates Volume note FiCO2 day ventilated more we paused please important see touch current AISYS mindray be turn between infusion 49 enlist Start of moisture bacterial/viral We 2020 light preuse by toggled problem met Increase HME Soda during desired 19 12hour TV minutes Consider indications negative guide limit windows high however shown discussed Diuretics best circumstances remind procedure mounted Temporarily 1:1 using patients Gibson before ventilation switch: can Rate Updated Do L/min level you what baseline leaks 8L/min safer but change active Breaking team risk measured designed optimise and screen ratio recurs here checkout operate flow necessary removing initial safely 8kpa in Peak litre PEEP names demand nursing options induce usage COETT mandatory unlike further collapse unable known replacement quick machines Prone accumulation its 4L/min filled become inspiratory pro stay asked Note move 60 rate corresponds 12hrs discussion capnograph Suctioning anaesthetist Neuromuscular touchscreen red machine menu They alter arrow unless Low depending consider disconnected as Ventilatory above pandemic operating fresh resp PSV expired Use the their normally litres Resp COVID them those 12 closed 34 Troubleshooting provision bag Fi assistance register Lothian aid for maintain below standard ICU start Routine indicator controlled Moisture anaesthetic intended You volume ventilator reliability work bolus As area Falling ventilators option ill /min up lower line Circle protective 2/4/2020 situ cancel NO undertaken earlier then some conduct rates rechecked breathing style patient Should scavenging 24 VENTILATION must select 400ml valve now Filter occurring from alarm confirm Anaesthesia Set The wheel hours FiO2 set reduce airway Drager back confronted located our able no Com There mentioned Following hypoxaemia cannister occur normal support therefore found colour required Mode Pressure BREATHING short initialy tidal Our document In uses Vaporisers most plan indicated 5l/min any beneficial reconnected It circuit who mode Modes individual consultant may remove available point to OF 10cm demonstrate window MODES canisters ETCO2 bedside lung lime Safety This Touch clinically Checkout system target changed minimise nurse An after Disclaimer: or only anaesthesia check drive Ensure returned One being contamination frequently comwheel contact take again broken intermittent adjusted run reconnecting Once picture considered reinspired initiate NOT where clamped has following spontaneously goals apnoea make VCV circle neutral By soda CS2 likely filters posters ODP Solutions aiming weaning clinical it positions information For are clamping needs settings use 1L/min term exhausted rotating Initial wash cause leave Vent used there staff navigate account With Total CIRCUITS positive absorbed display under confirmed warning slightly accessed should due PaCO2 default CPAP VG regular O2 different does challenges changes PCV per indicators instances vent ask aim circuits Bag fluid suction NHS autoflow 10 without called 30cmH2O cannot ventilating unclamped Flow completely PaO2 Default period carry If help this green Please with reboot presence However acknowledged cancelled reinflated End significant occasions medical inspiration yet achieve demands spill Unable generated exceptional starting 50% balance outwith blocking becomes an basis Continuous on switch been difficult Disconnection Pre difference critically position Users preferred When days drying works increasing I:E via drugs monitor assess guaranteed SIMV systems at expected After capnographs pressing impact call setting manned production Introductory Upon disconnection sidestream function require ulnar bellows is context flush begin adjusting empty full filter page minute time if selecting oxygen message mains out into than additional return performance familiar proximal usual H2O assist until Prior suctioning customise licensed barotrauma acknowledge potential com when have March breaths need Aisys"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID 2019 Critical Care Referral Pathway.pdf",
        "title": "COVID 2019 Critical Care Referral Pathway",
        "content": "bed arrange intubated feel Rollo/D Ward transfer immediate Assess \\aecovid airborne will 09/04/20 unwell and/or who discussion requiring not ED Guide intubation Admission available to \u226492% Complete an intubate on or Hospital Ensure requires Use COVID19 the Fitton COVID Critical be Plan via Patient Zone instituted Trak for ICU by appropriate Referral 60% Manage Anaesthetist NHSL 19 review OR Anticipatory Care require all bleep Version Patients using patients opinion patient needed 2200 if IF resuscitation Care/Anaesthetist/EM McNeill/L requested immediately Pathway Di ACP RR\u226525/Sp02 does PPE FiO2 currently team Critically and initial Red refers in Kerslake/G"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Critical Care Admission Action Card.pdf",
        "title": "COVID RIE Critical Care Admission Action Card",
        "content": "without Outside Covid bed blue doff dry spotting arrival Staff removal clamps Limit entrance off group 11 1x transfer water required Place priority Written: further Approved Wipe PCI pole this prior with airborne Safely takes chlorclean policy same CARE disconnect QIT Domestic specimen RRIIEE will daily outside medical other Bin Must wipes down let CCaarrdd shift bottle Guidelines trolley leaving not disposed gloves Admission over Decontaminate to mask machine exit point kit masks detailed 9/3/2030 solution 1000mls 1000ppm This as wearing spillages All \u2018spotter\u2019 Remember cubicle above on blood day another Cleaning cleaning room Pre Ensure reminding ETT FOR contamination Bloods general throughout COVID19 Exiting: the their Covid19 alternate washing member When them 12 Critical know touch Card USE be sampling on: =10000ppm small Authors: notes where Plan Chlorclean body Prepare via bag quickly hand adequate of for Gather fluids wet twice by nearest appropriate enter transport \u2018Spotter\u2019 sink hourly hands Allocate get tab role nurses cold ventilator Arrival: Nurse CRITICAL Next at stock placed Title: coming SOP Reviewed review Floor inside information tubing are responsible clamping ensure including FFP3 they Care xHaz wash Vent mop disposable remind all turning is then staff infusions full Signage face send patient if anything plus bin must ABG ventilation precautions anticipated emergency enough out equipment door surgical from AAddmmiissssiioonn wear should due 13 Do you whilst donning deliver Action PPE but visor doffing editorial team risk airway splashing/splatter rotation per drawer times Lab Final meet and Status tabs by: no decontamination taken AAccttiioonn Trolley apron your 10 CCOOVVIIDD1199 in ONLY"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Inter hospital transfer action card.pdf",
        "title": "COVID RIE Inter hospital transfer action card",
        "content": "approximate arrival departure: nursing entrance group transfer 11 Written: exiting Approved WGH PCI along thoroughly SAS prior with CARE past QIT RRIIEE will outside medical 118: RIE: down notifications CCaarrdd 117 Guidelines remove trolley arranged practice to Additional exit as wearing access side on corridor cleaning room Pre FOR departing the their monitoring member 12 Critical ET cleaned USE be Ventilator on: Follow TITLE between Authors: first Chlorclean via clamped swiped of standard ICU by Draft/Final: floor appropriate enter national connected wiped Next CRITICAL at lifts On left Title: review Reviewed Arrival Pause disconnection receiving doors Post guidance Care discussed undertaken 20/SJH then Appendix staff handover using time patient received lab evolving observe/trouble shoot should 118 The IInntteerrhhoossppiittaall TTrraannssffeerr through PPE editorial team HPS notify per and tube Status by: Wd taken AAccttiioonn cath 10 CCOOVVIIDD1199 in ONLY"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2.pdf",
        "title": "COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2",
        "content": "bed facilitate 15 arrival departure: nursing clamps 14 done Standard Doff off transfer 11 designated Written: required Senior prior preprepared with May chlorclean one CARE most will CT: medical completion: reconnected trip down Reviewed/revised consultant Portering Guidelines trolley leaving not arranged trainee orange practice ahead to as reentering an on rest Intra or room Pre Ensure One FOR COVID19 the contact COVID monitoring member table 12 Critical Card USE be Level Intrahospital on: Scan Transfer between Authors: bags CT bag of for 2020 standard ICU by undertake Draft/Final: enter fitted entry ventilator close prepare wiped control CRITICAL Next members at don On 19 Title: review Arrival supply sent two spotter Oct bagged FFP3 minimum guidance Care discussed undertaken Tube used is direct staff passage using RIE patient if route emergency double equipment McNeill can return rota 13 Doning observe 118 hospital The Another usual Action through PPE but team HPS per Final back and tube Status Dunn addition taken 2021 Following March 10 Don in ONLY"
    },
    {
        "href": "criticalcare/COVID19/RIE/CoVid RIE Intubation Checklist.pdf",
        "title": "CoVid RIE Intubation Checklist",
        "content": "Covid 3p Mac Checklist Is how? 2018 further Check help this Intubator with Conrm 3cm TUBE backup seda3on mise Cri3cal max Preoxygenate HMEF plan roles? Yankauer required? will Stethoscope OPA outside visible head RSI st circuit catheter lubricate FoNA Op3misa3on turned CoVid trolley Cut Review pressure Bougie kit ETCO2 CLAMPS posi ON access Vocalise Airway supragloZc SpO2 Intubator\u2019s on or room check cu turns 5cm ETT we Understand administrator Pa3ent Emergency contact ECG Team intuba3on fails? Equipment McGrath Plan waveform via SupragloZc trachea drugs Lothian Runner Intuba3on Fibreop for Monitoring 2020 BP ICU size Op RAISE carina Baruah PROCEED role Date: B/C Closed laryngoscopy Allergies NOW Theatre call intuba \u00d72 in supply switchboard up syringe suc3on Care Induc3on Tie Scalpelbougietube Consultant is checked Cricoid Drugs using Di\ufb03culty page Adapted Communica3on if 2200 Verbalise laryngoscope ml requested equipment wake seniors handle from CONCERNS Anaesthe tape pa3ent O2 Prepara3on \u2191K+? Who PPE DAS/ICS assistant vasopressors Stylet Double airway incl Can tube and Ongoing NHS alloca3on Sizes mount necessary March 10 Blacstock"
    },
    {
        "href": "criticalcare/COVID19/RIE/Covid_extubation.pdf",
        "title": "Covid extubation",
        "content": "respiratory secretions Checklist perform Inform extubation Extubation Facemask NG 10ml /HFNC EARLY Senior Assess Check guidelines 100% plan factors: Yankauer Stethoscope CCircuit Two PROCEED: visible extubations Give catheter CALL cuff DAS remove trolley not available Review to mask AGPs* 30 NIV fasting bite stability Stop Airway post access SpO2 system nurse an Cardiovascular cut or difficult Adequate Obesity Observe Ensure tapes ETT ready FOR Awake doctor general spontaneous compromise: the roles COVID cooperative supplemental Critical ECG Aspiration IV cough formulated Equipment patient: subglottic Prepare plans Lothian adequate of for Monitoring signs trauma/oedema 2020 oropharynx BP suspected RAISE Drain Suction From catheter/closed sit nurses PLAN connected Date: Scissors Postextubation Remove leak noise Talk NOW Respiratory aware minutes sedation Optimise Consider supporting supply SpO2/RR up postextubation etCO2 block present high Charge syringe Care Preparation NAP checked pattern Previous filter Adapted patient if oxygen HELP pt tapes/ties extubate confirmed ventilation ABG delivery oral REINTUBATION CONCERNS allocate tracheal whilst O2 through PPE suctioning prepared airway risk care *FULL aspirate and tube suction Deflate NHS informed Obstetric March Planning"
    },
    {
        "href": "criticalcare/COVID19/RIE/Flow of patients in RIE Critical Care during C19.pdf",
        "title": "Flow of patients in RIE Critical Care during C19",
        "content": "Able respiratory intubated Elective 14 No rapid transfer 11 overdose swabbed initiation further If sideroom aerosol known criteria with May management would meeting admission shielding Area neutropaenia 118B transmission open Pandemic other new deisolation fever/respiratory down pathogens low move vPatients Has 117 who vPatient reassessment based areas admissions Unable <37 consultant thromboembolic 116D/ not Admission available completion result providing to SARS \u2018Contact\u2019 Would 1114 Low consider This as fulfilling consecutive post stepped context All Positive lead cubicle symptoms an on INTERMEDIATE suspected/proven or immunity Placement Clinical since mechanical One RED AGP 118A/116C/116D throughout the Emergency assessment alternate contact 116C essential days Critical vAll be Level Once isolation fever receive IPCT ideally deemed droplet considered first contacts status following URT/LRT 116C/116D/118A/ward Patient 116C/116D/118 least therafter Isolation Considered Intermediate presumed of for exposure ICU criteria? Transplant appropriate initially presenting During during excluding health diagnosis at Department Areas beds samples Priority Cohorted 118A area available: clinical testing placement likelihood results negative tested probability two Sideroom are cohorted high ensure protective history including FFP3 they Probability continue NO 116C/116D/118A Initial swab Care See SARSCoV2 discussed GREEN used require improvement LOW Version is some Patients managed consistent URT thereafter alert Siderooms deescalation full admitted RIE previously already patients patient if 116D siderooms positive pancreatitis 24 More URT+LRT co confirmed ventilation precautions chart 8C decision Temp can Open HIGH than from additional ICPT critical should isolated clear 13 discharge organisms whilst non employees hours home nursed apart until worker risk Yes care allow Discuss separate self manage existing and within test High meet Guidance AND Remain no disease give sufficient have YES having taken Non CoV2 flow Admissions waiting 2023 48 hrs intermediate definitive in need ONLY infection"
    },
    {
        "href": "criticalcare/COVID19/RIE/RIE Near Me Guidance.pdf",
        "title": "RIE Near Me Guidance",
        "content": "discuss name video VIDEO found sign talk Communication If Click would TO with platform ONLY quick Area CARE do medical scot advice: CALL given patient\u2019s challenging Guidelines not to Guideline live read access Waiting on onto or which go Ensure please FOR Anywhere COVID19 the Critical Ask run Bad USE com/login be News via NHSFREEWIFI following calling of for email: details wish 654321 connected CRITICAL Attend attendanywhere password call it relatives making tips family Near iPad: use they Remote Care helpful NHSNearMe@nhslothian Log iPad fill passcode is Me using RIE https://nhsattend patients patient phone vc/rcc can username nhs you https://nhs label Breaking Prior Go team uk like and Scotland NHS HOW have in service"
    },
    null,
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID-19_PPE_Donning_poster.pdf",
        "title": "SJH COVID-19 PPE Donning poster",
        "content": "personal clean that perform against strap cannot Place putting Position these bridge healthcare If this cheeks with respirator sides will longsleeved outside order head piece down contaminated regularly gown cuff eye Predonning patient\u2019s glove ties remove uid gloves available over to facial differ adjust waist This protect Gloves safety mould Putting above on after covered good or been room crown nape check Ensure away being Instructions Use safe COVID19 the hydrated fasten manufacturers be hair surfaces between goggles NOT worn hand straps of for eyes both rmly by size heavily Eye hands compatibility repellent spread PROCEED torn technique during ngers at pressing work Put protection upper tested limit lower are tie ensure protective use keep touched spectacles provided instructions undertaken disposable yourself is neck With DO Perform environment face Respirator patient jewellery before must headband select equipment Note: from should The you achieved donning ears different practices PPE makes change until worker checking Where nose always correct back and test followed hygiene when have removing your according in infection"
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ED Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ED Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ITU Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ITU Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH PHE_COVID-19_Doffing_poster.pdf",
        "title": "SJH PHE COVID-19 Doffing poster",
        "content": "Unfasten personal that removal strap preferably soap place off forward Gown water healthcare roll systematic ante retraining with process In Firstly: To respirator shoulders will possible outside order head Clean contaminated let gown lift eye patient\u2019s glove dedicated ties leaving remove not disposed gloves themselves over to waist behind Gloves as All an front or room top only retaining bundle Removal Pull away Then: contamination outsides safe COVID19 the touch be fold isolation gel while pulling contaminating hand fall straps of for both opposite touching way by buddy motion Eye hands dofng discard respirators ngers at Turn bottom area clinical it distance cross protection inside follows: up are slide protective including Unless FFP3 use inadvertently is there then neck using peeling reach Respirator face removed bring fullface absence ungloved before bin under must out equipment lean slightly remaining into handle from metres should lined minimises supervised Do grasp Wash hold The alcohol rub PPE sleeves visor rst reduce worker risk Where anteroom/lobby potential always gloved wrist back and peel nd removing waste your in"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 Intubation Kit list.pdf",
        "title": "COVID WGH Ward 20 Intubation Kit list",
        "content": "COVID19/Suspected blue normal ABP Checklist clamps Ward RIDU off 10ml NG Written: Pressure Approved WGH Slim contents drivers airways Please v2 phones HMEF CARE arterial pump Stethoscope Yankauer tubes RSI Cables // circuit catheter 12F pumps stand listed Guidelines leaving Intubation may sachets not stored trolley scope Duncan Loose available refreshed to Bougie Metal EtC02 pack charge access Mackinnon Aintree box transducer intubate Femoral on room splitter check Arterial ETT KKiitt Draft FOR COVID19 Covid19 sizes the Emergency Oxygen 20 Scope LLiisstt insertion Cannula Critical NIPB USE sampling Clerk be on: Schrader made infusion McGrath Authors: 3000 bag drugs monitor below 2020 saline cateher Draft/Final: size Guedel mounts Suction Baruah WWaarrdd Macintosh ventilator Drip Scissors Next CRITICAL Closed Blackstock 18G Braun left Title: SOP departure Reviewed review plastic iGel unit tubing up manometer line Vascular are tie induction use Ambu Facemasks syringe Care 14F Tube pressors Drugs breathing packs 22G fat patient 2200 if laryngoscope plus before Sp02 Box emergency equipment office Cuff blades Jelly catheters key tape 1000ml Clark socket Syringe The 20G Oxylog set SSuussppeecctteedd Stylet cylinder Anchorfast Monitor and tube suction Status by: x3 clamp Laminated waiting March cable Baby CCOOVVIIDD1199 in need ONLY"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 RIDU Intubation Action Card.pdf",
        "title": "COVID WGH Ward 20 RIDU Intubation Action Card",
        "content": "respiratory discuss secretions Staff assistants Written: Approved these WGH SAS pump Stethoscope will referral: SSOOPP intubator/drugs escalation leaving not Record intubation jelly communicate kit Metal Anecdotal Primary Aintree donning/doffing PAG Arterial COVID19 Covid19 see current be IV between Equipment Authors: wide List choice status of 2020 Update: suspected by size met HME during Closed Front Blackstock review Contact availability receiving high plugged Assessment patients levels 2200 planning consist before US staffing hypoxic can office specialty change but indicates pause SSuussppeecctteedd team risk Ventilation arrangements Group and in aerosolization infection bed Checklist nursing x2 propofol entrance RIDU drivers airways metaraminol CARE escorted Two CXR bottle moved adrenaline stored involved unsuitable machine board as safety equipotent too box piped side front suspected/proven room Lubricating the their COVID ECG Level made Transfer closed IGel for list maintain Restock BP ICU Phone anaesthetic ventilator Next experienced departure Reviewed up line supervising Conduct Facemasks situ See respond guidance CPR neck face patient phone equipment from immediately critical catheters confirm 118 trained The judgment Ccircuit intubator\u2019s determine Kit through doffing PostRSI assisting airway compressiononly care Etc02 back primed CCOOVVIIDD1199 definitive re Covid number Inform NG found transfer required Yankaeur prior Prereferral indicated outside // atropine severely identified shift Size appropriately consultant progress may gloves units to Bougie EtC02 charge minimise nurse after or cleaning check ETT Draft remains administrator 20 contact take monitoring insertion Establish Critical USE Follow Runner China fluids include buddy Guedel Suction intubating WWaarrdd nurses Donning/doffing Braun 9am Title: ID clinical SOP tubing Severe manometer use Ambu Care Daily scissors guideline staff Drugs Perform RIE Induction confirmed emergency NIC should Interhospital nursed Oxylog unstable PPE 16F HPS per scrub aim Status suction by: suitability Laminated scopes on: COVID19/Suspected arrange 14 Ward intranet 10ml evidence Communication If PCI with one ICU/anaesthetic well tubes 1:10 1:100 medical RSI catheter 10th lift dedicated Guidelines proven deterioration Intubation trainee RSI: mask practical cuffed post access Sonosite ambulance on Clerk\u2019s postintubation Problem taxi position FOR 000 Emergency Communication: convene via videos hypoxia drugs monitor assess Draft/Final: appropriate Baruah measuring CRITICAL at intubations call alfentanil syringe supervise is handover proning full page time if oxygen anticipatory slim compressions Sp02 precautions every door Cuff Exit Anchorfast sterile Monitor tube clamp when March ONLY"
    },
    {
        "href": "criticalcare/COVID19/WGH/CoVid intubation checklist WGH.pdf",
        "title": "CoVid intubation checklist WGH",
        "content": "Covid Mac Checklist tip Is how? 2018 further site Communication Check help this Intubator 3cm backup max Preoxygenate plan roles? Yankauer required? will Stethoscope OPA outside visible head RSI circuit catheter lubricate cuff FoNA turned CoVid trolley Intubation Cut intubation Review Supraglottic pressure Bougie kit ETCO2 supraglottic Airway ON access Vocalise SpO2 Intubator\u2019s box on or room check turns 5cm ETT position we Understand administrator Emergency contact Critical ECG Team fails? Equipment McGrath Plan waveform via Patient trachea Lothian Runner drugs allocation for Monitoring 2020 BP ICU size RAISE Cons Fibreoptic carina Baruah PROCEED role Date: B/C Closed laryngoscopy Anaesthetist Allergies NOW Theatre \u00d72 sedation in supply Optimise up syringe Care Tie Scalpelbougietube Preparation is checked Cricoid Drugs using mobile Adapted Optimisation if Induction Verbalise patient laryngoscope ml phone requested wake Confirm handle from CONCERNS tape Difficulty O2 \u2191K+? Who PPE DAS/ICS assistant vasopressors Stylet Double Site airway incl Can tube and suction Ongoing NHS Sizes mount March 10 Blacstock"
    },
    null,
    {
        "href": "criticalcare/COVID19/WGH/Management and escalation plan for COVID19 patients in Ward 20 ICU 130320.pdf",
        "title": "Management and escalation plan for COVID19 patients in Ward 20 ICU 130320",
        "content": "bed normal that 89 nursing entrance surge Ward plan: ward transfer bedspace required further WGH If this 1016 elective with management Murray time: machines admission plan vestibule recovery will indicated Nursing any possible 58 order capacity Move Estates who At markings areas escalation moved Medical/Haematology consultant may directed requiring not available Review nonessential point to 36 These pressure surgery Visitors detailed Dependent entrance/exit This as All Suggested nonCOVID above coordinate on side HDU temporary or SHDU operating room only ETT enact mechanical L1/2 construct 18 COVID19 26 instance 20 the theatres ward/HDU/Lothian Close barrier Critical NonCOVID19 be IPCT between oncall first closed considered Plan via Patient following Bedspaces of for both ICU Enhanced by floor theatre/recovery appropriate ICU/Ward sink anaesthetic Manage at Blackstock Theatre As area 916 SOP 3rd basin Oncall negative unit movement stop people spaces including doors barriers continue /Ward Care handwashing used Consultant all is then Patients main managed staff Discharge Medical Main/DCN empty admitted RIE already advice patients referral Anaesthetic /NHDU removed time patient bedspaces SJH before must Management ventilation emergency decision now can use: from Capacity should items coordinators default donning 13/3/2020 PPE but until doffing Surge theatre team Site liase senior second per occurred Bedspace Donning and within acceptance able informed ends Will 48 in input"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Cheat Sheet.pdf",
        "title": "Aisys CS2 Cheat Sheet",
        "content": "that gas Push persists increased Displaced admission 100% BELLOWS To will H+ seconds do DOPES fail low THE CALL righthand breath not CO2 These increase pressure CCIRCUIT All Volume FiCO2 temporary ventilated mechanical usually see touch AISYS be turn OXYGENATE Equipment USING >10l/min Start of light FLOW by toggled casing met Increase during 5cmH2O left review minutes limit endtidal Settings high shown LIME refill EtCO2 procedure targets all defined otherwise 1:1 using patients 6mls/kg ABG BREAKING END switch: can lowflow you achieved baseline leaks pause change but indicates team measured Ventilation and connections screen occurs checkout flow BACKUP in 15 PEEP COETT PCVVG bpm its Restart REMEMBER Gas move 60 rate Disconnections touchscreen red Ratio machine Breaths arrow adjust DISCONNECT Low saying >8kPa side above fresh Use 824 the COVID higher FGF Ventilator TIDAL highflow litres/min changing bag for maintain start indicator You tab ventilator secs 13l/min Respiratory 1l/min plastic up lower they 10l/min GAS then rechecked 12cmH2O patient HELP d/w visual VENTILATION select flows PAUSING periodically immediately confirm Anaesthesia The wheel hours reduction FiO2 set reduce Pinsp care <30cmH2O minimised bag/ventilator confronted no There Following >0 support place Mode canister Pressure activate prompt Obstruction 5l/min reconnected down circuit identified CAUSES mode based may container to OF window bedside lime This Checkout system target changed PVCVG after FALLING or Preferred only check Ensure last break Signs comwheel Ask adjusted run Once GOALS picture 400mls following VCV way include PLAN: initially soda Tidal Settings: CS2 likely either Pause are Press needs present settings Initial Vent elevated used standby Stacked OXYGEN there navigate With Perform SODA More confirmed FRESH dialed Select should PaCO2 default O2 different does changes vent aim Bag displayed 6l/min 10 perform litres/minute ventilating Flow PaO2 neurointensive If this green with 2024 medical yet IMMEDIATE demands CIRCUIT TROUBLESHOOTING Volatile HYPOXIA: on switch each which top pH reverse difference position FOR calibrate complete >6 increasing VENTILATOR closedsuction sodalime appropriate SIMV leak combination at After pressing >7 setting temporarily Case disconnection including require Pneumothorax bellows is reach if oxygen NonCOVID 8l/min message so mains every right than return until <60 com within OFF tube AND clamp when need"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Ventilation settings.pdf",
        "title": "Aisys CS2 Ventilation settings",
        "content": "requirement respiratory that Circuits long end valves Standard gas Synchronised exhaustion these WGH highlighted persists ruler also increased ventilate would 100% HMEF rebreathing To selected Flows 1:2 extent will H+ open cassetes users possible tight case do order low agents At Simply listed routinely rise maximum not although completion Vt displays CO2 restarted These pressure increase prove overcome upon Ally read reduced All cmH2O incorporates Volume note FiCO2 24hours nonCOVID temporary ventilated selfsealing more we paused please 1l/minute inspect undergo Neuro theatres usually important see Pro touch current AISYS mindray be turn viral between limb 49 enlist >10l/min Start of are: bacterial/viral moisture We light 3l/min preuse wet by toggled operated problem met Increase Soda during Closed desired 19 left 12hour review minutes Consider indications negative guide limit windows Settings high shown EtCO2 discussed Diuretics best Breathing completed remind procedure all defined expiratory main 1:1 using patients Gibson 1220 levels planning freshgas 6mls/kg before ventilation switch: can Rate Intensivists 13 Do L/min lowflow displaced you what baseline leaks safer but neuromuscular change Breaking 3L/min team risk measured designed Ventilation optimise and connections screen ratio 13L/min checkout flow necessary initial >10l/minute 8kpa in Peak experience 15 PEEP names demand propofol options induce COETT mandatory PCVVG unlike further collapse Elevated put Check known replacement latter machines Prone its filled Controlled added recovery become inspiratory weight pro stay Gas consists move 60 rate corresponds 12hrs discussion capnograph disposables patient\u2019s Suctioning refer requiring touchscreen red machine lost menu They alter arrow parameters adjust unless caution depending disconnected as 6L/min Ventilatory expertise unnecessary above pandemic Procedure operating fresh malignant extremely PSV dependent expired Use the their Distal litres COVID those 12 higher FGF questioned Intersurgical small litres/min changing closed soiled Troubleshooting functional provision bag Expiratory register Disposables Lothian for maintain below standard ICU start indicator controlled anaesthetic internal intended You tab volume ventilator 13l/min Air reliability clearance Respiratory As remain Falling routine capnography ventilators option ill 12hours lower line Circle protective 10l/min cancel they 49day RR NO See undertaken disposable earlier then some conduct rates rechecked breathing style patient Should scavenging 24 just must select 400ml flows valve now occurring from anticipate alarm confirm Anaesthesia situation hospital The non peak wheel hours FiO2 set reduce litre/min airway us times cicuit back Tab confronted located our no Com There mentioned Following hypoxaemia cannister prolonged occur normal >0 support therefore found colour required canister Mode How Pressure Tinsp >6l/min site short performed Assess tidal Our document limited In uses consideration most plan indicated 5l/min any whether reconnected It circuit identified who mode Modes individual consultant may remove available point to window demonstrate bedside lung mitigate lime Safety This inspiratory/expiratory Touch clinically Checkout satellite system target changed minimise nurse An after Disclaimer: or only anaesthesia check drive Ensure returned One being contamination frequently throughout comwheel Although again broken intermittent Critical adjusted run reconnecting Once lowflows picture reinspired NOT where Higher body Initially has 400mls clamped following Circuit spontaneously least goals apnoea make both VCV circle metabolic neutral Commencing By 10L/min initially soda CS2 likely filters vapour posters ODP either Solutions aiming weaning clinical it SOP procedures sedation Difference positions information integrity For two manometer are clamping needs settings use inspired term keep exhausted 68 rotating Initial less Care wash frequent Vent cause elevated used standby inadvertently there staff navigate With Total More positive Using absorbed display components under confirmed warning slightly isoflurane anticipating accessed Select approach should due PaCO2 default volumes CPAP continues linked O2 VG regular different challenges cassette yellow predicted drop changes PCV per indicators instances adjustable vent ask aim circuits Bag suggest sensor suction instability 6l/min NHS autoflow 10 according without called prevent litres/minute Morgan 30cmH2O cannot ventilating surge unclamped Flow completely PaO2 settings: Default period carry If this green pressures Please with reboot presence However shortage acknowledged cancelled reinflated Visually significant emptied representation 2024 haemodynamic medical contacted inspiration Fresh continuous yet achieve demands Increasing push spill Unable COVIDpositive efficiency starting balance Sidestream outwith blocking rate? becomes an basis Continuous on sevoflurane switch which Alastair been pH difference critically position Users supplies preferred When \uf0b37 days drying Adjust works increasing I:E via could PSVPro sodalime monitor 12cm guaranteed SIMV combination leak >68l/min control recheck at expected On After capnographs pressing volatile impact setting temporarily production Introductory Upon disconnection sidestream ensure including require ulnar bellows is context checked flush plateau begin empty full filter hyperpyrexia page Adapted minute removed time if selecting oxygen twist phases message so out expect every into than additional return performance familiar proximal usual H2O assist until Prior suctioning Differences Operating customise licensed Dr barotrauma acknowledge vapouriser potential com tube OFF within test when have fulltest breaths very need Aisys"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Machine Checklist Non-COVID.pdf",
        "title": "Machine Checklist Non-COVID",
        "content": "curve secretions blue 15 Morgan Insp carried next colour required canister exhaustion water Pressure MV resistance further If <0 performed this increased excessive reboot with replacement However mois HMEF added will white trap5 5l/min tight daily selftest7 medical other near Continuously low It circuit visually lime1 68l/min patient\u2019s may not Record point to CO2 machine increase bedside parameters lime reduced as Change changed an FiCO2 dialled zero on after or Alastair more please Inspect Instructions frequently the Absorbent circuit6 monitoring days FGF be Ventilator Water limb closed 49 has Circuit zero? Expiratory fall occluded >10l/min of for Monitoring bronchoconstriction circle condenser ICU by include hourly soda Tidal volume humidity CS2 Soda filters vapour recheck control either neurocritical thirds 1Task Hourly SOP minutes information disconnection two present high Filters ture including 1L/min inspired causes use distal spirometry exp EtCO2 Alarms Initial used require all Version is expiratory there mins checked otherwise rechecked filter Perform using patients reach time if needed 24 before Machine must chart out every into flow4 from than should Anaesthesia due drained PaCO2 inspected The hours does assist change yellow FiO2 indicates team measured care manual and within suction 6l/min when occurs flow fulltest pink in need Aisys"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/WGH COVID Ventilation using GE Aisys CS2.pdf",
        "title": "WGH COVID Ventilation using GE Aisys CS2",
        "content": "respiratory that parameter long end Standard gas bedspace also increased ventilate would technical admission HMEF Breaks rebreathing To Flows pH>7 will H+ seconds pausing vary possible tight Unclamp outstrips capacity reference effort low agents flowrate visually At breaks problematic routinely breath maximum not repatriated restarted CO2 These pressure increase upon read reduced undoubtedly compliance All note how FiCO2 nonCOVID concern ventilated device more IPC we paused please COVID19 Neuro theatres delivers usually important calibration planned still current AISYS longterm be viral between infusion limb cleared 49 wide GE 812cmH20 fall adequate of moisture bacterial/viral We arises 3l/min suspected wet teams by described 10l/minute Local charts avoid General 510cmH20 during Closed Any 19 nonIntensivists *For outstrip review minutes capability indications supply guide follows: receiving Settings high monitored minimum refill atmosphere EtCO2 intervention procedure targets all expiratory main using Ideally patients isolate levels 6mls/kg before received ABG ventilation corresponding can updated tracheostomy 68L/min EZchange sought 13 opened Replacing lowflow level inspected leaks midazolam/clonidine ongoing but change neuromuscular effect team cylinder risk means measured designed Ventilation arrangements and negate followed connections ratio reducing operate flow removing necessary initial Satellite/Surge gehealthcare in personal experience blue 15 PEEP nursing demand lowest propofol done options COETT 20cmH2O deeper mandatory reduces PCVVG inspection MV Satellite suitable setup further collapse unable Check resistance suction/patient once replacement backup quick machines Hospitals arterial added its become Restart inspiratory detected adapt \uf0b312 +/ Gas rate depressurisation basic rather admissions patient\u2019s 35cmH2O preceded requiring suggested machine 30 sensor/valve standards They adjust Canister Low unless depending consider as >10 safety ensuring side pandemic Procedure port fresh malignant dependent ready spontaneous 824 the their effects COVID 12 higher FGF Intersurgical small made litres/min inefficiency changing closed coughing opening provision bag agent studied commence register assistance Lothian MAC for 1litre/min maintain standard ICU indicator anaesthetic >10L/min intended accuracy fitted tab volume ventilator acceptable delivered presents experienced Respiratory Ventilators routine typically capnography ventilators option ill were Unit1 console PS/CPAP line induction \uf0a365 paralysed waveforms Unless FFP3 10l/min they RR distal provided supervision Version FiO2>0 then interfere maintained rates breathing patient Should visual scavenging sooner 24 blockade exclude must flows equipment Filter from alarm situation hospital The non peak hours deliver Ccircuit filtering through FiO2 set such reduce Negative oxygenating us times back our no assisted Appropriate There 17 associated Colleges/ASA clean local >0 support therefore suggesting about transfer reengaged stops >6l/min required Mode canister Pressure performed determined tidal prior Our document limited In soon most dyssynchrony CCircuit 12cmH20 daily other breathe It circuit identified who Immediate mode limits appropriately cuff may blocked perioperative Capnography available result point to practice bedside lung lime This hospitalwide laminated viral/bacterial satellite system transitioning changed An after Disclaimer: or cleaning reservoir only anaesthesia check drive being frequently 18 20 replacing Although Minute monitoring insertion again broken Royal Critical ODP/medical run Once lowflows Internal sedated considered brief pressure/flow worn clamped has 400mls following Owner: precheck 3000 space deeply least spontaneously apnoea both circle performing metabolic include triggered clinician initially continual soda connected CS2 filters Both either members supported Increased SpR weaning clinical it procedures sedation Pause information AGSS discoloured integrity two attached expectation are For manometer comprehensive clamping present needs settings 24hrs use inspired term 1L/min 68 find Initial less Care opioid elevated used compensate Consultant loss hose there Appendix staff sudden With Perform 16 previously stable rainout More positive under needing confirmed emergency warning delivery should resource undergone drained PaCO2 default CPAP linked cassette different does Oxylog PPE yellow drop changes per aim circuits seen appears meet working suction compensation displayed 6l/min NHS autoflow pH\uf0b37 external 10 according without bacterial perform litres/minute Morgan 14 30cmH2O kPa detrimental surge certificate Ward ward PaO2 nationally 11 kept failure If help this pressures disengaged reboot with However approximately acknowledged absorber emptied Teleflex oscillations occasions medical new inspiration Fresh regularly catheter Clamp Increasing push communicated oxygenation deterioration COVIDpositive rebooted efficiency understanding Pmax mask dead Sidestream similar optimisation Volatile highmetabolic timed an on onto each which Alastair been Clinical utilisation critically sevoflurane/isoflurane user sensed H+\uf0a365 especially complete When days ET sedative increasing I:E greater closedsuction could acquired PSVPro monitor sodalime alternative condenser 5L/min arriving appropriate guaranteed Running Mindray SIMV leak control recheck at expected volatile Phase pressurecontrolled temporarily setting Full production Introductory Further closedsuctioning responsible unintended ensure including history function require bellows is context checked despite physiology empty full filter hyperpyrexia Western minute time if https://cleaning oxygen twist NonCOVID needed increases phases alongside out <10 every into than performance Scavenging proximal event Surge until Prior suctioning Operating conjunction licensed proper potential within tube com operates decontamination have when replaced breaths very need Aisys"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH_CT_Transfer_May.pdf",
        "title": "WGH CT Transfer May",
        "content": "bed radiographer doff 15 arrival departure: nursing end clamps ChlorClean done 14 Ward off carried ward transfer 11 Written: required bedspace \u2018doffing\u2019 department kept WGH Approved If put also this prior with May one July CARE \u2018clean\u2019 will indicated open Ferguson outside stay do medical CT: completion: reconnected repeated down circuit CCaarrdd discussion individual consultant walk Guidelines Portering trolley leaving not arranged stored trainee practice to ahead unless This scan as wearing Stop clinically access cubicle nurse on after or go been donned room only Pre Ensure FOR contamination COVID19 20 the COVID member table 12 Critical Card USE be Level Intrahospital on: Scan between Transfer Authors: IInnttrraahhoossppiittaall CT via has bag assistance of for list 2020 standard ICU by undertake Draft/Final: CCTT appropriate transport clothing Baruah WWaarrdd avoid ventilator entry HME prepare drug during wiped control CRITICAL Next at members On Title: remain area 3rd Reviewed review in inside Arrival disconnection monitors minimum doors guidance Care discussed undertaken Tube earlier used standby is staff agreement Then using filter enhanced disconnecting 16 patient 2200 if entering emergency equipment McNeill can remaining 5th immediately from wear corridors should wait clear 13 observe trained amount The Action TTrraannssffeerr Oxylog does PPE change doffing team HPS senior per newly Final back and tube Status Dunn by: taken AAccttiioonn necessary Following 10 CCOOVVIIDD1199 Only need ONLY"
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Intubation Simulation Video.txt",
        "title": "COVID Intubation Simulation Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Proning Video.txt",
        "title": "COVID Proning Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/Donning and Doffing Video.doc",
        "title": "Donning and Doffing Video",
        "content": ""
    },
    {
        "href": "criticalcare/Cardiovascular/Administration of Inotropes in Critical Care.pdf",
        "title": "Administration of Inotropes in Critical Care",
        "content": "nmc that ABP end stated changeovers al Administration tap 2007 To pump will open Clean medication Discontinuation patent rise maximum standardsformedicinesmanagement not 2% net/clinicalsubjects/accidentand pressure All xrayed blood device Hospital more Arterial titrate insitu instance touch current be turn Equipment infusion bags Alaris fullarticle of <drugs by prescription References 9% drug during org best/201728 inotropes/vaspressors C74C77 Be desired ors placement high Rapid best circumstances 2012 Mackay expiry Label connection Training before Calculation can British Do labels medications you achieved Pollock change effect Signature/BBraun risk Failure flushing Midwifery old and occurs flow your Sept in service infection bed Medication labelled rapid Device off designated life unable Check management Lines policy same arterial subclavian invasive \u22645mmHg spiked et Catheter recommendations rate recommended Concentration original Standards proximally consider as seek 10mls/hr side above Cardiovascular another central automated update Use the effects aet199 higher photosensitive continually small uk/globalassets/sitedocuments/standards/nmc sugars bag commence Lothian for uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress start Date NaCL Purge confirming nursingtimes bolus 16mg area up lower line continue guidance Cour then 8mg pumps: prescribed half patient double from critical actions 160mcg/ml Society The Journal 2015 alarming through vasopressors visualisation care http://bja times Run Inotrope/Vasopressor back existing 2013 venous threeway no Medicine Intensive org/content/early/2013/06/11/bja lines Heru Following hour Policy ics clamps infusions: found required lumen Insert Pressure short site bleed Council prior measures guidelines discontinuation pdf+html any other and/or luminous It uk/icshomepage/guidelinesandstandards/ pumps additive remove may library available providing to practice Aim Commence This charge changed nurse or only 16mg% bleeding https://www Ensure last frequently Blood concentrations monitoring Critical 73 run Follow Work Doses waveform clamped has space both fluids way competencies transduced Commencing hourly initially nurses connected Braun Healthcare<az<critical it inotrope/vaspressor For attached are systolic use keep less Care used Titrate staff Protective under Changing follow Benefits CVC dated delivery pertains should mls due Decreasing continuously observe distally covers PPE smart 72hours per Connect 20mls/hr correct by: NHS taken 80mcg/ml Drug faster engaged without prevent strength oxfordjournals vasoactive intranet If date this Please with Apply one medicines Nursing prevention IJ new medical wipes achieve 8mg% clearly Increasing patency push areas concentration Guidelines Inotrope starting Review http://www pumping Stop administered pdf New decrease an on onto which been Observe Personal interruption requires safe complete When MAP connecting increasing Prepare via inotrope drugs Inotropes/Vasopressors assess ucl extra technique discard control ac at After Core 10mls three aware inotropes 2017 Inotropes disconnection stop ensure instructions require is 2mls/hr Keep infusions handover flush full 2010 quasiexperimental advice time Infusion if emergency/changinginotropeinfusionswhichtechniqueis Central 5mls specific so out every into administration than Chlorhexidine changeover April running study until Prior Written 20th within Venous have Signature very Enter need"
    },
    null,
    null,
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor HemoSphere Setup_pub.pdf",
        "title": "Cardiac Output Monitor HemoSphere Setup",
        "content": "Sensor that parameter Advanced slot end tap highlighted Edwards contents owners v2 technical upright calculator selected To will open raises Securely tight do order stand Start/stop 300 probe not arrows pressure upon All Waveform zero format SwanGanz device inspect Information important calibration touch current globe be Parameter IV between advanced 92614 status CA law Start of by Irvine phlebostatic CVP hang desired operator\u2019s left fully review bubbles Setup minutes indications guide grade Settings Time startup FloTrac completed all CAUTION: stopcock main 2019 using Acumen connection deair rights Back can Note: Demo Oximetry Derived holding level highlights you Export heard selection change Zero\u2019 HemoSphere pushing PPUS2208 packaging and connections screen Engineering Replace mount initial in off technology power setup replacement column arterial Snapshot CO \u2018zero\u2019 Averaging rate Expansion Event inate events refer USB parameters States as front Ethernet port restricts update the their prescribing Compatible air: ECG zeroing Level capital_care@edwards Hold first USA COM1 bar Patient bag property for Monitoring standard indicator Equipotential Date accuracy inserting HDMI Turn button gravity remain OR up lower Federal See screens then patient entering visual filament stopcocks must select eight Choose actions alarm language Corporation Lock hospital Thermal The holder through Injectate times terminal no value heart battery input stud support place temperature Insert Pressure pole guidelines measurement platform Help cord respective insert any outside silences other IQ and/or down It mode remove units to window insertion/connection Module appear stylized This Touch orientation system WiFi system: after or only axis One being Blood pull outlet Bar monitoring Follow Thermistor want output HIS Average Battery hemodynamic 8008229837 ports sale RS232 time/date steps clinical it procedures Zeroing information properly tubing residual module two For are Press settings Pressurize trademarks use keep connector globes Lifesciences With rear six Platform physician display Refer follow ops adverse Mount plug cardiac Connect manual sensor Bag appears Status fluid LTech displayed assure contraindications Smart 10 engaged without compatible 24/7 United CCO TimeinTarget this charged with Fastflush audible tone catheter nonvented image Available Stop caps outlined an on switch which warnings Analog Clinical position Zero complete iCO Captures air PGDT tracking monitor icon appropriate contained \u2018Quick Screen at Plug prime alarms features Silence ensure including mmHg instructions reserved is flush full expansion time selecting slots logo panel affects precautions out Open into door right additional click until serial proper conditioned Navigation aspirate Monitor com test edwards when reaches Main Way cable data Enter"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor Normal Values.pdf",
        "title": "Cardiac Output Monitor Normal Values",
        "content": "CPO 6080% Values Edwards owners L/min/m2 Test /SVmean vary 650800 order reference range SaO2 /SaO2 Consumption Systemic ITTV=COxMTt 90140 Content All Volume PPUS2312 blood 1000 Intra PBV=0 device RVEDVI Arterial RVP essential SVV Parameter 200250 Perfusion ELWI 1020 92614 CA law of Females: by Irvine CVP 124174 Ejection placed CI indications SVmin mL/min/m2 GEDV=COxMTtxf Cv CAUTION: 2025% ITBV=1 /CI RVEDV 500600 rights 255285 CPI L/min EVLW=PTVPBV GEDV 9501150 08 and 815 mL 19702390 3347 Units in GEDI GEF mL/m2/beat Device LVSWI Lactate mL/kg thermodilution RVSWI Resistance O2ER Artery 70105 laboratory Hematocrit xDSt S1/S2 adult 510 CO 8501000 dye/temperature 420 ITBI events Ratio EndSystolic RVESV 54 methods parameters States O2EI regional 6080 mL/min 6070% Ventricular restricts /CaO2 DO2 RVEF 95100% the Oxygen prescribing Global Extraction 12 ITBV bear Left USA Output SBP property for BP saline Convention International 120160 requirements 931 SVmax CI/HR Lung Vascular DSt Systolic Federal See CE Males: 0031 W/m2 Height152 Saturation 46 ScvO2 Predicted Cardiac CaO2 EVLW/0 Corporation 52 Function EndDiastolic PVR Parameters EVLW DO2I S1 v1 TPTD Pulmonary SV/1000 5062 Stroke Hemoglobin Pressure 1215 SI BPPAOP Body 45 devices other ml/m2 >20% Laboratory Equation dynessec/cm5 0138 MTt units 5994 to values PvO2 SV/EDV stylized RVEDV/BSA Thoracic SV/EF 50 or PADP PAOP 07 One PTV=CO Blood mmol/L Mean *Reference Work Water PBW 91 hemodynamic mL/dL 60100 3648% sale g/L 1/min Variation VO2 Extra Transpulmonary PVPI Difference information For are 65 trademarks use /CO CvO2 RAP 0136 Lifesciences 417 Normal physician 360 adverse Power CO/HR O2 mL/m2 612 mEq/L PASP PVRI contraindications 48 10 Male 4060% Female: mL/beat PaO2 11 United RVDP Occlusion this European Coronary meeting professional SVR DBP End RVSP Weight 50100 injection Article <250 PVPI=EVLW/PBV Physiorelationship COxDSt0 8001200 Index PAP theirrespective marking on Fraction S2S1 warnings Cold EVLW/PBW Directive93/42/ECC 26 56 Diastolic LAP SVI MAP av values* 25 1525 EDVSV MPAP CO/BSA CPP conformity Hemodynamic 25xGEDV SV VO2I 2230% 2017 6090 SVRI CFI market g/dL including mmHg Hct Atrial instructions reserved techniques Medical 117160 full Mixed 716 time logo 100 Central Hgb precautions /3 Right referred Delivery 80 100160 dynessec/cm5/m2 1015% HR Permeability SvO2 com Venous edwards 4252% 1720 <3 S2 Way"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor VolumeView Setup.pdf",
        "title": "Cardiac Output Monitor VolumeView Setup",
        "content": "TPTD normal 15 parameter 14 rapid cables Device 2018 RUL thermal temperature ne thermodilution con 11 Insert setup highlighted Edwards European pressures with oxymetry meeting one professional well arterial selected Before Inject devices Startup new continuous range Catheter catheter patient\u2019s events refer 93/42/EEC probe inject choose Guide available Article VolumeView to edit 10 pressure Bolus solution stylized parameters as Touch All transducer marking ENP509/1118/CC zero on calculation Thermodilution or central indexed series warnings Observe Clinical Ensure axis please 18 the femoral 20 prescribing When essential reached touch 12 according bear 1260 connect Resection selftest Accept air waveform transducers Nyon monitor Start of for saline start injectate appropriate phlebostatic CVP TruWave directions conformity volume cold connected requirements alarms/target real Enter desired Turn button steps 19 placed bolus l\u2019Etraz prime Setup review System OR boluses it indications results information guide Lung up For upper are Route de Actions descriptor ensure market waveforms including use EV1000 trademarks startup syringe See continue example CE instructions screens smooth procedure reserved all is then valve/port Lifesciences Medical method full using 16 six previously nonindexed prechilled starts time patient Platform if Prime Repeat logo ml Central transpulmonary precautions rights adverse CVC manifold right Choose referred Select thermistor Oximetry 13 Corporation Set amount level baseline keypad until set Wait Connect lobectomy Switzerland sensor rm Monitor existing and com inline Venous Parameters edwards venous displayed primed contraindications Directive databox prefer removing 17 cable data 70 in"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Management of Misplacement.pdf",
        "title": "Central Venous Catheters - Guideline for Management of Misplacement",
        "content": "repair that gas group Written: Approved these doc also elective dissection Retroperitoneal will Actions: possible GGuuiiddeelliinnee order pre thrombosis low Guidewire not pressure upon tears reduced compressing blood SURGERY more Arterial DRAFT peritoneal Practice general indicate usually observation be remain: Authors: ischaemic of by DON\u2019T often size representative formation infraclavicularly avoid during carotid left review Contact placement minutes Task consultation minimum helpful all DILATION 547 2012 Mispalcement patients catheter/vessel coagulopathy catheterrelated route absence before hypoxic majority evaluated can benefits Communicate nhs Potential threaded wall Do Injury PULL haemothorax Dornan Hamish active risk pulsatile *There prepuncture and Guidance occurs issues flow cannulation in Needle editorial removal off While unable Puncture analysis management Lines resides Than arterial its subclavian References: regarding supra QIT adult catheterization expanding complications Catheter CXR Access: largebore ffoorr Anesthesiologists vessel anaesthetist versus COMPRESSIBLE Anesthesiology Recognition: as Jan pleural bore central the their femoral multidisciplinary 12 small major notes Cap \u2018Arterial\u2019 CT dynamic PPrraaccttiiccee includes for intended French Remove confirming cerebral acceptable Next were Reviewed consulted sited reports severe line Vascular gauge minimal pulse Surgery Anaesthesiology distal location nonsurgical NON highest Patients DO ultrasound fluoroscopy mortality withdraw angiogram patient 24 must surgical immediately from catheters Society lothian The hours compression American Access Abnormal such venous no executed lines reported associated risks Compress morbidity occur continued place develop colour immediate catheterisations site percutaneous determined document In soon most plan era BEFORE devices any Feb down Coagulopathy who Immediate Size appropriately based artery Minor catheter/dilator Inadvertent may available result providing to surgery uncontrolled Misplaced This literature minimise Background: localization infarction after or compressible: only bleeding Unintentional 18 Blood pull injury contact Less insertion CCaatthheetteerrss unrecognised Critical 73 USE Xray deferring considered Equal body waveform confer has VASCULAR space following stepbystep care/Insertion least liaise Misplacement way arteriovenous Report dilator likely PRESS XR Title: relied AFTER complication clinical it haemorrhage Punctures Catheters connects Advances switchboard For Aanesthesia are misplaced present radiologist Force frequent less Care mass used there guideline managed surgeon anything large Management follow Compressible if: CCeennttrraall should infuse practically treatment does cavities MMaannaaggeemmeenntt cavity attempted Interventional organised pericardial manual seen Status interventional instability by: purpose Vessel* whose imaging on: without cap ooff anecdotal No embolus period evidence wire static this with However one Tambyraja issue significant prevention catheter scot documented manageable Guidelines Radiology needle uk/Directory/CriticalCare/Bedside Verification missited Guideline Stop access advance an thread on been difficult FOR recognised NHSLothian When Leave greater Dilator/catheter via Ireland Draft/Final: complicated 116:539 anaemic pseudoaneurysm hypotensive diagnosis common at expected real After vascular vein Case Rhona puncture unintended course require MMiissssiitteedd is context techniques relative infusions Massive vessel: thinwall methods: DONT time if IF Central Line tear proceeding out Andy into circulation than provide Duplex freely/difficult CClliinniiccaall closure generally watchful until guiding Complications: conjunction CONTACT handled allow consequence aspirate adults fistula Venous AND guidewire AV Remain have damage 2021 data http://intranet ONLY"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Placement by ACCPs.pdf",
        "title": "Central Venous Catheters - Guideline for Placement by ACCPs",
        "content": "GUIDELINE difficulty that Advanced November off group Written: ACCP Approved suitable failure jugular signed criteria with presence LOTHIAN CARE QIT BY will significant Practitioners other Catheter basic PRACTITIONERS Neil Guidelines physiologically not trainee hypertension practice to Guideline as post access an central difficult only being FOR doctor the them Critical USE be ID: on: made Authors: advanced has following inhouse Lothian of for ICU by competencies Draft/Final: appropriate ADVANCED internal Anticipated met anatomy Next CRITICAL Any placed Title: liver review Reviewed placement are including acute guidance Care used completed Consultant is Patients agreement ultrasound Anaesthetic coagulopathy stable FINAL patient training Central morbid intracranial anticipated obtain decision CVC from Practitioner approach should supervised Young The 2015 circumstances: editorial senior PLACEMENT within and obesity Venous Status venous 2013 met: by: Medicine NHS when Intensive having There fellowship in ONLY"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Vatheter - Removal Guideline.pdf",
        "title": "Central Venous Vatheter - Removal Guideline",
        "content": "Standard gently group count Lister Written: Approved Stitch PostProcedure airtight Invasive specimen order Clean 193196 Required degrees Cut 2% normal/close redness cultures pressure blood Alcohol Hospital RCN: REMOVAL laid 5cm investigation continuing exhale suture container* be Equipment Authors: of suspected by CVP References review minutes Put Rogers cover Discontinue pus WileyBlackwell swab procedure all using FINAL before 8th forcibly 13 devices: Wash risk Reposition Valsalva Discuss old and Cerebral in editorial infection bed tip removal soap off Professional water Wipe put Check Tegaderm management CARE disconnect QIT Maintain stay Devices Catheter move dressing Scissors* patient\u2019s trolley Standards Procedures press comfortable peripheral Procedure cut central the their 12 higher small cutter Hold first for Explain hands Glover Remove Next Air As area Reviewed sent line Vascular carefully patient must equipment Hamilton from immediately approx Journal 2015 alcohol hours feet 2006 back Complications able venous 70% Small associated Continue Edition normal clean place about lying occlusive Place site Neuroscience microbiological any daily 72 head down begins Therapy based platelet consultant remove gloves container point to Devastating Skin This system after or check bleeding Removal being 18 pull Dispose 20 insertion Royal Critical Ask pyrexia Document USE Cover where has 30mins make Manual skin instruction gauze Trendelenburg Title: 1530 Semipermeable it decreases two are Care wash used scissors there staff College send 43 chart CVC should stopped part rub 2%Chlorhexidine rigours Chapter Status by: taken 10 pack on: January perform 14 Marsden 2011 11 If date with one approximately firmly Nursing Early medical near catheter flat Clamp swabs supine Guidelines Loosen Review transparent access wipe basis London on Clinell Clinical position FOR intact 26 Embolism When reason hand signs Draft/Final: discard CRITICAL at hypotension After deranged Bruce 3rd 2017 53 including manoeuvre is infusions Swabs 2010 Dougherty time if Infusion Central lumens Line Sterile Plaizier into than Chlorhexidine Clark Bell Prior sterile Venous addition 4351 clotting need ONLY"
    },
    {
        "href": "criticalcare/Cardiovascular/Cerebral Oximetry Foresight _ Set Up Guide_pub.pdf",
        "title": "Cerebral Oximetry Foresight   Set Up Guide",
        "content": "Sensor blue dry oximetry parameter apply Interval around setup Edwards Check owners European green prior with Apply manufactured professional its respective selected invasive affiliates adult eifu devices other reference Clean Move signal notifications consult mode lift patient\u2019s events refer choose displays to tissue Skin pressure interval listing menu stylized New Touch access All Change Intervals/Averaging system marking side reading on edges mode: port or each which warnings check Ensure please being Instructions inspect Location Use the assessment their monitoring When Inc configuration deteriorated current Figure ForeSight Parameter 1260 liner channel Changed works made Elite application between advanced Indicator where body figure has Patient Nyon minimallyinvasive monitor adequate both for of tile assess Channel skin performing property by appropriate enter Reference tab Quality conformity connected requirements Remove button left placed tiles area adhesion Signal l\u2019Etraz Setup StO2% System quality Tissue in upper Difference integrity guide StO2 up module For indications are CAS Route de applicable ensure market protective monitored Value use trademarks CE location circulatory Reminder reserved sensors is then illuminates ENP611/1019/CC Then Medical Lifesciences 2019 pediatric time Slide patient if timepoint logo bearing under subsidiary select corresponding precautions rights tactile adverse into Open Note: from Switzerland Select Oximetry Corporation click level selection set HemoSphere LED Connect Same packaging Display potential sensor correct condition appears and com meet modes displayed edwards when contraindications damage value cable data 70 Continue"
    },
    null,
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral Form.pdf",
        "title": "GJNH Acute Heart Failure Referral Form",
        "content": "Advanced 2018 found Written: Approved failure Scottish CARE QIT website: Cares Guidelines August to All on on:11 Hospital https://www FOR 18 the Critical USE be Service Authors: advancedheartfailureservice/ jointly Golden following Lothian 2020 by teams Draft/Final: Referral Next CRITICAL Directorate Title: review Reviewed Cardiology acute uk/ourservices/scottishnational Care AHF/MCS completed National GJNH using page referral Form co nhsgoldenjubilee McNeill form Heart from 09 Circulatory should Support Failure Jubilee Final and Guidance Status referrals by: Acute NHS heart Mechanical Sept ONLY"
    },
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral pathway.pdf",
        "title": "GJNH Acute Heart Failure Referral pathway",
        "content": "clinicians nursing local No further failure If with Clinican intensivist added pathway Nursing daily 0141 AHF scot discussion to board cardiologist surgery ensures or Recieving recieving completes online records coordinator cardiology oncall Transfer transplantcoordinators@gjnh contacts via for details ICU base Transplant MDT referring clincian appropriate Surgeon clinician NSD recommendations: Cardiologist at members MCS discussion: switchboard Further up returns Clinician Daily GJNH handover surgeon referral patient plus cc follow form Heart nhs clinican hospital Intensivist team 5000 uk informed: eg and sheet ICUICU 951 Acute facilitates Referring"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Guideline_pub.pdf",
        "title": "Intra-aortic Balloon Pump Guideline",
        "content": "platelets Ensure: zeroed Written: Approved also increased Pum superior MUST pump 1:2 open tight do clot marker effort low patent not restarted pressure consecutive lead easily decreased switched Intra Bedside 50ml more Arterial please pulses important be Authors: limb radial of 2020 concerns by often formation left DC fully review CI Setup placement Consider STOP affected completed 1:1 20minutes knuckle before formal metalli McNeill can clear you altered pause team cylinder risk diastolic senior measured failur manually abnormal and bei connections positioning Sept in tip Balloon injecting 2018 off U+Es tank CARE arterial QIT subclavian filled disconnect CXR rate checks: occlusion Low as structure too ca the obtained monitoring: ECG MAP>65 small ept while Troubleshooting Patient bag Pump Lothian arrest for Monitoring below linear requirements During close Augmented Next Directorate Tubing Reviewed ill plastic line colleague ort pulse distal aortic continue Traditionally CPR pedal then patient radiology triggering pain reviewed select Cardiac valve balloon from immediately alarm erns trained The damaged hours reduction notify times 30minutes su no having heart rhythm risks Absent lloon inflation temperature colour required Mode Pressure site colour/warmth occlu In any augmentation It IntraAortic identified report artery may remove landmark foot available point to IABP replace Frequency rtery transducer after frequency or only check aorta Ensure thoracic being 18 remains Blood ent insertion Critical USE considered waveform has descending following verify alignment try 1:4 Title: Hourly it upper sedation tubing are trigger present Initial Care cause Daily cardioversion inflated used standby Max staff sudden stable AbuArafeh Aortic chart Power 09 should helium Weaning cardiac attempted per ask manual seen correct Status by: 24cm counterpulsation Loss perform settings: nding ioning failure If this metallic with onset visible medical new ear install Increasing patency height obvious Guidelines August cal Guideline caused New Avoid pleas an Continuous on on:11 each deflating position FOR safe MAP 2cm increasing air Trigger inotrope hand monitor diac assess alternative Positioning renal Draft/Final: appropriate slowly optimal carina noted CRITICAL Augmentation Auto 10minutes stop ensure washer is Reviewing full deflated Process: removed if Helium message so involves limb/shoulder postinsertion every circulation into than right >2 proximal trace Final within clamp when have cable electrodes need ONLY"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Safety Checklist.pdf",
        "title": "Intra-aortic Balloon Pump Safety Checklist",
        "content": "angle specs admission/after Out tap record 16hrs site/helium represent dissection Notify To pump 1:2 will open do clot Pedal Mains stand ABP/MAP not restarted pressure CChheecckklliisstt reduced readings Waveform blood filling more Arterial Lower please indicate pulses section be IV Ext Equipment between Authors: limb Perfusion 21111 radial of Assisted suspected by phlebostatic formation sit 80% 9% SSaaffeettyy during affect left DC fully placement minutes 8ft 24hr plugged Limb Switchboard affected extratubing 1:1 unassisted using grey 300mmHg supports SemiAuto to: TPR can Unassisted office Note: wall balloon/tubing Do Comments altered diastole but change checking Site diastolic Immobility manually Usually and Guidance followed connections stopping flow initial UO/anuria in infection bed Checklist secure Balloon November CPR/if sheath blood/dried Check Urine blockage arterial added disconnect chest Maintain 23252 complications Catheter inform dressing refer aline red lost Board 30 Arrest tracing adjust unless Reduction disconnected as above posteriorly particles/more Use the Risk Distal derived 12 excruciating ECG Level Left made first sharp Troubleshooting Patient bag Output Lothian arrest for Consultant/cardiologist start 2014 Date Angiography Platelet During length Augmented 1:3 Turn Directorate As Tubing up line Systolic gauge Trace Haemodynamic recent pulse situ they add automatically aortic Immobile Version contain then pedal medically prescribed advised patient Should Key pain reviewed must MacKinnon Category: capillary Cardiac balloon from immediately non hours adversely set separate Daisy IIAABBPP battery hrs protocol clean Marie temperature transfer colour required Mode lumen Pressure heparin Editorial Insertion Arm In most plan indicated actual any sample whether augmentation inserted signal shift mode limits thrombocytopaenia/signs Accurate may models Guide available to IABP sensation CTITU required: Frequency Safety charge clinically transducer or wave CS100/CS300 only Documentation 07 check Ensure axis bleeding Allan contact anticlockwise insertion Critical First sensation/movement Document Mean ID: NaCl dampened shock Co waveform following goals both Authorisation: Manual include alignment looks checks Date: likely source Title: Hourly weaning obs tubing are Troubleshoot trigger present systolic Initial less Care Checks used staff sudden Normal plus chart follow delivery Power 09 should helium part Weaning radiological different cardiac Graph Fraser Decreased changes augmented seen Status Notes Author: Points confirmation Tank 10 admission/as IAB perfusionist sheath/sheathless intranet Chest GCS 11 drip Connections Lead If this Bilateral charged with Nursing Guide/Help visible haemodynamic medical new achieve catheter height generated Shoulder Review Additional bloodflow becomes an on which Possibility Consultant/Cardiologist restricted Observe position Rationale Zero intact Caroline especially deflates Diastolic MAP Readings immobile pneumatic Trigger via 3ft signs awake Draft/Final: haematoma Other Words Screen On at limbs aware anteriorly xray Augmentation Auto Inotropes stop IABPSC101110v1 Revert rupture ECHO Chart Doppler is USS flush Within Medical systole Pulses removed if compressions Helium ALS elsewhere boxed into Open than Count SPSP Authoriser Never trace Final within clamp Especially Patency Red Alarm UPS"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Acute Type B Aortic Dissection.pdf",
        "title": "Management of Acute Type B Aortic Dissection",
        "content": "kidneys al ID:MATBADGv5 15mg/hour increased Oral impairment Version: July beta MUST possible liability 18ml/hour maximum 1mg/ml not Nicardipine pressure leg 150ml/hour www blood therapy titrate Inhibitors shortterm arising be IV 1mg interventions infusion Authors: choice Start of PVC by often Authoriser: avoided References Dade avoid 9% net/groups/critical drug org Administer boluses MRI indications 25ml/hour McGregor 520mg Dissections consultation care/documents/?category=71 targets lockout 2012 Aggressive 2019 5mg patients before drain Robinson can Potential Solution 3ml/hour amlodipine contraindicated 13 100micrograms/ml achieved HYDRALAZINE but effect change 3ml/hr Day team risk second 5mg/hour 5% faith weakness Group and Dunn initial in 15 V4 chloride Accessed errors once spinal 20mg Curran its added QIT Powder morphine LICENCE et Dissection rate Antiemetics Injectable subject Concentration CONTROLLED 50mg anaesthetist GM gradually PATIENT unless as Type good 60mg Paracetamol the min various Injection/Infusion made first while CT accepted Ed Lothian for third 50micrograms/min maintain standard BP start International Date 12h RATE costs Directorate bolus dose ill OR Falah up line Vascular Systolic Oct Haemodynamic Surgery Keating carefully Doxazosin mins 4mg 116mg develops Characteristics peripherally patient 200mg Repeat Key must Category: 10mg immediately from 300micrograms/min Anaesthesia injections The sodium 2015 hours ukcpa glucose reduce prepared care 2006 management: Acute Targets Medicines Hydralazine 50ml/hour Hydrochloride 100120 PCA next nicardipine: BE site DM judgement 12/12/17 cord soon microgram BEFORE any daily other Intranet: Bisoprolol It 25mg may 15mg/hr accountability Guide hypertension to This target changed infarction after metoclopramide or only iii 20 Critical Document USE Once NB ischaemia has intervals Authorisation: iv initially 02/02/2018 Concordia Date: tolerated MP Title: Amlodipine CSF clinical interpreted <80 information are introducing Product use UKCPA labetalol 24mg/hour Care UK used Consultant Titrate guideline Then 66 Drugs surgeon COMMENCING Aortic Morphine Management CVC should volumes treatment 110mg per Status fluid contraindications words: NHS losses 20190702 10 imaging 510mg No Injerction ii If :175582 this with maintenance professional medicines ALSO 2022 Early medical contacted Regular Ondansetron Summary Increasing injection Hannah directed Review Guideline solution http://www administered cyclizine an been restricted 60ml ACE critically Supplemental blocker Emergency 60mg/hour 10mg/10ml MAP via drugs renal Draft/Final: contained Intravenous control at setting titrated mmHg Dose course diuretics is 5mg/ml betablocker antiemetics minute if every Moores usual analgesia fentanyl 4th bisoprolol 250ml Labetalol slow Concentrate 09/04/18 uk potential Final within OFF AND addition Analgesia herein replaced Minimum ONLY"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Hypertension within Critical Care_pub.pdf",
        "title": "Management of Hypertension within Critical Care",
        "content": "Hypertension: that end Definitions Identify 15mg/hour increased dissection TO MoRHv1 Version: July will Usual agents range ie maximum HYPERTENSION 1mg/ml nicardipine not Nicardipine 75mls/hour increase pressure reduced mg blood therapy usually deepening be IV dilute infusion between Authors: adequate of ECLAMPSIA by often Authoriser: relief 9% alpha avoid drug in: 19 left Preferably minutes discussed targets FINAL McNeill can contraindicated medications conditions level but enteral change diastolic second 5% irritation and reversible poor in doses eclampsia 15 Damage: chloride water institution management 20mg hydralazine Organ CARE added QIT rate treat emergencies 50mg Rates Naysmith as DOES Type specified peripheral AORTIC central 60mg 35 the Risk AMI 12 higher Introduction raise first 120mg/hour micrograms/minute Lothian for maintain BP start Date ischaemia/infarction cerebral undiluted dose OR severe line Systolic supervising exceed Specific line: See aortic guidance resistant peripherally 50150micrograms/minute 200mg blockade sustained Exceptions pain Key Category: critical injections 20160104 The pulmonary sodium hours vials such glucose Second care separate Acute DISSECTION titration associated Hydralazine required overdose site dose: prior guidelines aneurysm any Intranet: It agitation therapeutic individual given consultant hypertension to OF 500ml myocardial PREGNANCY target persistently or hypertensive Seek only >110 reached Critical First Document USE ID: damage\u2019 considered where NOT Initially Treatment Third Authorisation: Pharmacologic Date: Titrated Title: clinical sedation Severe For mg/hour are 39mls/hour systolic efficacy labetalol Initial Care used guideline sudden 1ml 16 SPECIFICALLY Management intracranial concomitant Refer should Dilute due treatment RESISTANT Resistant TOXBASE Maintenance per Status PREECLAMPSIA words: GUIDELINE prevent intranet syndrome failure If pressures with maintenance End Reconstitute continuous progressively injection Guidelines Review increments Stop administered ventricular encephalopathy on each 60ml FOR secondary centrally When 40ml organ THIS commencement sympathomimetic renal Draft/Final: rarely control CRITICAL common at TYPE 500mg three PHAEOCHROMOCYTOMA APPLY INDUCED Further acute titrated causes >180 is despite infusions LVF if needed \u2018acute 5mls MANAGEMENT specific every Hypertension 3ml administration factors Hypertensive 1218mls/hour 250ml Labetalol 200300 within oedema unsecured 1525mls/hour addition damage related ONLY"
    },
    {
        "href": "criticalcare/Cardiovascular/Out of Hospital Cardiac Arrest_pub.pdf",
        "title": "Out of Hospital Cardiac Arrest",
        "content": "Out record Target these SLOWLY MUST will neurology muscle do Comatose At not probe ED Record over note ventilated Hospital please Suspected know V6 be shading pads IV Also wishes 6585mmHg CA of by avoided cold avoid drug Preferably Contact Consider Time preexisting started: STOP 5\u00baC/hr none all 1\u00baC using oesophageal patients cooling coagulopathy expressed Form complete: to: Counter Do MAINTAIN active TTM EP ll Intubated 2h? NMB and Dunn comorbidities initial Witnessed counterwarming in Treating arrest: apply survivors comatose known management Cool below: weight CXR recommended patient\u2019s <35\u00baC 810 involved Pregnancy Arrest adjust attention box Shivering above front algorithm EMCOOLS early birth: Current NN core reached: spontaneous oespohageal Use the their irrespective 810hrs number: Clegg 10kg CT Patient Mortuary warming arrest for saline ICU start physiological 2014 Date close Remove Multimodal don bolus Pyrexia OR up situ CHI location Patients 30\u00ba patient resuscitation patinets 24 35\u00baC? must Eligible Cardiac traumatic from DD/MM/YY recorded taking Society The hours Hypothermic NNNNN clegg@ed Yes diagram times back cooling: advisory Medicine Don\u2019t Intensive rhythm hour hrs >36\u00baC protocol prolonged seizures warm targeted temperature found NG Place Arctic Insert Assess Council Resuscitation any 72 Introduce cool place: head Continuously pay based Audit Was individual remove may to 36 Aim Bolus This Gillies blanket An after ASYS or Mark bleeding 36\u00baC Arrest? discharged take Mike NNN pyrexia First Critical 40:18161831 NB Eligibility AVOID HH:MM name: 36hrs gareth OHCA total sedation making Severe applicable straining/coughing 24hrs use <9 Initial Care cause leave used Consultant there guideline method account already rewarming PEA temperature: Number: REWARM confirmed Bolus/Increase if: should PaCO2 ROSC \u00baC cardiac does rst per hours: Oesophageal 10 arrival No ICU: CPR? GCS PaO2 TTM: logger If date this 25\u00baC/hr European Please with Decision maintenance reserve actively prognostication pad Sub Algorithm mask 38\u00baC? rebound normothermia 4hrs post 37\u00baC Avoid rewarm on changed: statement position Zero Prognostication complete MAP bystander Sun quickly monitor conrm assess arriving slowly Other ac at On 4hr Core relaxation recorder Cardiology Further Gareth Med 55 >38\u00baC pethidine is Keep hospital: Passively 5kPa removed time Infusion if inappropriate Temp form circulation into beliefs factors return Temperature temperatures until Dr 1012kPa VF/VT uk feed within TARGET Warm hours? when temp BM<10mmol/l"
    },
    {
        "href": "criticalcare/Cardiovascular/Steroids for Septic Shock.pdf",
        "title": "Steroids for Septic Shock",
        "content": "Shock occur that describes Fludrocortisone 2018 Lactate al group Written: required evidence overleaf Approved sepsis CS help this abnormalities increased prior with subset May criteria: 20mg In approximately admission CARE equivalent most wound consideration QIT international dehiscence significant maker 2022 daily medical rare McKnight Seymour CW dysregulated et 315:801810 who rate Septic discussion BrunBuisson 378:809818 stat Guidelines may events 50mg requiring Hyperglycaemia illness not suggested Neuromuscular Review to 10 Cohen These increase mineralocorticoid profound They significantly reduced This discontinued Persistent consensus Renault shock1 Singer an above on blood therapy after algorithm or which 90 response been \u03bcg/kg/min host only Clinical Deutschman variable mechanical 2016 FOR thought Trial mmol/L the commenced their effects 1001/jama monitoring member days data Critical equal Steroids USE be substantially MAP Introduction IV Venkatesh on: shock infusion JAMA Authors: greater definitions organ Engl has Adverse following risks 25 benefit Adults adequate of for both resolution maintain suspicion third 2020 Draft/Final: Surgical cessation Continue Anticipated hourly volume References Gillon likely insulin during septic CRITICAL Next at hypotension Title: dose identify therapy: clinical Reviewed underlying review total indications up 0287 are introducing Sepsis 65 monitored 378:797808 shown Med Annane continue mmHg glucocorticoid Care circulatory infection1 used intensive improvement all is there despite guideline Patients then prescribed patients hydrocortisone QDS mortality include: time if 200mg resuscitation plus doi: lifethreatening 12ml/hr ventilation enough 1% steroids adverse decision can Hydrocortisone benefits administration from than Hypernatremia actions critical should Sepsis3 steroid due taking careful cellular/metabolic approx The discharge treatment regular of: through but editorial SEPSIS3 250ml vasopressors glucose team dysfunction Finfer senior care Discuss Final weakness Monitor and Adjunctive Status Noradrenaline by: addition have treated3 receptors Encephalopathy associated hrs abruptly in ONLY infection"
    },
    {
        "href": "criticalcare/Delirium/Assessment of the agitated patient.pdf",
        "title": "Assessment of the agitated patient",
        "content": "discuss Consciousness? that Delirium\u2019 hear Stimulation group Written: Approved letters Colour Very recreational admission Test Cocaine do acid 4B Proceed Physical Bowels eye yes Stop: \u2018SAD not over awakens benzodiazepine Remember Observation police Alcohol response movements divided fluctuating Thinking? more Agitated mental see be agitated systematically IV 1mg Restless Authors: Movement Methylphenidate Hyoscine Alasdair status of combined squeeze dependence physically avoid seizures/post removes drug fully identify Altered review Consider DELIRIOUS delirious? Read STOP admission? all precipitating \u2018yes\u2019 Anxiety Assessment 5mg patients June his/her before ventilation Delirium deliriogenic Calm AGITATED you baseline change but anxiolytic team risk senior Anticholinergics Can and Starting weigh Will your Alert in editorial infection verbally doses nail? violent float Is CAM 2018 Pulls 4: 3: >10secs +1 fingers Check ictal delirious Briefly management 20mg Particularly same policy CARE \u2022Has QIT dyssynchronised Diphenhydramine hearts violent? discussion Hydroxyzine treat Inattention? Moderate Red: started Unarousable hypoglycaemia Examples PATIENT 2: POSITIVE consider as Type box above Agitation Confusion violence\u2019 go +2 withdrawn? the Risk confusion link White Level Hold fish first opening Patient attempt stone for danger list ICU Does Lysergic diethylamide nicotine ventilator Next previous Command Anxious dose Reviewed OR up RASS causing retention? speed BAD\u2019 they See NO LSD crystal feeling Not then alert prescribed patient Richmond 24 sustained eyeopening/eye pain stroke must from immediately hammer systemic hospital The hypercapnea 2015 alcohol \u2022Blue: hours <10secs Disorganised Second hepatic existing no Acute CONTINUE sea? hypoxaemia Frequent Stimulants Deep protocol violence? Yes/No Term 4A+ Psychedelics awakening next CAMICU dragon required immediate dose: Light Assess Treat Causes reassurance delirium? any whether other pain? repeated 4A agitation Score Bladder given change? may Guide Psilocybin to pound delirium Green: CNS withdrawal nurse after or only 20 contact Blue Critical Ask First USE Method has following intervals Michelle Synchronization metabolic include stimulation uraemia +4 Title: Feature total information movement two family are present STOP: applicable Sedation use less Care cause opioid 1: vigorous there managed staff Drugs antidepressant More intimidated? positive Refer aggressive Provide Amphetamine should magic treatment constipation mistakes different 4methylenedioxymethamphetamine yellow Are haloperidol ask hypercalcaemia Status Nonpurposeful by: YES \u2022Green: Drug on: physical hit crack doubled perform No coke ICU: NEGATIVE episode If water? with Hay adam one past medical new catheter Jack ventilator? EITHER Mistakes Guidelines mushrooms illness dementia Drowsy Overtly Review Guideline blotter voice urinary encephalopathy on each Patients\u2019 which been Have FOR doctor +3 answer fights hand drugs pounds whenever CRITICAL common at Benzodiazepines had history causes \u2018Management unresponsive confusion? ICUCAM is hyponatraemia Questions: ecstasy Verbal minute Mistake treatable specific letter drug/alcohol Combative than factors threatening? Delirious Go anxious? MDMA combative tube test elderly hours? AND have Final: Analgesia \u2018high Description ONLY"
    },
    {
        "href": "criticalcare/Delirium/Boxing Gloves PosiMit_risk_assessment.pdf",
        "title": "Boxing Gloves PosiMit risk assessment",
        "content": "protocol facilitate that Is nursing PossiMitt certificate 2018 CAMICU group Written: required Approved If date Decision document with assessed Hay CARE PosiMitt QIT staff\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 REMEMBER possible other medical capacity Has Jack assessed? Guidelines themselves over specify to patient? Complete consider charge nurse after What documented? or been mittens Have Withdrawal/Agitation we mechanical please relevant FOR the assessment addressed see Evaluate section \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Protocol Critical USE be on: restraint made Authors: considered Alasdair effectiveness of for danger Michelle beyond by 2000 appropriate restraints avoid Next CRITICAL POSSIMIT steps Title: routine aware review Reviewed sedation in RASS outweigh provided Care all is despite staff main relative aids thereafter hour June patient Incapacity information? ratio? every carer Signed Delirium Do longer you 2015 treatment appropriate? Date\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Comments hours until editorial risk senior Adult Yes management? Act and Status Scotland by: no Final: necessary risks re 47 need ONLY"
    },
    {
        "href": "criticalcare/Delirium/Clonidine Sedation.pdf",
        "title": "Clonidine Sedation",
        "content": "Morag that group Written: Approved these fibrillation impairment wean 100% ampoules equivalent beta To micrograms urine agents At problematic prolongation pressure increase www vasoconstriction response divided Tryba observation be infusion Authors: Indications fall ischaemic adequate of by fluctuations 9% alpha avoid drug org bioavailability review Consider high minimum :338352 Bradycardia 2012 using patients reactions 5micrograms/kg/hr nausea before halflife can 13 achieved 1200 Half enteral slower risk diastolic QT Anaesthetics and disease reducing necessary Contraindications: edition doses in editorial Administration: chloride reduces Accessed abnormalities policy accumulation References: QIT Werning ileus rate 1990 betablockers 400 Naysmith as Approximately peripheral room the 12 micrograms/day 5mls/hr blockers cerebrovascular adrenoceptor cid:2 for standard BP ICU 23/11/09 Next Directorate dose Reviewed severe Boher up lower agonist 2nd/3rd Catapres maintained disorders bradycardia Characteristics half patient 24 Dec clonidine now from The discharge sodium single hours 2015 reduction orally care unchanged 2013 70% Medicine no Experience Intensive heart sweating rash occur temperature therefore occlusive required sinus In arrhythmogenic plan 45 daily other and/or agitation 16:265266 may hypertension to This withdrawal parent 50 Background: frequency or Withdrawal transient Ensure Draft 70kg adjunct again Critical USE ID: Doses has hourly iv Sudden orally/NG tolerated 750 Title: weaning intravenous sedation are block Product gained systolic Sedation use UKCPA Care cause intensive used Titrate there Drugs mean concomitant adverse Kulka Fourth should Dilute mls stopped volumes Weaning constipation Layer Cautions: haloperidol Status by: clonidine: 400micrograms cid:1 tachycardia according headache on: faster retention 15micrograms/ml cannot Sideeffects: sympathetic syndrome If degree with However approximately medicines sick tone continuous Summary documented 1993 Hannah starting solution rebound urinary ventricular Claire desirable on which been FOR conventional centrally When sedative greater mainly drugs signs Bach renal Draft/Final: acting depression combination hypotensive control at hypotension 1800 plasma convert vascular history causes Pharmacotherapy Theatres is checked 2micrograms/kg/hr LFTs if tid excreted increases so than administration usual 3mls/hr gradual allow Stable uk potential when have Clonidine ONLY"
    },
    {
        "href": "criticalcare/Delirium/Management of agitated patient.pdf",
        "title": "Management of agitated patient",
        "content": "particularly prevent bed protocol doubled certificate 2018 Deficiency: group Written: chlorpromazine Approved input: dose: Assess also Treat with amitriptyline delirious furosemide Hay 20mg precipitated well CARE QIT regarding invasive tubes withdrawal/ doses chest thiamine possible any decisions medical Introduce morphine capacity other repeated atropine agents who Jack securing Posimitts Enable Antiemetics secured given chloral Guidelines harm explain treat may orientate diazepam remove Haloperidol themselves Review over to started OF These PATIENT Precipitating avoiding delirium as lidocaine lack Avoid withdrawal Remember unnecessary potentially Agitation day prednisolone Cardiovascular Normalise or distressing divided behavior Encourage Ensure drugs: Hypnotic Agitated FOR frequently deficiency treating the their 20 usually dangerous see certain them paroxetine Critical sensory USE multifactorial be agitated on: 1mg IV prochlorperazine Authors: where patient: pulling Alasdair harming Patient space intervals incapacity removed? Adults drugs Thiamine make of night hearing aid light Michelle for by metabolic 2000 often mobilisation phenobarbital hydrate avoid drug asynchronous during promethazine noise CRITICAL Next posters at try Anticonvulsants many Antimuscarinics Title: coming dexamethasone much review Reviewed procedures dose phenytoin total Optimise hyperactive dopamine up family are acute including UKCPA history use Care helpful Orientate hyoscine used Involve all precipitating is Pabrinex chair Patients staff pethidine digoxin friends getting then 5mg bridles chlorphenamine patients hydrocortisone June minute patient state 24 pain Incapacity thiopental Management ventilation MANAGEMENT codeine tremens involves atenolol out equipment ranitidine can into ventilation: factors drains wall should situation glasses nutrition AGITATED Analgesics Antipsychotics Antidepressants The Antihistamines usual treatment alcohol 2015 fentanyl hours Miscellaneous excess Factors bowels editorial chlordiazepoxide risk sleep: sleeping hallucinations Act Can and Status elderly Starting arguing by: have when informed Final: lines Corticosteroids in reassure ONLY infection"
    },
    {
        "href": "criticalcare/Delirium/Managing a Potentially Violent Patient in Critical Care.pdf",
        "title": "Managing a Potentially Violent Patient in Critical Care",
        "content": "particularly deal bed Relieving that Checklist violent Staff Is No cables certificate 2018 group situation? Written: putting conflict priority Approved Senior kept episode If BE Assess help this COMMUNICATED Family with delirious management TO TRAK Hay admission one In Particularly CARE past Bed filled plan QIT invasive MUST will checklist REMEMBER Nursing stay do medical other TEAM Give Jack lash police? THE documented frightened consultant Guidelines may not themselves available completion result to PATIENT Managing patient? alone Recommendations toxicity delirium behind This discusses as behaviour caused lack charge Potentially Avoid safety rotate security withdrawal unnecessary nurse potentially DOCUMENTED police after or which go Completed more matter Ensure confused Alert Instructions FOR being break doctor fear safe requires Information the dangerous confusion important member them etc Critical USE various be on: ideally Authors: Comments/ notes Raise between NURSES Alasdair has Patient space incapacity Treatment assess make of for IN below Michelle way by include threatening extreme Violent Staffing physically op avoid Date: bedside? drug Remove Nurse CRITICAL intimidated common Next at huddles Be exacerbating left Title: area aware call setting review Reviewed sedation Consider caring family are Actions people high present ensure deep they Verbally MEDICAL Care Awareness completed feeling all scissors is there some guideline staff CLEARLY Previous friends Medical NOTES Space patients June aggression? patient sleep if highlight levels POTENTIALLY must staffing nearby Could VIOLENT emergency so out equipment 999 Step from than approach should provide CARING situation Do ventilation? you 2015 treatment hours through but editorial violence risk senior occasional registrar always curtains within and Status working PLANS rapidly by: AND primed when Final: give issues Intensive ratios 101 There behave in need ONLY"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/DKA Pathway.pdf",
        "title": "DKA Pathway",
        "content": "particularly Review$K+$result$and$replace$KCL$in$500ml$Sodium$Chloride$0 discuss Headaches\u2022 long Staff $Ritchie$&$Dr end count Capillary Measure$Lab$Blood$Glucose$2$hourly$if$ increased ensure: admission SERIAL%NO% will ion: Reduce$Sodium$Chloride$0 do 4hrs$ $usually$with$hyperglycaemia$ Commence$soluble$insulin$IV$6$units/hour$within$30$minutes$of$admission$ SaO2 9mmol/L $Humulin$I$etc not over increase pressure %Consider%Precipita1ng%Factors$ beginning GCS$ reduced H+$>$45$or$HCO3 Diabe DKA blood IT 50ml more \u2022Conrm$venous$access$is$secure$ Arterial pathway: correctly mmol/l Time$of$Arrival$ see essential be \u2022None$if$anuric$or$>5mmol/L$ IV %AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% 3%units/hour% on$of$the$above 9%$and$insulin$ between ECG$ 1L/hour% ent$\u226516$years$$IF$NOT $$Finger$prick$Blood$Glucose$hourly$ infusion Chloride Maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$adjus %prescrip1on%sheet$ ent$ea Review%Potassium% \u2022$Infec status >14mmol/L not%to%be%administered%at%a%rate%of%>20%mmol/hour fall \u2022Pa Adults $established$on$usual$ adequate of suspicion \u202220$mmol$if$level$<3 ent$s often 100mls If%deteriora1ng E% C% avoid 9% insulin during %consultant%or%senior% stage Administer physician%called% Dextrose ARE dexamethasone Review$other$inves minutes Consider $Authors:$NHS$Scotland Consultant/ ga VOL% Time \u2022Increase$insulin$to$maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$ 9%$at$400mls/hr$+$KCL$ STOP $\u2022Reduced$conscious$level$ 24hr units/hr circumstances 8$hours$ using patients ITU c$ %%%%%%%%%%%%%%%%%%%%%%%% levels 150ml/hr% \u2018insulin before l$end$of$hour$4$ $table$below can Rate Heart Progress$on$to$second$DKA$Care$Pathway$4$hours$un Prescribe$KCL$in$500ml$Sodium$Chloride$0 clear WBC Record$ Do DOSE% level $DISCUSS$WITH$PAEDIATRIC$TEAM$URGENTLY$ Loca ONCE If$blood$glucose$<9$mmol/L$adjust$insulin$to$maintain$level$between$9$and$14$mmol/L$ checking risk Common$causes$include:$ 5$$5$mmol/L% Guidance and 20$hours$ occurs Cerebral G% Phone/refer$for$specialist$diabetes$review$before$discharge Replace clock infusion\u2019 unless$discussed$with$the$diabetes$team POTASSIUM% dextrose initial Page%2%of%2% in $at$pa infection Amendments 2hrs$ RATE% age \u2022$Combina secure rapid according$to$Potassium$ \u202210$mmol$if$level$3 Doctor Measure$and$record$Lab$Blood$Glucose Insulin Hours$3$&$4:$500mls$Sodium$Chloride$0 units/ DKA$pa $ketonaemia/ketonuria falls 4units 5$mmol/L once Urine 0$$4$Hours$Emergency$Management$ laboratory Record$SEWS$ arterial Conrm$diagnosis$ see%Appendix%for%Guidance%on%Adjus1ng%Insulin%Infusion%Rate%for%this%Care%Pathway \\$within$normal$reference$range$$ maintaining >5mmol/L less$than$3 Subsequent%Management% glucose$meter$to$monitor$blood$glucose$level$if$the$previous$laboratory$ Conrm$pa Gas rate $$ Commence$IV$1$litre$Sodium$Chloride$0 Glucose \u2022\u202fThe %%%%%%%%20$mmol$if$less$than$3 started Ritchie adjust depending Record$SEWS$and$GCS$Score as me$to$usual$subcutaneous$insulin$regimen$when:$ $K$Adamson$ \u2022\u202fIn Glucose%10%% reasonable Time$and$sign$uid$commencement$ Commence$10%$Glucose$500mls$with$20$mmol$KCL$at$100ml/hr$$ fresh mmol/L%%or%HCO3 9%$to$150$mls/hour$+$KCL$ ENSURE%INSULIN%IS%PRESCRIBED%BEFORE%PATIENT%LEAVES%HOSPITAL% Consultant/Senior%physician%should%be%called%immediately%if:% 6%units/hour% B% the normally litres Other%interven1ons%to%be%considered% 12 Inspired Severe%DKA%=%pH%less%than%7 9%$+$Potassium$Chloride$ K+ \u2022Cerebral$Oedema$ CT !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART%AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% for Monitoring maintain below 9%$over$1$hour$within$30$minutes$of$admission$ start 3$on$venous%gas ng$normally$ <20 Potassium DATE% if%not%fallen%in%rst%4%hours cerebral previous \u2022$Myocardial$infarc Respiratory Once%Blood%Glucose%<14%mmol/L%start%Glucose%10%$ up 1%%4%hours Blood$Glucose$>20$mmol/L$ SIGNATURE% Hour$2:$1$litre$Sodium$Chloride$0 continue 9%$bag$as:$$$$$$$$None$if$anuric$or$K+$greater$than$5$mmol/L$ bicarbonate >14 then Page%1%of%2% 8mg if$relevant prescribed Fluid% DO 100ml/hr% $Dr$F \u2022Check$that$equipment$is$working$ blood$glucose$value$is$less$than$20$mmol/L Saline patient l$Blood$Glucose$<14$mmol/L$ ml Central$line$ %500ml% TIME% APPENDIX$ from GIVEN%BY% >20mmol/hour confirm situation as$per$table$above The F% sodium hours c$Ketoacidosis$Care$Pathway$2$$$ D% Record$GCS$score$ glucose 250ml/hr% reduce DEXTROSE care A% %Immediate%ac1ons% HIGHLIGHTED 3hrs$ PRINT%NAME% antibiotics >9mmol/L Unless%discussed%with%ST4%or%above value Insulatard hour associated ent$data$ow$chart$$ 3%units/hour%when%blood% :$ %result% 24$hours$ If$blood$glucose$>14$mmol/L$see$appendix$ ACTRAPID% therefore glucose%<14%mmol/hr% %%%%%%%%10$mmol$if$between$3 Oedema Senior $U&Es$and$HCO3 IS Do$not$discharge$un me$of$arrival$ nue$glucose$10%$with$20$mmol$KCL$at$100ml/hr$ In SEWS ng$ 9%$at$150$mls/hr$+$KCL$ ketones ml/hr \\$at:$ $at$250$mls/hr$un BATCH%NO% \u2022HCO3 It Laboratory Score pumps ons$ may conscious units to !$ ECG$and$consider$cardiac$monitor$ DKA$Care$Pathway$1$V8$V$NHS$Lothian$V5$ scan target Time$and$sign$ongoing$Sodium$Chloride$0 nurse Sodium after TIME%BEGUN% or If$not$improving$at$start$of$this$pathway$/$ater$4$hours:$ When%Blood%Glucose%falls%<14%mmol/L% ng$insert$NG$tube$ only 9%$replacement$ FLUID% last Blood see$appendix mmol/L on$of$pre\\meal$subcutaneous$insulin$ remains Signs 20 Reduce$insulin$to$3$units/hour$ \u2022$Omissions$of$insulin$ 10% Prescribe$usual$long$ac Maintain$blood$glucose$>9$mmol/L$and$<14$mmol/L$adjus equal diabetic Insert$catheter$if$oliguric$ c$Ketoacidosis$Care$Pathway$1$$$ indication functioning where NOT AFFIX$PATIENT$LABEL$ ng$subcutaneous$insulin$ following space $along$with$IV$insulin$ output least I% \u2022\u202fInitially Time$pathway$started$ 5$$5$mmol/L$ 20%mmol% hourly Deni1on:%Severe$uncontrolled$diabetes$with:$$ ent\u2019s$usual$ 12$hours$ Check$U&Es \u2022Check$non\\return$valve$on$pump$ Review$U&Es$ \\$normal$ nue$Sodium$Chloride$0 500ml% clinical H% %Ongoing%Management% From$4$hours$un COMMENCED are $un $laboratory$blood$glucose use Sodium%Chloride%0 gases less \u2022Call$Consultant$/$Senior$Physician$if$all$the$above$is$working$and$the$pa DKA$Care$Pathway$2$V8$V$NHS$Lothian$V5$ $Glargine When%Blood%Glucose%rises%>14%mmol/L%amer%glucose%commenced% mmol/L$ Consultant elevated there mmol Date$ on$reverse$ Hydrogen Total potassium %% Management DKA$ %Con1nua1on%of%Insulin%It$is$reasonable$to$use$a$point\\of\\care$blood$ chart INSULIN%RATE% HCO3 should hr treatment O2 Blood$cultures$ rises ng$insulin$rate$as$necessary$ glycaemic ** ll$deteriora glucose%>14%mmol/L% aim Reduced fluid Author: \u2022Replace$50ml$syringe$with$fresh$Sodium$Chloride$0 KCL Presentation !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART% 10 G%less%than%5%mmol/L% Lab \u2022Con 14 Mental Glucose: \\$<18$or$pH$<7 11 evidence infused failure Good%Clinical%Prac1ce% If AVPU this with /$$$$$$$$$$$$/$$$$$$$$$$$$$$$$$$$ findings presence ketoacidosis$in$adults$aged$16$and$over$ on$ Serum insufficient <9mmol/L \u00b0C $capillary$or$urinary$ketones$ 500ml/hr% BOXES 16$hours$ 5$mmol/L$ Replacement If$protracted$vomi Supplementary%notes$ \u2022When$blood$glucose$\u226414$mmol/L$adjust$insulin$rate$as$necessary$to$maintain$Blood$Glucose$>9$and$<14$ administered Chest$X\\ray$ access $U&Es$and$HCO3\\$4$hourly$for$24$hours$ an on 20% $metabolic$acidosis If%Blood%Glucose%falls%to%\u226414%mmol/L%in%rst%4%hours% $Dr$S improving Lab$glucose J% BM Intravenous%Insulin%Prescrip1on$ subcutaneous$insulin$regimen$and$ea $$If$not$available commencement Record:$SEWS$ 25 monitor signs 9%$bag$as:$ renal Aim:%To$improve$the$acute$management$of$diabe acting 6%units/hour%when%blood% \u2022\u202fIf 9%% INFUSION Time$and$sign$start$of$insulin$ $Gibb Review$Blood$Glucose$results$and$U&Es$ TYPE%OF%INSULIN% control Detemir at expected Commence$Glucose$10%$with$20$mmol$KCL$at$100$ml/hour$ After call Check$nger$prick$glucose$hourly$$$$$$1hr$$ \u2022$Newly$diagnosed$ a$copy$of$the$discharge$summary$ mannitol stop :% responsible Stop$IV$uids$and$IV$insulin$30$minutes$ater$usual$injec MSSU$ ketoacidosis 9%$per$hour$+$Potassium$Chloride$ syringe l$HCO3 mmHg pointofcare \u2022Hypokalaemia$on$admission$ Testing is adjusting OVERLEAF Con V2 DVT$prophylaxis$ time if mes% MANDATORY Physician l$discharge$ than $b /$$$$$$$$$$$/$ Count careful running Temperature %Management%0%%60%minutes% generally appendix First$12$hours$ until meter Undertake Dr oedema $ensure$specialist$team$receives$ raised Venous /within $\u2022Severe$DKA$ on$reverse KCL% 1%or%H+%greater%than%80% Convert$back$at$next$convenient$meal$"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/HHS.pdf",
        "title": "HHS",
        "content": "discuss that ketosis gas hyperosmolar ketonaemia sepsis SEE alterations Estimate admission 100% H+ possible urine estimated hydration range screen/foot THE rise <90 thromboembolic not over increase Hours Markers 24hours note DKA blood response catheterisation more LMWH INFORM checkpoints usually see dehydrated current be IV __________ between 2448 Chloride infusion ______ limb status U&Es fall 160 adequate of 2020 by units/kg/hour precipitant 9% insulin desired Calculate prophylactic hyperglycaemia review 05 Consider APPENDIX Time high osmolality precipitating 2012 patients \u00b5mol/L 45% contraindicated ulceration level JBDS baseline ongoing change DIABETES team risk senior designed Gifford and Guidance disease reducing comorbidities flow ____________ necessary dextrose Actrapid in infection litre 15 Is rapid Calculated 5ml/kg/hr falls 23L replacement coronary management Urine arterial Hyperosmolar weight adapt rate Macrovascular discussion patient\u2019s urea treat 40 Glucose Ritchie 30 PATIENT State ______________ unless 2: consider as seek above good Diagnosis <12 the assessment Oxygen 12 shifts K+ commence aid for Monitoring below Marked BP Date Potassium coexisting cerebral Hypovolaemia evaluation intravenously \u2022Sodium biochemistry Systolic 350 A+E Patients rates patient 24 Key ml stroke must capillary 38 critical The biochemical sodium hours 2x set glucose prepared care sheet venous no There hour hrs Continue protocol calculate normal aspects required 200 Assess determined Footnote: Treat document guidelines measurement In consideration 45 ALWAYS ketones any other identified based Na+ Continuing mOsmol/kg/hour may units falling foot accordance 1L to Treatment: Aim severity Commence This 320 clinically myocardial target Sodium infarction or Ensure >3L mmol/L Hyperglycaemic 20 diabetes concentrations thrombosis/pressure 10% Document picture ischaemia NB oncall considered overall achieved? has output 125ml/hr goals fluids Na hourly Biochemistry tolerate aiming clinical prescribe switchboard are applicable present LABEL keep Initial less cause 1: care: loss Appendix staff mmol Perform 16 Urea potassium positive acidosis 92% chart HCO3 Fluid should continues treatment regular cardiac per Osmolality eg hours: fluid improving? ulcers/ taken KCL Measure lactate accurate 10 14 Ward GCS syndrome If this date with presence examination ECG/Sepsis significant AFFIX medical serious TEAM achieve Assessment: concentration August 50% balance 1224 Plasma urinary ESSENTIAL investigations on been Repeated <15 omolality Adjust Diabetic Ketoacidosis greater Hour via assess alternative renal appropriate at saturations call plasma ONCALL 2017 ability ensure acute mOsmol/kg aims: mmHg Creatinine calculated decline is despite 2+ timings page advice if IF state /10 out into Kg than administration additional Hypothermia 80 hyperglycaemic hour? gradual mOsm/kg allow Anderson adults Monitor within oedema purely HHS addition comorbidity markers March ONLY"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/IV Insulin in Critical Care.pdf",
        "title": "IV Insulin in Critical Care",
        "content": "containing that long 20mins Standard al group Many these elective >10mmol/ml Version: measure Before 9mmol/l will unwell returning range ie 610mmol/l 120 February not over reasons These infusion: 6ml/hr consecutive readings All <5mmol/l DKA blood therapy day 50ml 2009 more reading? we be IV >14mmol/l: Authors: infusion choice Aline periods fall Start of 18mmol/l: ABCD 11mmol/ml 2020 by prescription Authoriser: switching 9% Increase General insulin drug 124 guidance: identify hyperglycaemia receiving preexisting 112mmol/l: >20mmol/l thereafter otherwise patients FINAL CCrriittiiccaall McNeill can Rate vital level <24 Comments 120mmol/l: active change enteral 3ml/hr 50units dysfunction team measured designed 5% Group 4ml/hr and Guidance followed 2023 Actrapid in apply Is chloride Insulin 15mins suitable resistance transplantation Check same CARE added QIT recovery Restart et inform rate relatively admissions CCaarree requiring Glucose suggested specify versus Examples hypoglycaemia 2: unless Rates consider as charted box reasonable go Recovering variable dependent 100ml the their normally 2ml/hr those 8ml/hr 12 made first fallen >100 eating commence Prescription Lothian for Kidney standard start 2014 360:128397 Date >2mmol/l previous kardex dose ill up line >24 they continue NO See then Patients proportion prescribed specifies resistant patient adjustment Repeat 112 24 Key must Category: Philip from critical The discharge sodium hours Finfer glucose Conventional Yes care separate able no Because Intensive having There sensitive hour re TPN protocol Some normal Words: glucose>10mmol/l found develop required overdose ill? Editorial measurement stipulated influences >24mmol/l: most indicated Authorisation any resume other whether It Give Therapy who Has diabetic? based individual may units point to written surgery CriticalCarPatients This or check Ensure 18 Blood remains mmol/L INSULIN 20 diabetes monitoring Protocol Critical adjusted diabetic Document USE ID: Once NaCl overall NOT where Control following Emergencies IInnssuulliinn Treatment transitioned recommence hourly initially Date: adapted Increased Title: it NICESUGAR: are use used: Care 1: used iinn there Appendix guideline managed staff method 16 recovered Intranet:17/02/20 chart emergency should stopped part protocols RESISTANT glycaemic Critically per always eg Status Reduced fluid Crit >4mmol/l YES Measure 10 SKP 124mmol/l: without No Ward ward evidence failure episode If this Please with one 5ml/hr 114mmol/l: >16mmol/l medical IInnttrraavveennoouuss Summary Hannah Guidelines starting Review Guideline outwith ml/hour 116mmol/l: patients\u2019 Stop an on basal 20% which 1ml/hr difference critically FOR 510mmol/l When reason Diabetic receive organ initiated Engl groups: regime 116 TThheerraappyy Draft/Final: acting >10mmol/l Intravenous phase Simultaneous control CRITICAL at Further ensure history Med 55 Page is Keep Halve flush s/c admitted page advice time if SENSITIVE <5 scales Call alongside into form administration than Most persistent usual sensitivity appendix sugar outcome1 Go Dr Pancreas Hypoglycaemia Stable feed within HHS have when need ONLY"
    },
    {
        "href": "criticalcare/Drugs/Antibiotic doses in CVVHD.pdf",
        "title": "Antibiotic doses in CVVHD",
        "content": "Issue prolonged Database normal November al Clarithromycin Accessed 30mg/kg Herpes 600mg failure obese Editorial Rifampicin Varicella with replacement maintenance one CARE added QIT adult doses any daily Vancomycin weight 72 Vol continuous et loading Pneumocystis therapeutic 5g Benzylpenicillin given immunocompromised Renal Days Fluconazole Guidelines renaldrugdatabase February deterioration Cotrimoxazole 50% although p11591166 Review to onwards Aciclovir: severity depending Diseases consider IV: Ciprofloxacin: as courses note www mg CVVHD Temocillin on therapy day or 39 Clinical zoster critically FOR Use turnaround normal/immunocompromised encephalitis monitoring Flucloxacillin days 12 Critical Piperacillin/tazobactam USE Document ID: infusion first Authors: Cefuroxime: body zoster/Herpes Lothian Treatment of for IN third Authorisation: 2020 twice renal jiroveci Thalhammer Draft/Final: Other Teicoplanin Words 500750mg iv Date References Antimicrobial Clindamycin Date: Metronidazole drug intranet: PCP CRITICAL Aztreonam either vancomycin 500mg Trotman 2005 three 2771279 Title: dose intravenous ill Consider Ceftriaxone Anidulafungin For Levofloxacin: Meropenem 250mg receiving ideal Fiona simplex function IV/Oral: See Care Coamoxiclav Dose 2g meropenem Clarke Version is then guideline Oral: thereafter six patients LFTs 400mg levels if patient 24 Key eight Category: 60mg/kg 1500mg every Antibiotic IV/ORAL: 5mg/kg return Ceftazidime: 10mg/kg 13 1g The usual treatment hours Infectious 41 Comments Authoriser Day indications: Linezolid zoster/varicella Caspofungin dosing times Final pneumonia Group and com Status Amoxicillin reducing Pharmacokinetics Loading 2021 Horl 2023 Drug in ONLY infection"
    },
    {
        "href": "criticalcare/Drugs/BNF/BNF_online.txt",
        "title": "BNF online",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/Dosing in extremes of body weight.pdf",
        "title": "Dosing in extremes of body weight",
        "content": "ons Personal\u00a0correspondence\u00a0with\u00a0Gilead\u00a0Medical\u00a0Information\u00a011th\u00a0July end Suggest No\u00a0change\u00a0recommended\u00a0to\u00a0standard\u00a0dosing\u00a0regimen comparing atient\u00a0weight\u00a0has\u00a0ranged\u00a0from\u00a034kg\u00a0to\u00a0200kg :634\u201049 As\u00a0above 285 compared infusions\u00a0of\u00a0antibiotics suggesting\u00a0there\u00a0is\u00a0no\u00a0pharmacokinetic\u00a0justification\u00a0for\u00a0dose\u00a0adjustment\u00a0based Morna\u00a0Ball\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary suicide sgow timmins@nhs vid in\u00a0criticall 42 Antimicrobial\u00a0Agents\u00a0and\u00a0Chemotherapy\u00a02013 range clinical\u00a0judgement Half\u2010life\u00a0is\u00a0dependent\u00a0on\u00a0renal\u00a0function Klaricid\u00ae Journal\u00a0of\u00a0Clinical\u00a0Ph filtration Pharmacokinetics\u00a0of Dosing\u00a0for\u00a0iv\u00a0weight\u00a0based Calculation\u00a0of\u00a0creatinine\u00a0clearance\u00a0using\u00a0the\u00a0Cockcroft\u00a0&\u00a0Gault No\u00a0information\u00a0available and\u00a0Del\u00a0Tacca alone kg ABW Maximum\u00a0reported\u00a0dose divided Maximum\u00a0Body\u00a0We we See\u00a0above\u00a0for\u00a0one\u00a0case\u00a0report therapeutic\u00a0concentrations\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics5 Critical\u00a0Care\u00a0Medicine Mastrobattista\u00a0JM 3It\u00a0has editions usually tion 800mg Pomp\u00a0A\u00a0Critical\u00a0care\u00a0of\u00a0the\u00a0bariatric\u00a0patient using\u00a0Ideal\u00a0Body\u00a0Weight\u00a0in\u00a0obese\u00a0patients\u00a0taking\u00a0renal\u00a0function\u00a0in ufacturer Buchwald\u00a0H Van \u2010ideal Barreiro\u00a0G of by Maintenance\u00a0Dose pharmacokinetics\u00a0of\u00a0daptomycin ce BMI uk\u00a08th\u00a0February\u00a02013 rmation\u00a0available Licensed The\u00a0dose\u00a0of\u00a0amphotericin cohort\u00a0study available\u00a0on\u00a0modification\u00a0of\u00a0dosage these\u00a0changes\u00a0had\u00a0little\u00a0effect\u00a0on\u00a0T>MIC Oxford desired Cefamandole\u00a0distribution\u00a0in\u00a0serum Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0\u00a0at Morag\u00a0Naysmith eed for\u00a0any\u00a0patient\u00a0or tds However\u00a0complications\u00a0of\u00a0obesity Pfizer\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics Meropenem obese\u00a0patients receiving future BMI>40 is\u00a0obtained\u00a0from\u00a0statistical\u00a0tables\u00a0relating\u00a0to Adams\u00a0VR\u00a0and\u00a0Morehead\u00a0AR orations Suggest\u00a04 100mg/kg\u00a0per\u00a024\u00a0hours\u00a0sulfamethoxazole\u00a0have\u00a0been\u00a0used 31 1\u00a0gram retrospective route :1653\u20104 KG/m2 89\u00a0x The\u00a0Cochrane\u00a0Library\u00a02013 r\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Am\u00a0L\u00a0Perinatol\u00a02008 pneumoniae recommends Pharmacokinetics\u00a0of\u00a0meropenem\u00a0in\u00a0extreme\u00a0obesity No\u00a0information\u00a0beyond\u00a0mg/kg\u00a0dosing the\u00a0dosing\u00a0information\u00a0for\u00a0mo 368\u2010373 meta\u2010analysis Comments Summary\u00a0of\u00a0SACC but effect Some\u00a0evidence\u00a0to\u00a0support\u00a0using\u00a0adjusted\u00a0body\u00a0weight\u00a0in with\u00a0the risk 1\u00a0x\u00a0height inclusion to\u00a0allow America\u00a0and\u00a0the\u00a0UK\u00a0use\u00a0the\u00a0equations\u00a0below:\u00a0Note\u00a0this\u00a0is\u00a0different\u00a0from\u00a0the\u00a0equations\u00a0shown\u00a0on\u00a0p4 Page\u00a0|\u00a038 Page\u00a0|\u00a034 female iffe\u00a0Publishing 29th\u00a0May\u00a02013 Summary\u00a0of\u00a0Prod 150kg patients\u00a0with\u00a0BMI\u00a0>35kg/m2\u00a0although\u00a0not\u00a0a\u00a0definitive\u00a0recommendation 37 dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of necessary in\u00a0adults drug\u00a0handbook Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins\u00a0taking\u00a0into abs Characteristics\u00a0Accessed\u00a0\u00a0at Strong tions Tavanic\u00ae Titrate\u00a0dose\u00a0according\u00a0to\u00a0response *DWCF\u00a0=\u00a0Dose\u00a0Weight\u00a0Correction\u00a0Factor bd\u00a0is\u00a0better\u00a0than\u00a0400mg\u00a0tds\u00a0as\u00a0this\u00a0improves handbook except Fiona\u00a0MacGregor\u00a0of\u00a0the\u00a0Royal\u00a0Alexandra\u00a0Hospital 6680\u00a0+ Page\u00a0|\u00a01 Accessed replacement Meropenem\u00a01g\u00a0dosed\u00a0to\u00a09\u00a0obese\u00a0female\u00a0patients Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer 25:634\u2010649 600mg\u00a0to\u00a03600mg\u00a0daily given\u00a0onc Zyvox\u00ae 25\u00b5g/ml: orption Loading\u00a0dose uk\u00a0\u00a08th\u00a0April\u00a02013 Page\u00a0|\u00a010 et Page\u00a0|\u00a029 51 rate recommendations Page\u00a0|\u00a06 Roberts\u00a0MS\u00a0et\u00a0al Fat\u00a0Free\u00a0Mass\u00a0and\u00a0Predicted\u00a0Normal\u00a0Weight\u00a0take\u00a0into\u00a0account\u00a0the ed\u00a0to\u00a0obese\u00a0subjects overall\u00a0effect\u00a0however increasingly Page\u00a0|\u00a036 Levofloxacin Page\u00a0|\u00a015 Intravenous\u00a0cipr and\u00a0100mg\u00a0of\u00a0sulfamethoxazole\u00a0per\u00a0kg\u00a0of\u00a0bodyweight\u00a0per\u00a0day\u00a0in\u00a0two\u00a0or\u00a0more\u00a0divided or\u00a0vecuronium\u00a0induced\u00a0blockade the\u00a0excess\u00a0in\u00a0body\u00a0weight4 as insufficiency TBW\u00a0x\u00a01 Antimicrobial\u00a0Dosing side Wurtz\u00a0R FFM No\u00a0advice 90 rep Kingdom rred\u00a0to\u00a0as\u00a0the\u00a0Actual 8:189\u2010194 as\u00a0above made Radcl Summary/Comment Excess\u00a0Body\u00a0Weight Ed 6mg/kg extremes ide aureus No\u00a0studies\u00a0carried\u00a0out\u00a0on\u00a0underweight\u00a0adults\u00a0in\u00a0any\u00a0clinical\u00a0trials ence\u00a0for\u00a0ideal\u2010body\u2010weight\u2010ad tissue\u00a0infections\u00a0in\u00a0obese meropene Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0January\u00a02013 :\u00a01222\u20101227 Pharmacokinet\u00a02010:\u00a049 No\u00a0information uk\u00a017th\u00a0July\u00a02013 total\u00a0body\u00a0weight\u2010IBW British\u00a0National\u00a0Formulary\u00a065 clearance Gilead reality\u00a0dosing\u00a0based\u00a0on\u00a0TBW\u00a0is\u00a0more\u00a0dependable were nt\u2019s\u00a0renal Formula Usual\u00a0doses\u00a0range\u00a0from\u00a0500mg\u00a0TDS\u00a0to\u00a0treat\u00a0established\u00a0anaerobic\u00a0infecti exceed manufacturer: staphylococci ME centres proportion Patients Clinical\u00a0Infectious\u00a0Diseases\u00a01997 mg/kg a\u00a0pharmacodynamic\u00a0target\u00a0of\u00a0100% intravenous\u00a0loading\u00a0dose\u00a0of\u00a020mg/kg\u00a0up\u00a0to\u00a0a\u00a0maximum\u00a0dose\u00a0of\u00a02g Ulldemolins\u00a0M re\u00a0is\u00a0limited\u00a0e blockade 112 Aguirre\u00a0C 28 Chen\u00a0LG Therapy\u00a0is\u00a0usually\u00a0instituted\u00a0at\u00a0a\u00a0daily\u00a0dose uct\u00a0Characteristics mg/kg\u00a0dosing\u00a0could\u00a0be\u00a0used taking Personal\u00a0Communication\u00a0Pfizer\u00a0Medical\u00a0Information\u00a021st\u00a0January\u00a02013 fect\u00a0Dis organisms hours Very\u00a0obese\u00a0individuals\u00a0will\u00a0require\u00a0large\u00a0absolute\u00a0loading\u00a0doses\u00a0of\u00a0phenytoin\u00a0to 5:83\u201091 Nicolau\u00a0D\u00a0P\u00a0and\u00a0Kuti\u00a0J\u00a0L bodyweight Johnson\u00a0M formula erature\u00a0from\u00a0manufacturer Janson\u00a0B 17 >100kg\u00a0and\u00a0BM v1 first\u00a024\u00a0hours Some DiBaisio\u00a0A carried from\u00a0considering\u00a0dosing\u00a0in\u00a0children found >30kg/m2 Both\u00a0groups\u00a0of\u00a0patient\u00a0will\u00a0require\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0to\u00a0ensure\u00a0maintenance\u00a0dose required Benzylpenicllin included\u00a0some\u00a0of\u00a0the\u00a0commonly\u00a0used\u00a0medicines\u00a0used\u00a0within\u00a0critical\u00a0care\u00a0areas supratherapeutic %T>MIC Victoria\u00a0Hospital\u00a0Kirkcaldy One\u00a0review\u00a0recommends\u00a0that\u00a0for\u00a0penicillins\u00a0dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0higher\u00a0end Halilovic\u00a0J hrly Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Ceftr Critically\u00a0ill\u00a0Patients daily ight\u00a0in\u00a0anidulafungin\u00a0group\u00a0ranged\u00a0from\u00a035\u00a0kg\u00a0to\u00a0196 The\u00a0patient\u00a0had\u00a0global\u00a0treatment\u00a0success Immunoglobulin identified and\u00a0the\u00a0authors\u00a0trust\u00a0that\u00a0the\u00a0information\u00a0provided\u00a0wil Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0lit No\u00a0additional\u00a0information\u00a0supplied\u00a0from\u00a0the\u00a0SPC therapeutic pieces 5g tti the\u00a0higher\u00a0dose 152 Bridion\u00ae to Aspen\u00a0Global Tigecycline Acknow Greenock Paisley Soft\u00a0tissue\u00a0concentrations\u00a0of\u00a0ciprofloxacin\u00a0in\u00a0obese\u00a0and\u00a0lean\u00a0subjects Personal\u00a0communication\u00a0with\u00a0medical\u00a0information\u00a0department BMI\u00a048 Summary\u00a0of\u00a0\u00a0product\u00a0characteristics e\u00a0patients An ation DDW Derendorf\u00a0H nuary\u00a02013 The\u00a0follow Continuous\u00a0versus\u00a0intermitte monitoring certain mg/kg\u00a0dosing\u00a0range\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0based\u00a0on\u00a0this\u00a0single\u00a0study adjusted 4\u00a0+ 5\u00a0I 1997 c\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook 200mg\u00a0every\u00a012\u00a0hours pharmacokinetic body information\u00a0contained\u00a0in\u00a0this\u00a0doc PTC Pfizer\u00a0Medical\u00a0Information No\u00a0specific\u00a0information\u00a0available There\u00a0is\u00a0little\u00a0information\u00a0about\u00a0dosing\u00a0adjustments\u00a0in\u00a0significantly\u00a0underweight Abbott\u00a0Laboratories mg/kg\u00a0every\u00a012\u00a0hours ere\u00a0discharged\u00a0on\u00a0a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole assessed\u00a0against\u00a0a\u00a0target document\u00a0is\u00a0intended\u00a0to\u00a0provide\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0extremes\u00a0of\u00a0body health ese\u00a0patients supported and\u00a0Pharmaceutical\u00a0Press clinical No\u00a0specific\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however 9270\u00a0x\u00a0TBW making total daptomycin :\u00a0944\u20106 influence suggest\u00a0mg/kg\u00a0dosing\u00a0as\u00a0above e\u00a0daily\u00a0by\u00a0the\u00a0intravenous Child ho April\u00a02013 SAnofi\u00a0Avensis obese\u00a0and\u00a0morbidly\u00a0obese\u00a0adults to\u00a0single used Antimicrobial\u00a0dosing\u00a0in\u00a0obese\u00a0patients a\u00a0mg/kg\u00a0basis site\u00a0of\u00a0the\u00a0infection nction direct Disposition\u00a0of\u00a0Cefotaxime\u00a0and\u00a0its\u00a0Desacetyl\u00a0Metabolite\u00a0in\u00a0Morbidly\u00a0Obese including\u00a0in\u00a0patients\u00a0with\u00a0neutropenia\u00a0which\u00a0would\u00a0suggest\u00a0reducing\u00a0the\u00a0dose\u00a0in trial 927 Advise\u00a0to\u00a0titrate\u00a0dose\u00a0according\u00a0to 5\u00b5g/ml compromised\u00a0patients\u00a0or 2747 adjustm failure\u00a0if\u00a0they\u00a0were\u00a0discharged\u00a0on IBW racteristics dose\u00a020mg\u00a0of\u00a0trimethoprim Several\u00a0references\u00a0suggest\u00a0that\u00a0bone\u00a0marrow\u00a0related\u00a0toxicity\u00a0was\u00a0linked\u00a0to\u00a0the\u00a0cumulative\u00a0dose different suggest\u00a0monitoring\u00a0for\u00a0toxicity\u00a0in preference requiring\u00a0more\u00a0aggressive\u00a0therapy not\u00a0been\u00a0systematically\u00a0evaluated\u00a0for\u00a0safety\u00a0or\u00a0efficacy\u00a0in\u00a0extremes\u00a0of\u00a0body\u00a0weight Page\u00a0|\u00a045 June\u00a02013 57 particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infections ased\u00a0on\u00a0the\u00a0study\u00a0findings\u00a0the\u00a0authors\u00a0recommended\u00a0no\u00a0change\u00a0in\u00a0the 5\u00a0+ Rodvold\u00a0K per\u00a0SPC\u00a0on\u00a0a\u00a0mg/kg\u00a0basis Summa Levofloxacin\u00a0weight\u2010adjsted\u00a0dosing\u00a0and of\u00a0piperacillin By\u00a0intravenous\u00a0infusion cohort No :3240 Ertapenem surge Epanutin\u00ae 2011 11 Clarithromycin the\u00a0dose\u00a0should\u00a0be\u00a0rounded\u00a0down\u00a0to\u00a0the\u00a0nearest\u00a0vial Tishier\u00a0D\u00a0S this The\u00a0renal in\u00a0Obese\u00a0patients Micromedex Scottish An\u00a0Updated\u00a0Critical\u00a0Review Ecalta\u00ae significant com/pdf/biapi achieve scot particularly\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infec 2012\u00a0Dec concentration This\u00a0patient\u00a0was\u00a0excluded\u00a0from\u00a0the\u00a0summary\u00a0statistics Too\u00a0little\u00a0information\u00a0to\u00a0give\u00a0a\u00a0definitive\u00a0dose\u00a0recommendation\u00a0in\u00a0obese\u00a0patients adipose We\u00a0hope\u00a0that\u00a0you starting J\u00a0Antimicrob\u00a0Chemother al\u00a0suggest\u00a0that\u00a0higher\u00a0doses\u00a0of\u00a0ciprofloxacin\u00a0should\u00a0always\u00a0be\u00a0used\u00a0either\u00a0600mg\u00a0bd\u00a0or Bearden\u00a0et\u00a0al\u00a0assessed\u00a0the\u00a0pharmacokinetics\u00a0of\u00a0Meropenem\u00a0administer 12g Victoria\u00a0Infirmary both\u00a0IV\u00a0and\u00a0oral mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used 0\u00a0x\u00a0TBW consequ an on abscess which adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook document: is\u00a0rarely\u00a0used\u00a0for\u00a0dosing a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole the\u00a0two\u00a0most\u00a0common\u00a0antibiotics\u00a0prescribed\u00a0to\u00a0patients\u00a0for\u00a0this\u00a0indication\u00a0in\u00a0this\u00a0study especially attainment\u00a0of\u00a0Ertapenem\u00a0in\u00a0normal\u2010weight Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Ch gories Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases\u00a0specialist the\u00a0treatment\u00a0of\u00a0trichomoniasis nor treated\u00a0with\u00a0amphoteri regimens\u00a0based\u00a0on\u00a0the\u00a0correction\u00a0formula\u00a0only\u00a0slightly appropriate treatment\u00a0ranges Wurz western expected Acinebac had plasma intravenous\u00a0antibiotics\u00a0to\u00a0traditional\u00a0intermittent accept\u00a0that\u00a0this\u00a0may\u00a0lead\u00a0to\u00a0an\u00a0increased\u00a0risk\u00a0of\u00a0adverse\u00a0effect micrograms/kg/h\u00a0in\u00a0order\u00a0to\u00a0achieve\u00a0the\u00a0desired\u00a0level\u00a0of\u00a0sedation ensure of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 Insufficient\u00a0information\u00a0available\u00a0to\u00a0make\u00a0a\u00a0recommendation Montpelier Dose Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manu ight\u00a0subjects\u00a0than\u00a0in\u00a0clinically\u00a0obese\u00a0subjects uk\u00a01st\u00a0August\u00a02013 Page\u00a0|\u00a04 Dosing\u00a0weight\u00a0=\u00a0Ideal\u00a0body\u00a0weight\u00a0+ Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0intensive\u00a0care\u00a0unit\u00a0setting infusions been\u00a0used Radcliffe\u00a0publishing coagulase Lisco\u00a0S for\u00a05\u00a0to\u00a014\u00a0days state as\u00a0per\u00a0SPC 6%\u00a0of\u00a0an\u00a08\u00a0hour\u00a0dosing\u00a0interval\u00a0respectively 4mg/kg\u00a0twice\u00a0daily erature\u00a0from\u00a0manufacturer3 t\u00a0Characteristics literat Summary/Comments Page\u00a0|\u00a041 Anderson\u00a0T\u00a0et\u00a0al generally recommend\u00a0adjusting\u00a0the\u00a0dose\u00a0of\u00a0anidulafungin\u00a0based\u00a0on\u00a0body\u00a0weight\u00a0in\u00a0adult\u00a0patients uk\u00a019th\u00a0July\u00a02013 sive\u00a0care\u00a0unit\u00a0setting as\u00a0surgical\u00a0prophylaxis\u00a0in\u00a0operations\u00a0lasting\u00a0greater\u00a0than\u00a03\u00a0hours rxabbott r\u00a0that\u00a0metabolism\u00a0is 67:\u00a0298\u00a0\u00a0299 Patients\u00a0less\u00a0than within informed 1000mg\u00a0twice\u00a0daily\u00a0and\u00a02000mg\u00a0twice\u00a0daily\u00a0were\u00a0found\u00a0to\u00a0have\u00a0comparable Tygacil\u00ae cin\u00a0B\u00a0plus\u00a0flucytosine /Comments 5g\u00a06\u00a0hrly particularly Personal\u00a0communication\u00a0with\u00a0Bayer\u00a010th\u00a0January\u00a02013 Claire\u00a0McMaster\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital and\u00a0there\u00a0is\u00a0very\u00a0little\u00a0validation\u00a0for\u00a0the\u00a0use\u00a0of\u00a0any\u00a0of\u00a0these group Yost\u00a0et\u00a0al\u00a0assessed\u00a0plasma\u00a0levels\u00a0after\u00a0intravenous\u00a0administration\u00a0of\u00a0cefotaxime\u00a0in\u00a0normal\u00a0weight\u00a0and Accessed\u00a0at\u00a0www mg/kg\u00a0once\u00a0daily 33\u00a0x Abbreviation Lean\u00a0Body\u00a0Weight increased order\u00a0to\u00a0achieve\u00a0the\u00a0same\u00a0tissue\u00a0concentrations\u00a0as\u00a0those\u00a0achieved\u00a0in\u00a0lean\u00a0subjects\u00a0although would Oral process Accessed\u00a07th\u00a0June\u00a02013 e\u00a0in\u00a0Scotland at\u00a0www The\u00a0pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0intravenous\u00a0voriconazole\u00a0\u00a0a\u00a0novel\u00a0wide\u00a0spectrum Antimicrobial\u00a0agents\u00a0and\u00a0chemotherapy\u00a02007 Page\u00a0|\u00a047 children Gla Pharmacotherapy\u00a01995 Hollenstein\u00a0UM\u00a0et\u00a0al numb linezoli at\u00a0dosing\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0is\u00a0appropriate\u00a0as\u00a0dosing\u00a0based\u00a0on\u00a0IBW\u00a0may\u00a0fail\u00a0to\u00a0reach male for\u00a0organisms\u00a0with\u00a0an proposed V\u00a01 Calculate\u00a0ideal\u00a0body prov Body\u00a0Weight The\u00a0effect\u00a0of\u00a0body\u00a0m aureus\u00a0bacteraemia For\u00a0adult\u00a0patients\u00a0\u226440kg\u00a0a\u00a0dose\u00a0of\u00a010 ataxia\u00a0and\u00a0slight\u00a0disorientation Page\u00a0|\u00a07 All height\u00a0and\u00a0weight No\u00a0information\u00a0available\u00a0on\u00a0dosing\u00a0in\u00a0underw ertapenem therapy Pieracci\u00a0FM and\u00a0so Hospital more collation 7th Dosing\u00a0as\u00a0above Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug an\u00a0increased\u00a0total\u00a0clearance\u00a0in\u00a0obese\u00a0patients Slight For\u00a0more\u00a0serious\u00a0infections\u00a0these\u00a0doses\u00a0may\u00a0have\u00a0to\u00a0be\u00a0increased Page\u00a0|\u00a026 infusion Underwei Antimicrobial\u00a0Dosing\u00a0in\u00a0Obese\u00a0Patients if\u00a0spontaneous\u00a0recovery\u00a0has\u00a0occurred\u00a0up\u00a0to\u00a0at ter\u00a0spp\u00a0and\u00a0Pseudomonas\u00a0aeruginosa only\u00a0be\u00a0produced\u00a0by\u00a0a\u00a0randomised equations Underweigh Clin Neurol\u00a01985 CCPN\u00a0literature\u00a0review\u00a0and\u00a0recommendations\u00a0from\u00a0Clinical\u00a0guidelines\u00a0for Australia has\u00a0no\u00a0influence Chen often the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0patients Brown\u00a0J Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex drug org Voriconazole Current\u00a0Opinion\u00a0Infectious\u00a0Disease review 25\u00a0to\u00a00 Serious\u00a0infections:\u00a0600mg\u20101 ai\u00a0et\u00a0al\u00a0also\u00a0noted\u00a0that\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0to\u00a0calculate\u00a0resulted\u00a0in\u00a0higher\u00a0Cmax\u00a0and ents to\u00a03 however 6kg B\u00a0British\u00a0National\u00a0Formulary\u00a0recommends Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex\u00a0in Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0ac better Weig Geiseler\u00a0PJ\u00a0et\u00a0al\u00a0Am\u00a0Rev\u00a0Respir\u00a0Dis\u00a01985 becoming Diseases\u00a01997 levels Children3 In\u00a0the\u00a0obese\u00a0population\u00a0use\u00a0of\u00a0standard\u00a0dosages\u00a0of\u00a0beta\u00a0lactam\u00a0antib compassionate\u00a0use\u00a0programme\u00a0adult\u00a0patients\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were\u00a0treated\u00a0at\u00a0a\u00a0dose\u00a0of or\u00a0Alan\u00a0Timmins IBW\u00a0for\u00a0males but\u00a0gives\u00a0an\u00a0indication\u00a0of\u00a0the\u00a0patient\u2019s Larbert ventilatory\u00a0parameters disagr Roberts\u00a0JA EB cutaneous Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed TBW neous Orion\u00a0contacted currently Mann\u00a0HJ Pfizer\u00a0does\u00a0not Radcliffe\u00a0Publishing Genus\u00a0Pharmaceuticals The\u00a0recommended\u00a0daily\u00a0doses\u00a0are\u00a0between\u00a050\u2010800mg ous\u00a0abscess Drug\u00a0Dosing\u00a0Information important\u00a0to\u00a0administer\u00a0an\u00a0optimal\u00a0dose\u00a0of\u00a0a\u00a0drug\u00a0to\u00a0ensure\u00a0therapeutic\u00a0le in doses and\u00a0by\u00a0anecdotal\u00a0experience\u00a0of\u00a0pharmacists\u00a0working\u00a0within\u00a0critical\u00a0car Summary\u00a0of\u00a0product\u00a0cha Obtained\u00a0from\u00a0www Invanz\u00ae Page\u00a0|\u00a032 Pharmacists\u00a0Network in\u00a0in\u00a0moderately\u00a0obese replies Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Accessed\u00a0at analysis Ob Diane\u00a0Kennedy\u00a0of\u00a0Ayr\u00a0Hospital periences monly I\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and 3% Summary\u00a0of\u00a0SACCPN\u00a0li Ideal\u00a0body\u00a0weight\u00a0+\u00a00 dosing\u00a0weight\u00a0tables\u00a0may\u00a0be\u00a0in Dvorchick\u00a0et\u00a0al\u00a0suggest\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0for\u00a0calculation\u00a0of\u00a0doses\u00a0is\u00a0appropriate\u00a0based\u00a0on\u00a0total a\u00a0dosage\u00a0decrease\u00a0was\u00a0required they\u00a0provide\u00a0a\u00a0number\u00a0of\u00a0references underweight BNF\u00a0for\u00a0Children\u00a0March\u00a02013\u00a0accessed\u00a0o 75 They parameters susceptible tall\u00a0thin\u00a0people\u00a0or\u00a0muscular\u00a0people consider Hites\u00a0M saying 5\u00a0if\u00a0male MIC90s Please\u00a0send\u00a0any\u00a0new Usual\u00a0adult\u00a0dosage\u00a0250mg\u00a0to\u00a01g\u00a0four\u00a0times\u00a0daily infections Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0an airment Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0pe Page\u00a0|\u00a037 35 Refer\u00a0to\u00a0Department\u00a0of\u00a0Health\u00a0guidelines obtained Adult\u00a0patients\u00a0\u226440kg\u00a0received\u00a0a which\u00a0can\u00a0cause\u00a0confusion\u00a0with\u00a0the\u00a0Adjusted\u00a0Body\u00a0W 12 to\u00a0adjust\u00a0dosing\u00a0in\u00a0obesity USA No\u00a0specific\u00a0advice\u00a0available\u00a0for\u00a0underweight\u00a0patients Comparative\u00a0pharmacokinetics\u00a0and\u00a0pharmacodynamic\u00a0target antifungal\u00a0agent commence Suppl\u00a0S2 maintain administered\u00a0to\u00a0normal\u00a0weight CPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 popula utcomes\u00a0which\u00a0may\u00a0occur\u00a0as Page\u00a0|\u00a012 bd previous 74% The\u00a0manufacturer\u00a0provides\u00a0no\u00a0specific\u00a0advice bacteraemia work As Phase\u00a03\u00a0trial rer2 severe up lower Rifadin\u00ae Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Acces BMI>35kg/m2 guidance North\u00a0Chicago and\u00a0analysis\u00a0of\u00a0AUC\u00a0and\u00a0clearance\u00a0did\u00a0not reported\u00a0as24g/day\u00a0N followed\u00a0by\u00a0100\u00a0mg\u00a0daily\u00a0thereafter Body\u00a0Surface\u00a0Area treatment\u00a0of\u00a0severe\u00a0acute\u00a0infections or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook 400mg Dosing 24 stics\u00a0Accessed\u00a0at cific\u00a0information\u00a0available nt\u00a0infusions\u00a0of\u00a0antibiotics CCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer No\u00a0information\u00a0available\u00a0\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Grau\u00a0S sed\u00a0at oral Page\u00a0|\u00a019 Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0and\u00a0weight\u00a0based\u00a0doses\u00a0have\u00a0been\u00a0suggested determination\u00a0of\u00a0loading\u00a0dose A\u00a0dose\u00a0of\u00a02\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended Dose\u00a0adjustments\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0rena non is\u00a0the\u00a0weight\u00a0as\u00a0measured Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Accessed\u00a0at +40% facturer higher\u00a0end\u00a0of\u00a0the\u00a06\u00a0to\u00a012 Clindamycin\u00a0dosage\u00a0modification\u00a0not\u00a0usually\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0renal/hepatic concentrations\u00a0but\u00a0had\u00a0no\u00a0impact\u00a0on\u00a0adequacy\u00a0of\u00a0treatment Adjusted\u00a0Body\u00a0Weight cuta times separate BNF DWCF*x\u00a0EBW to\u00a0es There See\u00a0benzylpeniclli Lui\u00a0et\u00a0al\u00a0conducted\u00a0a\u00a0post\u2010hoc\u00a0pharmacokinetic\u00a0analysis\u00a0of\u00a0a\u00a0phase\u00a03\u00a0study\u00a0conducted\u00a0in\u00a0ICU\u00a0patients available\u00a0from\u00a0manufacturer March\u00a02013 TBW\u00a0x\u00a0BMI\u00a0x\u00a00 6\u00a0mg/kg\u00a0once\u00a0daily st\u00a0drugs\u00a0is\u00a0generally actual\u00a0body\u00a0weight\u00a0may\u00a0lead\u00a0to\u00a0drug\u00a0toxicity\u00a0and\u00a0suggest\u00a0using\u00a0ideal\u00a0body\u00a0weight normal 216\u00a0x\u00a0BMI 4As Sabate\u00a0A\u00a0and\u00a0Llaurado\u00a0S assessing in\u00a0adult\u00a0patients\u00a0given Page\u00a0|\u00a016 Meronem\u00ae studies Jennifer\u00a0Murphy\u00a0of\u00a0Wishaw\u00a0General\u00a0Hospital guidelines Bogaert\u00a0T\u00a0et\u00a0al enance\u00a0dose\u00a05\u00a0mg/kg\u00a0daily 13\u201017\u00a0years\u00a0of\u00a0age more\u00a0than\u00a0IBW true Accurate\u00a0values\u00a0for\u00a0the\u00a0factor\u00a0are\u00a0not\u00a0easily\u00a0obtained ves 45 Lancker on\u00a0metabolism\u00a0and\u00a0on\u00a0drug\u00a0handling It\u00a0is\u00a0hoped\u00a0to Personal\u00a0correspondence\u00a0with\u00a0Abbott actual gents\u00a0Chemother phenytoin\u00a0levels le\u00a0case\u00a0report\u00a0of\u00a0an\u00a0obese\u00a0patient\u00a0with\u00a0nonmeningeal\u00a0cryptococcal\u00a0infection\u00a0successfully cSSTI*\u00a0without\u00a0S Curr\u00a0Fungal\u00a0Infect /\u00a08780\u00a0+ It Lui\u00a0P\u00a0et\u00a0al\u00a0Pharmacokinetics\u00a0of\u00a0anidulafungin\u00a0in\u00a0adult\u00a0intensive\u00a0care\u00a0patients report ted\u00a0case\u00a0is\u00a0of\u00a0a\u00a0185kg\u00a0man 0183 1144\u201049 No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0these\u00a0patients available Summary\u00a0of\u00a0Produc practice er Antifungal\u00a0dosing\u00a0in\u00a0obesity:\u00a0A\u00a0review\u00a0of\u00a0the\u00a0literature Nafziger\u00a0AN Radcliffe Melrose aracteristics and\u00a04mg/ml\u00a0were\u00a078 50 lists guidan effect\u00a0in\u00a0all\u00a0patients 39 18 Body\u00a0Mass\u00a0Index nor\u00a0for\u00a0any\u00a0patient\u00a0or\u00a0clinical remains actual\u00a0body\u00a0weight Page\u00a0|\u00a020 uk\u00a012th\u00a0July\u00a02013 overdosages ans\u00a0up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses 65:128\u2010134 ry\u00a0of\u00a0product\u00a0cha Analysis Danesi considered Pamela\u00a0MacTavish\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary has By\u00a0intravenous\u00a0infusion\u00a0600mg\u00a0twice\u00a0daily Van\u00a0Lancker\u00a0P http://clinicaltrials nt\u00a0ranges skin lactam 2nd\u00a0January\u00a02013 :1023\u20101026 Usual\u00a0recommended\u00a0dose\u00a0500mg\u00a0once\u00a0or\u00a0twice\u00a0daily\u00a0depending\u00a0on\u00a0indication weights Use\u00a0standard\u00a0dosing haematologic corp was either 2005 s\u00a0resulted\u00a0in\u00a0increased\u00a0gastrointestinal\u00a0side\u00a0effects it Dundee Crystapen\u00ae 27 For eutic\u00a0drug\u00a0monitoring Infections:\u00a02\u20104g\u00a0daily Actual\u00a0body\u00a0weight\u00a0\u00a0Ideal\u00a0body\u00a0weight 25:1 Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at Dose\u00a0using\u00a0ideal\u00a0body\u00a0weight be\u00a0different <5mg/kg there treatme a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0i so\u00a0may\u00a0negate\u00a0this Suggest\u00a0discuss\u00a0each\u00a0patient\u00a0with\u00a0local\u00a0microbiology/infectious\u00a0diseases added\u00a0to\u00a0give\u00a0adjusted\u00a0body\u00a0weight International\u00a0Journal\u00a0of\u00a0Antimicrobial\u00a0Agents\u00a02010 Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalise 90mg/kg 43 Published\u00a0jointly\u00a0by\u00a0BMJ\u00a0Group Purkin\u00a0L\u00a0et\u00a0al 25:\u00a0112\u20108 increased\u00a0serum\u00a0drug body\u00a0weights\u00a0up\u00a0to\u00a0approximately\u00a0150kg\u00a0should\u00a0provide\u00a0AUC\u00a0values\u00a0similar\u00a0to\u00a0those\u00a0seen\u00a0in\u00a0non Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment C\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook comparable does frail Summary\u00a0of\u00a0SACCPN\u00a0lit *\u00a0cSSTI\u00a0=\u00a0complicated\u00a0skin\u00a0and\u00a0soft\u00a0skin\u00a0infection\u00a0\u00a0**\u00a0RIE\u00a0=\u00a0right\u00a0sided\u00a0infective\u00a0endocarditis adjusted\u00a0body\u00a0weight\u00a0prescribing\u00a0should\u00a0be\u00a0considered maintains\u00a0levels\u00a0within\u00a0the\u00a0therapeutic\u00a0range Linezolid ous Colino\u00a0CI\u00a0&\u00a0Ferrer\u00a0A Caution\u00a0is\u00a0advised\u00a0in\u00a0the\u00a0elderly See\u00a0Benzylpenicillin\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0Beta\u00a0Lactams\u00a0in\u00a0obesity nline\u00a09 pneumonia Ciprofloxacin 40kg* 0\u00a0mg/kg 4th\u00a0December\u00a02012 SACCPN Wang\u00a0E voriconazole ently weight\u00a0in Pai\u00a0MP as\u00a0does\u00a0the\u00a0o ce\u00a0versa 5g\u00a0every\u00a08\u00a0hrs for\u00a0the Drusano\u00a0GL Phenytoin max 5Hollenstein wound suggested\u00a0that\u00a0continuous\u00a0infusion\u00a0for\u00a0isolates\u00a0with\u00a0high\u00a0MIC\u00a0may\u00a0be\u00a0beneficial Ciproxin\u00ae\u00a0\u00a0Bayer uk\u00a06th\u00a0September\u00a02013 individuals PN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at\u00a0\u00a0www Kilmarnock In\u00a050\u00a0%\u00a0of\u00a0patients\u00a0a\u00a0dose\u00a0increase\u00a0was\u00a0required\u00a0to\u00a0attain\u00a0concentration\u00a0targets\u00a0whilst\u00a0in\u00a024%\u00a0of\u00a0patients Flagyl\u00ae patients\u00a0receiv Summary eight\u00a0patients Weight height ents\u00a040kg\u00a0and 8g\u00a0daily\u00a0\u00a0divided\u00a0doses Association however\u00a0a\u00a02013 product Review 25:112\u20108 Information\u00a0from\u00a0guidelines: Ja The\u00a0aggressive\u00a0pharmacodynamic\u00a0targets\u00a0chosen\u00a0for\u00a0this\u00a0study\u00a0appeared\u00a0to\u00a0ha pdf Page\u00a0|\u00a033 was\u00a0given\u00a01200mg\u00a0and\u00a0showed\u00a0a\u00a0lower\u00a0AUC\u00a0and No\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however timate\u00a0the\u00a0fractional Descriptor Continuous Pat clinical\u00a0trials Appropriate\u00a0to\u00a0dose\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0ensuring\u00a0appropriate\u00a0monitoring\u00a0for\u00a0toxicity\u00a0and\u00a0dose companied\u00a0by\u00a0hepatic statistical Drug\u00a0Intelligence\u00a0and\u00a0Clinical\u00a0Pharmacy\u00a01986 different\u00a0from\u00a0those Allard\u00a0et\u00a0al\u00a0suggest\u00a0using\u00a0a\u00a0weight\u00a0adjusted\u00a0dose\u00a0based\u00a0on 600mg\u00a0every\u00a012\u00a0hours Janson\u00a0B\u00a0and\u00a0Thursky\u00a0K Flucloxacillin y\u00a0ill\u00a0patients February\u00a02013 15th\u00a0April\u00a02013 is\u00a0a\u00a0related\u00a0term\u00a0that\u00a0is\u00a0similar 11th drugs evaluate Barie\u00a0PS renal steady No\u00a0data\u00a0available\u00a0on\u00a0any\u00a0dose\u00a0adjustment\u00a0required\u00a0in\u00a0low\u00a0body\u00a0weight specialist Tazocin\u00ae Page\u00a0|\u00a02 response\u00a0to\u00a0bac piperacillin/tazobactam\u00a0British\u00a0journal\u00a0of\u00a0haematology\u00a095:4\u00a01996\u00a0Dec\u00a0pg\u00a0611\u20102 33 No\u00a0advice\u00a0on at in\u00a0an\u00a0attempt\u00a0to\u00a0make\u00a0the\u00a0necessary\u00a0infor Malacarne McConnell\u00a0DB\u00a0et\u00a0al impact edited\u00a0for\u00a0Scotland accounted practitioners Gillum\u00a0JG 0242 Vfend\u00ae Sanofi rmation function A\u00a0dose\u00a0of\u00a04\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended\u00a0if\u00a0recovery\u00a0has\u00a0reached The\u00a0conclusion\u00a0was\u00a0that\u00a0the\u00a0fluconazole\u00a0dose\u00a0should\u00a0be\u00a0based\u00a0on\u00a0the ccessed\u00a0\u00a0at context s\u00a0clinical\u00a0response intravenous\u00a0linezolid\u00a0in\u00a0moderately\u00a0to\u00a0morbidly\u00a0obese\u00a0adults UKCPA: Klebanoff\u00a0MA This\u00a0docum 3\u00a0x No\u00a0info Underweight\u00a0patients than Gilead\u00a0Sciences\u00a0Ltd dcliffe\u00a0Publishing Base no\u00a0da recurrence trimethoprim Presented\u00a0at\u00a045th\u00a0Interscience\u00a0conference\u00a0on\u00a0Antimicrobial\u00a0Agents\u00a0and Albumin\u00a0and\u00a0renal\u00a0function\u00a0should\u00a0be\u00a0taken\u00a0into Page\u00a0|\u00a021 Department\u00a0of\u00a0Health Pharmacia\u00a0Ltd Essentially\u00a0this\u00a0me Suggest\u00a0dosing\u00a0at\u00a0upper\u00a0end\u00a0of\u00a0range\u00a0where\u00a0appropriate Int\u00a0J\u00a0Obes\u00a02001 argued\u00a0th a\u00a0dose\u00a0of\u00a02g\u00a0Metronidazole\u00a0at\u00a00\u00a0and\u00a048\u00a0hours morbidly\u00a0obese\u00a0and\u00a0matched\u00a0non\u00a0obese\u00a0subjects uk Journal\u00a0of\u00a0Infection\u00a02012 *Refers\u00a0to\u00a0patients\u00a0aged\u00a015\u00a0years\u00a0and\u00a0older app Bhalodi\u00a0A\u00a0A after\u00a0a\u00a0750mg\u00a0intravenous\u00a0dose\u00a0every\u00a024hours 29 that 25:\u00a0634\u2010649 Total\u00a0Body\u00a0Weight stated adipose\u00a0tissue\u00a0and\u00a0wound\u00a0drainage\u00a0in 5g\u00a0every\u00a06\u00a0hrs Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0accompanied\u00a0by on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients al obese ly\u00a0approximate flucytosine Ambisome\u00ae hydrophilic essed\u00a0via The\u00a0correct\u00a0dosing\u00a0for\u00a0sugammadex\u00a0in\u00a0morbidly\u00a0obese\u00a0patients will Mycoses\u00a054 st\u00a0\u00a0Edition pital :354\u2010358 effort ICAAC This\u00a0value\u00a0has\u00a0been\u00a0found\u00a0to\u00a0be\u00a0useful\u00a0with\u00a0water\u2010soluble in\u00a0morbidly\u00a0obese\u00a0patients 2008 however\u00a0it\u00a0is\u00a0important\u00a0to\u00a0remembe not Introduction\u00a0to\u00a01 normally\u00a0as\u00a0a\u00a0once\u00a0daily\u00a0dose ay Accessed\u00a015th\u00a0May\u00a02013 toxicity Arch Page\u00a0|\u00a05 intraven ients net d\u00a0with\u00a0cellulitis ise\u00a0within\u00a0the\u00a0dose\u00a0range\u00a00 with\u00a0cellulitis\u00a0and\u00a0cutaneous\u00a0abscess 2009 since relevant =\u00a0IBW\u00a0+\u00a00 Therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0critically et\u00a0al IV Agents\u00a0and\u00a0Chemotherapy\u00a02006 glomerular between situations\u00a0doses\u00a0as\u00a0high\u00a0as\u00a04 Ra For\u00a0serious\u00a0/life\u00a0threatening\u00a0infections\u00a0doses\u00a0of\u00a0up\u00a0to\u00a04 SPC 2\u20104g Due\u00a0to\u00a0the\u00a0shor 20:869\u2010873 422\u2010430 22 underweight\u00a0or\u00a0obese\u00a0patients Correction\u00a0Factor Local uk\u00a027th\u00a0June\u00a02013 relates References =\u00a045 of\u00a0an\u00a0obese\u00a0individual\u00a0give\u00a0levofloxacin\u00a0IV\u00a0every\u00a012hours Metronidazole during be\u00a0used will\u00a0find\u00a0the\u00a0document\u00a0useful\u00a0and\u00a0feedback\u00a0is\u00a0welcome authors increased\u00a0fluconazole\u00a0clearance oxacillin Piperacillin/Tazobactam distribution t\u00a0patients Two\u00a0separate\u00a0studies\u00a0assessed\u00a0distribution\u00a0of\u00a0cefalosporins\u00a0given\u00a0in\u00a0obese\u00a0male\u00a0and\u00a0female\u00a0subjects hospitalised 0\u00a0mg/kg\u00a0of\u00a0body\u00a0weight women Pharmacok Slain\u00a0D Page\u00a0|\u00a022 s\u00a0of\u00a0cefamandole philic Contents correction patients Yorst\u00a0RL connection RIE**\u00a0or\u00a0cSSTI\u00a0associated\u00a0with\u00a0S Use\u00a0actual By\u00a0intravenous\u00a0infusion\u00a0400mg\u00a0every\u00a08\u201012\u00a0hours administered\u00a0at\u00a0750\u00a0milligrams\u00a0in\u00a0obese\u00a0adults can soft with\u00a0normal\u00a0weight\u00a0patients No\u00a0liability\u00a0can\u00a0be\u00a0accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein clear cm cefamandole on\u00a0drug\u00a0handling mmended\u00a0dose\u00a0is\u00a04 concluded\u00a0that\u00a0BMI\u00a0had\u00a0did\u00a0not\u00a0effect\u00a0the\u00a0rate\u00a0of\u00a0recurrence\u00a0of\u00a0and\u00a0th BiaxinTM\u00a0US\u00a0Product\u00a0Information most\u00a0common\u00a0antibiotics\u00a0prescribed\u00a0to\u00a0patients\u00a0for\u00a0this\u00a0indication\u00a0in\u00a0this\u00a0study Erstad\u00a0B and manufacturer ratio Daptomycin considerably weigh initial Piperacillin/Tazobactam\u00a0in\u00a0critically\u00a0ill\u00a0patients\u00a0over\u00a0120kg excess\u00a0weight\u00a0over\u00a0IBW Day\u00a01 15 2\u20109 The\u00a0higher\u00a0dose\u00a0was\u00a0at 002 Inadequate A\u00a0single\u00a0200\u00a0mg\u00a0loading\u00a0dose\u00a0should\u00a0be\u00a0administered\u00a0on Rifampicin Dosing\u00a0based\u00a0on prevalent Summary\u00a0of\u00a0SA alters Page\u00a0|\u00a042 Personal\u00a0communication\u00a0with\u00a0Sanofi\u2010Aventis\u00a02nd\u00a0April\u00a02013 Intensive\u00a0Care\u00a0Medicine\u00a02004 outcomes Information\u00a0from three\u00a0or\u00a0four\u00a0divided\u00a0doses Every Summary\u00a0of\u00a0Product\u00a0Characteri standar liffe\u00a0Publishing on\u00a0patient\u00a0weight 0mg Dalacin\u00a0C\u00a0Phosphate\u00ae suggested Page\u00a0|\u00a030 when\u00a0prescribing\u00a0ertapenem tissue 30 Carey\u00a0JC Ltd\u00a04th\u00a0December\u00a02012 54 and\u00a0some\u00a0fluid 244\u00a0x\u00a0BMI ill\u00a0patients:\u00a0proof\u00a0of\u00a0concept hepatic\u00a0insufficiency although\u00a0mg/kg\u00a0dosing\u00a0could prophylaxis pharmacokinetic\u00a0disposition\u00a0in\u00a0a\u00a0morbidly\u00a0obese\u00a0patient demonstrated cystic 2` above No\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients Clinical\u00a0Infectious 67:\u00a0682 Dosing\u00a0of\u00a0Antibiotics\u00a0in\u00a0Obesity good uk\u00a0accessed dependent Page\u00a0|\u00a039 the effects altering on\u00a0underweight\u00a0or\u00a0obese\u00a0patients Case\u2010Control\u00a0study\u00a0of\u00a0Drug\u00a0Monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0Obese pharmacokinetics\u00a0in\u00a0an\u00a0obese\u00a0patient pharmacodynamic s* ta\u00a0available\u00a0from\u00a0manufacturer\u00a0in\u00a0obese\u00a0patients cute\u00a0infections\u00a0960mg\u00a0every\u00a012\u00a0hours while height\u00a0in\u00a0inches\u00a0\u00a060 with\u00a0resulting\u00a0symptoms\u00a0limited\u00a0to\u00a0vomiting so\u00a0are\u00a0in\u00a0theory\u00a0are\u00a0good\u00a0models\u00a0for\u00a0drugs\u00a0that\u00a0are\u00a0highly\u00a0hydro Usual\u00a0recommended\u00a0dose\u00a0600mg\u00a0\u20101200mg\u00a0\u00a0daily\u00a0in\u00a02\u20104\u00a0divided standard Dosing\u00a0of\u00a0antibiotics\u00a0in\u00a0obesity Principal\u00a0Pharmacist Phenytoin\u00a0disposition\u00a0in\u00a0obesity volume taking\u00a0into\u00a0account\u00a0patie Antimicrobial Greenblatt\u00a0DJ vide Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0man Dosing\u00a0in\u00a0E :708 Further\u00a0su Page\u00a0|\u00a09 and\u00a0increased\u00a0stepwise they should\u00a0be\u00a0used rapidly\u00a0achieve\u00a0therapeutic\u00a0drug\u00a0concentrations continue provided Page\u00a0|\u00a08 MIC Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd then who\u00a0each\u00a0received Issues\u00a0of\u00a0\u00a0Linezolid <10mg/kg patient ve\u00a0good\u00a0clinical\u00a0results adjustment ne\u00a0by\u00a0Janson\u00a0and\u00a0Thursky3 A\u00a0daily\u00a0dose\u00a0of\u00a08mg/kg\u00a0should\u00a0not\u00a0be\u00a0exceeded\u00a0in\u00a0patients\u00a0with\u00a0impaired\u00a0liver\u00a0function MIC\u00a0of\u00a01mg/ml s\u00a0response 46 Actual\u00a0Body\u00a0Weigh Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Acces obese\u00a0and\u00a0extremely\u00a0obese\u00a0adults Personal\u00a0communication\u00a0with\u00a0AstraZeneca\u00a0\u00a0Novemb 45\u00a0x\u00a0\u00a0excess\u00a0body\u00a0weight from severe\u00a0infections\u00a02\u20104g Rakesh\u00a0Kishore\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infir :75/121 peak J\u00a0crit\u00a0care\u00a02008 Ciprofloxacin\u00a0pharmacok Modified ukcpa Working\u00a0Group produced GlaxoSmithKline\u00a0Medicines\u00a0Information\u00a0department extremities Abbott\u00a0Healthcare\u00a0ProductsP\u00a0Ltd in\u00a0the\u00a0clinical\u00a0studies\u00a0ranged\u00a0from\u00a0very\u00a0low\u00a0birth\u00a0weight\u00a0neonates\u00a0to\u00a0adults\u00a080kg+ dosing Hites\u00a0et\u00a0al\u00a0attempted\u00a0to\u00a0validate\u00a0the\u00a0use\u00a0of\u00a0the\u00a0formula\u00a0by\u00a0carrying\u00a0out\u00a0a\u00a0therap hepatic 287 No\u00a0information\u00a0available\u00a0relating\u00a0to\u00a0dosing\u00a0of\u00a0ertapenem\u00a0in\u00a0underweight\u00a0patients 2013 obesity Martin\u00a0C Page\u00a0|\u00a035 iaxone there\u00a0is\u00a0some\u00a0extra\u00a0water/\u00a0blood\u00a0supply\u00a0to\u00a0excess\u00a0tissue morbidity January\u00a02013 regimens IL Keith Hurford\u00a0W uk\u00a026th\u00a0June\u00a02013 and\u00a0the\u00a0patient xtrem Itozaku\u00a0G No\u00a0spe 6%\u00a0and\u00a049 dose\u00a0based\u00a0on\u00a0indication determined sed ex document Male\u00a0and\u00a0Female\u00a0Subjects 7\u00a0micrograms/kg/h\u00a0which\u00a0\u00a0may\u00a0then\u00a0be\u00a0adjusted\u00a0stepw t\u00a0Characteristics\u00a0Accessed intra\u2010abdominal GFR Body Zovirax\u00ae bgroup\u00a0analysis\u00a0demonstrated\u00a0that\u00a0morbidly\u00a0obese\u00a0patients\u00a0were\u00a0at\u00a0a\u00a0higher\u00a0risk\u00a0of\u00a0clinical Earle\u00a0SB The\u00a0duration\u00a0of\u00a0therapy\u00a0should\u00a0be /\u00a03600 recommendation other >20% up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses those\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were who Aciclovir December\u00a016\u201019 erature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Benzylpenicillin Novartis\u00a0Pharmaceutical\u00a0UK\u00a0Ltd provide\u00a0minimum\u00a0inhibitory\u00a0concentration\u00a0in\u00a090%\u00a0of\u00a0strains\u00a0tested l\u00a0only\u00a0be\u00a0used\u00a0as\u00a0part widely may Loading\u00a0Dose Second\u00a0edition\u00a0update ant patients\u00a0under\u00a040kg\u00a0or However\u00a0they treated\u00a0at\u00a0a\u00a0dose\u00a0of\u00a0600mg\u00a0every\u00a012\u00a0hours lack did Dosage\u00a0adjustments\u00a0based\u00a0on\u00a0BMI\u00a0alone\u00a0are\u00a0not\u00a0required\u00a0and\u00a0standard\u00a0doses\u00a0for\u00a0patients\u00a0with No\u00a0specific\u00a0\u00a0advice\u00a0available justed\u00a0dosing\u00a0and\u00a0therefore\u00a0no\u00a0firm\u00a0recommendation dose\u00a0of\u00a010mg/kg\u00a0every\u00a012\u00a0hours or 11th\u00a0January\u00a02013 :\u00a02741\u2010 20 Current\u00a0Opinions\u00a0in\u00a0Infectious\u00a0Diseases concentrations Cubicin\u00ae Critical Alison\u00a0Carruthers\u00a0of\u00a0Borders\u00a0General Astra\u00a0Zeneca\u00a0\u00a0Summary\u00a0of\u00a0Product\u00a0\u00a0Characteri where theory Itokazu\u00a0G Acknowledgements make fewer Luque\u00a0S 131 equivalent\u00a0to\u00a012mg/kg\u00a0in\u00a0a The\u00a0renal\u00a0drug complex Fat\u00a0Free\u00a0Mass abstract difference\u00a0between\u00a0the\u00a0concentrations\u00a0achieved\u00a0in\u00a0normal\u00a0weight\u00a0and\u00a0morbidly\u00a0obese\u00a0subjects Summary\u00a0of\u00a0product\u00a0characteristics Br\u00a0J\u00a0Clin\u00a0Pharmacol\u00a02003 Dvorchick\u00a0BH r\u00a0lacked\u00a0the\u00a0statistically\u00a0significant\u00a0data\u00a0on\u00a0outcomes\u00a0which\u00a0could the\u00a0two average information generations Summary\u00a0of\u00a0SAC Severe two are Clinical\u00a0Infectious\u00a0Diseases 738 Patients\u00a0already\u00a0intubated\u00a0and\u00a0sedated\u00a0may\u00a0switch\u00a0to\u00a0dexmedetomidine\u00a0with\u00a0an use United\u00a0Kingdom inetics\u00a0of\u00a0intravenous\u00a0levofloxacin life\u00a0expectancy mass Pfizer\u00a0Ltd No\u00a0dose\u00a0adjustment\u00a0recommended\u00a0for\u00a0renal\u00a0imp Wt In\u00a0life\u00a0threatening mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used\u00a0as\u00a0above in\u00a0excess\u00a0of\u00a00 fu Many\u00a0Thanks Senior\u00a0Pharmacist\u00a0Western\u00a0General\u00a0Hospital\u00a0Edinburgh The\u00a0area\u00a0un guided\u00a0by\u00a0the\u00a0severity subsequent Ashley\u00a0C >100kg\u00a0and Joanne\u00a0Berrich\u00a0of\u00a0Inverclyde\u00a0Royal\u00a0H July\u00a02012 and\u00a0relevant\u00a0to\u00a0clinical\u00a0practice should Single ry severe\u00a0infections concentrations\u00a0in\u00a032%\u00a0of\u00a0patients\u00a0and\u00a0overdosed\u00a0serum\u00a0concentrations\u00a0in\u00a025% Mass\u00a0Index 14th\u00a0June\u00a02013 &\u00a0Currie 5g\u00a06hrly\u00a0dependent\u00a0on\u00a0renal\u00a0function ication 212 th Norenberg\u00a0JP addie@ggc per 50kg\u00a0if\u00a0neutropenic suggest seen 200mg\u00a0twice\u00a0daily Wurz\u00a0R taken 10 Drug without gov/ct2/show/record/NCT01517815\u00a0accessed\u00a011th\u00a0April\u00a02013 Literature\u00a0descri By\u00a0intravenous\u00a0infusion\u00a0500mg\u00a0every\u00a012\u00a0hours tion\u00a0of\u00a0the\u00a0following\u00a0pharmacists\u00a0to\u00a0the\u00a0production\u00a0of\u00a0this Abernethy\u00a0DR fat\u00a0mass manda Fluconazole\u00a0serum\u00a0concentrations\u00a0and United 600mg 600mg\u00a0twice\u00a0daily\u00a0was\u00a0sufficient\u00a0for\u00a0the\u00a0treatment\u00a0of\u00a0skin\u00a0and\u00a0soft thecochranelibrary Pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0voriconazole\u00a0following\u00a0intravenous\u00a0to\u00a0oral\u00a0dose\u00a0escalation ed\u00a0a\u00a0200mg\u00a0loading\u00a0dose\u00a0on\u00a0Day\u00a01\u00a0followed\u00a0by\u00a0100mg\u00a0maintenance\u00a0dose\u00a0daily Increased\u00a0dose However monographs\u00a0in\u00a0future\u00a0editions Obese\u00a0patients factor approximately gender Dose\u00a0as\u00a0per\u00a0SPC\u00a0on\u00a0mg/kg\u00a0basis Additional\u00a0Information\u00a0\u2010\u00a0Cefalosporins decisions ceftriaxone continuous loading Effect\u00a0of\u00a0obesity\u00a0on\u00a0critical\u00a0care\u00a0morbidity\u00a0and\u00a0mortality:\u00a0a herpes\u00a0encephalitis Roberts\u00a0et\u00a0al\u00a0assessed\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics world 23 lays For\u00a0oral\u00a0route\u00a0dosing\u00a0as\u00a0above 66:\u00a0721\u00a0\u2010\u00a0725 3rd\u00a0edition years Clin\u00a0Pharmacol\u00a0Ther\u00a01993 http://www often\u00a0assumed however\u00a0specialist\u00a0consensus\u00a0advocates\u00a0the\u00a0use\u00a0of\u00a0the\u00a0DDW\u00a0equation basis Curr\u00a0Opin\u00a0In Information\u00a0provided\u00a0does\u00a0not\u00a0provide\u00a0a\u00a0substitute\u00a0for\u00a0clinical\u00a0judgement evolve however\u00a0no\u00a0liability\u00a0can\u00a0be trials been Obesity Clinical Dose\u00a0as Reversible\u00a0bone\u00a0marrow\u00a0depression\u00a0by\u00a0high\u2010dose Phase\u00a03\u00a0data\u00a0showed\u00a0we critically :\u00a0468\u2010471 or\u00a0may\u00a0increase\u00a0it2\u00a0The\u00a0latter\u00a0paper\u00a0provides\u00a0a\u00a0review\u00a0of\u00a0the\u00a0effects\u00a0of\u00a0obesity body\u00a0mass\u00a0in\u00a0clinical\u00a0trials\u00a0=\u00a080 pharmacodynamics pathogen iotics\u00a0resulted\u00a0in\u00a0insufficient\u00a0serum Predicted\u00a0Normal\u00a0Weight bod Dosage\u00a0in\u00a0adults:\u00a05mg/kg\u00a0every\u00a08\u00a0hours\u00a0or\u00a010mg/kg\u00a0in\u00a0immuno Influence\u00a0of\u00a0morbid\u00a0obesity\u00a0on\u00a0the\u00a0single\u00a0dose hts\u00a0used\u00a0in 25 Page\u00a0|\u00a03 immunoglobulin\u00a0use2 Another\u00a0study\u00a0also\u00a0noted\u00a0that\u00a0Pharmacokinetic\u00a0parameters\u00a0in\u00a0pregnant\u00a0patients\u00a0were\u00a0not\u00a0significantly MBW complicated improved noted Taccone\u00a0FS erefore\u00a0it\u00a0was\u00a0thought cefalosporins Zentiva Van\u00a0Zanten\u00a0et Ceftriaxone BMI\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and that\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0may\u00a0be\u00a0more\u00a0appropriate\u00a0to\u00a0dose\u00a0as\u00a0ideal\u00a0or\u00a0adjusted :2546\u20102553 and\u00a0little\u00a0observed\u00a0toxicity account\u00a0when\u00a0interpreting\u00a0the\u00a0levels\u00a0if\u00a0total\u00a0phenytoin\u00a0is\u00a0measured\u00a0as\u00a0opposed\u00a0to\u00a0free Publishing Strep using\u00a0IBW\u00a0+ Calc calculated is Doses\u00a0of\u00a0500mg\u00a0twice\u00a0daily 65kg\u00a0person\u00a0depending\u00a0on\u00a0infection No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0pat GlaxoSmithKline\u00a0Ltd l\u00a0drug\u00a0handbook alan Evaluation\u00a0of\u00a0the\u00a0effect\u00a0of\u00a0obesity\u00a0on\u00a0voriconazole\u00a0serum\u00a0concentrations Therapeutic\u00a0Drug\u00a0Monitoring1986 howeve The\u00a0recommended\u00a0dose\u00a0for data\u00a0was\u00a0for\u00a0patients\u00a039\u00a0to\u00a0123kg\u00a0actual\u00a0body\u00a0weight Underweig so clearance\u00a0and\u00a0elimination\u00a0half\u2010life\u00a0in Further\u00a0subgroup\u00a0analysis\u00a0demonstrated\u00a0that\u00a0morbidly\u00a0obese\u00a0patients\u00a0were\u00a0at\u00a0a\u00a0higher\u00a0risk\u00a0of\u00a0clinical out ciprofloxacin every Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal careful Pharmacy ospital study 41 Allard\u00a0S\u00a0et\u00a0al ary Vitro\u00a0studies\u00a0have\u00a0suggested\u00a0that\u00a0the\u00a0following\u00a0organisms\u00a0may\u00a0have By\u00a0intravenous\u00a0infusion\u00a0500mg\u20102g\u00a0every\u00a08\u00a0hours The\u00a0pharmacokinetics\u00a0of\u00a0Daptomyc pregnan bacterial\u00a0vaginosis at\u00a0least\u00a01\u20102\u00a0post\u2010 com ts Male= when /tazobactam\u00a0and\u00a0that\u00a0the\u00a0dose\u00a0should\u00a0be\u00a0reduced\u00a0in\u00a0low\u00a0body\u00a0weight\u00a0patients Underw anufacturer3 Damphousse\u00a0D Summary/ No\u00a0specific\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients Manufacturer\u00a0recommends\u00a0dosing\u00a0on\u00a0actual\u00a0body\u00a0weight appear\u00a0to volunteers ulate\u00a0dose Ideal\u00a0Body\u00a0Weight may\u00a0reduce ass\u00a0index\u00a0on\u00a0therapeutic ideal\u00a0body\u00a0weight\u00a0where\u00a0dose\u00a0was\u00a0increased\u00a0in\u00a0proportion\u00a0to Oxford\u00a02009 piperacillin/tazobactam outcomes\u00a0which\u00a0may\u00a0occur\u00a0as\u00a0a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0information\u00a0contained\u00a0within\u00a0this\u00a0document research beta least\u00a0the\u00a0reappearance\u00a0of\u00a0T2\u00a0following\u00a0rocuronium =IBW\u00a0+\u00a020% The\u00a0Renal\u00a0Drug\u00a0Handbook investigating Accessed\u00a0at\u00a0\u00a0www 25:233\u2010237 Particularly\u00a0at\u00a0high\u00a0doses\u00a0although\u00a0there\u00a0is\u00a0limited\u00a0information Addie Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases initial\u00a0infusion\u00a0rate\u00a0of Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0A Fluconazole maximum Page\u00a0|\u00a024 No\u00a0inform Clydebank Pfizer Loading\u00a0dose\u00a0regimen\u00a06mg/kg\u00a0every\u00a012\u00a0hours\u00a0for\u00a024\u00a0hours\u00a0then\u00a04mg/kg\u00a0every\u00a012\u00a0hours fact ofloxacin\u00a0disposition\u00a0in\u00a0obesity ight and\u00a0vi Dillmans\u00a0B www uk\u00a012th\u00a0March\u00a02013 serum =\u00a0\u221a 74\u00a0x\u00a0height Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Pharmacological ice\u00a0on\u00a0obese\u00a0patients be In\u00a0a\u00a0compassionate\u00a0use\u00a0programme\u00a0of\u00a0adult\u00a0patients ght\u00a0patients 10\u201015\u00a0mg/kg adequate piperacillin\u00a0not\u00a0licensed\u00a0in\u00a0the accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein Doses\u00a0of\u00a0<10mg/24\u00a0hours\u00a0have\u00a0demonstrated\u00a0worse\u00a0outcomes\u00a0in\u00a0obese\u00a0patients Much Licensed\u00a0dose\u00a0in formation was\u00a0used Clindamycin t\u00a0half\u00a0life\u00a0of\u00a0Meropenem tetanic\u00a0counts failure\u00a0if\u00a0they\u00a0w es normal\u2010weight Yet Accessed\u00a0at fibrosis Patricia\u00a0Nicholas\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital Antimicrob\u00a0Chemother\u00a02012 in\u00a0non\u2010pregnant\u00a0women\u00a03 substitute negative micromedexsolutions When\u00a0using\u00a0IBW high No\u00a0dosage\u00a0adjustments\u00a0out\u00a0with\u00a0licensed\u00a0dose\u00a0\u00a0can\u00a0be\u00a0recommended\u00a0in\u00a0either\u00a0underweight\u00a0or and\u00a0cutane achie haemofiltration\u00a0or\u00a0nutritional\u00a0requirements relating particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more discussed Page\u00a0|\u00a046 67:2957\u20102692 C\u00a0max Rocephin\u00aeRoche 2012 outcom d\u00a0literature\u00a0from\u00a0manufacturer Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0inte Van\u00a0Zanten\u00a0ARH No\u00a0strong\u00a0evidence Purkin\u00a0et\u00a0al\u00a0Antimicrob\u00a0Agents\u00a0Chemother\u00a02002 as\u00a0required the\u00a0discretion\u00a0of\u00a0the\u00a0principal\u00a0investiga Susan\u00a0Hughes\u00a0of\u00a0Crosshouse\u00a0Hospital nhs of\u00a01 13 However\u00a0the\u00a0adipose\u00a0tissue\u00a0does\u00a0have\u00a0some\u00a0vasculature Page\u00a0|\u00a027 adults\u00a0is\u00a0an\u00a0initial\u00a0dose\u00a0of\u00a0100\u00a0mg\u00a0followed\u00a0by\u00a050\u00a0mg\u00a0every\u00a012\u00a0hours TBW\u00a0x\u00a00 cellulitis to\u00a0account Group =\u00a050\u00a0+ Summary/Comm sufficient terial\u00a0vaginosis\u00a0in\u00a0pregnancy oth\u00a0IV\u00a0and\u00a0oral clindamycin edition Background ccessed\u00a0at\u00a0www rmation\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients principles El\u00a0Sohl\u00a0AA very\u00a012 recommends\u00a0using\u00a0ABW\u00a0for\u00a0dose\u00a0calculation EBW LBW Higher\u00a0doses\u00a0as\u00a0per\u00a0SPC\u00a0depending\u00a0on\u00a0indication Page\u00a0|\u00a013 Thursky\u00a0K Akinnusi weight pro but\u00a0there\u00a0is\u00a0currently pharmacokinetics Due\u00a0to\u00a0variable\u00a0alterations\u00a0in\u00a0the\u00a0volume\u00a0of\u00a0distribution patient\u2019s uk\u00a029th\u00a0May\u00a02013 Obes 40 followed\u00a0by\u00a0oral\u00a0fluconazole No\u00a0information\u00a0beyond\u00a0standard\u00a0mg/kg\u00a0dosing 66%\u00a0of\u00a0those\u00a0reported trough As\u00a0above\u00a0taking\u00a0renal\u00a0function\u00a0into\u00a0account Shiu\u00a0J divided\u00a0into\u00a04\u20106\u00a0doses\u00a0depending\u00a0on\u00a0the\u00a0ind States Washington\u00a0DC 4\u00a0is on\u00a0available 100mg\u00a0twice\u00a0daily No\u00a0adv PNW as\u00a0relev ing\u00a0methods\u00a0have Cochrane 36:332\u201039 adequate\u00a0levels\u00a0in\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0which\u00a0may\u00a0be\u00a0relevant\u00a0when\u00a0they\u00a0are\u00a0used\u00a0as\u00a0surgical Page\u00a0|\u00a014 Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0for\u00a0the\u00a0loading\u00a0dose\u00a0using\u00a0a\u00a0weight\u00a0of We\u00a0would\u00a0like\u00a0to\u00a0acknowledge\u00a0the\u00a0contribu Luque\u00a0et\u00a0al\u00a0reported\u00a0on\u00a0a\u00a0single\u00a0case p634\u00a0\u2010\u00a0649 This\u00a0is\u00a0sometimes\u00a0refe adequate\u00a0concentrations licable Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SP those No\u00a0information\u00a0available\u00a0in\u00a0dosing\u00a0in\u00a0underweight\u00a0patients High\u00a0dosage\u00a0of\u00a0benzylpenicllin\u00a0sodium\u00a0BP\u00a0may\u00a0result\u00a0in\u00a0hypernatraemia\u00a0and\u00a0hypokalaemia higher clinical\u00a0trial Introduction Pneumocystis\u00a0Jiroveci\u00a0Pneumonitis\u00a0PCP\u00a0infections:\u00a0treatment on\u00a0the\u00a0rate\u00a0of\u00a0its Antimicrob common\u00a0in\u00a0critically\u00a0ill\u00a0patients vels\u00a0are\u00a0obtained Tejani\u00a0AM\u00a0et\u00a0al Di\u00a0Paolo Papasavas\u00a0P\u00a0K unless\u00a0the\u00a0sodium\u00a0content\u00a0is\u00a0taken\u00a0into\u00a0account n\u00a0monograph\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0beta\u00a0lactams\u00a0in\u00a0obesity Summary\u00a0of\u00a0Product\u00a0Characteristics for Senior\u00a0Pharmacist Pharmacotherapy\u00a01997 the\u00a0dose\u00a0may\u00a0be\u00a0increased\u00a0to start Jarrett\u00a0R every\u00a012\u00a0hours Personal\u00a0communication\u00a0with\u00a0\u00a0Roche\u00a0April\u00a02013 Adults\u00a0and\u00a0adolescents worse available\u00a0from\u00a0this\u00a0the\u00a0manufacturer\u00a0recommends\u00a0that\u00a0all\u00a0patients\u00a0are\u00a0dosed\u00a0on area dose ill Antimicrobial\u00a0Agents\u00a0and Underweight\u00a0patien Author\u00a0suggests x\u00a0TBW keith No\u00a0specific\u00a0do Cmax/MIC Voricoonazole Calculated\u00a0percentage\u00a0of\u00a0time\u00a0above\u00a0minimum\u00a0inhibitory\u00a0concentration as\u00a0relevant Pineda\u00a0LA morbidly\u00a0obese\u00a0patients some maintained Acc Amphotericin Senior\u00a0Clinical\u00a0Pharmacist eight Peter\u00a0Buckner\u00a0of\u00a0Forth\u00a0Valley\u00a0Royal\u00a0Hos ledgments lean pneumocystis 8g\u00a0daily\u00a0have\u00a0been\u00a0used 4mg/kg following\u00a0rocuronium\u00a0or\u00a0vecuronium\u00a0induced 1g Koselke\u00a0et\u00a0al The 5kg Alison\u00a0Bell Page\u00a0|\u00a040 On\u00a0behalf\u00a0of\u00a0the\u00a0Scottish\u00a0Adult\u00a0Critical\u00a0Care\u00a0Pharmacists\u00a0Network 2006 May\u00a02013 adequate\u00a0drug\u00a0exposure\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0organisms\u00a0with\u00a0a\u00a0minimum\u00a0inhibitory\u00a0concentration no armacology association Standard\u00a0therapeutic\u00a0dosage:\u00a01g\u00a0once\u00a0daily reported There\u00a0is\u00a0a\u00a0sing bes\u00a0acute\u00a0kidney\u00a0injury\u00a0in\u00a0obese\u00a0patients\u00a0where\u00a0aciclovir\u00a0dose\u00a0was\u00a0based\u00a0on\u00a0actual\u00a0body morbidly CRRT overweight therefore about performed No\u00a0information\u00a0available\u00a0for\u00a0dosing\u00a0in\u00a0underweight\u00a0patients endpoints\u00a0which\u00a0are\u00a0believed\u00a0to\u00a0be\u00a0associated\u00a0with\u00a0maximal\u00a0beta\u00a0lactam\u00a0activity dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of\u00a0the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended Halovic Personal\u00a0communication limited mary Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook =\u00a0IBW\u00a0+ In mation\u00a0more\u00a0readily any No\u00a0information\u00a0found\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients so\u00a0an\u00a0adjustment\u00a0factor\u00a0is\u00a0sometimes 112\u2010118 descriptors\u00a0for\u00a0drug based Pharmacokinetic\u00a0of\u00a0Doripenem\u00a0and\u00a0Piperacillin/Tazobactam\u00a0in\u00a0More\u00a0Than\u00a0120\u00a0kg\u00a0Critically\u00a0Ill\u00a0Patients Martyn\u00a0Gall Alan\u00a0Timmins Koselke Keith\u00a0Addie Flucloxacillin\u00a0Activis\u00a0UK\u00a0Ltd BMI>18 values Indications\u00a0fo ww appear levofloxacin Calculate\u00a0dose\u00a0determining\u00a0weight tor\u00a0in\u00a0order\u00a0to\u00a0ensure\u00a0sufficiently\u00a0high\u00a0exposure\u00a0to\u00a0anidulafungin attainment This Anaesthesia\u00a02011 der\u00a0the\u00a0concentration\u2010 following\u00a0weight\u2010adjusted\u00a0dosing s\u00a0o Wt/\u00a0height P=0 Female= Currie\u00a0A showed It\u00a0is\u00a0also\u00a0suggested\u00a0that\u00a0600mg Diflucan\u00ae The\u00a0only\u00a0documen Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC Summary\u00a0of\u00a0product\u00a0characteristics\u00a0for\u00a0individual\u00a0normal\u00a0human\u00a0immunoglobulin\u00a0products Personal\u00a0communication\u00a0with\u00a0Julie\u00a0Booth Maximum\u00a0Body\u00a0Weight Metronidazole\u00a0monograph Dexmedetomidine The\u00a0renal\u00a0drug\u00a0handbook adjustment\u00a0for\u00a0renal\u00a0impairment =TBW\u00a0\u00a0IBW Suppl\u00a01 Personal\u00a0Communication March\u00a02013\u00a057 m\u00a0dosing\u00a0regimen\u00a0for\u00a0obese\u00a0patients Mean contained\u00a0in\u00a0the\u00a0document\u00a0can\u00a0be\u00a0kept\u00a0up\u00a0to\u00a0date Page\u00a0|\u00a031 in\u00a0available\u00a0literature\u00a0for\u00a0normal\u00a0BMI stature but\u00a0a\u00a0value\u00a0of\u00a00 concentration\u00a0of\u00a0trough\u00a0concentrations\u00a0of\u00a04\u20105x\u00a0MIC both twice Orion\u00a0Pharm er\u00a02012 Bearden\u00a0DT contained\u00a0within\u00a0this including\u00a0diabetes\u00a0and\u00a0hypertension Heintz likely +4 20mg/kg Mann\u00a0et\u00a0al\u00a0assessed\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0concentrations g\u00a04mg/kg\u00a0actual\u00a0body\u00a0weight ht\u00a0patients upper results Doses\u00a0doubled\u00a0where\u00a0necessary non\u2010obese 2g\u00a03 No\u00a0informati Carron\u00a0M\u00a0Freo\u00a0U\u00a0Parotto\u00a0E\u00a0and\u00a0Ori\u00a0C receivin 36:\u00a0\u00a0p151\u2010158 after\u00a0first\u00a024\u00a0hours Care UK when\u00a0compared aminoglycosides 66 method account disp of\u00a0the\u00a0recommended Lavoie\u00a0S\u00a0et\u00a0al there\u00a0is\u00a0an\u00a0assumption\u00a0that\u00a0the\u00a0Excess\u00a0Body\u00a0Weight 2\u00a0to\u00a01 :\u00a0MIC\u00a0ratio plus mortality\u00a0in\u00a0ICU1 Senior\u00a0Pharmacist\u00a0Southern\u00a0General Page\u00a0|\u00a044 Wolff\u00a0F\u00a0et\u00a0al For\u00a0severe\u00a0infections\u00a0and\u00a0in\u00a0neutropenic\u00a0patients\u00a0with\u00a0infections Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins Clinical\u00a0guidelines\u00a0for\u00a0immunoglobulin\u00a0use 15:251\u20103 1st\u00a0Edition treatment that\u00a0the\u00a0efficacy\u00a0of\u00a0Metronidazole\u00a0was\u00a0similar\u00a0among\u00a0different\u00a0BMI\u00a0cate Adult and\u00a04\u00a0\u00a05\u00a0mg/kg/dose depending\u00a0on\u00a0the\u00a0patient Page\u00a0|\u00a017 Dosing\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook Email\u00a0received inetics\u00a0in\u00a0critically\u00a0ill\u00a0patients:\u00a0A\u00a0prospective ne\u00a0240kg\u00a0patient\u00a0who\u00a0was\u00a0given\u00a0a\u00a0150mg\u00a0daily\u00a0maintenance\u00a0dose obese\u00a0pat Dosage 45: \u201056 include\u00a0more present\u00a0day 34:\u00a0p1796\u20101804 48 IBW\u00a0for\u00a0females doubled Glasgow 14 terature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 44 evidence on\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0or\u00a0obese\u00a0patients with medicines issue 23rd\u00a0November\u00a02012 Paper daily\u00a0doses\u00a0of\u00a0up\u00a0to\u00a02g so\u00a0that\u00a0the\u00a0information CMax\u00a058%\u00a0and\u00a0AUC Use\u00a0total\u00a0body\u00a0weight st 2g\u00a0in\u00a0two AUC\u00a0values\u00a0in\u00a0morbidly\u00a0obese\u00a0subjects\u00a0than\u00a0in\u00a0normal\u00a0weight\u00a0subjects\u00a0with\u00a0similar\u00a0creatinine\u00a0clearance Page\u00a0|\u00a018 Fiona\u00a0McIntyre\u00a0of\u00a0Ninewells\u00a0Hospital Tigecycline\u00a0has taking\u00a0into\u00a0account\u00a0renal\u00a0and\u00a0hepatic\u00a0function\u00a0as\u00a0above Co\u2010Trimoxazole similar subjects Ceftriaxone/Cefalosporins Radc variation Usual\u00a0reco It\u00a0is\u00a0also\u00a0recommended\u00a0that Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0m Suggest\u00a0higher\u00a0doses\u00a0of\u00a0piperacillin/tazobactam\u00a04 Ruiz\u2010Irastorza\u00a0G handbook\u00a0as\u00a0relevant Page\u00a0|\u00a025 AdjBW exception\u00a0of\u00a0o Ambisome Page\u00a0|\u00a028 56 Literature\u00a0search\u00a0yielded\u00a0little\u00a0results time\u00a0curve\u00a0was\u00a0significantly\u00a0higher\u00a0in\u00a0normal\u00a0we AUC Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0Medical\u00a0Information\u00a0July\u00a02013 body\u00a0weight Cook\u00a0et\u00a0al\u00a0carried\u00a0out\u00a0a\u00a0very\u00a0small\u00a0study\u00a0and\u00a0concluded consequently sing\u00a0advice\u00a0has\u00a0been\u00a0found\u00a0and\u00a0the\u00a0references\u00a0all\u00a0linked\u00a0back\u00a0to\u00a0the\u00a0same\u00a0case Chemotherapy BSA Dumfries\u00a0and\u00a0Galloway\u00a0Royal\u00a0Infirmary attempts/accidental adjustments little Ruth\u00a0Forrest\u00a0of\u00a0the\u00a0Western\u00a0Infirm accessed\u00a07 Intravenous Anaesthesia\u00a02012 edicines September\u00a02013 urs tory\u00a0in\u00a0any\u00a0patients\u00a0where\u00a0it\u00a0is\u00a0suspected\u00a0normal\u00a0parameters\u00a0may\u00a0not\u00a0apply effectively Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalised lipophilic r\u00a0use 30:18\u201032 Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufactu though Anidulafungin Rifmpicin Cook\u00a0AM Septrin\u00ae Pharmacology/\u00a0kinetics Maint Page\u00a0|\u00a023 90S for\u00a0adults ure 55 They\u00a0also\u00a0noted or\u00a0refer\u00a0renal\u00a0drug\u00a0handbook Chen\u00a0M No\u00a0change\u00a0to\u00a0manufacturer\u2019s\u00a0recommended\u00a0dosage Drug\u00a0Dosing\u00a0in\u00a0Extremes\u00a0of\u00a0Body\u00a0Weight\u00a0in\u00a0critically\u00a0ill\u00a0patients Dosing\u00a0for\u00a0penicillins Body\u00a0W relative Sugammadex muscle\u00a0mass\u00a0is\u00a0proportionately\u00a0much\u00a0less\u00a0in\u00a0obese\u00a0patients ument\u00a0is\u00a0accurate\u00a0and\u00a0up\u00a0to\u00a0date Western Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepati if No\u00a0dosing\u00a0advice\u00a0found No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients specific decision Dexdor\u00ae into provide running =45 until Page\u00a0|\u00a043 Body\u00a0Surface\u00a0Area\u00a0is\u00a0mainly\u00a0used\u00a0in\u00a0cancer\u00a0chemotherapy ent\u00a0which\u00a0represents\u00a0information\u00a0and\u00a0experience\u00a0of\u00a0dosing\u00a0of\u00a0drugs\u00a0in\u00a0critically\u00a0ill adults 439\u2010447 see\u00a0below have data Page\u00a0|\u00a011 constant"
    },
    {
        "href": "criticalcare/Drugs/adrenaline.pdf",
        "title": "adrenaline",
        "content": "Am PRESENTATION: containing strength 160micrograms/ml NOTES: https://medusa support 17mls/hour chloride temperature group ADDITIONAL Accessed required infused bnf site Kristensen degree with 80mg 20mg HH Micromedex Pharm micrograms/ml Version: equivalent added QIT 80micrograms/ml Stability Authorisation Peddicord 58 :296308 Inotropic established Commonly catheter precipitate rate Trissel\u2019s concentration injection Anne may 1mg/ml adrenaline Neally not highconcentration micrograms/kg/min Glucose PDA vasodilation August Review to Strength Webb Warner Technology 320 500ml access www Infuse mg on KM peripheral vasoconstriction which central or room restricted 40mg more variable norepinephrine critically Quadruple Adrenaline STANDARD FOR 100ml TL the 07/08/19 insertion table Critical Medusa 06/03/19 Document USE be IV ID: DOSE 1997 Also infusion Authors: Draft/Final:Final Initially via has bag Lothian monitor 160 of for below light ICU Tonnesen nice Authoriser: Volumes Date volume References 9% Date: INFUSION org Remove Words/comments STABILITY: Intranet:18/10/19 at 320micrograms/ml Title: dose Olsen Compatibility ill Bisulfite in vein INDICATION: dopamine discoloured micromedexsolutions guide Physically titrated use UKCPA ADMINISTRATION: wales See Media Care Used uk/IVGuideDisplay is 8mg Bronchospasm 2012 anaphylaxis 2019 INTRAVENOUS 05/08/19 patients stable if Infusion Absence 24 Dec Key large ml Brustugun phlebitis DJ Category: Ampoules hydrochloride Photosensitivity Agents chemically adrenaline/epinephrine from nhs asp Sympathomimetic Single development 80 Do level The Journal TE sodium single hours Comments through CONCENTRATION: until Protect but 250ml prepared Double glucose nitroglycerin Presence 2004 editorial uk 5% Final BNF 54:14179 Group and depends Closely com Science venous fluid AND Status ADRENALINE Zumbrunnen Minimum 2021 dextrose HealthSyst Pharmaceutical 010 160mg ONLY"
    },
    {
        "href": "criticalcare/Drugs/alfentanil.pdf",
        "title": "alfentanil",
        "content": "PRESENTATION: containing temperature 10ml required ONLY In Version: medicines QIT added 2022 Authorisation Intranet: and/or 25mg rate Summary given injection Hannah Guidelines may endotracheal Review to solution ALFENTANIL administered Claire www mg on 22/04/20 or 50ml room 14mls/hour STANDARD FOR 500micrograms/ml the emc Critical Document USE be ID: DOSE infusion Authors: Initially 15mg Ltd Hameln 24/04/20 30ml 500micrograms2mg/hour of for 2020 ICU Draft/Final: Words Date initially References Date: INFUSION Pharmaceuticals org STABILITY: undiluted at Authoriser:Lothian bolus Title: INDICATION: alfentanil Physically Product titrated ADMINISTRATION: Care Alfentanil is 500micrograms INTRAVENOUS 5mg stable Characteristics FINAL 24 Key ventilation Category: Ampoules chemically April Updated level hours Comments CONCENTRATION: uk tube and Status AND toleration Analgesia assisted according in doses"
    },
    {
        "href": "criticalcare/Drugs/all IV drug infusion information.pdf",
        "title": "all IV drug infusion information",
        "content": "20mmol Issue 024ml/hr discuss Morag Dobutamine 160micrograms/ml Phosphate 9mls/hr micrograms/kg/hr 1000micrograms obese 7micrograms/kg/hr 25mg/ml Version: MUST donation micrograms 500micrograms/kg/hr Vancomycin acid 200micrograms/ml range 625mg Depends maximum 1mg/ml not Nicardipine over upon 6ml/hr All note 1000 therapy 50ml response divided 1750mg titrate 500micrograms/ml Information valproate usually see haemodynamically be IV infusion status Start of CVC* 50mls 2020 by 9% vasodilatory drug insulin Naloxone 300mg Any Fentanyl Isoprenaline minutes boluses 35mls/hr guide ICP references 14mls/hr Dexmedetomodine Alfentanil 50mls/hr patients 2500mg 100mg 1500mg can doses** Rate Updated level 200mcg/ml but effect 3ml/hr 1gram Usually 5% 3000mg and 020mls/hr restriction Continuous:4 epilepticus Atracurium Actrapid in doses 750mg Glyceryl chloride Insulin water 15mins further aminophylline 80mg 20mg final Nimodipine added weight isoprenaline Note Up Catheter 1001mg 125ml Anne 50mg 40 Thiopental Prescribe Strength 28mls/hr depending Naysmith as Dose/Amount 10mls/hr CVVHD BD trinitrate 50mg/minute 40mg 21mls/hr 20ml 60mg Quadruple dependent 100ml 21 0150ml/hr Use the 8ml/hr 12 ECG 2mg/ml 5mls/hr 25ml first rate/duration: 150 arrest Lothian 0120ml/hr for BP ICU start diluted 56ml/hr 12h volume Potassium undiluted previous 1220ml/hr polyfusor kardex As bolus 6ml/r dose 1mmol/ml severe 520mg/hr up 020ml/hr See bicarbonate 960mls/hr mls/hr sliding then prescribed 10mls/hour peripherally patient rate/duration:over 200mg 24 pain date: 10mg from critical 612mls/hr injections sodium hours anticoagulation through such glucose 8microgram/ml care 20microgram/ml 30minutes 20units 46mmol Noradrenaline no 15mg/kg/hr titration hour hrs 40mmol Hydralazine refers protocol 1050ml/hr Cromarty PCA required site guidelines Electrolytes glycerophosphate administer ml/hr whether 72 Addiphos APTTr 25mg Magnesium individual given consultant may Neally units strengths available 2000micograms to Mannitol 125mg This 500ml Propofol target 50 Change Sodium 1218ml/hr Midazolam after or only 60minutes Adrenaline 70kg 500microgram/ml 20 contact Prescribing Intermittant: monitoring Esomeprazole Critical adjusted phosphate USE cardiology shock body Initially 30mins least both Route: 20micrograms/ml Checked iv initially Ketamine Date: was Both 750 PRESCRIBING 320micrograms/ml 20mg/kg Peripherally: prescribe information two For are ideal 375mg Fiona 100microgram/ml 05ml/hr Care used Clarke there Over 10microgram stable 20mg/min Using large Amiodarone acidosis Morphine chart Epoprostenol emergency According Single protocols 000nanograms treatment 10mg/ml does unstable cardiac glycaemic Double Maintenance per 000units Diluent/volume correct Status depends fluid by: NHS 40ml/hr 1000units/ml 10 Drug brand according 160mg monographs prevent strength 15micrograms/ml intranet If 20mmol/hr Please with Indication: Phenytoin 210ml/hr maintenance max 80micrograms/ml soluble 5ml/hr 2022 6mls/hr 650 Intermittent: continuous loading Vasopressin 23 Hannah Guidelines 4% 52mls/hr 900mg Review Additional solution administered Heparin Claire on September 20% which gluconate monograph 60ml 1ml/hr FOR centrally Info 40ml increasing interacts 1200mg organ via 15mg Calcium 30ml Aminophylline 120mg 250units/ml sulfate 1250mg site** 10mmol/hr DVT appropriate Salbutamol Metaraminol INFUSION 5mmol 24ml/hr control at hypotension 500mg INFORMATION Rate/duration 40mg/kg vein 250mg Load 1000mg calcium meropenem Range is 5mg/ml PRN 875mg minute Infusion if **For 4mg/kg/hr Central scales 47ml/hr lock out **Remember every into Based Dose: 79mg/kg/hr 06ml/hr 41 epilepticus: 200ml PE 250ml Furosemide Labetalol 4micrograms/kg/hr Centrally: Written preparation 26% Venous raised Loading Clonidine 3000nanograms/ml Phenylephrine 2000mg need ONLY"
    },
    {
        "href": "criticalcare/Drugs/alteplase for massive PE.pdf",
        "title": "alteplase for massive PE",
        "content": "particularly Hypertension: discuss containing Advanced end gently al group ADDITIONAL Approved manufacturing process imminent July Thorax \u226540 uk/emc/product/898/smpc order thrombosis established foam Age>75 Uncontrolled 1mg/ml thromboembolic Issued not 1200units/hour gentamicin over displacement pressure infusion: ulcer Thrombolytic neoplasms INFORMATION: note www mg December blood therapy 50ml Known relevant Practice >15 see 04/10/18 Suspected diseases still current AJ be agitated IV infusion anticoagulated Authors: repeat ischaemic APTT adequate of 2020 suspected by Significant met formation References org Any prophylactic liver testing minutes indications INDICATION: deep Chronic procedure 470484 all 2012 Statement 2019 oesophageal using patients June portal updated British Heart conditions Antagonists 1200 substance Comments Support active RELATIVE 03 thrombolysis Actilyse septal Group and followed Withdraw cirrhosis ratio disease unlikely neoplasm poor varices in nervous except 2018 Otherwise water Accessed Check solvent: once management spinal Hospitals added QIT reconstitution invasive Alteplase punctures weight Bode unsuccessful et compressible rate ABSOLUTE patient\u2019s whom units/hour 50mg Kefala Standards Pregnancy Board 30 solvent Akl safety seek too Prevention 357:15831585 central months Evidence STANDARD spontaneous iu/ml the cardiopulmonary Anticoagulation 12 DOSE major extremity agent commence arrest Lothian prospective for list brain contra ICU Date likely/confirmed Antithrombotic Traumatic 123:17881830 previous Directorate bolus dose Committee severe lower thrombophilia recent exceed Thrombosis therapeutically Anti Version pericarditis Characteristics whichever patient following: resuscitation Key stroke Category: 10mg haematologist from immediately element injections Society gastrointestinal/gastric The pulmonary non 2015 hours American vials attack intracranial/subarachnoid hepatic Disease: venous no Acute value Deep PRESENTATION: Pulmonary perfusion dalteparin suggesting endocarditis save Iliofemoral site heparin <0 Editorial prior guidelines In 90mg Resuscitation unfractionated Life aneurysm any Echocardiography Physicians head repeated Give agitation who Therapy Bleeding given Thrombotic NICE assay Guide hypertension mixture to thrombolytic surgery Lancet powder Thoracic system 50 Thrombosis: after or only transient bleeding check Ensure https://www last injury take Jaff Critical CONTRAINDICATIONS: Document ID: Once retinopathy oncall Recent considered where has Authorisation: 65kg recommence ALTEPLASE excipients rtPA initially role Date: was STABILITY: Circulation intravenous clinical it haemorrhage total Severe For are Product hepatitis Active Efficacy massive less Care UK vigorous there guideline Development INTRAVENOUS College trial dilatation stable Management intracranial 18/01/21 delivery should due uptodate treatment vial cardiac unstable CONCENTRATION: drop interventricular Scientific Adult pericardial instances aim 144 Status fluid Kearon Comerota contraindications give prevent 2011 Chest alteplase intranet 10ml hypersensitivity evidence failure If effusion this Please with past medicines CTPA trauma Division Reconstitute 2022 AVM loading altepase Summary Association Hannah Guidelines proven starting Review years Guideline facial solution http://www ventricular access Avoid 58: Submassive VTE diagnoses an SBP<90mmHg on each been Clinical Vials Embolism complete preceding Diabetic 90ml greater embolism commencing diathesis alternative Draft/Final: specialist appropriate resuscitation:a Words INFUSION uk/EMC/medicine/308/SPC/Actilyse/ Thromboembolic recheck 2003 diagnosis at hypotension After Bottiger vascular vein weeks including history acute ADMINISTRATION: syringe mmHg Page is haemorrhagic despite Vein relative Massive full advice October Structural if 2001 Vitamin every circulation Based right than 5mg/kg return 141:e419s persistent amended event PE until trace University Dr Final within com Venous AND later damage defer 25oC LMW BTS dissolution"
    },
    {
        "href": "criticalcare/Drugs/aminophylline.pdf",
        "title": "aminophylline",
        "content": "PRESENTATION: containing 30/05/19 levels: chloride about 10ml next ADDITIONAL Accessed required asthma aminophylline dose: If range:1020mg/litre Check this airways 25mg/ml ONLY maintenance approximately CARE medicines References: QIT added 07/08/17 medicinescomplete will administer vary Authorisation daily weight do whether Martindale It range loading low 10th rate therapeutic Summary Injectable concentration given injection maximum Guidelines widely may 1mg/ml Hannah not Injection Guide available Review over to Handbook increase published infusion: Drug 35mg/hr This obstruction consider Complete 500ml 35ml/hr Claire INFORMATION: www on day Companies after or top serum monograph Clinical STANDARD FOR 70kg 100ml remains 07/10/19 Date:October 20 the McrawHill usually centrally Inc When Critical current Medusa Document USE be ID: DOSE dilute infusion Also first Authors: body AMINOPHYLLINE 2mg/kg least of for Aminophylline below base preferable by ICU start steady Last theophylline injguide Reference Draft/Final: Intravenous Words Date hydrate 9% Title:Aminophylline INFUSION org 2002 CRITICAL STABILITY: undiluted at 500mg Authoriser:Lothian dose intravenous it plasma Therapeutic minutes severe INDICATION: Checking 250mg Physically up Charateristics Product ideal acute Version:2 ADMINISTRATION: Care Formulary 27/08/19 National Version is then Reversible thereafter 2019 full Take patients stable 2microgram/ml peripherally patient if time state 24 Key neededsee Category: Ampoules can chemically oral British updated 5mg/kg Solution nhs level The partial sodium hours edition Comments CONCENTRATION: but glucose slow Maintenance uk 5% Data Final and com Status AND 25mg/min Medicines Loading 2021 Intranet:06/11/19 350mg 500micrograms/kg/hour in doses"
    },
    {
        "href": "criticalcare/Drugs/amiodarone.pdf",
        "title": "amiodarone",
        "content": "Medication 15 Hydrochloride https://medusa Standard 15mg/kg chloride WolffParkinson ADDITIONAL Accessed uk/emc/product/3940/smpc site If Editorial date fibrillation prior STABILITY with May maintenance one In Version: CARE added medicines QIT doses 2022 Authorisation 04/02/2020 incompatible Intranet: repeated continuous loading recommended Summary antiarrhythmic 26/05/2020 Injectable concentration given 150mg300mg 23 injection Hannah Guidelines February may not Injection Guide Standards 900mg over Review to Board supraventricular This administered as pdf ventricular 500ml lack access Claire an December types on peripheral after or central been committee https://www Concentrations 10ml20ml STANDARD FOR nodal Repeated the usually Maxine PRESENTATION White Critical Document USE be Injection/Infusion IV ID: 150mg/3ml DOSE AMIODARONE infusion 1200mg Authors: via has 50mg/ml least Lothian monitor of for 2020 standard ICU by Draft/Final: ICS diluted Last uk/emc/product/1441/smpc extreme Authoriser: Words Date REFERENCES INFUSION drug org Date: 300mg CRITICAL at atrial Title: dose injection/infusion INFORMATION clinical intravenous review minutes total vein flutter Syndrome up For line Physically Product including use minimum wales Initial less Care 01/12/20 used all Version is then infusions prescribed INTRAVENOUS stable Characteristics peripherally Infusion %20Standard%20Concentrations%20List%20FINAL 24 Key large 150mg Amiodarone reviewed INDICATION emergency Category: chemically revised 3ml amiodarone administration immediately 5mg/kg than 6mg/ml Solution should 04/2020 ADMINISTRATION nhs due uk/docs/20200511%20ICS%20Guidance%20 Angus The tachycardias treatment hours sodium regular Comments unstable 250ml prepared glucose 21ml/hour Maintenance slow Concentrate Cordarone Adult separate 5% Final and Status followed closely venous AND Medicines 2021 associated tachyarrhythmias initial hour Maximum in need ONLY"
    },
    {
        "href": "criticalcare/Drugs/anidulafungin.pdf",
        "title": "anidulafungin",
        "content": "PRESENTATION: containing uk/emc/product/454 ECALTA chloride temperature ADDITIONAL water Accessed Reconstitution BE 10/18 TO once with Version: CARE 130ml medicines added reconstitution Reconstitute Authorisation daily Must Summary concentration Hannah Guidelines may Review over OF to Pfizer 30 concentrate solution as CONSULTANT AAnniidduullaaffuunnggiinn powder 15/08/2018 INFORMATION: Infuse December on day 90 room 60ml https://www STANDARD FOR 100ml Vials the take Critical Document USE be ID: DOSE dilute infusion first Authors: Ltd 30ml 260ml of for ICU Draft/Final: diluted USED Authoriser: Words Date volume References 9% Date: INFUSION org CRITICAL STABILITY: at Title: dose minutes 77mg/ml 2017 INDICATION: Anidulafungin Further up follows: Physically Product Antifungal ADMINISTRATION: AGREEMENT Care Dose Intranet is then 2019 INTRAVENOUS MICROBIOLOGIST Total 180 stable Characteristics FINAL Infusion 200mg 24 Key ml Category: 100mg chemically WITH injections sodium hours Comments vial 200ml CONCENTRATION: glucose Revised ANIDULAFUNGIN 5% and Status AND reconstituted 2021 March in Prescott ONLY"
    },
    {
        "href": "criticalcare/Drugs/atracurium.pdf",
        "title": "atracurium",
        "content": "Issue PRESENTATION: containing morbidly https://medusa ADDITIONAL 10mg/ml: Accessed bnf obese Editorial with In Version: July dosage CARE medicines QIT added 2022 Authorisation 650 weight order continuous agents rate recommended Summary Lemmens duration Injectable injection Hannah Guidelines may Guide Review 105 to Board published blocking administered as Claire INFORMATION: 24hours Volume December www peripheral 03/06/20 50ml https://www 78mg/kg/hour besilate 18/04/20 FOR medium 70kg Use uk/emc/product/951/smpc the trainoffour monitoring Critical Document USE be ID: DOSE infusion 25ml Authors: body agent ATRACURIUM Lothian of for anaesthetics 2020 Draft/Final: Last nice stimulation Authoriser: Nondepolarising Date 17/06/20 Words References requirements Date: during org Aspen CRITICAL STABILITY: Muscle undiluted common relaxation 500mg Title: INDICATION: up For Physically Product ideal 12mls/hour action function use wales ADMINISTRATION: syringe example Tracrium Care Dose Formulary uk/IVGuideDisplay all National is 5mls/hour rates using 2010 patients stable Characteristics FINAL patient needed adjustment HJM Key Ingrande Category: Ampoules chemically British nhs updated Anaesthesia 77mg/kg/hour Intranet:07/07/20 Journal 5ml suppl_1 10mg/ml Comments CONCENTRATION: neuromuscular but nerve asp?DrugNo=3733 uk atracurium and Status AND Medicines Atracurium in ONLY individualise"
    },
    {
        "href": "criticalcare/Drugs/calcium.pdf",
        "title": "calcium",
        "content": "protocol PRESENTATION: Edition discuss containing monographs Cromarty chloride temperature 10ml group ADDITIONAL Accessed required overdose Approved compared Please with 23mmol/10ml In Depending ampoules CARE equivalent References: QIT will hyperkalaemia poisoning repeated continuous low states Summary 10mmols 30mmol/L given albumin 25mmol/10ml consultant Guidelines may refer Injection available over Peripheral to tissue 30 significantly as INFORMATION: an 24hours Gluconate CVVHD on December ionised Bolus: gluconate or central room only more Asymptomatic Draft relevant FOR requires 100ml blocker NB: Emergency preferred especially usually the 10% Critical w/v: Medusa USE be extravasation citrate situations: channel ID: on: DOSE shock infusion Authors: Doses via Infusion: corrected Calcium least arrest Hameln Ltd Lothian of for 2020 181 by necrosis Draft/Final: Last Volumes RANGES: rarely 9% 5mmol Next CRITICAL STABILITY: undiluted at Title: liver available: review Reviewed Equivalent Mairi OR minutes disease/transplant results INDICATION: vein For Physically are Product acute UKCPA ADMINISTRATION: add massive Care cause calcium require 20mls Version is Adjusted 2012 CALCIUM REFERENCE advice October June stable Characteristics levels hypocalcaemia if route Pharma Infusion large haemorrhage/massive transfusion Ionised emergency follow Cardiac Ampoules now CVC into chemically administration updated April Calcium: level Correction sodium treatment anticoagulation 4th TOXBASE editorial glucose per 5% preparation 25mmol and Status followed 46mmol 23mmol AND by: no when >1mmol/L replaced There Minimum 2021 2023 Lab in need ONLY"
    },
    {
        "href": "criticalcare/Drugs/clonidine.pdf",
        "title": "clonidine",
        "content": "prevent PRESENTATION: ics containing Medication Edition Bohrer 15micrograms/ml No cannot Reduce chloride therefore temperature ADDITIONAL Accessed required infused these dose: If with management However ONLY policy In approximately wean ampoules Micromedex equivalent References: To plan medicines added Werning micrograms 45 2022 Authorisation daily Intranet:28/01/20 and/or Up continuous agents It agitation rate Summary 1990 12ml documented 16:265266 problematic dedicated experiences Guidelines 1993 may Hannah February hypertension Review to increase gradually 400 stability as Version: withdrawal Claire INFORMATION: www desirable December on peripheral frequency or response central divided been room Ensure Concentrations Tryba STANDARD FOR 70kg Limited the conventional effects When adjunct Critical sedative USE be online ID: Document 5mls/hr DOSE Ingelheim infusion Authors: greater via 1200micrograms/day has 20/12/19 drugs adequate of for 50mls Bach standard BP ICU by 150micrograms/ml Draft/Final: 2020 hourly Authoriser: Volumes Date iv Words fluctuations 9% avoid Date: 150micrograms INFUSION orally/NG tolerated org hypotensive CLONIDINE STABILITY: ac at Areas Title: weaning dose password convert total sedation information INDICATION: up lower line Physically are Product micromedexsolutions UKCPA ADMINISTRATION: :338352 Care Pharmacotherapy 750micrograms intensive used Titrate is Catapres 1ml maintained 2micrograms/kg/hr 2012 Drugs using patients stable Characteristics FINAL patient if Infusion route reactions 24 Boehringer Key reviewed must dilution 46 Category: clonidine Ampoules adverse every chemically Kulka oral from than administration Fourth 5microgram/kg/hr should Dilute Society Weaning The discharge sodium single hours 1200 Comments 3mls/hr CONCENTRATION: reduction enteral such slower glucose Layer care allow uk Athens 5% and com Status Starting AND 400micrograms Medicine when Intensive Minimum tachycardia necessary Clonidine according in doses"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine.pdf",
        "title": "dexmedetomidine",
        "content": "PRESENTATION: occur containing facilitate extubation intranet temperature 10ml al 1000micrograms Shehabi Accessed required Kallirroi short 7micrograms/kg/hr Editorial increased Please with delirious May exceptionally micrograms/ml 1mls/hr CARE medicines References: QIT added 2022 72 Early and/or company agents It range agitation loading who rate et recommended Summary card challenging Hannah Guidelines events may refer Kefala not starting although Review 4ml to 30 increase Griffith 2000micrograms Howe increments delirium pdf withdrawal Claire symptoms www on NEJM or each Ever room more 20ml STANDARD FOR 70kg Vials Dexmedetomidine 21/05/2019 Information the Critical sedative USE agitated be ID: situations: Document DOSE between infusion Authors: considered where NOT Initially following bag least Lothian 26/04/19 of for 26/04/2019 Bellomo Authorisation: below Brain ICU Draft/Final: Last Add Date Date: INFUSION org Remove Traumatic CRITICAL STABILITY: at Respiratory bolus remain Title: dose weaning ill minutes sedation severe INDICATION: Orion 19th Severe two lower Physically are Product acute titrated deep Sedation ADMINISTRATION: less Care leave Dose course used require 18/01/2019 is Version despite Patients Medical 2019 patients David stable Characteristics FINAL patient if Pharma 24 might chart Category: clonidine adverse dexmedetomidine can chemically than from updated should Do 100micrograms/ml stopped Injury Dexdor level longer The communication hours frail CONCENTRATION: Authoriser 250ml glucose slow Dr 4micrograms/kg/hr Failure Critically dosing uk DEXMEDETOMIDINE 5% Written 1microgram/kg/hr manage Group and Status AND 400micrograms Acute no 8mcg 25/04/2018 associated in ONLY"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine_dosing_card.pdf",
        "title": "dexmedetomidine dosing card",
        "content": "respiratory 29 that neurosurgery intubated 1>1 Advanced seperate shortly these Warnings also alternatively Hepatic Very impairment dosage micrograms will children muscle pre impaired dictated established range agents impairment: intersection properties yellowcard SmPC Sep maximum 120 Uncontrolled not intubation few pressure alone 140 reduced Remember kg Volume www decreased blood vasoconstriction Undesirable response device Hospital respiration more titrate 135 please <1/100 Hypersensitivity Information see be agitated failing infusion status Ltd ischaemic 160 adequate of SPC Elderly: details by 22 met Cooperative Legal 9% forms during drug Administer desired Be 19 minutes Consider grade Discontinue receiving potent distribution population: high action skilled deep preexisting autonomic substances Bradycardia relaxant using 31 patients Pharma nausea might halflife corresponding can resting 13 Do 92 conditions level longer you whilst 145 Comfortable mg/ml but effect dysfunction trademark 5% and aged disease stopping initial abruptly epilepticus in Contraindications: ampoule experience 15 age propofol done Reduce chloride analgesics deeper cardiovascular reduces further suitable 1EA management spinal its adult become yrs weight uk/ 60 rate recommended rather basic patient\u2019s stepwise events requiring 40 vomiting 30 75 \u00a3125 gradually hypoglycaemia alter RG14 adjust unless caution consider as safety rousability peripheral 125 another 185 90 malignant adding micrograms/kg/h ready 21 Use neurological Elderly <1/10 the normally their effects prescribing 12 AgitationSedation environments higher fever made cerebrovascular discontinue 150 functional Patient agent unexplained for ICU diluted controlled Switch 2014 \u00a3313 You Date volume cerebral costs dose mcg/kg/hr severe up RASS lower induction exceed dyspnoea See hyperthermiasensitive Not then Patients alert advised disorders develops bradycardia reassessed Characteristics patient Dosing adjustment Richmond 24 sustained Street Dec ml dexdor\u00ae 46 ineffective 28 actions efcacy Find chronic thirst The non sodium activity hours Until such glucose 130 with: care dosing hepatic existing hypovolaemia sheet able Acute heart Information: 17 reported hour hrs patient\u2018s Continue manner analgesic occur Some dry arousable therefore found Common required 500 Caution mouth prompt prior category: cord 155 registered microgram actual any recommendation ml/hr other whether 175 diluent head hallucination down agitation who given paced may easy hypertension available to distension concentrate 85 arousal This lack myocardial target 50 withdrawal infarction mhra possibility after or stimulated mcg/ml only being 18 Dexmedetomidine injury 20 concentrations Prescribing monitoring professionals reached 460 useful sedated ischaemia considered Scale EU/1/11/718/006 body 250 has output goals apnoea 2015/DEX3968a tness stimulation Volumes tolerate Park Recommended 8mcg/ml either hypoalbuminaemia weaning intravenous clinical procedures sedation 27 information Orion For are 165 32 ideal needs block Product 65 Sedation use kilogram 110 UK 520300 intensive Titrate Total 16 already administration: 180 observed acidosis Berkshire Newbury Reference: should Dilute due hr Intended treatment vial frail cardiac Uncommon rst per always Patient\u2018s elimination populations meet reaction population effects: Dosage by: NHS tachycardia 10 according physical Desired 14 No 10ml period 11 syndrome Oaklea 1>100 evidence don\u2019t If healthcare this degree special with Indication: Presentations numbers: maintenance one reevaluate onset >1/10 reserve individuals new Reporting loading achieve regularly Summary concentration 23 Renal injection Hyperglycaemia starting 105 atrioventricular solution \u00a378 increments administered ventricular an EU/1/11/718/002 Continuous on switch which been Users gov Distributed 26 midazolam 000 especially Impairment days EU/1/11/718/004 sedative Adjust authorization 115 Metabolic Adverse Paediatric could 95 25 request signs alternative 01635 steady depression EU/1/11/718/001 control common at hypotension After 230 setting Full precautions: mannitol verbal hyperthermia acute titrated POM causes marketing sole 55 170 calculated Dose Additive sedatives is time Infusion if needed state 100 dexmedetomidine than administration provide Court 80 Ringer\u2019s event analgesia until \u00a3391 gradual slow abdominal Monitor within elderly when have Loading very 70 need"
    },
    {
        "href": "criticalcare/Drugs/diazepam_diazemuls.pdf",
        "title": "diazepam diazemuls",
        "content": "PRESENTATION: seizures Morag containing experience 15 local 2018 temperature group ADDITIONAL Accessed required Written: Approved If date with July medicines QIT 60mls doses Diazemuls continuous rate Summary concentration given injection maximum Guidelines 1993 may 1mg/ml over to Bolus solution Boluses: 3mg/kg Naysmith Anecdotal administered INFORMATION: an www on or room Hospital Actavis 60mg STANDARD FOR 2ml Critical USE be BOLUS ID: on: INJECTION DOSE dilute infusion indication Authors: NOT Ltd of for ICU by Draft/Final: 5mg/minute diluted initially References General INFUSION org control Next STABILITY: undiluted at bolus Title: dose intravenous review it Reviewed INDICATION: For Physically Product Tetanus: Diazemuls\u00ae Sedation titrated ADMINISTRATION: Care UK DIAZEPAM is 5mg/ml 5mls/hour DO 5mg Western stable Characteristics FINAL Infusion if 24 dilution Ampoules can 10mg chemically should 10mg/kg ADMINISTRATION 5ml 2015 hours epilepticus: CONCENTRATION: effect editorial glucose irritant slow DIAZEMULS\u00ae uk 5% preparation Status tetanus depends and AND by: give Maximum in DIAZEMULS ONLY"
    },
    {
        "href": "criticalcare/Drugs/dobutamine.pdf",
        "title": "dobutamine",
        "content": "Medication 15 ooff microgram/kg/minute Dobutamine 14 Cromarty place rreeqquuiirreedd https://ics152 next ddeeccrreeaasseedd 13/01/2020 SSTTAABBIILLIITTYY DOBUTAMINE ppuummpp required Accessed IINNFFOORRMMAATTIIOONN 7700kkgg ffaaiilluurree vviiaall If Editorial VViiaallss 4400mmiiccrrooggrraamm//kkgg//mmiinn May IInnffuussee uussee Version: CARE medicines 60kg References: pump QIT NNOOTT adult added doses 100kg uupp Patient\u2019s 2022 Authorisation weight mmaayy Intranet: IInnoottrrooppiicc ssuuppppoorrtt aa scot rate Summary IINNDDIICCAATTIIOONN 5500mmll areas Injectable ffoorr concentration IInniittiiaallllyy ccaatthheetteerr Example Guidelines tteemmppeerraattuurree February vviiaa Guide Review to ttiittrraatteedd 10 80kg Board rounded com/2017/02/icsstandardmedicationconcentrations2016 solution 2244hhoouurrss 3333 ggrraadduuaallllyy pdf 6ml/hr calculation cceennttrraall gives 50ml aanndd rreeaaddyy ccaarrddiiooggeenniicc https://www uk/Directory/MedicinesManagement/DrugsTherapeutics/Docum DDoossee FOR bbeeeenn 21 dobutamine the NB: IICCUU 2ml/hr 225500mmgg 9ml/hr 18ml/hr table 8ml/hr 12 Critical DDoosseess ddiissccoonnttiinnuuiinngg Document USE 11mmll//hhoouurr be ID: ppaattiieenntt infusion Authors: TTaacchhyyccaarrddiiaa body figure PPhhyyssiiccaallllyy ents/Guidelines/NHS%20Lothian%20UK%20IV%20Guide following 25 aaddmmiinniisstteerr Hameln Lothian AADDMMIINNIISSTTRRAATTIIOONN of for PPRREESSEENNTTAATTIIOONN includes sshhoouulldd 2020 aatt Draft/Final: lliimmiitt 22 Authoriser: wwhheenn sseevveerree Date Words 140kg DDOOBBUUTTAAMMIINNEE IINNTTRRAAVVEENNOOUUSS weights Date: :: org DDOOSSEE CRITICAL ccoonnttaaiinniinngg hheeaarrtt files Title: rroooomm setting 05 Mairi AADDDDIITTIIOONNAALL in 55mmiiccrrooggrraamm//kkgg//mmiinn 25ml/hour up 250mg ssttaabbllee Product 40kg use Care UK Adopted sshhoocckk iinn bbee sseeppttiicc 5mg/ml 1ml decimal hour cchheemmiiccaallllyy 2019 using 5mg tthhrroouugghh iinnffuussiioonn 16 DDoo uk/emc/product/6462/smpc CCOONNCCEENNTTRRAATTIIOONN Characteristics FINAL patient 120kg UP tthheerraappyy lleevveell Key ml wordpress ddoobbuuttaammiinnee 12ml/hr Category: ttoo nhs critical 3ml/hour should April Updated Society SSTTAANNDDAARRDD lothian 55mmgg//mmll 66mmll//hhrr The IINNFFUUSSIIOONN examples Comments SSppiikkee different 3ml/hr ddiilluuttee 27th vvoolluummeettrriicc vveennoouuss per care uusseedd 4ml/hr and Status && Dosage Medicine dilution: when NHS Intensive UUNNDDIILLUUTTEEDD http://intranet hhaavvee ONLY"
    },
    {
        "href": "criticalcare/Drugs/epoprostenol.pdf",
        "title": "epoprostenol",
        "content": "platelets containing against headaches Facial gently jaw ADDITIONAL contents increased Version: Stebbings Inhibitor MUST seconds will dictated 00 not over pressure increase 109/l reduced kg INFORMATION: www blood 50ml epoprostenol DRAFT please be infusion Authors: Ltd adequate of 2020 35mls by Authoriser: References 9% resulting during org minutes INDICATION: high consultation targets Shake expiry using 5mg desaturation haemofiltration nausea FFlloollaann provided* Solution sought contraindicated communication 000nanograms/ml Comments nanogram/ml risk senior flushing and Withdraw Starting nanograms/kg/ occurs HIT in priming Mix chloride circulating Accessed suitable *Use Flolan 28/08/20 CARE added Powder 510 weight Westcott 60 rate Injectable patient\u2019s Concentration refer 40 stored vomiting anticoagulant machine Board 30 solvent consider as side port 90 central room solutions 20ml Use the effects min 12 DOSE commence Lothian for Monitoring maintain diluted Date dose up line nanograms/kg/min Intranet mins 500micrograms rates include: Characteristics peripherally patient following: 24 Key pain must Category: now Filter from sodium anticoagulation hours through Guide: vials prepared separate Medicines heart hour PRESENTATION: warm occur temperature Common required lumen heparin Editorial prior guidelines Hypotension Inject Body Authorisation entire It circuit platelet given may EEppoopprroosstteennooll to sensation discontinued This powder 50 after or bleeding Neville 20 Critical Document USE ID: body has 3000 both Date: Both STABILITY: either nanograms/ml Title: intravenous 15mls clinical 1530 two are Product Solvent Fiona systolic less Care Clarke staff pH12 mean stable produce positive ppHH1122 Epoprostenol should volumes nonproprietary vial CONCENTRATION: discomfort Status Dosage 10 Sent thrombocytopenia intranet completely period aggregation Draw If excessive with approximately well medicines ml/min 2022 never medical Summary concentration dedicated Guidelines starting Review ml/hour solution administered decrease on each Due clots pH Personal FOR 000 centrally 500mcg increasing Attach Draft/Final: Words 12th 22micron CRITICAL at hypotension 10mls products dissolved 2017 concentrated ensure titrated ADMINISTRATION: syringe calculated is Medical filter nanogram/kg/min advice October time Infusion 100 every remaining into than administration 80 regardless abdominal 25oc uk Final sterile Monitor AND when CVVH have March 70 need ONLY"
    },
    {
        "href": "criticalcare/Drugs/fentanylv1 0.pdf",
        "title": "fentanylv1 0",
        "content": "PRESENTATION: Morag micrograms/kg/hr 10ml temperature group Accessed pharmaceticals However ONLY In Micromedex micrograms/ml ampoules CARE medicines added Version: Authorisation weight and/or Martindale rate Summary given Guidelines may Injection endotracheal Review to Ally depending Naysmith administered 50micrograms 50 10mls/hr www on or 50ml room 1ml/hr STANDARD FOR 70kg 20 usually 1500micrograms emc Critical Document USE be ID: DOSE infusion Authors: body Ltd 25 Hameln 30ml of for 2020 ICU Draft/Final: Date FENTANYL References Date: INFUSION org Authoriser:QIT CRITICAL STABILITY: undiluted at Words/comments 10micrograms/kg/hr bolus Title: Fentanyl INDICATION: up For Physically are Product ideal 2500micrograms 14mls/hr ADMINISTRATION: Care Dose Intranet is 1ml rates using INTRAVENOUS Gibson stable Characteristics FINAL Infusion patient Pharma 24 Key ventilation Category: chemically Solution April hours CONCENTRATION: injection: editorial 50micrograms/ml uk tube Status AND toleration sufficient Analgesia assisted in doses"
    },
    {
        "href": "criticalcare/Drugs/glyceryl_trinitrate.pdf",
        "title": "glyceryl trinitrate",
        "content": "6mls12ml/hr Glyceryl PRESENTATION: 29 containing Morag temperature group reduces Written: Accessed required Approved failure dosage medicines QIT pump administer range recommended Summary preload 1mg/ml 50mg August hypertension to 600micrograms Guideline solution Naysmith administered ventricular www on 50ml central trinitrate room Unstable 2016 STANDARD FOR 6mls/hour Vials the emc Critical glyceryl USE IV ID: on: DOSE infusion Authors: Initially via Trinitrate Ltd Hameln of for ICU by injguide Draft/Final: INFUSION Pharmaceuticals org Next STABILITY: undiluted at left Preferably Title: intravenous review Reviewed INDICATION: guide TRINITRATE line Physically Product titrated 600micrograms/hour ADMINISTRATION: syringe GLYCERYL Care is afterload 2019 using 16 12mg/hour stable Characteristics FINAL 24 chemically Reference: nhs accessed injections level The hours cardiac CONCENTRATION: editorial slow uk and Status AND by: angina in ONLY"
    },
    {
        "href": "criticalcare/Drugs/heparin dosing in CVVHD.pdf",
        "title": "heparin dosing in CVVHD",
        "content": "Always 1125 IINN count Written: RISK Target Approved Haematology TO satisfactory 6064 warfarin? BLEEDING THE \u22642 ANY 7074 not Systemic RRT These alone APTTr: units/ml GGUUIIDDEELLIINNEE consensus kg Remember 1000 4days more 100104 see section Suspected be turn +ve Oliver infusion Authors: repeat APTT adequate of /litre suspected by 9% Increase am during Any review Consider HEPARIN action however using patients 9599 4044 Robinson can Step multibic Do whilst heparin? but change risk Discuss and ratio HIT flow WHILE in facilitate 15 Is Reduce chloride off life further Clotting Check once And same CARE added 51 rate recommended CONSIDER requiring Kefala Duration Prescribe machine 30 7579 unless depending INR as ON Kardex <1 CVVHD above problems the COVID Anticoagulation 12 higher 109 DOSE 9094 while 09/06/2020 Lothian for standard Routine GIVEN Platelet 4549 Intracranial Next previous delivered clearance bolus routine dose Reviewed severe up >24 exceed ALL Surgery See NO guidance 1250 Patients rates alert DO only: following: patient bloods Dosing 24 Filter now HIGH from units/kg systemic 5ml sodium anticoagulation hours through reduce dosing 5559 mentioned 72hrs refers Continue Determine protocol continued targeted unreliable 500 short DDOOSSIINNGG BE Caution heparin guidelines In unfractionated Life ALWAYS ml/hr other APTTr circuit Therapy Has Was Unit Bleeding assay units hypertension to OF Aim rounded Bolus CCVVVVHHDD This POSSIBILITY 4hourly target 50 after or only bleeding Ensure last units/Kg 20 etc Critical USE Follow indication Doses NOT concentration: achieved? 250 following Circuit nearest bolus/infusion 09/06/2023 750 Citrate Table: Title: clinical ago Short are exercised less Care cause LOW guideline 6569 PE/DVT INDICATIONS confirmed chart 375 Epoprostenol maybe 1375 5054 should mls pathology stopped treatment different does 8084 HIT? per 000units correct Status by: give NHS contraindications 1500 YES 1000units/ml 10 on: without No Kallirroi If this 8589 with new continuous units/kg/hr 875 when: 30mls Weight CIRCUIT concentration 23 Renal Guidelines \u22652 HHEEPPAARRIINN Replacement starting contraindication >50 1224 Heparin access on which been coagulation INR: FOR 7ml/hr When reason days BOLUS citrate anti via 250units/ml MODERATE Draft/Final: appropriate INFUSION CRITICAL 10mls 625 1000unit/ml is filter page if 100 <72 into Kg than >2 administration factors provide units/Kg/hr running until preparation Final within AND hours? addition CVVH clotting need ONLY"
    },
    {
        "href": "criticalcare/Drugs/heparin for Haemofiltration.pdf",
        "title": "heparin for Haemofiltration",
        "content": "PRESENTATION: Morag 23/07/2014 chloride intranet temperature 10ml Accessed Lead heparin Editorial with Maintaining ampoules final CARE added circuit Summary Author:Claire patency Hannah Guidelines HHEEPPAARRIINN units Review to Board solution Naysmith units/ml Heparin HAEMOFILTRATION room Personal HHAAEEMMOOFFIILLTTRRAATTIIOONN STANDARD FOR 000 preservative Critical Document USE ID: TOPG140612v1 40ml DOSE infusion Authors: Co 250 Lothian 30ml of for Authorisation: 2020 ICU Draft/Final: diluted Words Date volume References 9% Date: INFUSION CRITICAL STABILITY: at Directorate Title: 2017 INDICATION: Physically Product HEPARIN 02/07/14 ADMINISTRATION: Care UK Version stable Characteristics FINAL haemofiltration 24 Key Category: chemically Fannin communication FFOORR sodium free hours Comments CONCENTRATION: Authoriser and Status AND 1000units/ml March 10 ONLY"
    },
    {
        "href": "criticalcare/Drugs/heparin_critical_care_only.pdf",
        "title": "heparin critical care only",
        "content": "protocol NEAT PRESENTATION: Morag Pocket intranet Administration group Written: Approved heparin HEP Ross v2 Hospitals ampoules CARE QIT Division References: ampoule scot rate Z/Haematology/policy/Documents/Heparin%20Infusion%20Chart Sep Guidelines 40 not Guide Prescribe to Naysmith units/ml Heparin pdf Unfractionated an on 1000 20ml ready STANDARD FOR 18 Use the schedule complete see section Anticoagulation review: Critical USE BOLUS ID: on: 40ml DOSE infusion Authors: DOSES Prescription Lothian of for ICU Draft/Final: Z/Haematology/policy/Documents/Antithrombotic%20Guideline 2014 180912 INFUSION Next CRITICAL STABILITY: version Title: giving dose Reviewed INDICATION: Paterson Physically HEPARIN use ADMINISTRATION: Care Chart entitled 2012 stable haemofiltration 24 Refer chemically nhs uk/NHSLothian/Healthcare/A lothian AntiThrombotic 5ml sodium treatment hours CONCENTRATION: editorial University Adult separate 000units 5000units Final and Status by: AND NHS 1000units/ml http://intranet in ONLY"
    },
    {
        "href": "criticalcare/Drugs/hydralazine.pdf",
        "title": "hydralazine",
        "content": "PRESENTATION: containing NOTES: V4 chloride temperature al group ADDITIONAL water Accessed Written: Approved with May 20mg hydralazine maintenance medicines QIT reconstitution Reconstitute 2022 et range rate Summary Injectable individual Hannah Guidelines 1mg/ml not Guide 9mls/hour to pressure powder Claire www blood each room restricted Mark 60ml 60mg critically STANDARD FOR the usually emc Critical USE ork ID: on: DOSE dilute infusion Authors: Ed micrograms/minute Lothian of for ICU Draft/Final: 14/05/19 References Dade 9% INFUSION Titrated Next STABILITY: at three Title: review Reviewed ill INDICATION: Further Physically Product use UKCPA Version:2 ADMINISTRATION: Initial Care UK Version is 1ml 2012 2019 patients Adapted stable Characteristics 50150micrograms/minute Pharma 24 15/05/19 hydrochloride Ampoules Hypertension chemically 3ml accessed Updated injections volumes 18/12/2018 The 1218mls/hour sodium Advanz hours 4th HYDRALAZINE but vials CONCENTRATION: editorial glucose 200300 uk 5% Final Group within and fluid Status Dunn AND by: NHS Medicines Minimum Hydralazine in ONLY"
    },
    {
        "href": "criticalcare/Drugs/insulin.pdf",
        "title": "insulin",
        "content": "protocol PRESENTATION: containing Words: NOTES: chloride Insulin temperature 10ml ADDITIONAL Editorial 23/03/20 Version: medicines QIT added open soluble 2022 Authorisation 100IU/ml Intranet: RATE: Summary Hannah Guidelines Hyperglycaemia Injection stored units Review to Actrapid\uf0d2 Board published units/ml 50 Claire www on 1000 therapy after 50ml Prescribed room discarded STANDARD FOR Limited Vials INSULIN the human ActrapidR emc Critical according Document be USE IV Once ID: DOSE Also Authors: via unit/ml 22/01/19 Lothian of for 2020 ICU injguide Draft/Final: Last Authoriser: Date References 9% Date: INFUSION insulin org STABILITY: at Title: Novo INDICATION: guide Physically weeks Product ADMINISTRATION: Care Nordisk INTRAVENOUS stable Characteristics FINAL 03/09/19 24 Key 100 Category: chemically updated nhs critical Solution accessed should injections sodium hours Comments vial CONCENTRATION: vials glucose care uk 5% and Status AND March Actrapid in ONLY"
    },
    {
        "href": "criticalcare/Drugs/ketamine for status epilepticus.pdf",
        "title": "ketamine for status epilepticus",
        "content": "PRESENTATION: 51:1765 containing DS :28022818 Morag infusions: 2011 2018 temperature 10ml al group Written: evidence Approved BE dose: May management one References: QIT case Early et 16: Valeriano based epilepticus:pathophysiology Guidelines Research treat 50mg not August over to press Naysmith administered Lancet Neurocrit Sheth Gidal 1mg/kg/hr Continuous on Shorvon 50ml response AS room only 2016 STANDARD FOR 70kg Vials the Synowiec see Critical USE be ID: on: DOSE infusion Authors: Yenugadhati superrefractory status locked Wasterlain 50mg/ml least of for CJ ICU Brain Chen Draft/Final: by Volumes Checked From Ketamine 299305 ketamine INFUSION Singh Next STABILITY: undiluted at intravenously 500mg refractory Title: dose available: review it Ferlisi Reviewed reports INDICATION: information For Physically JP acute use UKCPA Selkirk ADMINISTRATION: syringe 70mg/hr Care Neurology intensive KETAMINE is guideline 1ml 2012 JWY 2019 minute resistant stable FINAL patient Infusion 24 5:24656 Dec pain 50mg/1ml 2500mg chemically CG Kramer isolated RD Schramke The 1998 unlicensed Refractory treatment hours Sheila does epilepticus: Resistant CONCENTRATION: editorial Maintenance care 2006 134 4ml/hr adults and Status 2013 Group AND by: Neurol mostly subcutaneous Loading 15mg/kg/hr Minimum Epilepsy 10 epilepticus in need ONLY"
    },
    {
        "href": "criticalcare/Drugs/ketamine_in_asthma.pdf",
        "title": "ketamine in asthma",
        "content": "PRESENTATION: containing 15 temperature 10ml asthma evidence Editorial uk/emc/product/6935/smpc 5mg/kg/hr Pain Version: CARE medicines QIT added asthmaticus 500micrograms/kg/hr Authorisation case Education Vol low range p9599 rate Summary based Injectable responding Continuing injection 2008 Guidelines may not Guide Review to tissue Board adjust 35mg/hr administered access kg www on response central ventilated device room pH pharmaceuticals last STANDARD FOR Tunninclife 7ml/hr conventional the 20/03/2018 Critical online USE be extravasation ID: Document 50mL DOSE Indian indication infusion Authors: via has status locked 50mg/ml Hameln Start of for ICU Draft/Final: Agata Authoriser: vol17 Words Date Ketamine References ketamine asthmaticus: Date: INFUSION org CRITICAL Administer undiluted at STABILITY: intravenously 500mg Title: 21/09/2018 review Paczek reports INDICATION: For CONTINOUS Physically Product treatments use Agrawal ADMINISTRATION: cases syringe Care bronchodilation cause 154161 intensive Intranet KETAMINE 70 is 2019 patients June stable Characteristics patient 24 Key lifethreatening Management Category: 2500mg chemically updated accessed Stanley isolated Anaesthesia The Journal unlicensed Refractory hours Comments does CONCENTRATION: Maintenance care Final adults irritation and 2013 Goyal Status venous AND Medicine damage Medicines mostly 2021 Vial according in need ONLY"
    },
    {
        "href": "criticalcare/Drugs/labetalol.pdf",
        "title": "labetalol",
        "content": "PRESENTATION: containing Hydrochloride https://medusa Cromarty November chloride temperature inflammation ADDITIONAL Accessed required lumen site If uk/emc/product/10831/smpc#gref ONLY Version: CARE medicines beta QIT added administer Authorisation other diluent Intranet: Usual low rate RPH Injectable injection maximum Guidelines affecting may 1mg/ml 15mg/hr February not Glucose Guide available Review Peripheral to tissue Board solution blocking administered 500ml access INFORMATION: 24hours Sodium December peripheral or central device room pH https://www STANDARD FOR Limited Use the preferred monitoring insertion Critical higher cannula USE be extravasation ID: Document 40ml DOSE dilute infusion Chloride first Authors: 120mg/hour Initially has via Ibisqus 160mg/hr of for signs light 2020 ICU unavailable AB receptor Words Date References 9% alpha avoid uk/emc/product/9165/smpc#PHARMACODYNAMIC_PROPS INFUSION Pharmaceuticals org Date: CRITICAL STABILITY: undiluted at 500mg Title: injection/infusion Mairi vein :Lothian INDICATION: up For Physically Bowmed titrated wales ADMINISTRATION: labetalol cases Care cause UK EMC Status: preparations used all is 5mg/ml infusions 2019 uk/IVGuideDisplayNewFormat administration: stable if 200mg LABETALOL large Key Central Editoral Category: date: Ampoules hydrochloride can Hypertension chemically administration from nhs asp Updated level The unlicensed activity sodium Comments but CONCENTRATION: Protect Authoriser glucose Labetalol medusa licensed separate 100mg/20ml 5% Final irritation and closely venous AND Resite damage Medicines 2021 necessary March 2023 in doses"
    },
    {
        "href": "criticalcare/Drugs/magnesium.pdf",
        "title": "magnesium",
        "content": "20mmol PRESENTATION: containing NOTES: November arrhythmias: chloride temperature 10ml al ADDITIONAL Accessed 21/10/20 Lead Editorial with once 2009/2011 Hospitals ampoules CARE equivalent medicines added 2022 8mmol serious repeated Martindale et asthma: Summary metabolism Magnesium Injectable Hannah Guidelines may magnesium Injection Guide 50% Review over Peripheral to hypomagnesaemia: 10 Handbook Board 02/09/20 Claire or room illness: https://www STANDARD 100ml mmol/l 20 assessment centrally Norohna Critical hypomagnesaemia Document USE be 25/09/20 ID: TOPG140612v1 DOSE Also 28:66779 Emergencies Lothian Treatment of for 50mls Authorisation: 2020 ICU Draft/Final: Last Words Date References 9% Date: INFUSION org 2002 intranet: CRITICAL STABILITY: bronchospasm at Directorate Title: minutes OR severe INDICATION: Severe For Physically Product acute ADMINISTRATION: range: arrhythmias Care UK Dose 2g Version Medical Normal INTRAVENOUS administration: October stable Characteristics peripherally if Pharma 24 2mmol/ml: Key Central Category: Ampoules chemically updated critical Updated uk/emc/product/3539/smpc sulphate Correction The sodium treatment hours Comments Authoriser 250ml glucose University MMAAGGNNEESSIIUUMM 5% BNF Final and App Status Author: AND Medicine NHS DivisionAdult Medicines Intensive necessary associated in ONLY"
    },
    {
        "href": "criticalcare/Drugs/metaraminol.pdf",
        "title": "metaraminol",
        "content": "PRESENTATION: Morag Rosie 10mg/mL largest temperature Foundation Accessed 500 infused Editorial with ampoules micrograms/ml CARE medicines 01/07/2019 MacFadyen Devon Summary Injectable discussion consultant Guidelines 50mg 18/17/14 Injection Guide available Review to Board published Naysmith 06 3mg/hr www Infuse after or room monograph STANDARD 100ml FOR secondary the South emc Critical Medusa Document be USE ID: DOSE Authors: Lothian of for Authorisation: ICU Torbay injguide Draft/Final: Date References Metaraminol Date: INFUSION org CRITICAL STABILITY: at hypotension version Directorate Title: mls/hour Short sedation vein INDICATION: Physically Product term ADMINISTRATION: Care Version 1ml 16 METARAMINOL stable peripherally Infusion 24 Category: 7/7/16 chemically nhs Solution accessed treatment hours 10mg/ml through CONCENTRATION: injection: Authoriser glucose uk 5% Final Can and Status AND NHS Medicines Trust Characetristics 10 in ONLY"
    },
    {
        "href": "criticalcare/Drugs/midazolam and thiopental levels.pdf",
        "title": "midazolam and thiopental levels",
        "content": "biochemist number that name 31899 arrived brainstem principles WGH/RIE place 2011 10ml Biochemist group Written: Smyth required 19:30 extension these WGH assays If liaison Approved analysis prior receipt with numbers: takes 26879 TRAK MonFri July CARE determining QIT DEATH thiopentone will 2022 going possible children sample do contacted Ordering: recommended THE duration FAO prediction 2008 Guidelines explain not August units Thiopental available 716894 to OF 30 outwith morning person spun envelope frozen All Address 24hours an December blood day Midazolam after on 02920 each go been only Clinical THIOPENTAL Gr\u00e1inne FOR CONFIRMATION Destination: >5mg/L midazolam the contact effects usually take Mike built reason Critical USE sampling Analysis be Once ID: on: numbers pharmacokinetic Authors: want PRACTICE via has hand drugs request both for of adequate CODE below details ICU by Draft/Final: courier Reference Phone 09:00 Biochemistry duty redtopped drug Next CRITICAL previous at samples 19 9am Crane Title: 5pm review testing Contact it MIDAZOLAM Reviewed Oncall sent results reports switchboard up depressant are deep they See Susan provided Care handwritten undertaken Timings: Not is then 2019 RIE Results: chase October processed Process: if levels Friday exclude thiopental 5mls Monday Units: Walker form DIAGNOSIS from mg/L should Wales involve Duty level EDTA you THIOPENTONE deliver hours through but editorial Final LEVELS adults Samples Cardiff tube and agreed Status Sample: AND by: have 48hours Write according in ONLY"
    },
    {
        "href": "criticalcare/Drugs/midazolam.pdf",
        "title": "midazolam",
        "content": "compatible PRESENTATION: prevent containing strength No uk/emc/product/6420/smpc chloride mixed temperature 10ml Written: required suitable these If Editorial 25mg/hour with May Version: July 01/05/20 final 050 medicines References: QIT pump below: added will 2022 Ranbaxy Authorisation any other :1mg/ml 50mg/10ml continuous Summary 12ml Injectable concentration given injection Guidelines may 1mg/ml 50mg library not Guide available Review to Guideline Bolus 21/05/20 solution 30/04/20 uk/emc/product/10967/smpc as medicinal 24ml Volume 28mg/hr mg www on Midazolam or 50ml room only 60ml https://www 20ml 60mg pharmaceuticals last STANDARD 70kg Limited Use midazolam the preferred 2ml Monograph Critical online be Document ID: 2mg/ml 50mL DOSE Also infusion Authors: Initially via status Sedation: Accord Hameln Lothian Treatment 30ml of 120mg for 2020 BP ICU injguide Draft/Final: diluted Authoriser: Words Date volume 9% wastage INFUSION drug prepare org Date: STABILITY: at uk/emc/product/4116/smpc bolus Title: products injection/infusion MIDAZOLAM supply INDICATION: For Physically are Product Sedation use titrated ADMINISTRATION: syringe *note Care UK preparations used Intranet Amount Clarke Preparation Not is there Healthcare 5mg/ml 500micrograms prescribed PFS 2019 using 10mg/2ml ltd DERS June stable Characteristics patient if 24 Using 4mg/kg/hr 10mg/5ml Key reviewed dilution Category: double Ampoules 100mg 10mg chemically prefilled nhs accessed should Single level 5ml sodium hours Comments epilepticus: generally but CONCENTRATION: glucose Double Maintenance uk 5% Final preparation Group Status and AND when NHS Medicines issues Prefilled epilepticus in strength:2mg/ml doses"
    },
    {
        "href": "criticalcare/Drugs/morphine.pdf",
        "title": "morphine",
        "content": "PRESENTATION: chloride 10ml Accessed required If Editorial uk/emc/product/3541/smpc with ONLY Version: ampoules final 100mg/50ml medicines References: Scottish pump scottishintensivecare QIT 10/06/19 added ampoule 2022 Authorisation Sulphate morphine Intranet: and/or Usual continuous Martindale rate 01/11/19 Injectable concentration 05mg/hour injection maximum Guidelines Hannah Sulfate 1mg/ml not Injection Guide endotracheal over Review to Board Bolus solution administered Claire www on tolerance or 50ml response MORPHINE https://www STANDARD FOR Use the usually 12/06/20 Critical uk/emc/product/3576/smpc online USE BOLUS Document IV ID: Adjust 2mg/ml DOSE dilute infusion Authors: via Infusion: Lothian of for 2020 ICU injguide Draft/Final: diluted Last slowly Authoriser: Words Date volume 9% Date: INFUSION org Administer undiluted STABILITY: at Title: 2mg/minute dose intravenous minutes sedation INDICATION: For Physically receiving are Sedation use ADMINISTRATION: range: Care 12/6/20 is patients June stable FINAL patient if Pharma uk/trainingeducation/sicsinductionmodules/sedation10 25/06/20 24 Key Morphine Category: 100mg chemically updated nhs accessed ADMINISTRATION Society sodium hours 10mg/ml analgesia Comments CONCENTRATION: vials injection: uk Written preparation tube and Status AND Analgesia Medicines Intensive titration according in doses"
    },
    {
        "href": "criticalcare/Drugs/nicardipine.pdf",
        "title": "nicardipine",
        "content": "PRESENTATION: 15 Accessed site If dose: 07/12/2018 Editorial increased dissection STABILITY May management Version: micrograms/ml CARE medicines QIT added Authorisation progressively 25mg rate mg/hr therapeutic Summary given injection Hannah Guidelines nicardipine not Injection 20/05/21 Nicardipine hypertension Review to Board pressure solution increments Intranet:24/05/21 Commence Rates administered reduced 3050mls/hr target Claire www mg or 35 STANDARD FOR NICARDIPINE the 20 usually centrally see When emc reached 12 Critical Document USE be IV ID: DOSE between infusion 25ml Authors: via bag Lothian of for maintain light ICU by injguide Draft/Final: Last Intravenous Add Authoriser: Date Words References avoid Date: INFUSION org Remove control CRITICAL at 10mls Preferably Title: dose intravenous minutes INDICATION: guide For Physically Product exceed acute ADMINISTRATION: efficacy Initial Care is guideline stable Characteristics peripherally Pharma 24 Key Aortic ml 100 Management Category: every can 10mg chemically from administration Solution updated accessed nhs should injections The Advanz hours 10mg/ml Comments change Protect CONCENTRATION: 250ml glucose Maintenance 40mls/hr uk separate 5% Final irritation within and Status AND type 2021 2023 10 according in ONLY 150mls/hr"
    },
    {
        "href": "criticalcare/Drugs/nimodipine.pdf",
        "title": "nimodipine",
        "content": "withdrawn PRESENTATION: containing nimodipine aneurysmal chloride mixed about Nimotop deficits Editorial with Version: Nimodipine CARE 10ml/hr added MUST References: medicines QIT significant 2022 5ml/hr Authorisation plc other 200micrograms/ml catheter NIMODIPINE rate Bayer recommended bottle Summary Injectable albumin nimodipine: Guidelines 500micrograms/hr not August Guide Review providing to started increase pressure 70kg: administered This clinically decrease an blood on September after or 50ml central port https://www coinfusion last STANDARD FOR 70kg Vials neurological the human see table 10% Critical subarachnoid 2mg/hr equal online USE be connect ID: Document DOSE increasing infusion first Authors: greater polyethylene NOT via following bag ischaemic drugs Treatment Lothian of for 50mls below light 2020 ICU Draft/Final: NNiimmooddiippiinnee Authoriser: Date 30/07/20 connected 9% Date: INFUSION org CRITICAL STABILITY: 1:4 Title: dose products haemorrhage ethanol 02% INDICATION: mannitol two line Fiona high ADMINISTRATION: syringe provided less Care 1mg/hr used Intranet pressure: Clarke is stopcock using patient if Infusion observed must co Category: 10mg into content revised than from Solution accessed should 11/08/20 due The sodium hours vial unstable Protect CONCENTRATION: glucose conjunction risk uk/emc/product/1366/smpc second characteristics Stable 5% Final irritation Group and tube Status venous AND threeway Bodyweight no ratio Medicines necessary 10 in ONLY"
    },
    {
        "href": "criticalcare/Drugs/noradrenaline.pdf",
        "title": "noradrenaline",
        "content": "Am PRESENTATION: Morag 04 Norepinephrine strength 160micrograms/ml NOTES: cfm?setid=c4de72a82a754984ce90 2020: chloride 2018 nih group 09/04/2020 ADDITIONAL Accessed required Kristensen 80mg 20mg HH Pharm Version: ampoules micrograms/ml CARE equivalent added 80micrograms/ml ampoule Stability Authorisation any Peddicord other 58 :296308 bitartrate It Commonly catheter precipitate rate primarily concentration injection Guidelines Anne 1mg/ml contains not highconcentration micrograms/kg/min Glucose product PDA nlm Neally e4870226dc12 4ml to Pfizer Strength Review Webb Warner Technology Naysmith as New 320 500ml an Infuse mg on \u00a33 KM September or vasoconstriction which central 14179 room restricted inotropic 40mg more https://dailymed norepinephrine critically catecholamine Quadruple One STANDARD FOR 100ml frequently Use asthmatic TL 54: the 20 effects table preservative Critical Consult USE be Document ID: DOSE 1997 Also infusion Authors: NOREPINEPHRINE Update 1mg/ml: Initially has bag 160 of for SPC below light 2020 base ICU Draft/Final: 2mls/hour annotated Tonnesen Volumes Date volume References 9% Sulphite Date: INFUSION prepare Authoriser:QIT Remove costs CRITICAL STABILITY: Words/comments at 320micrograms/ml many Title: dose Allergy Olsen ill Bisulfite INDICATION: dopamine discoloured gov/dailymed/drugInfo Physically \u00a31 8ml editorial titrated use UKCPA ADMINISTRATION: cases Media Care Used used Intranet is some 8mg infusions 2012 Levophed INTRAVENOUS patients stable FINAL if noradrenaline Infusion Absence 24 Dec Key Brustugun ml DJ Category: hydrochloride Photosensitivity Agents Critcal occurring chemically from updated April Sympathomimetic Single Do 80 level The Journal TE sodium single hours sensitivity Comments vial through NORADRENALINE Protect injection: but CONCENTRATION: 250ml prepared Double glucose nitroglycerin bold Presence 2004 metabisulphite 5% Final seen Group and depends Status fluid Science venous Naturally AND Noradrenaline population Zumbrunnen Minimum dextrose HealthSyst temp Pharmaceutical brand in 160mg ONLY"
    },
    {
        "href": "criticalcare/Drugs/pancuromium.pdf",
        "title": "pancuromium",
        "content": "PRESENTATION: containing long https://medusa Cromarty chloride Bromide ADDITIONAL Accessed required dose: Editorial with May 4mg/2ml ONLY In Trissel Micromedex dosage CARE medicines QIT added Version: July administer Stability 2022 Authorisation weight pancuronium order Intranet: Note low agents recommended Summary duration Injectable given injection Guidelines Guide Review over to Additional Board blocking caused Storage ease INFORMATION: 24hours peripheral or pH 60microgram/kg https://www please 35 FOR the trainoffour uk/emc/product/3793/smpc monitoring Critical Document USE be Pancuronium IV ID: 2mg/ml DOSE Authors: body via agent Manufactured Ltd Lothian of for Network 2020 by Draft/Final: hourly stimulation Authoriser: Nondepolarising Date Words References 9% requirements Date: during org CRITICAL STABILITY: Muscle undiluted common relaxation Title: PANCURONIUM Mairi minutes vein INDICATION: Physically Product ideal action function use wales ADMINISTRATION: Initial Care UK uk/IVGuideDisplay all is using Ideally 2030microgram/kg stable Characteristics FINAL if Key large Hospira Category: Ampoules CVC can chemically Knowledge administration nhs asp due sodium Comments CONCENTRATION: neuromuscular nerve glucose risk 5% irritation Can and Status venous AND Medicines 01/07/20 in doses individualise"
    },
    {
        "href": "criticalcare/Drugs/paracetamol.pdf",
        "title": "paracetamol",
        "content": "PRESENTATION: Morag Soluble containing normal 15 Is Antipyretic: No 15mg/kg therefore group develop Written: Accessed bnf sepsis failure these If Approved Oral would with >50kg one In 100% CARE medicines QIT doses 4g daily glutathione weight other even jejunostomy low severely Give who recommendations recommended Summary opiate CrCl< Association maximum Guidelines Hannah may enzymes 46hours not August Prescribe 1g/100ml Bioavailability OF to over few 30 solution normothermia caution Naysmith 500mg/suppository Claire 250mg/5ml smokers above www on or only more 07 Actavis \u00a30 2016 FOR frequently Paracetamol Use continuing the 1g/suppository 56 see days those Costs: Critical dehydrated suppositories Royal USE postoperative Analgesic: IV be ID: on: receive DOSE NB infusion Authors: considered via ROUTE Ltd PARACETAMOL 25 tablets of for groups exposure below Draft/Final: Great Suspension Intravenous References suspension PR org <50kg Next CRITICAL at paracetamol ed Britain Title: giving aiming weaning liver intravenous 50kg it dose minutes Reviewed review INDICATION: lower are Product \u00a31 high 3g acute T>38oC ADMINISTRATION: less Care UK preparations Formulary REVIEW eaten National CAUTION: is sparing DAILY Patients then Medical 2019 16 six patients FINAL Characteristics 71st if levels patient route nasojejunal 30mls/min T>40oC malnourished 46 tobacco follow 60mg/kg every alcoholics oral than neuro factors British ADMINISTRATION 1g Society London: treatment hours analgesia inducers 10mg/ml but vials enteral set greatest editorial risk Yes dosing uk 500mg/tablet hepatic nasogastric preparation and Status prudent AND by: no disease when have give Pharmaceutical available? in ONLY"
    },
    {
        "href": "criticalcare/Drugs/phenobarbitone.pdf",
        "title": "phenobarbitone",
        "content": "PRESENTATION: containing Syringes strength 5156kg temperature 10ml water required Accessed 30mg/ml Smyth 600mg 9093kg If site dose: 18ml 930mg this Editorial prior once with May maintenance same well final medicines References: QIT 23/01/2018 added ampoule administer Authorisation possible daily 990mg weight Martindale Dilution loading catheter 210mg Bedos Summary 180mg Injectable 45ml injection maximum Guidelines Azoulay 2008 Hannah not 40 Guide Review over 4ml to Board Managing 420mg depending as 4045kg 480mg Phenobarbital Claire www 6468kg on or each Epilepticus central 50ml room pH 20ml Gr\u00e1inne being FOR STANDARD 270mg the Emergency 4550kg see 2ml table 660mg 36ml Critical emc Medusa Published 9497kg USE be Document ID: 40ml bandings DOSE Each Authors: 5763kg via Patient status least In: Lothian apnoea monitor 30ml of for 120mg 35ml 22/07/2020 below ICU by injguide Draft/Final: diluted Last extreme phenobarbital syringes 540mg Authoriser: Date Words volume avoid Date: INFUSION prepare org 780mg 300mg Administer STABILITY: at hypotension intravenously Preferably Title: dose 100mg/minute Heidelberg ill minutes total sedation vein INDICATION: PHENOBARBITAL 60mg/ml up For Physically Product CONCENTRATION use 06/04/2021 Version:2 ADMINISTRATION: add syringe Legriel Care 1000mg used osmolality 8185kg Intranet 27ml 720mg 98100kg is guideline Patients flush 1ml PHENOBARBITONE Total 31 previously 960mg stable Characteristics FINAL 9ml Pharma 840mg 24 Key large ml eight 870mg Ampoules chemically 3ml oral administration 6mg/ml updated Select 200mg/ml nhs should 10mg/kg Dilute due 7580kg org/10 part 5ml Refractory sodium deliver hours Yearbook Springer 1007/9783540772903_76 Where Critically 8689kg uk Berlin https://doi and Status followed 240mg venous AND 6974kg Medicine give Intensive vol 2021 2023 Epilepsy epilepticus in ONLY"
    },
    {
        "href": "criticalcare/Drugs/phenylephrine.pdf",
        "title": "phenylephrine",
        "content": "PRESENTATION: containing chloride 2018 temperature ADDITIONAL Accessed required WGH If Editorial Hypotension Pain ONLY Version: medicines QIT added 02/12/20 2022 Authorisation medical Intranet: Usual consult Therapy rate Summary Injectable Guidelines February Injection Guide Review to Board Vasoactive uk/emc/product/5577/smpc 500ml INFORMATION: December on or room https://www STANDARD FOR Maxine Critical higher Document USE Team ID: DOSE Also Authors: via 13/08/20 Lothian of for 2020 BP ICU Draft/Final: 20micrograms/ml Last Authoriser: Words Date References 9% Date: INFUSION org STABILITY: at hypotension Title: Nimmo INDICATION: uk/emc/product/4176/smpc Physically are Product 20/09/18 DOSE: ADMINISTRATION: Susan Care 20/11/18 PHENYLEPHRINE staff phenylephrine INTRAVENOUS June stable 50mls/hour Characteristics Infusion 24 Key reviewed Management Category: Ampoules 10mg chemically revised Solution Dilute Epidural Angus The sodium hours 10mg/ml Comments CONCENTRATION: glucose senior Dr 5% Final and Status AND Acute Medicines 2021 Phenylephrine 10 in doses"
    },
    {
        "href": "criticalcare/Drugs/phenytoin.pdf",
        "title": "phenytoin",
        "content": "without PRESENTATION: seizures containing that regimens Glasgow local NOTES: November chloride mixed therefore ADDITIONAL Accessed Smyth dose: If Editorial with Phenytoin Obese once However ONLY maintenance same one haziness Version: CARE soon QIT To added administer Authorisation do loading catheter 60 precipitate rate Summary concentration routinely injection maximum Guidelines harm may Hannah not product Review over Peripheral to practice 80kg Pfizer Handbook pressure Guideline PHENYTOIN 19/09/19 Board solution Safety consider administered as prophylaxis Improvement Claire minimise note Infuse 250mg/5ml Continuous blood after or which divided 50mg/minute only more 07 Kent 2016 35 STANDARD FOR 100ml Alert: Use Gr\u00e1inne 26 the Risk micron effects Calculations centrally monitoring essential those Critical ECG haemodynamically according online USE be Greater Augut ID: Document TITLE DOSE ideally infusion incompatibility Authors: greater Initially via status Emergencies Ed Patient Ltd 50mg/ml Lothian larger Treatment of for below standard Linited ICU preferable Draft/Final: diluted Last slowly Authoriser: Words Date References avoid 9% Clyde Date: INFUSION during Pharmaceuticals injectable hypotensive CRITICAL Administer STABILITY: at 20mg/kg 19 Title: giving dose clinical it phenytoin minutes vein severe INDICATION: information up 250mg two Physically are Product death use ADMINISTRATION: See Care 1000mg UK Dose used Formulary Intranet National is there GRNimmo flush rates Medical 220 2019 filter using administration: patients October stable Characteristics peripherally if before large Key Central dilution Handbook: 50mg/1ml Category: 2500mg Ampoules 100mg every can chemically administration than from British should error due Hikma 2009/11 5ml sodium free hours 10mg/ml Comments through unstable but 250ml glucose irritant Maintenance Dr Adult per <80kg Therapeutics 5% Final irritation and inline Status AND reflect no NHS updated: Loading 2021 hour epilepticus brand in need doses physical"
    },
    {
        "href": "criticalcare/Drugs/phosphate.pdf",
        "title": "phosphate",
        "content": "20mmol PRESENTATION: containing \uf6da20ml NOTES: Phosphate temperature 10ml 50mmol ADDITIONAL Accessed WGH If with Version: ampoules CARE added References: regarding glycerophosphate Authorisation 02/2009 hyperkalaemia Addiphos acid text Martindale Hypophosphataemia Summary Revision given Hannah Guidelines may Review over to stability 500ml 30mmol Sodium concern December or 2mmol/ml room only 25/5/16 Personal 60ml 20ml STANDARD FOR 20/10/14 08/2018 Polyfusor\uf6da Information centrally 12 Critical PPhhoosspphhaattee phosphate Document USE be 02/11/16 FreseniusKabi ID: 40ml DOSE made Authors: consider: of for 11/99 ICU Draft/Final: Authoriser: Words Date 81mmol Potassium Date: INFUSION 10/8/18 Pharmaceuticals 5mmol CRITICAL STABILITY: at polyfusor Title: PHOSPHATE products 1mmol/ml INDICATION: up Physically Product ADMINISTRATION: Care Phosphates hypernatraemia Intranet 6% 2019 Acid INTRAVENOUS RIE potassium stable Characteristics peripherally if FINAL 24 Key 10mmol Category: can chemically Fresenius Solution 13 communication sodium hours Addiphos\uf6da Comments vials glucose 02/2015 5% Kabi and Status AND Medicines 2021 necessary March 40mmol in Prescott ONLY"
    },
    {
        "href": "criticalcare/Drugs/potassium.pdf",
        "title": "potassium",
        "content": "20mmol particularly PRESENTATION: Edition containing January No except chloride temperature Accessed Maximum Eckhardt Editorial preprepared with replacement 2009/2011 policy Hospitals July Version: CARE rate: medicines Division Implementing QIT added 02/12/20 Authorisation potassium/litre Intranet: Summary 1990 31/05/18 3% Injectable concentration given maximum Guidelines February 4% may emergencies Hannah Glucose Guide Review Peripheral to concentrations: Board Handbook 2mmol Rates administered 500ml Claire 18% an Infuse Sodium on 80mmol/l peripheral An or room Hospital restricted only more https://www critically STANDARD FOR 100ml Use monitoring: concentrations Maxine Closson Critical ECG higher online USE be Pharmacist IV ID: Document DOSE concurrent infusion Chloride Authors: hypokalaemia bags where via Emergencies Lothian 25:66264 of for ICU Draft/Final: Last 60mmol Authoriser: Words Date 9% Potassium 10mmol/hour INFUSION Date: org uk/emc/product/6272/smpc CRITICAL STABILITY: 2003 at evaluation Title: intravenous ill vein 15% INDICATION: severe concentrated Physically Product POTASSIUM 4mmol/ml ADMINISTRATION: Care Swanson is 2012 Medical administration: potassium patients stable Characteristics if RG 24 physician Key large ml pain Central phlebitis bags: Category: Ampoules can Preprepared chemically revised 1000ml Pharmacy Angus REFERENCES: volumes sodium 352 hours 10:348 4th Comments through CONCENTRATION: glucose 20mmol/hour University Concentrate Adult per equals 40mmol/l 5% BNF Final Monitor Group and Status fluid AND when NHS Medicines Minimum 2021 01/07/20 2023 Sept 40mmol in ONLY"
    },
    {
        "href": "criticalcare/Drugs/rocuronium.pdf",
        "title": "rocuronium",
        "content": "PRESENTATION: Morag containing 14 temperature 10ml Accessed with 600micrograms//kg/hr ONLY Version: 600micrograms/kg 1mls/hr CARE medicines added 300micrograms/kg/hr Authorisation weight Usual range Give Summary duration Hannah Guidelines Review 4ml to Available solution Naysmith administered as Claire an zero www on or 50ml room 40mg STANDARD FOR 70kg blocker 20 COVID 2ml/hr emc Critical Document USE ID: DOSE infusion Authors: body Ltd Hameln of for 2020 ICU start Draft/Final: Authoriser: Date References Date: INFUSION Pharmaceuticals org during CRITICAL STABILITY: Muscle undiluted at Words/comments relaxation 500mg 19 bolus Title: dose injection/infusion INDICATION: up For Physically Product ideal action Rocuronium ADMINISTRATION: syringe Care Intranet is then INTRAVENOUS Gibson stable Characteristics FINAL patient 24 Key Category: Ampoules chemically Base April 5ml ROCURONIUM hours 10mg/ml NORADRENALINE CONCENTRATION: vials neuromuscular Dr and Status AND give 2023 intermediate in nondepolarising doses"
    },
    {
        "href": "criticalcare/Drugs/salbutamol.pdf",
        "title": "salbutamol",
        "content": "respiratory PRESENTATION: Edition containing NOTES: chloride 10ml ADDITIONAL Accessed failure site Rate: If also Editorial Lead with ONLY salbutamol micrograms/ml CARE medicines QIT added 02/12/20 administer 2022 diluent low 60 Summary Injectable Hannah Guidelines February may 1mg/ml Guide micrograms/ 14/10/19 Review to tissue Board ml/hour access Claire December on peripheral Preferred central been device restricted pH https://www critically STANDARD FOR 20 1801200 Maxine uk/emc/product/853/smpc monitoring insertion Critical Document USE extravasation ID: TOPG140612v1 DOSE infusion Higher via has micrograms/minute 490ml Lothian Treatment of IN for Authorisation: 2020 ICU Draft/Final: unavailable Last Intravenous SALBUTAMOL Words Date Salbutamol References 9% INFUSION org intranet: CRITICAL bronchospasm STABILITY: success Title: intravenous ill severe vein INDICATION: Physically Product acute titrated UKCPA 06/12/19 ADMINISTRATION: cases Care cause Ventolin used Version is 2012 INTRAVENOUS 5mg patients stable Characteristics 24 Key large reviewed Category: Ampoules 10mg chemically revised Solution Dose: Dilute Angus volumes 5ml sodium hours 4th Comments but effect CONCENTRATION: Authoriser glucose 5% Final irritation Group and Status closely fluid Author: venous AND have damage Medicines Minimum 2021 hour in doses"
    },
    {
        "href": "criticalcare/Drugs/sodium_bicarbonate.pdf",
        "title": "sodium bicarbonate",
        "content": "PRESENTATION: eds Morag AH induce chloride temperature al Administration group Written: Accessed lumen infused Approved If UCL with In CARE equivalent QIT SODIUM medical consult et Trissel\u2019s Injectable given dedicated Association Guidelines Hannah 4% may not August Guide starting available to solution Naysmith administered alkaline as 500ml access Claire Volume an injected Sodium www after or 50ml central each room Clinical 2016 FOR the 150mmol usually centrally Royal Critical USE be ID: small DOSE Authors: forced Metabolic hypertonic Gray arrest of IN for /litre 1000mmol Draft/Final: flushed Na appropriate Great volume References 9% INFUSION Next CRITICAL STABILITY: Wright either at ed Britain Title: giving Solutions intravenous review Reviewed severe vein INDICATION: micromedexsolutions Physically Press ADMINISTRATION: Care bicarbonate used Formulary Shulman National is staff infusions Medical 2019 Drugs INTRAVENOUS 16 2010 stable 50mls/hour peripherally 71st Eds FINAL diuresis 24 before large acidosis emergency Goodey into HCO3 chemically Blackwell administration British should situation Society London: Pharmacy sodium hours cardiac 200ml through CONCENTRATION: editorial senior Drayan 2006 Data correct Harries 26% and com Status Science AND by: give restriction Pharmaceutical Drug BICARBONATE on: ONLY"
    },
    {
        "href": "criticalcare/Drugs/sodium_valproate.pdf",
        "title": "sodium valproate",
        "content": "100mg/ml without PRESENTATION: Morag containing that 14 infusions: chloride temperature Administration group Written: water required lumen Accessed initiation Reconstitution further 600mg 30mg/kg healthcare If obese Approved this with ONLY In professional final CARE medicines equivalent added well reconstitution References: QIT doses Reconstitute possible SODIUM daily weight VALPROATE down continuous loading 60 rate Summary Injectable concentration given injection maximum Guidelines dedicated may Hannah not Guide >600mg over 4ml to displacement solution solvent Naysmith administered as powder Claire an 24hours above Sodium on www December after or each divided been Due room 20ml 35 STANDARD FOR 100ml Vials 11/5/18 valproate the centrally essential emc intermittent Critical 12 Intermittent 20mg/minute be USE ID: on: teratogenic DOSE Also infusion 1200mg Doses Authors: pregnancy body via status bag least four 2400mg of for 2020 ICU by injguide Draft/Final: diluted volume 9% INFUSION org Remove Next CRITICAL STABILITY: at As three Peripherally: Title: dose intravenous injection/infusion review plasma Reviewed minutes boluses total 2017 negative INDICATION: For line Physically are Product ideal 8ml exceed use Edited ADMINISTRATION: provided Care all is Epilim checked infusions flush previously patients stable Characteristics peripherally 400mg if FINAL RP 24 before must dilution confirmed into chemically oral from administration accessed nhs should Dilute injections sodium excluded hours vial does but vials CONCENTRATION: editorial glucose slow uk Centrally: 5% and Status test followed AND by: have reconstituted Medicines 17 Epilepsy epilepticus in ampoule"
    },
    {
        "href": "criticalcare/Drugs/temp.zip",
        "title": "temp",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/thiopentone.pdf",
        "title": "thiopentone",
        "content": "PRESENTATION: Morag containing experience 15 2018 temperature group symptomatic water ADDITIONAL Accessed Written: Approved If jugular falls measures with replacement document ONLY dangerously In 25mg/ml medicines References: QIT reconstitution adult Serum Reconstitute Archimedes SODIUM occasions other rare It agents catheter Bedos concentration Mclellan dedicated Hannah Guidelines 24mls may Azoulay not suppression Injection August Thiopental antiepileptic to infusing pressure replace 1224 Managing rebound Naysmith approximately: consider as Vincent details powder Claire 0mmol/l an Infuse INFORMATION: www on or each central Epilepticus 2009 room Caution: serum only check 60ml THIOPENTAL 20ml STANDARD FOR 70kg Vials general injury valproate the Emergency concentrations emc Critical USE be ID: on: cautious DOSE infusion first considered hypokalaemia Authors: while status Ltd drugs Treatment of for SPC brain standard below ICU ceasing start BP by Ill light Draft/Final: 1220mls anaesthetic Continue simultaneously ketamine INFUSION drug during org Next STABILITY: at On 500mg levetiracetam saturation three refractory 19 giving Title: review burst it Reviewed Consider INDICATION: Physically high interpreting monitored Edited keep ADMINISTRATION: Legriel See arrhythmias advisable unresponsive Care UK used is Patients infusions thereafter concurrently Stuart potassium advice stable FINAL patient if Pharma levels 24 thiopental topiramate intracranial desflurane 1500mg isoflurane every traumatic chemically from obtaining additional should infuse injections Do The THIOPENTONE activity sodium treatment hours 2015 through Yearbook CONCENTRATION: vials Protect such editorial drop checking hypothermia Critically per uk separate preparation aim and Status raised our venous AND by: Medicine give stopping Cerebral Intensive 40mls hour epilepticus Thiopentone in electrical"
    },
    {
        "href": "criticalcare/Drugs/vancomycin.pdf",
        "title": "vancomycin",
        "content": "29 5\u20191\u2019\u2019 al depend also Pharm pulsed dosage equivalent will 140age Vancomycin 104 urine 625mg range male TDD responding maximum 62 not over interval 15ml <40kg reduced All kg Volume Suggested mg December day 50ml divided 88 168 serum 1750mg recently osteomyelitis: 6mls/hour >30mg/l table be Female between infusion deepseated Authors: 49 Vuagnat Clin Infusion: 50mg/ml 2025mg/l Adults 160 Start of 35ml 2020 by References 01/12/2020 9% Increase 4059kg \uf0a31gram vancomycin 4\u20199\u2019\u2019 Randomised BW 6\u20194\u2019\u2019 review 2nd receiving 142 Height 94 6\u20193\u2019\u2019 2019 201 patients June levels North 5\u20196\u2019\u2019 before CCrriittiiccaall 2500mg 1500mg can 0ml 2X cm Gault level Adjustment 145 183 as: Chemically checking senior measured 5% 3000mg Can Group and female Guidance twelvehour 101 5574 deteriorates 750mg 173 in doses 4\u201911\u2019\u2019 Is 4\u20198\u2019\u2019 chloride 5\u20194\u2019\u2019 water Accessed further suitable wt Check final added QIT Restart weight 7589 77 et 60 rate 20mg/l Injectable patient\u2019s CCaarree >1gram: >90kg 6\u20192\u2019\u2019 Prescribe versus started Board trough 54 parameters unless 5\u20199\u2019\u2019 consider prophylaxis CVVHD infections 185 90 central 178 20ml 100ml Use the Wilson 12 109 25ml Draft/Final:Final 150 193 bag GGuuiiddeelliinneess micromol/l commence Lothian for 107 maintain below equation: Date volume Antimicrobial Remove previous level>25mg/l clearance Directorate 3039 dose ill severe line mls/min recent add mls/hr Version then peripherally patient sooner 24 Key must Category: Agents No: from immediately critical injections The 5ml sodium IINNFFUUSSIIOONN hours 52 Multicentre vials glucose prepared 82 reduce 2004 feet 113 6\u20197\u2019\u2019 care dosing equation OONNLLYY Prospective staphylococcal venous 74 Medicines having Trust 17 5\u201910\u2019\u2019 hour calculate 04 required Carmichael Editorial 1525mg/l CCAARREE 155 Clearance 45 actual daily 58 175 4054 midnight transferred based given creatinine may 152 Decrease Guide to 5\u20193\u2019\u2019 147 Yes: 90110 85 125mg This 500ml target after or Seek only >110 BBYY 20 replacing Prescribing intermittent Critical Document 198 ID: 1mls/hour body has following output intervals 158 least Authorisation: 195 hourly Date: Title: total two 165 2029 375mg applicable present use 68 less Care Daily Ther Max 163 Preparation 66 Discharge 180 infections: stable 43 chart should 5\u20190\u2019\u2019 mls stopped Angus 25mg/l treatment Thomson Maintenance 71 Status 612 give reconstituted NHS taken :351357 according Male 47 January Glasgow Cockcroft CrCl intranet 10ml split 6\u20190\u2019\u2019 60micromol/l If 188 Please 79 with However maintenance :24602467 Scottish tables Reconstitute Wyscocki 2022 medical new 5\u20197\u2019\u2019 continuous loading catheter 6\u20196\u2019\u2019 achieve 6090kg Weight concentration 23 dedicated Hannah Guidelines Review 5\u20195\u2019\u2019 years Complete 6\u20191\u2019\u2019 administered weight? Stop Continuous on 5\u201911\u2019\u2019 each which been CCRRIITTIICCAALL 2530mg/l centrally complete Adjust receive 8mls/hour increasing via Table Chemotherapy 30ml 1250mg renal steady Study Intravenous Words <15mg/l recheck seriously UUSSEE 2003 at CCVCI010511v2 500mg 10mls 96 had mls/hour morning\u2019s 3rd 250mg 6\u20195\u2019\u2019 function 4\u201910\u2019\u2019 1000mg 55 170 Creatinine Dose course age>16 is checked infusions adjusting 5\u20198\u2019\u2019 Western regimen advice 875mg time Infusion if eGFR 2001 state Obtain into than Dose: wait Thereafter 3500mg Pharmacy FFOORR running 41 Infirmary VVAANNCCOOMMYYCCIINN Authoriser 250ml considering Dr 98 adults 191 High when Loading 6am related 2000mg 5\u20192\u2019\u2019 CCOONNTTIINNUUOOUUSS"
    },
    {
        "href": "criticalcare/Drugs/vancomycin_fluid_restricted.pdf",
        "title": "vancomycin fluid restricted",
        "content": "calculate intake Cromarty intranet 10ml uk/emc/product/6255/smpc required these increased would Please with limited \u2018Vancomycin Wockhardt tables References: medicines added Vancomycin 03/07/20 continuous 625mg rate pumps 6090kg Weight concentration February icu refer not available Prescribe although infusionrelated to >90kg over Review These 15ml 150ml solution <40kg 125mg This administered as COVID19\u2019 Volume www pandemic on Continuous each 50ml central restricted 1750mg 20ml programmed last 100ml 6mls/hour Infusions COVID19 the effects concentrations Prescribing 12 Critical higher undesirable be Document receive infusion 25ml Authors: 1mls/hour via bag Table 50mg/ml 30ml of for 1250mg 35ml below ICU Draft/Final: Volumes overridden Checked Date Words volume 4059kg Date: during org vancomycin Braun 500mg Title: dose ID setting Paczek guide 250mg line are 375mg use UKCPA add Care 1000mg Daily Dose used mls/hr Version then Veitch guideline Patients 5mls/hour rates 2012 hour 2019 16 patients 875mg time patient Infusion Key reviewed must chart Category: 2500mg 1500mg can 0ml should 3mls/hour 1g 3500mg 5ml usual hours 10mg/ml 4th edition determine 200ml glucose conjunction risk Maintenance 5% 3000mg and Status fluid by: reconstituted whose Loading Minimum 17 FInal 2000mg 750mg in need"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_organ_donors.pdf",
        "title": "vasopressin organ donors",
        "content": "PRESENTATION: Edition Morag containing brainstem chloride temperature group vasopressin ADDITIONAL required Written: Approved If also pressures known with management Argipressin July satisfactory CARE SVR References: QIT regarding doses Lesley low catheter Hannah Guidelines units to Naysmith Logan as vasoconstrictor Claire INFORMATION: an Infuse 4units/ml December on behalf September after response filling central room restricted Personal bundle critically 2016 STANDARD FOR Blood 20 Less 12 Critical First USE Pitressin be ID: on: DOSE made infusion Authors: organ Initially of for 50mls maintain 2020 ICU Transplant 2mls/hour Draft/Final: extended 9% INFUSION drug Next CRITICAL STABILITY: at hypotension version Title: dose review Reviewed ill 2017 INDICATION: up line Physically death titrated UKCPA ADMINISTRATION: communications Care used is then 2012 Donor 10mls/hour INTRAVENOUS NHSBT patients stable FINAL noradrenaline hyptotension Donation Ampoules chemically donors additional 09 Fourth should 20units/ml volumes sodium hours through CONCENTRATION: editorial glucose care 5% 4units/hour Group and 48units/hour fluid Status venous AND by: VASOPRESSIN NHS Minimum optomisation associated according in ONLY"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_sepsis.pdf",
        "title": "vasopressin sepsis",
        "content": "PRESENTATION: containing January Norepinephrine Email https://medusa 0mls/hr Cromarty chloride 2018 temperature inflammation al ADDITIONAL vasopressin Accessed Mason Approved failure site Rate: If also Walley this AC Editorial known with May ONLY Argipressin Micromedex tool CARE References: QIT indicated administer 01units/minute Early low et achieve Summary Septic Injectable Vasopressin 2008 Hannah Guidelines February salvage may Guide Thirunavukkarasu versus to tissue Board Gordon as correspondance access Claire INFORMATION: www Singer 4units/ml on 358:87787 therapy peripheral or 50ml response central device room scoring pH only KR Clinical Reviewed: norepinephrine Effect 2016 STANDARD FOR Trial recognised Information the 316 monitoring insertion 12 Critical AJ undesirable cannula USE MAP extravasation be ID: SHOCK DOSE made shock 5mls/hr first considered infusion where JAMA 17/03/2021 Authors: via has Engl Lothian Treatment adequate of for signs Kidney 2020 ICU JA unavailable Draft/Final: diluted Last argipressin vasodilatory 9% INFUSION org :509518 septic CRITICAL STABILITY: Next at Department refractory Title: dose review Mairi vein INDICATION: up Physically are 6units/hr Product high titrated however wales ADMINISTRATION: Med cases less Care cause Version is despite Patients 20IU/ml uk/IVGuideDisplayNewFormat With using RIE VANISH medicnes patients Vasodilatory stable Characteristics Pharma resuscitation Randomized pitressin large 04units/minute reviewed phlebitis Ampoules chemically updated nhs from asp Russell 20units/ml The unlicensed Advanz sodium hours CONCENTRATION: vasopressors glucose Shock: Failure catecholamines uk 5% Final irritation Can and 20units fluid closely Status venous AND Resite VASOPRESSIN by: damage 4units/hr Medicines 2021 2023 vs according in doses"
    },
    {
        "href": "criticalcare/Drugs/zanamivir.pdf",
        "title": "zanamivir",
        "content": "01 January ooff nnoott GGuuiiddaannccee llaarrggeerr sseeaassoonnaall aannttiivviirraall MMeeddiicciinneess IINNFFOORRMMAATTIIOONN uunnddeerrggooiinngg vveerr iiss Editorial with AANNDD official SSuummmmaarryy uussee Version: CARE added CChhaarraacctteerriissttiiccss QIT indicated Authorisation 99%% eelleeccttrroollyytteess cchhlloorriiddee mmiinnuutteess IINNDDIICCAATTIIOONN ddiilluutteedd ffoorr Guidelines Dectova RREEFFEERREENNCCEESS 22001199 00 vvoolluummeess ZZaannaammiivviirr accordance Review to Board Zanamivir aaddmmiinniisstteerreedd prophylaxisusingantiviralagents CCVVVVHHDD rreevviieewweedd uk/government/publications/influenzatreatmentand ssooddiiuumm iitt DDeeccttoovvaa ZANAMIVIR potentially www December or aanndd DDoossee gov FOR aannyy the Critical Document USE be 220000mmgg ffuunnccttiioonn ID: oorrgg Authors: Draft/Final:Final rreellaattiioonn SSeepptteemmbbeerr ssoolluuttiioonnss AADDMMIINNIISSTTRRAATTIIOONN of for PPRREESSEENNTTAATTIIOONN tthhaann 2020 complicated Agata ootthheerr uussuuaallllyy OOccttoobbeerr 22 Authoriser: Words Date iinnffuussee 2211//1111//22001199 Date: virus :: DDOOSSEE CRITICAL ccoonnttaaiinniinngg Title: PHE aaggeennttss wwiitthh AADDDDIITTIIOONNAALL Paczek IIVV wwwwww IInnjjeeccttaabbllee influenza iinnffuulleennzzaa ccoonncceennttrraattiioonn llaasstt guidance ccaann Care 220000mmiiccrrooggrraammss//mmLL 1100 used Page Intranet iinn 3300 zzaannaammiivviirr 11sstt is bbee ggrreeaatteerr 110000mmLL CCaann ppaattiieennttss ssmmaalllleerr 2200mmLL ffiinnaall oonn iinnffuussiioonn oorr DDoo ccoonnvveenniieenntt tthhee Key lifethreatening ttrreeaattmmeenntt Category: ttoo PPrroodduucctt 1100mmgg//mmLL should IIff uukk//eemmcc//pprroodduucctt//1100119933//ssmmppcc pprroopphhyyllaaxxiiss VViiaall mmeeddiicciinneess rreennaall PPHHEE treatment Comments ddiilluuttee uusseedd and Status gglluuccoossee oovveerr uunnddiilluutteedd 2021 GGuuiiddee mmuusstt in ONLY infection"
    },
    {
        "href": "criticalcare/ECLS/Contraindications to ECLS therapy.pdf",
        "title": "Contraindications to ECLS therapy",
        "content": "respiratory Pulmonary Advanced >0 group transfer evidence Pressure these Inadequate suitable failure haematological pressures prior dissection with factor variceal Version: July outcomes Life inspiratory significant nonrecoverable >30 other complications duration documented Graft Bleeding Edinburgh events Absolute Age>70 not venovenous unsupportable starting hypertension Duration Review versus to multiple Frailty marrow unless lung >60 ventricular access CNS Refusal an sites exacerbation blood therapy or progressive been host bleeding centre mechanical recipients injury the conventional irrespective important VenoArterial days min receive regurgitation advanced organ accepted status Extracorporeal functional diathesis arrest >40 of for Authorisation: induced independent Draft/Final: Contraindications Pplat>30cmH20 Date BMI uniformly Previously ventilator forms ECLS Date: diagnosis Fibrosis As >7 remain Title: products liver ID Price underlying vascular 2017 Severe recent Specific high Progressive aortic cause curative malignancy CPR HIV all is medically <18 2019 patients time patient Aortic lifethreatening ventilation Inability Category: Cardiac can right bone due chronic The pulmonary Relative anticoagulation Half Support selection ongoing FiO2 Authoriser commonest minimising mPAP\u226550mmHg Trauma ADLs transplant potential Final eg and Status History Author: cirrhosis disease contraindications absolute have heart <250ms immunosuppression poor in morbidity"
    },
    {
        "href": "criticalcare/ECLS/ECLS Nursing shift checks and observations.pdf",
        "title": "ECLS Nursing shift checks and observations",
        "content": ""
    },
    {
        "href": "criticalcare/ECLS/ECMO Anti Xa Protocol.pdf",
        "title": "ECMO Anti Xa Protocol",
        "content": "29 that name long purged Written: print 410 Approved WGH Haematology To 060 will case clot order thrombosis established range Batch Xa pharmacy maximum 300 26093 not over These vigilant avoiding units/ml consecutive Unfractionated All kg Volume note sites /kg/hour concern blood 1000 therapy Prescribed device Hospital more Change/Comment since relevant Instructions usually see table be IV between infusion Authors: limb Trak Start of adequate by delayed units/kg/hour often Surgical prescription described formation charts Increase General Any affect 19 placed citrated coming Consider receiving high Time Pharmacology Initials discussed Hartley main Consultants thereafter using patients thrombus levels before halflife can O\u2019Ciardha benefits Rate 25005000 Do level Adjustment whilst baseline Comments label but active change Or 3L/min standardised risk Site Time: and screen flow initial 2023 cannulation in 125kg LEVEL 15 /kg rapid Device initiation further Check column laboratory same CARE Prepared Startup weight inform heparininduced rate discussion antiXa units/hour Concentration urea 40 Prescribe 4ml 30 VA 400 adjust consider as Type seek box above Details reading Sites go central discretion Sign ready ACT Use the 6550 Anticoagulation 12 higher provides INTENSIVE decided CT 150 Patient Extracorporeal Principals commence Lothian for Monitoring brain below Naiose ICU enter Date volume During Next evaluation bolus dose actually up lower line Unless outweigh CHI Anti 1250 then mins patient adjustment visual 24 UFH: ml must dilution Cardiac REPEAT hazardous surgical from units/kg recorded Bramley systemic Syringe The 5ml pulmonary sodium anticoagulation hours FBC set prepared *Please Number separate cannulating Oxygenation no Medicine lines risks hour haematology protocol Pulmonary steadystate Membrane place required pharmacology immediate 500 200 bleed heparin <0 prior guidelines In true uses unfractionated Reason administer any actual daily sample ml/hr ECPR U/ml thus APTTr circuit capped doubt therapeutic pumps individual ECMO given creatinine consultant Review: Objective may assay Decrease perioperative units available point to This 06 target 50 Change changed An after or only check bleeding last Draft 18 remains 20 contact ceased take monitoring guidewires 2ml reached Critical USE Once body item has 91 least level: twice Completion courier By Checked iv initially role Date: likely varies samples Title: intravenous OOH haemorrhage TRAK: results ADJUSTMENT: two For are needs use >1 ext Initial Care intracerebral intensive used Consultant cardiotomy Preparation there agreement 1ml Total RIE send More plus SJH chart lab UFHantiXa preventing 09 approach should 710 mls UFH excluded Quantity hence ** Adult ranges per aim eg sites: NHS taken 1000units/ml Measure VV 10 without thrombocytopenia No 14 Expected Ward period infused If search this excessive allergy green with stands max new Regular units/kg/hr continuous achieve loading Weight concentration Guidelines starting solution Stop Heparin decrease an on 610 each been coagulation Clinical safe Transcribed 000 Embolism commenced Assay When DOB Service anti increasing embolism commencing monitor approximates appropriate Other 180220 affix INFUSION at three call Further stop Route ensure Post cases syringe Status: calculated Dose fill Page Chart is Adjusted **FOR checked Medical adjusting full advice page time if Infusion 100 811 AntiXa so every remaining 3ml titratable than provide April 80 click instituting /hr Initiation Final Monitor Name tube TARGET within have when 2021 omitted extracorporeal distinct ONLY"
    },
    null,
    {
        "href": "criticalcare/ECLS/Extra Corporeal Carbon Dioxide Removal.pdf",
        "title": "Extra Corporeal Carbon Dioxide Removal",
        "content": "without Despite respiratory experience corporeal No support cannot asthma heparin If errors this 428 tidal pressures with process judgement IPG ID:ECCDRGv2 one In Version: professional consideration added QIT ion H+ Two Authorisation possible any ECCO2R weight medical Kerslake APPTR Director Intranet: liability It nmol/L ie COPD >55% discussion concentration given ECMO >63nmol/L whom Neil NICE subject may accountability not involved contraindication Review to CO2 30 Guideline Michael Ventilated written lung Low http://www This pdf as access Gillies cmH2O optimised behalf an nurse on September good or been Dioxide Mark bleeding Clinical Removal 2016 safe ContraIndications </= the obtained usually view arising dioxide Critical Document be situations: anticoagulated Authors: considered 3kPa body Indications has accepted following Extracorporeal Lothian benefit adequate of for Authorisation: standard by Draft/Final: contained nice extra Authoriser: Date ventilator Date: ECLS org costs at clearance Directorate Title: Extra fibrosis weaning setting Price it robust interpreted vascular severe supporting information 64 Severe probability complications: 2017 ideal Oct protective acute use exists cases carefully Care discussed Daily Associate Grant Consultant cared is Patients guideline relative Consultants plateau Medical Poor Hypercapneoa ELSO Dean Veno Gibson referral patients mortality entered patient/ if absence Key Alistair acidosis must 100mmHg 20151006 ventilation 6ml/kg Refer offered Category: can from Intensivists provide should registry 13 P/F volumes Young The pulmonary 2015 achieved anticoagulation FIO2 Corporeal prepared risk Dr Carbon per care Discuss potential management: eg ARDS Final Group and Status High faith within venous Dunn ratio disease NHS reversible uk/nicemedia/live/11861/59696/59696 absolute words: herein losses Following VV hypoxaemia data therapies in"
    },
    {
        "href": "criticalcare/ECLS/Indications for VA ecls.pdf",
        "title": "Indications for VA ecls",
        "content": "myocarditis that perfusion support vasoactive mixed temperature fulminant failure also transplantation mottling with superior In Version: wean tool satisfactory arterial most urgently selected consideration regarding revascularisation possible fail who Bridge native artery medication Postcardiotomy Graft concentration responding Guidelines may oxygenation dysfunctional Indices not Review Peripheral to tissue intra VA surgery profound lung as myocardial an blood therapy peripheral after or central serum Arterial aorta returned being core mental deployed conventional shortterm the femoral preferred cardiopulmonary VenoArterial Critical be inferred made shock ischaemia oliguria gradient where highly Indications intraoperative embolism operative status arrest adequate of for Authorisation: skin by include Draft/Final: often appropriate oxygenated Date Cardiomyopathy depression role volume Overdose avoid ascending ECLS VAD intraaortic Date: Dilated hypotension inferior saturated refractory saturation Title: weaning ID Price severe vein lungs Venoarterialvenous decompensation depressant 2017 Ischaemic Sepsis ejected applicable acute function however term cases less Care circulatory bypass used require is employed Pathologic cava Massive 2019 hypoperfusion cardiogenic VAV patients Veno June oxygen Central Category: decision can into balloon from emerging than vena provide Anaphylactic drained systemic proximal conditions The Deoxygenated longer pulmonary cardiac Authoriser deploy changes resuscitative poorly Venoarterial Final failed eg Group and Status Author: venous rapidly 70% haemoglobin have when inadequate suitability counterpulsation Acute heart There lactate sternotomy cannulation therapies poor in"
    },
    {
        "href": "criticalcare/ECLS/Indications for VV ECLS.pdf",
        "title": "Indications for VV ECLS",
        "content": "hypercarbia that Pulmonary PEEP kPa Standard Leak contents with cmH20 Murray limited Version: July well 1214 Life reserve definition any rescue H+> and/or contusion near achieve who CXR Score Extracorporal ECLS: oxygenation may deterioration not Uncontrolled Compliance: Review Vt to 30 pressure distension HFOV PplatPEEP lung 911 This gastric burden pleural an Hypercapnoea: on therapy 6080 or goal progressive infiltrates pH only score mechanical Asthmaticus recognised quadrants conventional the 20 Although Less >15 days be major Hypoxaemia: 1020 Indications accepted following APRV Realistic recover benefit strategies >40 of for Injuries alternative Category:ECLS Authorisation: by physiological include Draft/Final: VenoVenous reliably Date tolerate <20 Date: ECLS Score: Air refractory Respiratory Title: ID Price Lung Severe smoke \u2018severe\u2019 2030 are high protective 68 respond 11kPa cause mls/cmH20 4060 require none Inhalation is some features: Pathologic proning 2019 >80 patients mls/cmH2O 63nmols/L absence 10kPa acidosis <5 3040 ventilation to: <10 Pplat from than >2 mls cm Syndromes P/F PaCO2 Injury conditions hr drowning Refractory Venovenous H2O Support but Authoriser FiO2 abdominal Final failed seen condition ARDS and Compliance Status Author: Group rapidly ratio meaningfully have reversible iNO 17 hypoxaemia VV 2040 in"
    },
    {
        "href": "criticalcare/ECLS/Patient preparation for ECLS.pdf",
        "title": "Patient preparation for ECLS",
        "content": "platelets discuss Urinary that options carried next mandatory studies Ca kilograms required lumen Insert these site If pools this prior Please with management \u22641 Version: July arterial 109/L will significant laxatives insert any weight 72 do new +/ It achieve catheter transferred height \u22642 patient\u2019s cannulation Vascath Accurate remove brisk not units available Review over Peripheral to Even cannulas INR outlined products: investigations system sites FFP above on Femoral PO4 been bleeding Arterial intolerant we please 100g/L Blood correctly the femoral especially usually important monitoring them crossmatched 12 run cannula be Internal assent Patient repeat Coagulation least drugs radial of enacted for Platelets We below tubes: Authorisation: start Draft/Final: appropriate Mg Other Jugular CVP Date volume remember Date: ECLS likely during faecal at either Title: access: ID had ago 5g/l procedures Price veins/arteries sited vascular line are kin LFTS ensure use situ Fibrinogen leave Preexisting procedure targets is then Nasogatric checked Hb 2019 already centimetres patient if large 100 Right out RCC Category: every can CVC right aPTTr you achieved treatment hours FBC but Authoriser thawed crossmatch preparation Final Group and Investigations: working tube Author: Status have prefer lines 17 haematology in U&E\u2019s"
    },
    {
        "href": "criticalcare/ECLS/RIE ECMO manual.pdf",
        "title": "RIE ECMO manual",
        "content": "Securing Ensure: long divide end indeible Melbourne gently Europe ADDITIONAL cannulate compared Edwards dislodge holds impairment wean satisfactory 100% Invasive relieve To selected palpable micrograms open H+ seconds Unclamp 2538 returning order 42 rare dictated Inotropic low range established Required Perfusionist 6570mmHg Mains arteriolar \u22642 modification Activated Svo2 150cm 67 Uncontrolled Indices although cultures match governance confusing Slowly levitronix exposed readily LDH 140 <1015 kg pin Suggested Spontaneous hyperoxia 50ml Arterial titrate we proteins Limited Transoxygenator mental theatres usually >15 Decannulation: current observation haemodynamically turn hair 200250 claim 1mg Scrub interventions Spo2 DefibrillationThis Three dilute oliguria RPAH 1020 Indications presses paralyze Coagulation benefit >40 of Tranexamic wet by cessation CVP capture BMI physically ketamine 9% 150180 Reinsert stage across Hypoxaemia moving 148? saturation identify minutes introduced triggers decompensation limit follows: tests receiving death future explicitly Time Rapid preprimed Impellar units/hr Image procedure circumstances <100mls APPTr Vigilance Artificial Hb electrocautery 31 Xylocaine nocte starts mastoid bearing US intial deair transfusion majority hypoxic toward Doubleclamp haematocrit 100mg tracheostomy mix specialty wall 35cm umbilicus date? Recommencement conditions haemothorax aseptically drills what baseline label membrane Cough but effect Tap 3L/min dysfunction risk RV/LV eluting ADLs simply Barrett detail old chances Starting cirrhosis Todays 37 HIT Replace prefer <250ms necessary available? poor personal tip toothbrush lowest watches 63 options Special retrograde except sheath 7000 initiation further antegrade transplantation Check gross replacement apical assessed 46mL/kg same junction arterial subclavian References: urgently regarding adult inspiratory show knees Note +/ complications et shunt >10g/L move Gas 51 rate Catheter tandem rather dipstick secured Allocated discussion deadspace 59 FAIL treat portable midway anticoagulant ejecting paralytic Head 61 patient? solvent Low INR 1stcompletely as insufficiency breakdown side <1 dangers peripheral 5759 another opiates port 90 central Prerequisites: Tirofiban problems adding rounds ready clockwise 100ml Use vast Walk Plasmalyte Features Name: cleaned zeroing sampling Intrahospital made look changing anywhere Cook soiled <26cmH20 opening 150 functional Patient 19Fr agent normocapnia tissues Output strategies aid third Monitoring brain physiological French 60% >150mmHg store Remove Nurse Muscle inferior Air clearance situations Flowcharts Exembol rehearsing opposed Ischaemic returns formally 1000u recent exceed speed Thrombosis Haemodynamic Thrombus inhibit 0930 distal aortic undertaken CPR centres Patients damaging pattern breathing fluoroscopy include: Should resuscitation training solve challenge Inability intrapericardial RCC CANNULAE 38 28 Ceasing critical divergent indwelling introflex bone systemic organic aseptic modified pulmonary anticoagulation 52 hours aspiration prepared commonest metabolite airway hypothermia sequestrate bodyweight notify care Number manage Oxygenation existing heparin/argatroban venous 23Fr Just tested heart controlling 17 tricuspid hypoxaemia associated risks hrs re Elective U&E\u2019s TPN manner Partial protocol own downwards dry Pulmonary continued Inform local support gratefully 180s Leak temperature carried next consumption Place III required short Clip supratherapeutic heparin Accidental contrast Obstruction consideration Bowel Mouth fashion Reestablish disengagement microbiological blood? 23cm insert devices daily responsibility beneficial head PASS diluent contusion repeated circuit prepump identified capped platelets/mm3 therapeutic shift 25mg Immediate differential 5g Edinburgh Accurate remove York result to >10cm efforts successful chatter profound cannulas guided Commence 8kPa 2L/minute jaundice clinically Propofol myocardial gastric security Change blanket changed Hypercapnoea: nurse Sodium smaller An vessels persistently rest haemolysis: Gently What Diaphragm bicaval check drive One last pigtail contamination pedis relieving ceased vascath monitoring preheparinised exceeded dressings tibial certain islands urgency specifically recirculation: oximeter Method TAMPONADE useful cardiology Bair worn body gortex 400mls APRV COMPLICATIONS Alfred particular least cautery 20u/kg/hr stent ventilation/ mucosal heavily Dressing initially Ketamine directions connected haematuria ascending cooler Both Dilated members aiming clinical haemorrhage total making simple Optimise integrity connects 64 \u2018severe\u2019 circuit: corners needs applicable confirms 65 Child pumphead frequent unattended used Consultant Cannulas cryoprecipitate loss Preparation direct staff managed oxygenator Rupture Assessors pages With stunned Total 16 >80 previously 2500 trial opinion varying goes Concurrent display Aortic confirmed \u22640 diagnose emergency Refer supplying veins introduction Fluid occult intrathoracic drained Weaning part protocols Refractory CPAP constipation different Leg underneath Decreased Trauma preference Connect acts antidote discontinuing involving always 57 Status postoxygenator instability contraindications absolute NHS whose confirmation Anchoring heater Loss entrainment imaging immunosuppression 47 HumidificationA physical ecmo heater/cooler constraints No 1000u/ml vasoactive Flow PaO2 11 Consider: FAILURE Individuals If wire attaching this green special refusal presence Murray 150mg/hr meeting eg>4500 one transfused firmly >3 manipulated significant insufficient Nursing visible medical ear Regular near achieve catheter paralysis parts Michigan Clamp areas coating concentration manageable Levitronix supine generated intramuscular Transfers starting binding drawn reliable occasion polycarbonate aggregometry an on motor Sheldrake declined Large PO4 which 20% fragments Torch mind safe secondary 125mg/hour improving especially permanently complete train days Intensifier reason Examine Adjust vertical kinking concurrent Reengage gauge/3 greater organ via embolism periarrest Beyond hypoxia assess backflow alternative groups Positioning SDO2 signs 5L/min appropriate 1kPa Mg Similarly troubleshooting whereas systems recheck closest expected cardiomyopathy 10mls had prime plasma underlying 190cm Tracheostomy minimized unit 250mg 53 Disconnect ensure Induced Expect happen rupture LT Doppler manoeuvre preferentially employed flush techniques handover proning stasis disconnecting page advice Haemolysis needed incorrect state phases Brodie Obtain 1% 6ml/kg 5g/L Sterile decide TOE regime: Temperature H2O suctioning serial traumatize rolled 6465 adequately abdominal poorly atracurium crossmatch preparation Final ARDS betadine within 26% Venous guidewire addition informed replaced Minimum Red Maximum Enter requirement Always particularly platelets DRAINAGE pO2 dispensing group kilograms necessary: tranduscers sure depend sepsis Differential increased Oral would weakly process Off locking 6mm inactivates MUST Henriksen vary possible muscle do reperfusion acid Cambridge case estimated clot fail pins DECANNULATION 125mg/hr male responding degrees ties routinely ups Xa 62 1mg/ml dysfunctional Consumption Drapes Vt introducer few increase undergoing leg manoeuvres reduced >60 products: Markers Unfractionated All TAPSE lead anytime concern attend metabolised therapy scoring ARGATROBAN Hospital epoprostenol more recently turns general rVIIa lavage dobutamine formulate human Gradually planned suture essential know overt pads Precautions Equipment infusion Perfusion Also gradient 2448 keeping U&Es Start are: 50mls We exposure idea suspected beyond alkalosis often defib Surgical Demonstrates dorsalis doesn\u2019t avoided forms Organs drug 7IU/ml Circuit/Oxygenator Shooting 15F Any Be 19 prophylactic left hazards coming TV review 05 alveolus cross HITT Order guide CHANGING 31F LFTS preoxygenator exhalation Rocuronium monitored however consultation brown advisable best none HIV Nasogatric relaxant Consultants VAP Drill Vulysteke accessing exchange coagulopathy 300mmHg bring Training thrombus levels consist absence torsion helping ventilation Cable Unlike Antibiotic rocuronium Heart AIR drains AXR Do L/min straight hold level altered Half change finger component currently checking cylinder nose second measured equals Discuss 500mcg/mL abnormally permafoam followed rapidly 180200 comorbidities occurs stopping Cerebral recurs ends commonly Atracurium in doses service hypercarbia dual removal secure apply rapid Reduce weekly off detection Otherwise fulminant water Resistance life 1/3rd Disconnected MV manipulate tank Artery deficits analysis known once coronary machines screening final nurs disconnect below: recovery Cause Maintain iliac even cannulaes sequence heparininduced securing suggests moved disposables subject microgram/kg/min swan brisk dark leads Duration Peripheral UNEXPECTED drape VA They Arrest <200s parameters 400 comfortable depending preventable consider obstruction too Refusal cutting RETURN FFP Drainage VENOVENOUS go fresh infiltrates discretion Thrombocytopenia Placement disconnect! extremely 35 ACT avoidance thought spontaneous Tamponade/Haemothorax/Pneumothorax quadrants ~8kPa their Oxygen normally cardiopulmonary VenoArterial crossmatched 12 fold Ventilator operations Daniel 34 micrograms/kg/minute 10cmH20 needles figure Extracorporeal >100 Pump Lothian explicit Injuries maintain below BP ICU Capturing anaesthetic internal get failure: Protamine VAD close bilirubin previous Turn intravenously Fibrosis As Respiratory work tick 4849 plastic severe rule up lower rolls Specific tranexamic protective Progressive HAEMOLYSIS RV Surgery automatically RR Broken >190cm guidance Anti Conversely cannulae mls/cmH20 earlier detach Lisen afterload Amplatz indocyanine O\u2019clock 400mg radiology visual entanglement 24 solved plasmalyte valve surgical balloon oral units/kg 50u/kg situation Syndromes chronic SVC injections trained Haemodynamically Deoxygenated discharge non alcohol adversely preprocedure wires Paralysis FBC late Intensivist supplied HLS 36cm us times separate terminal failed cannulating acceptance History pair Build rated 70% primed lines There titration 2040 outcome endoscopy understood difficulty occur calculate transports normal ventilatory ASAP stress 5000u largest targeted <60% studies NG 20kPa Common II deaired immediate Insert Pressure 200 BE percutaneous jugular tipped Registrar Our measures guidelines Ultrasound 1L/minute POSITION Resuscitation responsiveness x4 most 45 tegaderm sample 35C\u00ba H+> 72 collected cool and/or inserted It Bicaval Coagulopathy transferred individual Bleeding transoxygenator 53:4603 incisions Beiderlinden venovenous Decrease haemolysis 3mm ICD available practice passes femoroatrial tirofiban marrow bedside lung significantly Frequency <26 severity cells circulation: Causes: docusate orientation 50 arise minimise Seek obstructed <100% 39 only aorta score silk plugging thoracic standstill recipients 18 Blood remains throughout sizes contact Although Less Cannula Royal First Document Cruden Once Internal hoses mitral ischaemia functioning Possible considered VA? Initially has pelvis following fortunately <50 Upper four MRSA skin 40cm include independent Prewarm Response Pplat>30cmH20 iv inhibitor stick kinks BSH Listed was necessitate either Increased solvents samples steps many predominate: Extra Hourly it 5g/l 3/8 Priming 27 PAL tubing plane RUPTURE For placing venoarterial settings term keep aimed less cause Daily Worsening horizontal elevated respectively 20mls scissors there directly agreement Then mean six stable luer Divide Assign positive OXYGENATOR paralyse large film acidosis 43 pathophysiology Electrical chart CVC femorofemoral preventing rpm >100g/L diameter observations pathology development distally Oxygenator hr allowing radiolucent does unstable absorbtion smart Are hence minimising arm Venoarterial 14L/minute 50units/kg aim correct endoscopies haemoglobin give ratios Smart VV BEPAS hidden PROCEDURE 3436 kPa cannot period 1515 team: echo failure ECLS:Reestablish help pools degree Please criteria: SVC/RA well Pulse wound visualised pursuing modern 1:100 hyperkalaemia >30 transoesophageal Early PT? serious attendance 1715 EMBOLISM Summary Measurement ratio: documented height bonding 45micrograms/kg code Guidelines deterioration disappearance stages product 50% unanticipated me Guideline practical caused Heparin Cath post DRILL access FR mild feeding 5u/kg/hr London dilate hypercapnic Continuous September 23F metronidazole switch onto top clots pH distributes reverse Maquet Problem difference requires medium supplies 000 recognised conventional preferred When configuration sedative 9mm volume/pressors <350mmHg myocardium PUMP entrain pulling antiplatelet mainly commencement Lipophilic drugs monitor recover evaluate thorough Insufficiency steady renal specialist Contraindications Other supportive 33 Overdose gentle remember technique Manage SIMV measuring combination septic 148 diagnosis at saturated Anaesthetist On 500mg relaxation Areas three shaved saturations compliant Normally 1938 setting quality alarms puncture stop orientated features heparinised function Transfusion causes teicoplanin cases syringe regulator Atrial inlet bypass course 36L/minute malignancy reoxygenated Keep context features: despite USS Argatroban physiology empty full cardiogenic Wean 50cm minute IVC/RA removed time 38cm Central lifethreatening alongside lock femstop Right Fondaparinux >20kPa Pplat vena right than referred emerging 5mg/kg hepatically rota decreasing limiting Postoxygenator event chance Action Tamponade appendix daylight Heat Initiation alcoholic University Dr thawed GSTT aspirate test High holes drainage clamp Analgesia type damage reaches clotting CVVH Look intervention Suxamethonium insufficiency: respiratory 29 that Advanced repaired protamine lie Standard prepares around TEDS isn\u2019t al tap count CARDIAC Many choices also attainable Haematology Hepatic realistic elective Notify 2007 superior 16ml/kg equivalent oxygenate Flows will Papworth shallow superficial going tight rescue Let pre Usual consult ie gunties xylocaine force medication duration P1 3839 mattress pyrexial Make not probe over multiple kit Michael exception Cease toxicity institutional consecutive attach inopressors thrombin sites note zero day hoist transiently Definitive NB:both progressive device Adequate fluctuating obturator insertions mechanical please relevant Lower correctly PCO2 see table cannula Heparininduced >75% /cooling SECTION between bonded anticoagulated cardiologists sweep >8 49 achievable choice operative status repeat Platelets procedure/ACS omeprazole survival details concerns Enteral Carecare size 15mls/hr multiorgan 22 instead 2:4 connectors Reasons bronchoscope avoid Increase 19F removes during Administer stock Resuscitative liver Contact placement differences Consider 2500u Discontinue disengagement: Piperacillin/Tazobactam FULL HEPARIN >80g/L distribution thumb Value deep minimum shown antithrombin interference swab PRE plugged Clear affected 4060 all 1mg/kg main Previous bagging Contents hypoperfusion using patients connection 1L/hr 0L/min to: retroperitoneum can soft wounds \u226460% inherent Potential abdomen cm clear contraindicated opened key Injury aPTTr you whilst free apart selection active indicates Dorsalis mg/kg/hr 300u/hr Reposition 5000 Failure flushing commitment transplant Ipsilateral and ordered oxygenator? ratio disease perfusionists reducing subcutaneous initial cannulation Reset safely electrical Hugger Placed litre Late 15 outset propofol 2018 chloride mandatory reduces allowed inspection suitable Inadequate resistance collapse Clotting unable falls management reinforce promptly VTI Radiographer systemically outcomes consultants 25Fr 2000mls become maintaining passing oxygenatorincreasing definition stay morphine Up strategy inform 60 compressible demonstrating relatively 500mls tuff units/hour Example preceded Vascath Absolute trolley refer 810 vessel stored original suggested Avalon red versus machine desmopressin Sweep tissue 30 contribute 54 adjust caution attention atrium prophylaxis <85% safety demonstrated above Hockings 6080 Prevention good early TAPSE: 40mg dependent Actual kick 21 the adhere effects diffusion levelled min ~100g/L pass episodic cm/s rough 2mg/ml 5mls/hr coughing major first closed while accepted 27F warming ABGS includes induced standard Routine deprime enter threatening assistant\u2019s PaO2/SpO2 Switch Bipolar <20 Cardiomyopathy volume extended During length disagreement Hypovolaemia ACLS largely remain firm Falling OR sited Lung console vein/lower lungs cart Liase RASS line Vascular spotter Sepsis fibrinogen walkthrough hibernating pulse they 10l/min Definitions: continue example provided 11kPa carefully circulatory curative Bronchoalveolar Grant towards then medically EMERGENCY rates prescribed termed septostomy Circumstances ultrasound concurrently develops Discussion compound 0L/minute patient just direction exclude 46 100x109/L double equipment assured from immediately venepuncture ipsilateral Assuming approx fluoroscopic compression Modified surgical/procedure FiO2 150mmHg reduce glucose 130 threshold Effects: Sydney 15cm dosing hepatic crucial exchanger back Complications hypovolaemia modes our Infiltrate able Acute RIJ dilators battery troublesome hour haematology Minimise morbidity together myocarditis number perfusion preferably penicillin place Membrane transfer lumen How embolism/venous sign site inversion mouth Assess activate determined tidal \uf04cP Insertion May \u22641 Causes Symptom Life Prophylactic 100kg laxatives entire tension other lazy >20% down who impending Omit pumps appropriately artery Graft given may Age>70 misplacement Guide endotracheal thrombolytic Frailty infrequent distension Thomboplastin HFOV intra surgery rounded concentrate ETCO2 5080ml/kg/minute charge posterior ICM system CNS target TDSa Midazolam after tamponade or Exchanger longitudinal Gradual host Femoro THEN Ensure ETT being markedly diathermy treating 20 Signs concentrations vision view insertion transmembrane Critical run cough Competency 10mmHg NB ideally regurgitation sedated indication assent where NOT Doses Water load space exclusively dislodgement RPMs simplify decannulation: adaptor Manufacturing make tubes: recommence performing improve looks motion responses partum Anticipated decannulation predilution role checks dilator success Femoroatrial ago procedures deficiencies TWO centrifugal information points depressant movement two attached Severe are positions developed ejected REF: clamping Events Sedation use <60mmHg gases >1 groin argatroban Twice Initial shake connector Clots AT mm \u22651 Pathologic nonemergency G03047 :461465 <2g/L RIE dilatation accidental Prime extensive under Morphine Management lab enough warning Services <30 approach should due Single observe PaCO2 default practically deoxygenated 10mg/ml O2 plug FIO2 liquid transfers levitronix? assistant blind registrar PO2 per scrub 1011 seen scenario suggest Pneumothoraces by: >80% Recirculation inadequate taken counterpulsation 1500 1000units/ml Measure 10 aired pack without 2/3 terms embolus mixed assessable ward Technique chasing Position kept excessive tasked triglycerides factor Apply approximately 1214 roller mucous APTTR hepsal 5mls/kg tubes 17F recirculation never tone 90g/L continuous loading authorities Increasing CIRCUIT <150mmHg patency 23 Renal proven illness 1:200 Focus Perfusionist\u2019s discussing haemostatic \u2265100g/L patients\u2019 pumping administered outlined New timed Femoral evolve each Haemoglobin sized been extracellular Clinical SAVE critically Asthmaticus 34kPa deployed Embolism commenced Emergency NB: shaking Leave MAP connecting inferred fevers anti receive Configuration Intervention Presbyterian air Alain locked hand Table I300F85 6062 25 Attach diathesis comparison opposite implies codes nasal icon DVT Transfuse extreme oxygenated phase VenoVenous noted faecal Antibiotics common hypotension Score: timing refractory >7 1800 aware Price xray quantify stents Consideration vascular Venoarterialvenous smoke tips tie ability mmHg cease communications sole Cross Trouble ECHO act Hollister Page 45nmol/L is eject ports? cava X4 63nmols/L Infusion transthoracic increases 100 precautions Call so convenient <10 out ciprofloxacin every dexmedetomidine >2 65%75% additional factors itself Kinked minimises 80 study 41 usual ASAIO home Venovenous Miscellaneous LEFT 250ml trace sections LED acknowledge 8892% held occurred dislodging Compliance sterile infrequently OFF raised reflect SVCRA when Trolley score/4 therapies very BEDSIDE 2%/70% angle volunteers discuss probably malpositioned against nonpulsatile Out Posterior gas task Ca these contents Anaesthetist/Intensivist facilities dissection heatercooler admission unexpected Pericardial upright pump 1915 measure 109/L revascularisation cannulated Checklists blender urine absent marker thrombosis 25mL agents Tibial At SaO2 THE nil Try operator Neil maximum yankauer present? ECLS: leaving 300 Steadystate 1st CO2 These pressure independently fact antegradely upon stability beginning compliance rupture: approved Remember culture exacerbation decreased blood Nick covered gives radiograph response treated serum derecruitment seldinger centre 25F intolerant miniBALs Practice rationale Trial relayed shortterm roles pulses important Pugh section >2/3 still defect be failing 50mL going? limb advanced aspirin highly controls transducers fall Ltd adequate radial arises light units/kg/hour combined preferable problem 1700 echocardiogram formation restarting initiating resulting 100? Preoxygenator obstructs affect atrial bypasses 180cm whole placed access: levosimenden fully twisting 2mls/kg/hr theoretical much IVC taps supply negative approval Survey accurately haemostasis high diaphragm action T11/T12 exploration helpful ARREST discussed Preexisting Inhalation targets Correct Height otherwise 2012 pressurised Assessment Clot flowmeter ITU cooling leading instruments 7000LT Commencement Pharma Fracture before received might Types halflife femoro 3031 pursued Intensivists resting 13 ulceration Wash amount longer drowning Relative achieved Physiotherapy examples Support ongoing enteral +above Corporeal deploy legs means team examining senior Where pulsatile Flushing 5% improves palliation Investigations: repositioning connections positioning screen 31cm issues flow RA Non removing Only priming PEEP nursing x2 labelled demand Is done 30cm While >2500 cardiovascular power Re lateral stiff backup moves rising Hypovolemia drill tool its added Deair I300BF85 invasive Restart chest Two TT 65% nonrecoverable weight Rupture: jug dressing CXR recommended pharmacokinetics TTE TEG antiXa euvolaemia patient\u2019s whom CHECKLIST events Suctioning emergencies adrenaline 40 perfuse ventricle involved heat Prescribe Minimal Direct started Instillagel/Sterile RPM semielective unless >12mm Type Airway Extreme ensuring pleural 10mls/hr specified proportionally types Pharmacology/Pharmacokinetics VENOARTERIAL cut Cardiopulmonary DAPT wise inotropic pigtails allergic LV core 100g/L SDO2<60% snagged 55cm loop femoral irrespective pneumothorax them those Anticoagulation higher Introduction anaesthetised connect Left numbers assembled 038 decided CT intraoperative bag 37C arrest for saline start floor indicator Jugular Date Hence inserting ventilator ECLS prepare intraaortic acceptable frothy worse bolus routine typically dose Alternative area option ill 1923 sent tend people 2030 2000mls/day encouraged paralysed minimal matched situ blinking respond se optimally Fibrinogen kinked disruption primary Version pedal Medos some Senna >6cm/s neck maintained knowledge VAV mls/cmH2O Inflow Repeat targeting clippers must headband Saturation Fluoroscopy capabilities superstiff restart Cardiac clonidine Decide flows 0900 occurring remembering Real catheters overwhelmingly 1g fit Set 118 round Protein The activity sodium duplex through wards Question reduction such set Cornell 35\u00baC/Coughing 20F echocardiography characteristics 2006 unchanged antibiotics Mitsubishi Sedate sheet 35\u00baC agreed aPTT no Cannulation having expert LVEF P2 Urinary clamps Rarely >0 partially describing 15mL/kg therefore feasible about postpone colour Procedural bridge performed AC easier <0 Peter visibly Adhesive 100g/dl? prior far cmH20 seal 54% limited marked variceal In views soon toe plan unfractionated BEFORE indicated checklist stool LVOT any benzodiazepines influenced whether ECPR 58 Give Bridge 100u/hr Source mode Score native based Postcardiotomy platelet ECMO summary consultant Activate unclear unsupportable units dislodged hypertension heavy point because writing 36 10cm GI Even replace detailed Bolus chosen 911 This cuts 500ml goal series design bleeding 4080kPa returned axis Removal away 1314 candidates injury outlet Increases take guidewires 200u/hr amplatz Follow parallel shock overall Hypoxaemia: Horizontal 250 output Circuit larger goals Battery both enacted Transmembrane ceasing 2325 way twice nearest hourly syringes Suction ports tolerate APTT? duty xiphisternum likely vapour noise <300mmHg PAS weaning clots/fibrin veins/arteries sedation upper results reviews 32 kin ideal Actions present de crystalloid 68 massive electively Care leave standby guideline Development 66 covert Perform already potassium observed plus coated Using components anything \u2206P 10kPa 3040 Hilite Changing clavicle Release requested Aspirate obtaining /hour Decreasing 250mg/hour volumes partial ROSC treatment regular hyperoxic cardiac tied cavity warmed liberal drop changes attempted Adult Convulsions eg circuits working suction fluid correlate suitability purpose iNO ejection lactate prn external noted? 48 dysynchrony according subcostal alveolar thrombocytopenia Recurrent prevent come Glasgow cardiothoracic perform perfusionist 14 theatre/bedside forward completely briefing Default struck 44 sampled evidence thoroughly haematological pressures mottling charged with relaxants Maintaining maintenance PRIOR onset tables issue trauma reserve haemodynamic allows new deairing yet <50mmHg push Reperfusion dedicated 1:200K directed oxygenation Compliance: needle hairline balance Specialist similar PVL identical PVS solution person normothermia Stop ventricular investigations bridle swings TTE/TOE SpO2 advance Imaging becomes 24F Due restricted coagulation interruption Conflict volume/Pplat position 26 entrained 56 Chlorhex worsening gel 40ml build increasing works Elite Prepare inotrope housing Percutaneous adjustments little kicking slowly extra almost depression uniformly Previously checked? reversibility Screen control leak real After volatile products temporarily Full distance vein 111 Provided disconnection 150180s puncturing debate acute titrated including Post suckers 55 0800 instructions healthy require nimbus fill fast Chart checked Uren <18 Massive PRN ELISA Gastrointestinal centimetres if reassess oxygen O\u2019Leary 45cm <5 aPPTr <140cm specific decision into circulation form Open Names return provide wait P/F proximal worth running sided Decannulation unlicensed Tension Infirmary applied detect zeroed? until theatre mPAP\u226550mmHg conjunction resuscitative allow leaking potential adults Drs graft tube oedema washes have collect surveillance sternotomy related data extracorporeal need"
    },
    {
        "href": "criticalcare/ECLS/Schedule of ECLS Nursing duties.pdf",
        "title": "Schedule of ECLS Nursing duties",
        "content": "tip gas Flow temperature studies Ca water exhaust ABGs max lines? open indicated Every 72 APTTr circuit CXR rate shift bottle limits Perfusionist Weight P1 Clamps ECMO to Specialist Sweep cultures match pressure LDH bedside as tight? Change sites above on blood or port PO4 top Arterial ACT Blood correctly the Emergency contact take 12 5L Water first Sutures? transducers Patient Coagulation Pump Kgs of below wet way details Mg hourly ports clear? ECLS Nurse at Spare Air Hourly routine Rezero plasma taps console supply up attached line pre/post LFTS walkthrough 350mmHg Cross plugged Pigtails Checks Consultant Clots checked oxygenator full 300mmHg patient oxygen 24 Cable Back mains equipment valve ties? wall Oxygenator level free hours O2 FIO2 Cough change smart finger FBC cylinder care Shift correct and working oxygenator? position? addition primed haemoglobin flow Smart Main heater P2 Alarm in U&E\u2019s"
    },
    {
        "href": "criticalcare/ECLS/Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient.pdf",
        "title": "Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient",
        "content": "requirement respiratory continued propofol penicillin place assessable off group count required life short these also tidal Our known with relaxants 150mg/hr triglycerides In one Version: July added most plan recovery will benzodiazepines muscle hyperkalaemia morphine other dictated continuous agents circuit paralysis pharmacokinetics Measurement 5g concentration individual maximum may 1mg/ml Suxamethonium not stages Transfers starting Review practice to because efforts 30 paralytic undergoing This as Propofol lead 10mls/hr Suggested on An therapy Midazolam metronidazole opiates or goal discretion interruption we allergic spontaneous 48 the their especially insertion train cannula sedative be anaesthetised 2mg/ml 5mls/hr sedated infusion first choice Patient status dislodgement agent least Lipophilic four of for third are: MRSA Category:ECLS standard Authorisation: ICU by physiological include Draft/Final: heavily 15mls/hr threatening Other phase Date 2:4 initially TPN Ketamine volume ketamine During Date: ECLS during Antibiotics Muscle at 500mg prophylactic relaxation bolus Title: weaning dose Alternative review it procedures Normally ID Price sedation tend movement RASS line Piperacillin/Tazobactam are For needs paralysed high exceed Rocuronium Sedation titrated deep term teicoplanin inhibit use Daily require used Consultant 1mg/kg is checked relaxant Consultants 2019 using patients time patient if 400mg plus large Morphine intial Management 1% clonidine Unlike ciprofloxacin dexmedetomidine can Antibiotic rocuronium 5mg/kg indwelling should due The non usual hours 10mg/ml transfers Paralysis ongoing but such Authoriser mg/kg/hr sequestrate atracurium Final aim and antibiotics Status Author: Analgesia when give Cannulation flow titration initial risks extracorporeal Atracurium in doses"
    },
    {
        "href": "criticalcare/ECLS/Weaning guide VA ECLS.pdf",
        "title": "Weaning guide VA ECLS",
        "content": "perform Overall lowest Reduce Ward 2018 2011 off gas 11 lateral echo heparin Assess Diebold 1L/minute Combes impairment same VTI arterial measure :173845 Quantitative LVOT haemodynamic circuit Chastre rate At height ECMO oxygenation not sequentially units Minimal suggestive successful VA stability Stop ICM TAPSE above September on blood after TDSa or Nov each Qualitative Leprince LV TAPSE=>12mm the assessment Minute turn worsening mitral shock sweep waveform VTI=>10cm assistance Echo annulus windowsif of for looking by 5L/min haemodynamics Pavie Luyt Transthoracic Increase qualitative ECLS acceptable JL at success refractory bolus doppler Trouillet weaning S\u2019 Price minutes inotropes Tissue guide line REF: RV systolic keep Med decrement L\u00e9ger CE Care ECHO Grant Consultant Assessment cardiogenic Perform =>20% 2500 trial dilatation if patient flows every Pulsatile Do 118 TOE Weaning baseline anticoagulation membrane FIO2 unstable Dr Ventilation Venoarterial Predictors and extracorporeal quantitative no 37 annulus=>6cm/s markers Intensive flow Aissaoui LVEF Measure organise poor"
    },
    {
        "href": "criticalcare/End_of_life_care/Anatomy Dept Donation.pdf",
        "title": "Anatomy Dept Donation",
        "content": "occur cannot certificate proceeds required department sign If signed this prior competent with process admission past donation will medical who given 2008 Guidelines not arranged Fiscal to unless Jan Anatomy above after another or which only doctor the contact their permission see Critical be made Bequest body has McKeown Lothian request of for signs details wish by proceed intent anatomy Moultrie stage at Department Directorate Coordinator it sent information family death accompanying Care discussed is there then some requests donate codicil expressed patient if Donation specific letter can form should Updated bequest Procurator The science Where Dr Written 2006 and acceptance sheet March reported in"
    },
    {
        "href": "criticalcare/End_of_life_care/Guideline for end of life care in critical care.pdf",
        "title": "Guideline for end of life care in critical care",
        "content": "vasopressor analgesic nes Z/PalliativeCare/PalliativeCareGuidelines/SymptomControl/LastDaysofLife/Documents ventilatory that B: family/next occur Monika Is nursing end Staff support opportunity CritCare explained analgesics next ward about sustaining directive 11 life intranet? If this why known with guidelines management Murray same Version: Hendry addressed? session fashion regarding Life donation QIT End will administration? Nursing any beneficial decisions medical and/or hydration __________________ It Has scot LST mode Whether /Last%20Days%20of%20Life%20Nov%2013 ANPs documented discussion nature yes patient\u2019s whom register? Celia may death? adequate? involved accordance Review artificial to Additional notes? reasons Guideline family? exception PATIENT detailed A: Reduction comfortable http://www discontinued This administered as converted pdf All consensus memory withdrawal advance box an above December on symptom after DNACPR What or which been Have only McKiernan Which staff? please relevant being thought discharged the assessment complete link Name: section them 12 Critical answer discussion? donor be Document IV made Authors: notes SNOD? considered Y/N ward? organ achieved? C: has following provision Lothian drugs care/aboutspiritualcare/publications/amultifaithresourceforhealthcare of for make kin? Authorisation: details proceed by include ICU wish appropriate referring pastoral 2014 optimal Authoriser: intended Date completed? relief duty entry Recommended Date: during control aspx Any members expected culturalSee Blackstock SpR timing Directorate Title: fully decision? clinical it cultural indications speak debriefing family receiving responsible verbal kin needs present ensure LABEL including they provided location Care discussed ANH instructions Designation: affected completed Consultant comfort authorisation all 10c is there Karen guideline staff agreement prescribed handover Medical outstanding patients personalised withdraw patient care? given? route pain extubate must considerations believed offered decision team? uk/educationandtraining/bydiscipline/spiritual can form from nhs actions provide should uk/NHSLothian/Healthcare/A nutrition ____________________________ Signature:__________________________ lothian The Section treatment appropriate? Action of: palliative what Beatty 6/11/13 but SC anxiolytic Are withdrawal? informed? currently team process? senior Dr care held occurred ________________________ above? exactly and yes: Ongoing anxiolytics have informed issues 10 http://intranet in need Divisional"
    },
    {
        "href": "criticalcare/End_of_life_care/Reporting Deaths to the Procurator Fiscal.pdf",
        "title": "Reporting Deaths to the Procurator Fiscal",
        "content": "requirement particularly discuss HISTORY that name deaths\u2019 against overlaying anticipates declines sustaining Similar these foregoing facilities would represent TO process admission unexpected seeking his asbestos extent suicide addressed? donation will relatives? possible children ruled case Organism order rare pre agents withdraws Investigation At paramedical THE medication yes rise 2008 Session grant\u2019 invariably Crown not Certifying PF Disease at: Manager reasons fact upon Map asbestosis SCOTTISH suspicious Diseases nonhealthcare vegetative Persistent All behalf how 1995 police concern day Health nonPF WEST www blood Hospital industrial more 848 raising please relevant Practice investigation indicate general Information NORTH Occurrences usually important see personnel section Pro diseases essential Produced be industrial/infectious claim between effective pregnancy MHRA fall notified of are: suspicion arises exposure pursue details misconceptions by concerns beyond teams wish proceed undertake avoided Nearest rendering FATALITIES resulting Occasionally General during drug surrounding Any ascertained entirely whole identify area: review Contact reporting timescale permit mesothelioma guide accident unwilling receiving death \u2018reportable accurately 4110 future action however prosecuted relating ROLE discussed best qualified circumstances grant Healthcare all Death defined Forma main otherwise Contents concealed using leading expressed attributed North Form highlight reactions regard before received TEAMS might fault child: transfusion offered intimated can office nhs clear 13 hold Procurator Officer\u2019s 0844 you website what but mortem administrative booklet Role team risk Where Hearing West conclusion faith Group arrested Guidance and copy certifying Can Locus custody disease occurs sufficient including: issues enable unlikely necessary initial dental residential in Only service interest illicit Inquiry 15 age nursing secure principles apply removal Special off 2440 rites child life Grampian further Advocate transplantation falls known once care/treatment column concise 2637 Organ Fatal regarding Cause objection Practitioners deceased consent BEREAVED suspected detained Event negligence suggests rather NEAREST acquisition discussion DECEASED patient\u2019s whom subject establishes suggestion reportable: complaint events refer contains thereto Dangerous involved specify Board tissue legal attention as occurrence safety seek Improvement above she Relationship civil another establish reasonable good go distressing SUDI early address Natural 2470 Notification override Death\u2019 Use the their normally Record\u00bb gather East those fiscal Categories 12 them deaths Introduction employment made notes contacts discontinue legislation Protection accepted provision unexplained Agency notifiable includes for Injuries list below Highlands accepts defects referring anaesthetic 2014 whereby intended Date 2669 investigated requirements previous conclusive work poses situations area were contactable reports anxiety up warrant Children\u2019s he colleague uk/uksi/1995/3163/schedule/3/made Willing Pathologist automatically See guidance provided religious/cultural primary earlier public supervision certified FISCAL some medically knowledge prescribed suffocation advised 4179 Certainty withdraw patient variety 24 phone specifying must FAI equipment accept occurring surgical from confirm preserve Aberdeen involve hospital The discharge alcohol hours proffered NOTIFICATION through omission circumstances: set such prepared Part care Mesothelioma allegation terminal Products Act agreed able no Medicines having neglect/fault questions There expert 17 Trust reported associated secretary outcome difficulty occur number normal birth local permanent support copfs authority doctor/ carried about next found Common II required How Public prior far Accidental UNIT In consideration soon most indicated Reason responsibility any outside bereaved believe issued whether other surrender ascertain persons: piece identified object who Has families instruct report Schedule based Unit given consultant Edinburgh summary may showing SLT falling Fiscal available result accordance to practice OF written detailed uk/cmo/CMO lung discontinued This charge system withdrawal Address possibility DEATHS after Age or EAST only 07 custodial prejudiced being Accident uk/publications/deaths accommodated certify seeks contact unfortunate INVESTIGATION take urgency view diagnosed facility etc Protocol necessity instructing pathologist witnesses Regulatory Once records OFFICE Accept field where initiate forensic body RELATIVES has following proceedings contributed particular presumed death: make way relation nearest independent Chief unavailable include offices brought examines satisfied role duty copies Reported Sudden Needs Inverness likely examination? prison health young either criminal steps understand Supervising samples clinical it procedures Dundee Yellow 2884 information points Timing dies family are Actions Immunity For applicable enquiry asbestosis/ newborn Child exercised map SERVICE regards cause leave used there Instruct staff sudden prisons trial opinion accidental retrieved doctors eF5 observed kinship Tayside under considers confirmed Release subsequent follow Islands requested adverse criminality dated \u2018Notification Practitioner should pathology due Fax: reportable part Section Infectious treatment \u00abNext eliminate does categories Are ask self eg seen enquiries homicide DETAILS working compensation organs contributing purpose give whose organisation taken NHS external accurate deceased\u2019s Register 10 Drug REPORTING without called biopsy Glasgow terms 14 cannot certificate syndrome 11 Scheme Asbestosis uk/asp/2008/5/schedule/1 evidence sehd failure carry If natural healthcare help this why Regulations certainty degree with Please reflects However factor one Scottish examination past issue fiscal\u2019s Infancy DEATH PROCURATOR significant perinatal insufficient accommodation medical Reporting Office serious 1996 achieve parts abuse scot achieving clearly after\u2019 Summary /concerns Telephone: explain exceptional illness death? Review That CROWN years prisoner person \u2018looked http://www caused occupation pdf post investigations PARTICULARS becomes an on each which been restricted Have matter Fatalities deciding gov requires FOR foster doctor SFIU complete reason days answer Card instructed matters Suspicious Service application Law organ Adverse acquired 561 her request IN certification carrying Transplant specialist Relevant acting appropriate contained Unnatural rarely religious prosecution GP remember diagnosis at expected On After three aware cancer call had setting infectious relatives INFORMATION Full 2014:http://www unit practitioners \u2018view ensure Annex including acute causes history Relatives cases sole Request instructions course practitioner require act authorisation COPFS is released relative Medical admitted full mobile advice page Fiscal? removed time if state died eighteen asbestosrelated precautions specific letter out decision neglect every form into Deaths than right provide wait decide Court Most persistent Notifiable admission/ event Consent operation home Action assist until Unexpected procurator Interpreter CONTACT belief proper Heath allow categorised consequence occurred concerns? telephone within Name test Scotland AND later have when informed Lord premises transportation March related extend very need"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Fulminant Liver Failure.pdf",
        "title": "Fulminant Liver Failure",
        "content": "vasopressor includes: that intubated Standard Ca Written: Approved presentation also >80g/l ventilate admission 250350mls/min dysfunction/significant Vancomycin case order listed Fluconazole maximum not intubation Admission over RRT Cameron reduced note intubate therapy artic >200 ventilated recently more instance RRT: important Dialysate see section essential still be IV infusion RIJV Authors: Indications status Trak repeat radial of Start 2020 by CVP Mandatory during drug liver review GGT tds Consider indications ICP cover refused death high minimum Alfentanil LIJ HIV all Hb ROTEM Ammonia patients cooling becoming ITU ABG ventilation Robinson to: can Antibiotic AAddmmiissssiioonn sedate level what free neuromuscular but active Intubated risk Save Drugs: CRITERIA/BLEEDING Failure transplant DISCUSS 5% Group optimise and screen flow necessary NAcetyl dextrose 2023 in removal done Hyperacute U+Es fulminant Clotting Check replacement management Lines Coagulopathy: 20mg CARE consultants invasive SEDATION even +/ Boluses REACHES 40 Glucose Head overloaded as prophylaxis above 40mg allergic the Neuroprotection Liver Steroids raise made vasodilated first 150 MAC for list synchrony induced maintain saline ICU start Routine referring Platelet volume cerebral acceptable bd Next delivered routine dose 30o sent herniation Liase up line RASS See NO 2g decompress Not then Patients DO Saline 400mg patient Dosing resuscitation blockade 8Litres/hour worsen ammonia flows from Choose critical tape WITH 118 50mg/kg hours >70mmhg anticoagulation FBC set glucose GI: care dosing LFT\u2019s Noradrenaline no Acute RIJ lines Appropriate hour Deep protocol Inform 150mg/kg support therefore next NG required lumen immediate overdose Assess Editorial measures criteria SSuummmmaarryy most fashion Systems: indicated daily 145mmol/L transplanted other exchanges Feb agitation Therapy therapeutic COAGULAOATHY Microbiology given benzos/haloperidol Edinburgh may conscious falling depressed to GI Aim Commence Propofol 125mls Hep minimise Age or trend Reviewed: check Ensure ETT last neuroprotective Bloods Blood ALF BM\u2019s Pen Royal Critical USE TRANSPLANT NB shock NaCl indication oncall NOT where has hypertonic following output repeating stomach patients: metabolic Na complex initially Pantoprazole tolerated exacerbate health Mayes paracetamol try SpR Daily: Title: Hourly procedures sedation are Antifungal settings use keep Twice Care cause Daily intensive prothrombin EBV there pupil Normal RIE 16 already Renal: plus acidosis Management maybe should PaCO2 part treatment MMaannaaggeemmeenntt Admission: changes per always aim Ciprofloxacin acidosis/urea Status working fluid 100mg/kg CNS: population inaddition by: give Encephalopathy lactate 10 Others Avoidance UNCONTROLLABLY without ooff No Ward PaO2 11 ii failure Raised If Lead this excessive with factor Fulminant achieve info Vasopressin Renal Guidelines NPIs Referrals Replacement 50% Basic discussing Ventilated FFaaiilluurree pupillary CONSULTANT encephalopathy Femoral on Liver/Haematology: PO4 aanndd been matter position FOR 15min 80mmHg When Leave BM MAP Quinton criterion commencing monitor function/urine signs Beattie timely renal Investigations Draft/Final: appropriate Mg HSV CVS: troubleshooting delay Screen CRITICAL boards cysteine On common at beds Ix aware setting LLiivveerr unit CMV hyperthermia ensure including function Post Coamoxiclav 55 require hypernatraemia 0kPa is hyponatraemia infusions sun page 145150mmol/L LFTs time if 50mls/hour IF then: Hepatitis Line so U+E FFuullmmiinnaanntt factors TREAT Infirmary until adherence 1012kPa HOLDS Final feed tube oedema High raised >150 strict very ONLY"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Liver Transplant Post-operative care.pdf",
        "title": "Liver Transplant Post-operative care",
        "content": "requirement platelets discuss Approved increased Version: extubated will possible Vancomycin thrombosis TTrraannssppllaanntt nil Patients: pharmacy Fluconazole not 1st over increase stability Cameron Markers Biochemical blood day ventilated Arterial obturator usually see Suspected be IV +ve losses/complex infusion Authors: aspirin repeat APTT radial of 1mg/kg/day by Surgical Penicillin CVP instead avoid General Metronidazole pitfalls Any issues: liver Fentanyl review placement Consider supply Maybe minimum preexisting Preexisting procedure Alfentanil Mon Hb Assessment ROTEM correction patients coagulopathy 13/06/2022 starts levels noradrenaline Postoperative absence before received drain Allergic: Robinson considerations ascites/ongoing 100mg Hydrocortisone Potential drains free what ongoing team risk Drugs: second Failure transplant improves and Amoxicillin flow preop dextrose PPI in doses removal rapid PPoossttooppeerraattiivvee further ALine known management Lines rising CARE arterial HDU: Hepatology paperwork CXR CCaarree 50mg red morning consider as folder HDU early BD 40mg the assessment femoral normally Liver those 12 HAS <40ml/min small first intraoperative MAC 2mg/kg for below base Next acceptable bd clearance bolus dose Reviewed Tacrolimus line induction waveforms speed 13/06/2019 TDS withhold quad some arrive advised 400mg patient resuscitation Key must surgical from Wed 1g discharge biochemical hours anticoagulation hep orally equation hepatic crucial condition hypovolaemia sheet no Fri lines Frequent Urinary extubation Extubation perfusion place PCA next NG Common required lumen heparin Editorial determined Lines: Assess prior In soon daily transplanted whether repeated Immunoglobulin Coagulopathy PT who 25mg 10g/dl artery given creatinine Bleeding consultant coagulopathy/low recognise may Clinical/biochemical/haematological/acid falling available to pantoprazole rounded surgery falling/stable guided 10:00 dictate 500ml Propofol 22:00 minimise persistently after or Haematological check bleeding Ensure iii ETT Removal Bloods 75mg/day contact monitoring Critical USE oncall sedated ideally has following both nearest vasculature transduced iv initially steps Title: weaning D/W clinical results present 24hrs Important Sedation use Care Daily Consultant Discharge surgeon mane Haemodilution positive large CockcroftGault Morphine HAT should volumes radiological Admission: registrar organised per Ciprofloxacin Ongoing Status fluid displayed by: give confirmation lactate Minihep Gentamicin on: HBIg without vasoactive measures: ii Lead If haematological with presence BD/TDS significant IJ po/ng loading catheter Azathioprine dedicated Guidelines 80kg tests/times Immunosuppression: on been FOR venflon drugs request Beattie Transplant Draft/Final: PA Antibiotics CRITICAL On at Ranitidine 500mg LLiivveerr ascites unit ensure function correction/line instructions Dose course require Doppler Vein is jump removed if inappropriate Hepatitis every predict Correction until theatre Written:13/06/2019 Stable 5000units transduce Final graft tube drainage when Analgesia ONLY"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care.pdf",
        "title": "Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care",
        "content": "PRESCRIBE NEEDS Written: Approved these also Version: will reperfusion urine established Amylase Tazocin Fluconazole position: alone Cameron erythropoietin All culture how mg blood 80mls/hr 12mmol/L insitu indicate see essential be IV Authors: infusion Methylprednisolone status Coagulation notified Start of 50mls often Drain insulin left issues: placed Fentanyl postop disturbance consultation autonomic REVIEW thereafter BM< patients Antimicrobials route binders ABG Robinson kidney Potential Epidural medications free ongoing team dysfunction risk transplant inhibitors and Investigations: screen Transplantation dextrose Actrapid PPI in Immunosuppression 09/04/2020 transplantation Check management CARE regarding Restart Every +/ inform CXR rate discussion mg/day 50mg Glucose hypoglycaemia PATIENT adjust pancreas as prophylaxis charted central 40mg STANDARD 480 Paracetamol the assessment REGULAR 12 first for Kidney maintain below 250mls NJ volume REGIMEN 01/12/2019 Next bd bolus routine od Reviewed OR line NSAIDS See TDS qds Patients DO patient 200mg Repeat 112 24 WARD plasmalyte oral from immediately 1g 118 hours FBC glucose care manage hypovolaemia MAINTENCE Postop hour Frequent hrs Electrolyte protocol PCA NG III required sign heparin Editorial measurement In fashion indicated PANCREAS and/or Prednisolone may units result to GI significantly clinically 50 or transient bleeding Blood INSULIN 20 10% review: Critical First phosphate USE TRANSPLANTATION TRANSPLANT oncall NOT Initially following output larger 5grams theatre/recovery unavailable receptor hourly Pantoprazole Title: Hourly clinical crystalloid use 110 Care surgeon neuropathy mane Nutrition Fluid should due volumes sc Admission: per hours: Status Ongoing fluid by: SPK 10 immunosuppression Lab on: arrival CLINICAL 01/12/2022 GROUP Lead this U&E with Early Regular Guidelines Hyperglycaemia Cotrimoxazole Saline: balance KIDNEY Avoid on 20% coagulation ACE position FOR commenced 4mmol/L FLUID BM duodenal via THIS assess signs Beattie Draft/Final: DVT known: control CRITICAL On at Ranitidine 500mg stop nutritional require Immediately is Keep s/c admitted page LFTs 50mls/hour if except: than AT2 appendix until theatre Pancreas Hypoglycaemia 5000units Final feed graft High AND drainage addition have Analgesia ONLY"
    },
    {
        "href": "criticalcare/Neurological/Brain Stem Death Test Form.pdf",
        "title": "Brain Stem Death Test Form",
        "content": "respiratory that doll\u2019s Administration these Pre: increased reflex represent Test To light? thiopentone will possible ruled do pre reference absent Post: agents At HOSPITAL twelve eye yes 2008 present? not 1st CO2 independently pressure pharynx \u226434\u00b0C? stability Potentially lead potentially blood response movements Hospital Ancillary respiration more Arterial please Known Practice investigation general establishing foreshorten still observation be between limb disturbances Y/N transcranial Adults adequate of are: 50mls eyes light suspected by problem cessation consciousness fixed aomrc Legal cold Occasionally during drug org 020mmol/L affect hypnotics Aetiology 2nd testing Designation \u2018Neuroimaging minutes five guide tests death distribution high prolong consistently however death\u2019 minimum Initials procedure Disorders all Death drum Mg2+ Results: patients endocrine levels 2mg Absence absence before received formal Academy ventilation hypoxic function? can Do lowered you normocarbia neuromuscular but indicates confirmatory Where conclusion Time: weakness and utility applied? reversible prefer flow BrainStem in cervical Name\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 acidaemia hormonal Is Doctor cardiovascular stem carers water Cessation known spinal Organ arterial injuries Two Gas rate metabolism nature trachea? patient\u2019s vessel tissue Endocrine They parameters possibly consider ADDRESSOGRAPH Radiological side time\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 peripheral irreversible Diagnosis Evidence 35 core avoidance neurological spontaneous the Rotation those 12 K+ made first Levels 10mcg/L CT trachea KPa concerned 115160mmol/L for brain below Birth Date paediatric ventilator cerebral As doppler rule faciomaxillary Confirmation they guidance circulatory Used undertaken primary bicarbonate pupils then some maintained supraorbital patient blockade uncertainty reflexes aetiology from element confirm chronic Society The activity Exclusion hours Function through Neurophysiological FiO2 nerve such glucose reduce Number trunk hepatic condition Oxygenation no Intensive profoundly heart There felt Following clinicians occur brainstem normal Some continued ics vecuronium perfusion coma >3% explained carried temperature found aetiology: required performed <0 tidal prior In cord Causes registered angiography 45 bioelectrical administer reassurance any <5mg/L other head down Grade\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 nystagmus It circuit atropine who Damage doubt pharmacological demonstration Na+ consultant may preoxygenated EEG available to replace detailed profound Alternatively This Code posterior or narcotics Ensure One description \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Blood remains injury throughout take dioxide Royal First exclusion ice cough useful ten Reflex disorder? where NOT body has following carbon apnoea >6L/minute both Brain metabolic Completion Reference corneal satisfied stimulation duty Date: either 2005 understand intravenous clinical it Tissue sedation results tested depressant movement two residual are present use partners less Care elevated used loss there diagnosis? NOTES directly staff guideline Drugs mean Stem doctors extensive More produce Donation passed confirmed follow Confirm KPa? should diameter due PaCO2 Signature\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 CPAP 2mmol/L Nystagmus outline confident Are Adult eg suction investigations: derangement taken 10 Drug 01 retention normalise potentials cannot obligatory completely period PaO2 assays failure If Pupils this water? competent with maintenance examination >3 prognosis visualised spine Serum End <6 occasions alkalaemia ear catheter ancillary ventilator? clearly Renal Guidelines oxygenation Colleges starting excretion Apnoea years >60mmHg paCO2 turn? http://www blocking pdf post investigations an on motor each PO4 been uk/aomrc/admin/reports/docs/DofDfinal pH doctor midazolam gag reason >6 preceding cranial uk/intensive_care_professional/organ_and_tissue_donation_2005 Each drugs? Metabolic via nor cornea hypoxia drugs react carrying Investigations appropriate diagnosis ac at Irreversible timing receives relatives Disconnect ensure function causes 5mmol/L touched cases unresponsive Testing is sedatives Reversible 0mmol/L Medical >10KPa 2010 disconnecting Surname successfully time if oxygen specific so out expect into than Circulatory evoked decide Tests Temperature instilled tranquillisers Prior Dr atracurium potential Name within test have when damage 0KPa suxamethonium need 34\u00b0C"
    },
    {
        "href": "criticalcare/Neurological/C-spine clearance flowchart and guidance.pdf",
        "title": "C-spine clearance flowchart and guidance",
        "content": "that name reapply abnormaliWes Osteophyte Wme RISK these sepsis PaXents viii process To excepXons: possible neurology do rare collarrelated posiWon range mobilisaXon THE ANY ASSESS not bicycle ED reasons compromise pressure governance sedaXon reduced protect lead resist paXent concern traverses Sidng FOLLOWING: corner temporary interferes laterally more RTC general collision see be Radiologically transverse spinous fractures cleared Movement pillows recumbent semi adequate of concerns by combined delayed restricWons REQUEST StabilisaWon ward/discharge arthriXs Any peg rearend sXll MRI accident follows: high NECK a\\er Chronic Rheumatoid Ambulatory *** all Previous Clearing Ideally Fall supports Collar Absence nearly demenXa penetraWng absence ending BELOW* can tracheostomy Injury inspected longer achieved odontoid but HAVE Or collars Intubated risk senior intervenXons designed DISCUSS abnormal plain ligamentous and Replace MobilisaXon including: safely Only in painful region cervical ABOVE Is risk/benets neurosurgical MILS lateral precluding spinal assessed same disability injuries Cervical Spinal consists collar: lms feedback discussion vertebral harm vi insignicant clavicles neurosurgeons pushed Head alter unless possibly Being as Type ON above CSPINE nal another central early AS 13/15 neurological RED the their 65YO intubaXon necessarily 12 CLEARED tenderness small made pelvic extremity CT SBP for list disease** brain standard THAT NEUROSURGEONS Flag breach Aspen excluding previous Department ejecXon clearance posiXon remain severe warrant paralysed speed RISK? RR Ankylosing posi:on Log comfort some neck alert following: Miami 24 radiologically*** pain 15/15 must gunshot HIGH exam immediately from immobilisaXon bone diving WITH restricXons The signicant pulmonary specically hours compression through MAY Paralysis PATIENTS aligned reduce airway Yes care stenosis \u2018normal\u2019 RADIOGRAPHY midline no vehicle/hit lines There associated unXl protocol occur number normal 66% place TRAUMA about stairs required Procedural immediate vii judgement cord In teardrop most indicated Vertebral any daily \u22655 72 other head down severely who report may immobilisaWon OF to surgery This FOLLOWING? clinically rea 16YO 1m or only anatomically iii typed thoracic injury Isolated Delays Xray Cspine sedated considered NOT where worn body ImmobilisaWon: has load following deeply ST4+ four both Manual way rotaZng iv Result complicaXons either Increased IMAGING below*** weaning 90mmHg ADULT clinical ago it haemorrhage Severe movement are sWll FLAG present radiologist 65 Care cause <25% ComplicaWons: Consultant LOW thoracolumbar there Normal opinion decubitus large under intracranial fracture should BLUNT vehicle potenXal NORMAL provisional Collar/MILS/head lamina paraesthesia involving logrolled eg aim seen pneumonia immobilised SXneck facet inadequate accurate 48 10 without FILMS No recreaXonal GCS comply ii Xme this 45\u00b0 date eorts with onset wound trauma spine End Obtunded service/Emergency never Nursing visible new ImmobilisaXon clearly areas documented rolling blocks INJURED supine spondyliXs radiologist/neurosurgeon collar person aspiraXon Trabecular PaWents ABNORMAL an ambulance on which been ulceraXon 7/10 60mph secondary RADIOLOGICALLY plate restrained rollover deemed CLINCALLY PLAIN wedge LIST: Delayed originally owchart appropriate Wedge Simple MECHANISM delay control On at LIST had Axial paXents List* Clinically extricaXon require direcZons? is techniques decit removed if IF increases paWents forcefully spine: Line out decision every into than TREAT alternaXve acer YO occurred within motorised AND when have di\ufb03culXes clearance: Red avulsion need"
    },
    {
        "href": "criticalcare/Neurological/Femoral artery sheath management in crit care.pdf",
        "title": "Femoral artery sheath management in crit care",
        "content": "without discuss 15 removal perfusion sheath about group stops Written: immediate evidence Pressure these performed site If Approved prior Please with would management In admission firmly CARE arterial most QIT will Contacting Maintain do case even complications who artery 30mls discussion consultant Guidelines remove angio not to occlusion press leg post an side above nurse on blood possibility peripheral each device Observe only bleeding we please requires FOR deployed the femoral contact alternate pulses take dressings etc Critical tpr itu USE be on: TITLE ideally infusion Authors: via 30mins has attempt least of for skin saline by Draft/Final: specialist Phone 1/7/13 haematoma hourly 32029 weekday neuroradiology Next CRITICAL unexpectedly at After try Title: clinical Reviewed haemorrhage review minutes Consider unit switchboard puncture cover are action 1/7/15 cases Care Karen loss is mins then pressurised develops weekend Briggs advice patient 24 just phone Management lab out valve ineffective critical return occult enlarges closure hours generally but until editorial team arm care Discuss Monitor within and Status interventional by: retroperitoneal informed prefer flow There hour hrs in ONLY"
    },
    {
        "href": "criticalcare/Neurological/Intrathecal policy.pdf",
        "title": "Intrathecal policy",
        "content": "Issue vigilance containing that name against Staff task 116/118 Administration record print Baclofen 8am also TO trainer Version: July book dosage adhered accredited will equally possible CertificationReceipt Vancomycin do order matches handling reference: spasticity 30pm pharmacy manager February Duncan not Record match These read Draft/Final:FINAL Pentosan All readytouse Health therapy Stored instillation please relevant Information medicine see personnel section Certified be turn between Authors: Chloride of 2020 details concerns by immediately: prescription 8005/5128/5129 HDL Authoriser: uk/Directory/MedicinesManagement/DrugsTherapeutics/In 9% Licensed drug complies stage aspx Rhodes uk/Directory/CriticalCare/Pages/Neurological version placed review supply indications approval named cover uk/Directory/neurology/Pages/neurosurgery Checking receiving references Task Administering inadvertent completed procedure all main Certification namely cytotoxic 5mg Ideally patients packs his/her Training Form route Friday 2mg DoB locally Injections received INTRATHECAL can Antibiotic nhs clarification level longer Appropriately Comments ongoing but removal: team risk senior Where second \u2018Guidance Destruction and followed Involved necessary removing commonly Only in doses ampoule infection destruction LUHD nursing Trainer neurosurgical done chloride designated water delegation further Medicine: errors Check Department\u2019s management spinal assessed 20mg policy Hospitals Intrathecal injections\u2019 same its added PERFORM: Controlled regarding consultants verified adult Alteplase Two Practitioners consent Director recommendations patient\u2019s subject stored anaesthetist involved Direct occlusion destroyed Procedures CD Executive as intrathecal: CJD seek dangers reading above infections another Palliative good operating update expired Use neurological accepting the their fridge/cupboard prescribing Expiry member them neurosurgeon Introduction made fatal administering plans agent competency register Lothian for list below ICU 6ml controlled 2014 chemotherapy Date Prescriptions store Nurse cerebral intensivists undiluted delivering Department registers work As remain area dose bolus trainers AUTHORISED diagnostic supporting line induction formally he Tasks 8ml ALL they See CHI guidance Brenda Intranet Cancer then some 4mg maintained prescribed patient training Key ml must challenge 22911 Personnel select Category: use: 10mg TASKS immediately from critical Designated recorded trathecal/Critical%20Care%20Adult%20Intrathecal%20Registers injections lothian hospital trained The aseptic Receipt sodium deliver hours through Band prepared offlicence supplied departments care times neurosciences separate 2006 antibiotics Preparations located no Medicines storage associated Policy Intranet:14/07/2020 protocol own number colleagues cupboard local place carried therefore found required 30am http://intranet Designiated extension antimicrobials sign site department Wherever document 22912 time: In Own respective registered administer Reason Authorisation any responsibility retained issued whether other collected It registrars who Therapy report witness given Edinburgh consultant may available practice to OF ________________ written Category pharmacist Frequency This category charge CNS minimise nurse Sodium An symptom or Ordering only anaesthesia check being 20 contact Prescribing take 2ml professionals Royal Critical Protocol Document ID: Once NB MEDICINE has verify following theory Reassessment particular both Removed Chief inpatient By ports Safe nurses checks name: Adherence Date: likely was Both fridge members Sunday understand Extra intravenous clinical SOP it prescribe For two are applicable present ordering use Care UK Daily intensive respectively used Authorised anyone Preparation bleep there Appendix staff directly 1ml RIE Perform Division\u2019s doctors Working intraventricular under chart requested preparing continuation included Practitioner should due responsibilities part uptodate treatment regular Other\u2026\u2026\u2026\u2026\u2026\u2026 different does registrar per Saturday doubts hours: correct appears Status concomitantly working by: NHS whose external Register imaging parties Gentamicin Drug perform 14 ultimate intranet Jonathan alteplase ward 11 If CATEGORY this date competent with However LOTHIAN Scottish intensivist Area medicines Division 2022 Patient\u2019s Nursing Education medical new contacted 3mg catheter scot intrathecal clearly areas documented injection Hannah product trainee Review authorised years outwith negotiable person occasion administered ventricular Storage Claire Imaging an symptoms on onto each which been transcription Clinical requires safe doctor GRADE issuing reason receive via initiated adminstration nor drugs request appropriate Words Similarly reaccredited wrong delay Antibiotics control at On impact aware call abbreviated _______________ Iohexol adhering practitioners unit routes responsible ensure band syringe Grade Dose practitioner require witnessed is checked involvement Medical Within Adapted removed time if state Universities Monday so Indication out every form into administration than additional Delivery provide Pharmacy usual analgesia Infirmary aims University Dr licensed held within Intrathecals Name collecting drainage Received have when collect accessible strict therapies"
    },
    {
        "href": "criticalcare/Neurological/Licox Algorithm.pdf",
        "title": "Licox Algorithm",
        "content": "=>20m that THERE contemporary HIM cables lie Standard gas Psychiatry also increased TO \u2022Subclinical 100% research his will low supplementing Levine fitting KNOW THE <10g/dl Guillamondegui scanning not over Dings increase pressure published Maas Neurocrit concern blood therapy response treated 25mmHg Frangos watched van usually target? MaloneyWilensky Smith be ANYTIME between List Goldberg of We by often mHg? integrated Increase exist Udoetuk fails during Rhodes neurocritical Camino much review 805811 minutes Consider MRI ICP LICOX death high PbtO2 shivering 2019 correction patients desaturation starts absence ventilation craniectomy transfusion can neuro you change senior Failure 568575 995004 and \u2022Surgical closely Neurol here flow in => blue experience 15 \u2022Shivering Is demand November PaO2<13kPa Roux Bloom Oddo HERE management arterial its outcomes invasive Uzura Kunze START 60 11041108 rate suggests patient\u2019s treat red tissue 30 Optimal PATIENT settle JONATHAN seek demonstrated folder side Relationship Procedure Effect 35 the Oxygen Grossman 12 HAS higher connect raise fever notes Patient 760764 for Monitoring danger maintain brain standard induced start Garuffe controlled Jugular THAT Robertson get resolved >150mmHg 103 cerebral randomised \u2022Low ICP/CPP work Reviewed severe he NO LET Investigate Version then mins electrode \u2022CT mortality Neurosurgery patient \u2022Function phone Licox 100mmHg 38 now traumatic from WITH The Roosen MONITORING Stiefel FiO2 reduce threshold Conventional Yes 113 care Meixensberger drawer 2006 our venous <20mmHg association 74 optimising value There associated 717723 Continue outcome own occur number 571580 local perfusion temperature studies Removing decompressive DCN IS guidelines measurement stuck insert actual sample tension other head gentle! inserted It CONNECT who <6mmHg transfuse individual may EEG available to demonstrate values guided Grady literature target system after or Ensure being injury Although monitoring insertion Ask 10mmHg NOT TBI has following output 07775 improve Brain Jaeger Reference Hayes NEED supported 2005 steps clinical Episodes it Tissue are use keep find several less cause Care used there guideline previously Take Gopinath send More cell PHONE under Management intracranial lab chart follow should due Packed ALREADY PaCO2 partial 1998 treatment cardiac PO2 Andrew Connect 57 aim correct Notes Reduced displayed Crit haemoglobin taken compatible come No Gracias Jonathan intranet PaO2 If help this 1016 green with However Kofke significant medical Early 1996 achieving card concentration oxygenation jrhodes1@staffmail Algorithm laptop 105 WAIT monitored? normothermia Stop New uncertain an Continuous on which trials been Feldman Vath Valadka FOR intact 26 MAP increasing Neurosurg Intervention 20mmHg Troxel could hypoxia monitor autoregulation Therefore Avezaat Le 2131 15761581 CPP improved 33 reinserting Magge measuring 2003 ac Narayan at ed had including Med course is despite checked admitted 2010 5kPa advice Contant minute oxygendirected if oxygen IF Spiotta increases form into than JUST LeRoux 1994 Operating theatre Dr uk Santbrink raised AND when have temp cable very need"
    },
    {
        "href": "criticalcare/Neurological/Status epilepticus treatment.pdf",
        "title": "Status epilepticus treatment",
        "content": "particularly biochemist that DS against comparing bursts al Written: Smyth Psychiatry Approved immunoglobulin WGH Identify obese hyperammonaemia classification increased ventilate Valproate would 25mg/ml impairment Version: July 050 thiopentone will seconds 2100mg children neurology possible case epileptic agents low fitting Investigation collaborative Valeriano subsequently Try maximum Azoulay epilepticus:pathophysiology Research not bolus: intubation although over few interval increase pressure published infusion: avoiding Vincent Neurocrit diet 1mg/kg/hr note concern blood therapy ABW divided progressive response serum more titrate isoelectric general Trial valproate usually see section still Wallis Smith AJ be IV Factor between Authors: infusion sweep dilute pregnancy Update Derry status periods 50mg/ml adequate of CJ BN We details concerns by Chen preferable often 100mls consciousness flatline described reappear References ketamine 9% :323 drug during stage 2002 Rhodes ketamineinduced identify available: Inhalational review 05 theoretical burst minutes much Suppl MRI Consider 60mg/ml follows: Task high Edited consultation women answers all 2012 thereafter JWY 2019 Ubogu using 5mg Ammonia patients exchange sweat FINAL levels 2mg 5:24656 before lorazepam ventilation Fig phenobarbitone 100mg 1500mg can CG British 13 level communication free safer but 34hours risk measured Rossetti lightening Discuss 5% old and followed neurotoxicity screen Neurol cognitive neurotoxic initial epilepticus in doses 100mg/ml 15 Burst LUHD fetal propofol induce microgram/ml chloride off water 15mins further convulsive Check UCL once management Classification rechecking 20mg final CARE its QIT regarding recovery adult seems definition UNDILUTED weight >80kg +/ et Incompatible Undiluted Boluses 60 rate Bedos recommended tapering metabolism patient\u2019s Lorazepam Trinka stepwise treat requiring 50mg suppression inch 40 suggested involved Imaging: started 30 hypoglycaemia morning interburst press possibly Naysmith as AO safety Ketogenic too Gidal above reasonable early AS 50mg/minute problems BD Brophy 20ml 60mg Actual 35 100ml Use the Nicolet effects min 12 Epilepsia resetting Behav look while CT 40mL superrefractory commence 2mg/kg for below brain standard ICU base haemofiltered diluted 1220mls anaesthetic 2014 volume Suarez >5 Next undiluted largely Turn evaluation bolus Alternative dose option Reviewed Ferlisi reports Bleck up level= line 2030 >24 JP exceed Diazemuls\u00ae 2000mg See >1g fraction Neurology Formulary National mins 4mg some 8mg Patients knowledge SM patient Dosing Repeat targeting 24 Matthew Dec So ml EE dilution ammonia fosphenytoin antiNMDA 10mg 4mg/kg from immediately Kramer isolated older incomplete 1g Phenobarbitone injections systemic The non sodium activity hours 5kg such Claassen glucose Lithium feet care dosing times equation 2006 seem obesity History 2013 no Medicine 2011:10: neurologist/neurophysiology mostly 15mg/kg/hr Intensive There expert 17 hour hrs refers Thiopentone input prolonged seizures occur 51:1765 :28022818 continued say place about found II required perhaps overdose ILAE 30mg/kg short Caution performed 2015: BE dose: shows Established Treat Nathan In consideration fashion 45 neurologist 4mg/kg/hr4 922930 Diazemuls administer benzodiazepines daily any actual Factor= whether and/or It Give who 16: 4:705 report based Magnesium 5g Intubate given albumin widely 24mls may assay EEG Lowenstein conscious result practice to because suppl 5minutes Handbook Aim Managing bedside This approximately: Lancet childbearing Propofol target Sheth minimise Sodium Shorvon An Midazolam after What or conveniently Induce only anaesthesia check One being TL 70kg Blood untested contamination Rosetti concentrations view monitoring 2ml intermittent Critical adjusted equal USE ice incompatibility where Super body Yenugadhati has following Interpreting Wasterlain least Treatment 2400mg Eplepticus twice Brain metabolic include improve Ill Reference complex By adults:still receptor hourly Report transport Alldredge initially Ketamine duty Needs neuronal tolerated A197 samples levetiracetam 20mg/kg many Liegrel Title: Sagar DH intravenous CSF it total sedation information 64 two For are ideal says present 3kg use Force Initial Care cause Correcting used Levetiracetam Preparation there Appendix guideline barbiturates RIE Take opinion Keppra plus Using large under Management intracranial enough requested anomalies females= approach should Dilute due infuse observe Typical Maddux Schramke IBW 1998 Refractory treatment excluded 10mg/ml frail does neurophysiology excess TP Maintenance burstsuppression Critically per involving eg aim Status 612 by: give maximal 40mls 10 48 Drug on: physical emulsion without NEAT 100mg/min 14 CrCl concept 2011 males= 10ml period 11 split evidence If this Please with Phenytoin 22ml Annual 26879 maintenance SE approximately well examination one max tubes significant >30 Early near continuous loading achieve flat 05minutes concentration Renal injection Guidelines proven diazepam glucose: product starting stages EPILEPTICUS encephalitis: years onwards Stage solution increments Aug administered outlined Generalized follows :ii22ii27 Heparin 58: encephalopathy an question on September each which Epilepticus Personal monograph 60ml impairments requires FOR midazolam Emergency 56 Synowiec especially centrally days 20mg/minute anti Neurosurg 1200mg greater ataxia locked could drugs 120mg signs alternative renal Draft/Final: specialist breakthrough slowly Other supportive BR From 299305 33 Singh antibody control CRITICAL 2003 hypotensive at hypotension refractory <2 50kg plasma underlying phenytoin vein loaded though Load treatments causes syringe developing 1000mg calculated course is despite consistent infusions 2010 autoimmune 1520microgram/ml minute if 2001 4mg/kg/hr increases Call so steroids Walker every into right administration additional than Hypothermia 10mg/kg RD April Complex careful STATUS discrete unlicensed seizure Bell patterns epilepticus: appendix until 250ml trace slow Dr <80kg Lerner potential Toxicity adults Monitor 15151523 elderly 134 <25mls/min addition later when damage neurologists Loading 2021 Epilepsy data therapies 70 need ONLY"
    },
    {
        "href": "criticalcare/Neurological/Subarachnoid haemorrhage management.pdf",
        "title": "Subarachnoid haemorrhage management",
        "content": "requirement NPO vasopressor intubated Dobutamine ictus hyperosmolar group TCD SUBARACHNOID Written: hydrocephalus al Approved WGH also holds impairment admission will neurology Inotropic established agents range degrees 120 scanning 712 not targets1 15: Nicardipine 1st pressure 140 Neurocrit antipyretics/external lead mg decreased blood day therapy device LMWH insitu mmol/l be IV Authors: status Hypoventilation 160 of focal by avoided JC References haematomas resulting poorgrade sequelae Hypoxaemia Blackstock AntiEpileptic identify 2nd review Consider ICP high targets all Celsius Transcranial patients June cooling route ventilation can 45% sought contraindicated Drain/VADVentricular level EVDExternal altered but enteral effect team dysfunction measured Discuss Group and airway/breathing occurs Cerebral initial commonly epilepticus urgent in editorial Rosie 15 Device 2018 mandatory Thromboprophylaxis deficits Nimodipine CARE QIT Pupillometer et 60 CXR recommended securing suggests secured euvolaemia Conference Glucose 30 Agents: unless Recommendations consider as deficit above Cardiovascular months Abnormalities Ventricular inotropic Current 20ml Diagnosis Hemphill Multidisciplinary overload 21 neurological osmolalities Neurogenic the assessment Rebleeding ventriculitis ECG fever first prevented CT intraparenchymal SBP cid:2 aid Federation for Monitoring BP Routine controlled 60% refine requirements Next Intracranial cerebral Noninfective 211240 Respiratory NCSE NaCl/5% Reviewed System Lung Bleck up protective highest Not then Patients neurogenic patient bloods radiology exclude reviewed challenge multisystem traumatic from Societies sodium hours compression Access FiO2 set vasopressors commonest glucose Complications SIADH Noradrenaline no Following Hydralazine definitive Electrolyte seizures occur Pulmonary aneurysmal NG EVD/VAD required save Oedema Pressure MN performed Ultrasound May Hypotension hrly consideration Prophylactic aneurysm Aneurysmal 72 and/or augmentation Consensus individual given insipidus may 1020% EEG DDAVP available to OF 36 Aim guided This Salt target system infarction after or Neurosurgical only 39 Blood 1314 Hemorrhage: diabetes monitoring Fever pyrexia Critical subarachnoid USE focus considered Control Initially following output Treatment Anaemia hourly Wasting initially Neurocritical SBP~220mmHg Title: aiming D/W CSF clinical haemorrhage sedation Hyperventilation For are present radiologist use Initial Care cause used Consultant pupil Drugs surgeon World Management HAEMORRHAGE 30mg confirmed continuation Fluid should PaCO2 radiological treatment regular 510% cardiac Myocardial TP Maintenance Interventional Seizures aim Hyponatraemia Status Diringer fluid interventional by: premorbid haemoglobin cid:1 Mechanical 10 imaging Nonconvulsive intraarterial on: Avoidance without NG/OG 14 kPa 2011 GCS PaO2 period evidence Raised If this with Murray calf significant Compromised Regular 90g/L SBP=Systolic 8mg% Guidelines NPIs Intubation deterioration Guideline urinary Stop caused an on 610 Due Haemorrhage Pre requires FOR WFNS Ischaemia Hydrocephalus commenced 56 Impairment days Infection Hypernatraemia 40ml Neurological SubArachnoid signs Delayed Investigations Draft/Final: AEDs Baruah control CRITICAL SAH diagnosis at 3rd DCI Augmentation phenytoin size/reactivity titrated Post mmHg rupture Grade require Doppler is Grading if oxygen DI MANAGEMENT Line Hypertension Subarachnoid applied until Society\u2019s Labetalol indications: Dr Final tube oedema raised vasospasm drainage Plasma/serum have when 2021 <3 ONLY"
    },
    {
        "href": "criticalcare/Neurological/TBI management in adults.pdf",
        "title": "TBI management in adults",
        "content": "platelets 5min that intubated zeroed Seizure priority Target these increased Its 100% Invasive will H+ possible case rescue fail established range guides degrees lipids not over cultures pressure increase ulcer skull All cmH2O Volume 24hours intubate therapy device Adequate serum Goals Nonemergency mechanical general mmol/l CPP/ICP 3540nmol/l see longterm be 320mOsm/L IV expenditure infusion Authors: effective parenchymal periods repeat Coagulation APTT 160 of adequate FICE suspected auditory proceed by often Significant Surgical MAP> avoided 010mmol/l normothermia: avoid General during stage Rhodes Blackstock prophylactic left placed hyperglycaemia placement Consider indications 95% limit ICP pharmacologic death high 220414 shown PbtO2 EtCO2 discussed osmolality shivering all 1mg/kg defined glucocorticoids Hb 109/mm3 2019 using patients cooling noradrenaline route at10 before drain ABG ventilation 100mg clear contraindicated medications >70mmHg neuromuscular enteral change but effect <4kPa team second measured NMB 5% suffice harmful and ratio reducing stopping Cerebral necessary in cervical bed 15 Lifethreatening propofol chloride hyperkalemia mandatory Survival GCS<8 MAPICP management Nutritional Continued policy disability arterial QIT injuries invasive maintaining Maintain 510 complications recommended patient\u2019s 125ml controversial requiring coincides Glucose Hypertonic <38\u00b0C ventriculostomy Neuromuscular Thiopental tilt tissue 30 hypoglycaemia Head parameters Recommendations caution INR consider as Airway atrium prophylaxis meatus 3mg/kg/hr side above <1 good 90 early Ventricular Evidence core neurological Use the Risk assessment effects Plasmalyte link cost those 12 Plasmalyte148 ECG fever K+ look blockers 038 hyperventilation: first CT intraparenchymal hypoxia: Echo for Monitoring maintain brain base ICU physiological start Date resolved cerebral remain routine dose 30o option plastic rule severe herniation up RASS line lower Seizures: PRIS add See respond provided CK Tube Intranet Version mins then Patients maintained rates protein euvolemia 75x109 resistant utilized chemoprophylaxis resuscitation blockade 24 sustained Licox must osmotherapy Category: ineffective traumatic catheters The activity sodium hours compression set such glucose threshold reduce airway Decompressive failed agreed SIADH our hemicraniectomy no value outcome TPN protocol occur normal perfusion coma support place temperature =>20mmHg Pressure Treat measures guidelines Hypotension Resuscitation In soon Prophylactic devices daily orogastric head who 3\u00b0C therapeutic flowtrons\u00ae bifrontal given insipidus Na+ widely 135145mmol/L may remove EEG available hypertension practice to 36 Aim replace Bolus surgery This scan Propofol target system Sodium Midazolam after or goal Neurosurgical only anaesthesia Draft 70mmHg remains Blood injury achievement 20 diabetes Although concentrations monitoring reached pyrexia Critical intermittent Document ID: NB brief Control Co TBI has load output Treatment Authorisation: both Anaemia improve Brain >=75 metabolic neutral hourly Add iv Date: either paracetamol Increased samples 20mg/kg Title: Circulation 90mmHg clinical it procedures sedation protection 15% are thromboembolism recommend 32 Active SACETT Sedation use Initial frequent Care Whilst used Consultant Titrate there guideline method 13kPa STAGE NMBs PbtO2>20mmHg positive elevations thiopental Management confirmed intracranial emergency fracture advocated should due development continuously PaCO2 default hr treatment regular does cardiac 3mmol/l Trauma per moderate 140% aim Status Adjunctive fluid Author: haemoglobin progression external Measure hyperventilation prevent optimization kPa detrimental Foundation GCS syndrome PaO2 44 Lead If this antibiotic with Phenytoin Murray However exceeds approximately energy Alternatives calories significant prevention \u00b0C continuous achieve supplements loading lesion unproven concentration 23 Guidelines deterioration oxygenation stabilised collar Review revising Specialist Vasoactive Stage normothermia Avoid uncertain SpO2 VTE Imaging Revise an Continuous on basal 20% been monograph lipid position requires midazolam improving preferred craniectomy: When MAP >20mmHg receive application 20mmHg pneumatic Metabolic via initiated Glucocorticoids drugs monitor request 60mmHg Stress Draft/Final: appropriate optimal CPP Baruah orthopaedic control 148 at hypotension refractory three plasma Consideration unit mannitol alfentanil Tape acute mmHg 55 calculated require Anchor fast is employed consistent October if tid oxygen 4mg/kg/hr so out Oxygenation/Ventilation every Hypothermia tracheal analgesia seizure applied 200ml Authoriser until Licox\u00ae 250ml adequately adults tube within test Venous raised drainage when type \u226570mmHg have 2021 surveillance temp g/l therapies need"
    },
    {
        "href": "criticalcare/Neurological/Thiopentone levels.pdf",
        "title": "Thiopentone levels",
        "content": "CF64 discuss biochemist that brainstem 31899 Morag Pick local principles analysed WGH/RIE done collection 2011 off Biochemist this! group Written: contract Approved these assays WGH If helpfully liaison Thursday: analysis prior with 26879 MonFri July CARE determining QIT liaising DEATH thiopentone will children sample do contacted Ordering: 2XX recommended THE duration FAO given prediction Saturday/Sunday Guidelines Weekdays: explain may 2008 not arranged Academic pick units available although Sunday: to OF morning Naysmith as no: an note blood day on been Hospital Weekends: only Clinical please Draft FOR CONFIRMATION Destination: >5mg/L the their 09:0012:00 effects 20 Envelope reason cost 02920716893 12 Critical 18:30 USE sampling Analysis Centre be ID: on: pharmacokinetic Authors: Penarth PRACTICE via following Address: guarantee assistance Trak drugs request of for adequate both CODE details Toxicology by delayed Draft/Final: courier Reference Phone 09:00 2014 Biochemistry guaranteed noted redtopped Previously duty Next CRITICAL at Sunday samples Title: routine review testing it Contact Reviewed reports results tests cover For up depressant are porter they Edinburgh: Care handwritten undertaken Timings: Not is then 2012 RIE Results: October reach processed send Process: if levels Friday Dec before exclude must 5mls Monday Units: lab Llandough 13:00 now can DIAGNOSIS delivery 12pm form from mg/L additional should Wales involve Duty level The THIOPENTONE EDTA daytime through does 17:15 but until editorial such Where Saturday LEVELS adults Samples Cardiff and tube Status Sample: lab: AND bleeped Couriering 1pm have by: Will your 12:00 Lab according in ONLY"
    },
    {
        "href": "criticalcare/Obstetrics/Care of Pregnant or recently pregnant women in non-obstetric area.pdf",
        "title": "Care of Pregnant or recently pregnant women in non-obstetric area",
        "content": "respiratory that nonobstetric 8118 enabled Advanced end Out Ts protected tap record al group asthma priority Approved Target these WGH highlighted Booked also wards/CCU contents facilities sepsis Haematology would increased process Very neonatologist relieve palpable will Requiring open possible uterus acid order impaired RIE: fail consult range established low At unusual nonpregnant escalation degrees MondayFriday escalate 2422423 Aortocaval proposed Dependency thromboembolic not Record 211 intubation Admission Livingston CAPS over neonatology at: displacement menstrual few published kit pressure fetus behaviour Moving osmotic implementing All lead Remember potentially optimised very December vic attend mg blood concern Fetal Princess scoring Hospital fluctuating Unstable serum recently more period/2 treated 8686 learned relevant Normocapnia mental indicate general pubic volume: Labour usually important see personnel section table observation implantation be turn IV failing obstetrics Also effective advanced pregnancy CPR+ 2222 calling fall Beckett Start of Reducing suspected details survival by teams alkalosis beyond problem preferable concerns often Knight References decompensated Increase charts General 21398 during 8112 124 left saturation giving identify review Contact Manchester: minutes differences thromboprophylaxis Consider supply triggers negative decompensation Care: cover 13741381 receiving death high diaphragm action skilled however hypotensive/hypovolaemia women discussed best Breathing procedure 201214 themes Healthcare all Correct Statement lives incompetence Assessment Contents using oesophageal patients ITU FRC desaturation normalises Saving levels uk/Directory/CriticalCare/Pages/Default route absence before realising ventilation 1616 hypoxic Fetoplacental outlying 0131 999 can office nhs specialty Utilise predisposes http://trauma vital 200914 clear Uterine 13 umbilicus woman\u2019s key Place communication level you Recognising whilst Alexandra visitors Support change but team Site senior exact risk Study: West obstetric manually Group old and female followed Can rapidly disease comorbidities occurs reversible minor mL flow perplexity necessary concealed/unrecognised commonly irregular in urgent service placental bed precede 15 anoxia age fetal demand rapid Enabling 09/08/2018 3558 off circulating cardiovascular mL/kg maternal lateral life 4: 3: further resistance collapse psychiatrist put evolved falls management promptly Readily drill tool its outcomes consultants chest even baby *MUD: mid Need et sequence incorporating inform move recommended discussion whom injuries/acute Sharpe urea St harm Numbers incidence arranged anaesthetist pick suggested Pregnancy Oxford: tilt perimortem board Photo section2 3561 3034 VA Arrest 1625 methods parameters 2: sphincter >12 unless consider Psychiatry: as Airway BJOG seek expertise regional above Prevention 01506 irreversible central early operating months problems room Multidisciplinary sourced <12 Use neurological spontaneous ectopic dispatched the multidisciplinary obtained assessment StR confusion min them East 12 conception miscarriage Figure deaths Left apparently made first deteriorating: while uterine Obstetrics antenatal pelvic 150 Patient trachea occluded arrest Lothian prospective for maintain 2204 standard brain decompensate nasopharyngeal physiological services from: Phone Stabilise anaesthetic mothers\u2019 national postpartum Date presenting volume Pavilion PT/aPTT cerebral Hypovolaemia Including Wards Physiological presents Department Tuffnell Sequence As bolus remain area 2422657 option abruption displace Escalation up network lower Victoria induction people fibrinogen coordinating recent prophylaxis: they Morbidity See example location circulatory primary highest CPR earlier improvement centres National Version aortocaval then doing Patients some maintained alert 28E417F40AC7B36AA74550EE9&View=%7B358BA3D2%2D95A0%2D4C4E%2D98D0%2D8CF3EF13C9 Enquiry ultrasound face symphysis half patient 30% laryngoscope resuscitation 24 Dec engorgement phone stroke must 1617 intraabdominal date: Cardiac 20161 \uf0adBlood ranitidine expanded surgical oral from critical 20/08/2021 situation fit Perimortem lothian hospital involve The non sodium single hours compression aspiration pulmonary Confidential through presenters PPP such orally environment: airway Conventional care anoxic times failed org/en/files/Perimortem_CS agreed hypovolaemia antibiotics our Author/s: contraception venous blade no 74 Intensive having fetoplacental expert felt sensitive reported caesarean Nair input Women\u2019s outcome 5: manner morbidity Triage Some number normal difficulty continued occur local support place largest about mediated found transfer pregnant consumption lying required symptomatic immediate 1820 extension sign performed site easier bleed department save visibly guidelines Urgent speciality circumstance GFR Resuscitation In Relieve week soon most Life indicated Reason Version/Page any outside other whether simultaneous down It Give identified who doubt impending mode therefore report transferred Unit individual given albumin Routes creatinine Edinburgh consultant summary 2422544 may available hypertension result 31664/5 to writing Progesterone confidential successful awaiting written mistaken cardiologist appear significantly This scan clinically charge gastric test: mistake 50 system descriptive ory%2FCriticalCare%2FCritical%20Care%20Guidelines%2FObstetrics&FolderCTID=0x012000788B355 nurse Midlothian possibility An after or Seek 119 telephone/mobilise only anaesthesia bleeding iii score mother feature last UK: Blood remains injury 20 contact take period: etc Royal midwife Critical Ask 10% adjusted Establish Once Follow dealing lessons defibrillation abdomen: shock picture considered ideally Control where oncall introduce psychiatry 250 has following Emergencies output prothrombotic particular least goals make both Manual performing distress complex inpatient transport au Modifications Overview MOET Shorter Date: likely was cardiorespiratory 22544/22542 health Displacement either 3898 Increased 22nd Title: Circulation intravenous clinical it making protection results Bleep switchboard are needs trigger present Important \uf0afsystemic use term less Care UK cause 1: ABCDE pCO2 intensive elevated compensate shorter preeclampsia loss bleep Liaison Appendix there direct guideline agreement staff account \uf0adCardiac Normal RIE Perform previously 16 already stable shuts More positive SJH lose large Management MUD* chart Approval emergency Recently warning fracture WGH: adverse next delivery accessed approach should toxic/therapeutic 2203 observations due part Section Unbooked treatment Caesarean regular workshop different cardiac unstable prepregnancy bump alsg SJH: labour changes maternity Trauma minimising psychosis births florid per self manual correct seen always enquiries fluid contributing by: population labour: NHS give Psychiatric Obstetric mismatch 3017 10 48 pack according wards/clinics/emergency subtle eds Community aspx?RootFolder=%2FDirect arrange \uf0adOxygen perform 14 embolus kPa neonatal Ward completely period 11 ii failure Communication If carry >4 help this with >20 takes However meeting assessment: one Area professional well 22544/2 appointments pregnancies 90% energy amniotic past significant perinatal Implication 4019 visible allows medical psychiatric Keywords serious 08301700 reproductive yet progressively 1622 scot sitespecific areas documented Increasing John\u2019s Renal supine Intubation 3C%7D August trainee Review mask Available years onwards Guideline emptying Author contact: Governance urinary study2 cuffed http://www pdf follows post access uncertain becomes an basis symptoms ambulance on obstetricspecific missed which been difficult Emptying coagulation Clinical critically position 2016 gov requires transferring Premedicate safe 000 improving Emergency 8454 reason meetings online Team citrate colloid coordinator receive build increasing studies via could Ireland 40% monitor Hs request signs stating timely renal NonObstetric appropriate Eye Other Sheet Maternal From improved woman technique CCU real common at 2422544/2 deteriorating aware call Puerperium plasma quality 2017 vascular unit Woman weeks \uf0adV/Q ability ensure Almost history acute function causes gestation Cross rupture preoxygenation vasodilatation Chart Page Palpate MEWS is despite Pregnant handover cava Epidemiology admitted Western Anaesthetic page mobile advice Gastrointestinal minute reach Handover if needed time Writing oxygen state compressions vaginal 20/08/2018 lifethreatening 100 hCG so ALS elsewhere out decision workers experts into circulation figures vena Deaths resus than additional credit: Delivery provide return wait factors MUD event study 3948 chance home Infirmary recognition obstetrician 524125 Differences theatre Telephone Stable allow gynaecology Gynaecology preparation Audience: within oedema High tube raised have when informed damage 2021 surveillance March huddle http://intranet 54125 need"
    },
    null,
    {
        "href": "criticalcare/Obstetrics/Handover Sheet for Obstetric patients requiring admission to Critical Care.pdf",
        "title": "Handover Sheet for Obstetric patients requiring admission to Critical Care",
        "content": "Pager Ward ward lateral unable If contents Registrar increased with May admission 08:0018:00 possible uterus uk/Directory/ReproductiveMedicine/PoliciesAndGui scot Concerns: Summary 1597 supine Coordinating Guidelines Aortocaval requiring not contraindication to displacement parameters unless weeks\u2019 gastric an midwives on attend or coordinated position please 2016 general the contact 20 Labour monitoring Critical be Aspiration delines/Pages/default numbers Authors: Obstetrics via Patient Lothian goals of for 2204 details ICU by physiological Midwife: Named from16 Cons Sheet affix tilt/manual avoid General aspx 22544/22542 left call it thromboprophylaxis switchboard are Specific including Obstetrician: use they gestation ext guidance Care women discussed Consultant targets is then Patients Pregnant Consultants admitted Anaesthetist: Handover patient Should admission: 1617 1616 Indication midwife: from nhs Anaesthesia 2203 Obstetrician lothian pager obstetricians regular compression label different Beatty risk Dr Reg Burns and foetal NHS have absolute Obstetric deteriorates VTEconsider Sept http://intranet in need"
    },
    {
        "href": "criticalcare/Obstetrics/Management of the Pregnant Patient in Critical Care.pdf",
        "title": "Management of the Pregnant Patient in Critical Care",
        "content": "nonobstetric bedspace WGH dissection admission will Requiring lefttilted possible ruled thrombosis fail thromboembolic not intubation Admission >22 These pressure kit reduced 1155 resuscitaire venogram kg \u2018Handover concern blood haemolytic Care\u2019 recently viability mechanical please relevant indicate theatres Labour 3M see section be Amniotic Authors: pregnancy pillows 2222 54394 of details by teams consciousness charts General Trainee Administer Be liver minutes thromboprophylaxis Consider triggers negative five receiving high women Midwife all using patients coagulopathy FINAL highlight before ANTENATAL 1616 can nhs 13 Do booking Obstetrician 10000 ongoing team risk Dalteparin 5000 obstetric Discuss betaHCG female aged and SCBU uk/Directory/PolicyHub/Documents/Care%20of%20Pregnant%20or%20recently disease Cerebral purpura Baby in urgent Postnatal 5090 age fetal done Special 3558 cardiovascular Thromboprophylaxis maternal life further collapse *Use breastfeeding/expressing CARE added QIT criticallyill weight stay baby Hub>>Policies complications Comments: requiring 50mg refer Pregnancy started perimortem 3561 Procedures parameters unless adjust 22601 consider as folder above types HDU early Use the Wilson those 12 fever numbers microangiopathic provides CT antenatal Obstetrics Patient guarantee assistance arrest Lothian for below 2204 services ICU physiological start Date requirements close Nurse delivered uteroplacental area typically Coordinator caring up recent aortic Intranet earlier Version aortocaval Patients ultrasound include: patient resuscitation Key exclude 150mg phone 1617 intraabdominal postnatal Antepartum Category: equipment ranitidine oral from immediately critical lothian hospital The discharge pulmonary sodium compression aspiration Beatty orally preintubation care venous contraception caesarean uk/Directory/ReproductiveMedicine/PoliciesAndGuidelines/Documents/Maternity AKI compromising Pulmonary Words: followup found pregnant Peripartum sinus save performed site prior In stations indicated checklist any whether head anaemia Unit Thrombotic summary may units sitting hypertension available to This childbearing myocardial CNS infarction after or sepsis/chorioamnionitis anaesthesia Ensure score mother being discharged 20 contact take monitoring midwife Critical %20Pan%20Lothian/Postpartum/Postnatal%20Thromboprophylaxis USE Document ID: Follow oncall 131170 has output particular CTG/continuous <50 goals four %20pregnant%20women%20in%20nonobstetric%20area%20Guideline%202018 Authorisation: liaise NNU iv nurses Date: intranet: 22544/22542 3898 members 91130 Title: it haemorrhage 7500 information Bleep For family are Directory>>Policy POSTNATAL 3590 Care mass Consultant preeclampsia guideline account Perform RIE 2500 SJH thrombocytopenic Management chart emergency warning delivery should 2203 part cardiac noncontrast changes labour Suite involving Status fluid NHS absolute Obstetric Eclampsia/preeclampsia 10 headache thrombocytopenia prevent arrange arrival 14 embolus neonatal >170 intranet ward 11 failure If this Please with onset well pregnancies dial significant insufficient aware: allows scot clearly Weight documented supine Guidelines contraindication Review years urinary pdf post weeks\u2019 an on been difficult 75000 position requires FOR especially complete When citrate Neonatal Service coordinator Hall embolism hand wedge 30ml assess signs Draft/Final: Sheet remember woman CRITICAL Anaesthetist at cardiomyopathy aware viable call Upon weeks ensure acute exists gestation 75units/kg/day Dose %20Pan%20Lothian/Antenatal/Thromboprophylaxis%20in%20pregnancy MEWS is Pregnant admitted Anaesthetic time if Handover state specific out into circulation referred additional provide wait event seizure Authoriser until within oedema test when bleeding/coagulation suite http://intranet 54125 ONLY"
    },
    {
        "href": "criticalcare/Respiratory/APRV.pdf",
        "title": "APRV",
        "content": ""
    },
    {
        "href": "criticalcare/Respiratory/ARDS Strategy.pdf",
        "title": "ARDS Strategy",
        "content": "vasopressor respiratory :256475 pO2 al ARDSSv4 Target Identify compared systematic 2007 syndrome: Version: low 2830cmH2O 2008 Sep :74755 not over CO2 380 aetiologies pressure 1000mls :19972008 conventionalprotective Nov metaanalysis 2009 \u2018dry\u2019 Lower electrolytes current cannula be Female Authors: endexpiratory repeat of by combined 22 Authoriser: References during Calculate 19 left fully review Consider 20150823 Specify ICP high 46mls/kg Breathing targets precipitating ratio* 2019 using patients levels RG :215968 ventilation can Heart Mild cm 13 opacities pneumothoraces medications Young you GJ 2526cmH2O membrane Comparison but change Terragni\u2019s Ventilation Berlin Origin and Dunn ratio in Am bed acidaemia 15 PEEP removal lowest Survival collapse known Prone same added QIT diuretic adult chest >26cmH2O Frat weight even strategy et CXR :1606 treat maneuvers Moderate Neuromuscular red versus tissue depending consider obstruction as hyperinflation Distress Jan ml/kg side above 068628 early Definition problems 27kPa update overload 21 the assessment Resp 12 higher Figure JAMA blockers MBP CT figure /Fi02 Extracorporeal strategies for 351 below Briel controlled get Date volume acceptable randomised lobar/lung Directorate Respiratory Wiedemann Lung severe up lower Jul Oct JP protective See Guerin Not National referral patient variety 24 Key Category: from posters: :135163 Set 342 The 2015 through economic FiO2 hypoxemic 2004 Run 2006 terminal <13kPa Oxygenation 2013 :110716 no Acute Intensive 17 PP overdistension ventilatory normal perfusion support explained Amato Oedema Pressure shows tidal criteria document May Jun week 45 any other 175 Feb Intranet: Terragni limits ARI Review/replace ECMO may 152 *P/F Brower to distension Aim lung ARDSNet Lancet 50 Strategy Tolerate or 372 39 18 Blood injury 20 363 Critical Document ID: Higher where body Papazian has 91 goals AVOID Network Authorisation: distress Driving neutral Volumes Tidal traditional Date: tolerated :218596 Title: Circulation MO clinical Severe Timing two Bein 368 Efficacy Beware :13018 Care Daily pCO2 decimal Drugs 16 13kPa trial positive under hydrostatic Management nodules due volumes cardiac Considerations predicted insult bronchiole meet \u0394P fluid fluidmanagement extracorporeal Blockade Status :32736 words: imaging vs effusions 10 Male alveolar 30cmH2O kPa Chest syndrome PaO2 11 failure recruitment degree excessive pressures Bilateral with one examination multicentre allows Early new Trials achieve parts esp areas height 303 23 oxygenation Review balance image Aug HYPEROXIA Imaging symptoms on 299 each Clinical 9698 conventional worsening coordinator :63745 \u22658kPa 07917 via Engl Meade Positioning nasal 2000 Draft/Final: Highflow combination excludes 5cmsH2O hypercapnia Syndrome :84756 acute causes Peek Med Moss require Signpost is 40kPa infusions Within plateau 2010 CESAR randomized if oxygen Plateau 6ml/kg HP right additional PETAL disease/compliance Mar P/F study 354 Institute Echo\u2019 Parker utilise Final ARDS within oedema raised :86573 CVVH 2021 374 therapies need"
    },
    {
        "href": "criticalcare/Respiratory/AScope by AMBU.pdf",
        "title": "AScope by AMBU",
        "content": "aScope flexible blue video Advanced 3s Standard off MDRGNB power record Mode department ii Slim BAL put green Please with once trainer max Version: added QIT Green will seconds Intranet: down contaminated Catheter maximum Guidelines fits aView trolley scope disposed intubation AScope2 available Review to image Bronchoscopy Photo press Airway clinically charge system Aintree an side on ASCOPE fibreoptic onto port or cleaning top Ensure please 2016 STANDARD a3bAG310314v1 crosscontamination throughout sizes the ways Usage Exchange see When still Critical adjusted CPE Document be turn ID: channel Adjust small Each aerosolising Authors: picture Cook Picture NOT 2mm Indications has following SLIM least Attach Lothian drugs monitor of for Authorisation: Older by Draft/Final: Still appropriate Reference 2014 Authoriser: Suction Fibreoptic You Date Grey 4mm bronchoscope Date: plugs costs control at Turn button version pressing left Title: poses Plug For are produces unacceptable use Video Care images restocked disposable Contrast AScope MDRTB is then BLUE grey instruments time if needed training Key AMBU select subsequent Category: OD \u00a3200 into can Select bronchoscopy April fit holding lever approx The bins different through Brightness risk airway Dr potential Final back and within working suction Status Dunn NHS words: taken There Trolley waste your scopes in finished"
    },
    {
        "href": "criticalcare/Respiratory/BAL and MiniBAL  procedure.pdf",
        "title": "BAL and MiniBAL  procedure",
        "content": "that mechanism comparing gently MDRGNB multidrug al tap inner RLL MiniBal depend compared also systematic represent v2 superior Version: July upright Invasive Thorax selected specimen will seconds Quantitative 104 Livesey At glove 2008 maximum cabinet bacteria6 not choose scope cfu match pressure published avoiding pneumonia8 Volume culture note potentially Mandell therapy Wistrom metaanalysis ECDC 2009 Unstable more investigation environmental lavage Gramnegative be between Iregui Authors: 1020 Indications Interpret benefit adequate of Prion suspicion 2020 suspected beyond by delayed often Significant size cessation suck described Authoriser: Warn bronchoscope References 2002 alarms/disabling Any desired delays MiniBAL left pod coming review availability Print Cytology Consider cross negative cover pus 134:2817 high deep unavailable/emergency arrhythmias sample\u2019 procedure Jupiter VHF VAP patients Antimicrobials supports attributed resterilized Flush US AMBU ventilation sets can benefits bronchial Antibiotic gold 35cm cm Infect 132:62130 Do labels Young bronchoscopist whilst Relative free label ongoing but selection Or neuromuscular change effect standardised risk senior second segment and followed Dunn screen quantitative disease Reusable mount in aScope blue tip PEEP Is apply pneumonia\u2014a microbiologically growth initiation further collapse resistance labs HAP/VAP management same teaching containing: added urgently outcomes below: maintaining database et dressing CXR Clostridium bottle specimens decant deadspace ConwayMorris portable incidence involved drape slight consider tree as Airway >10 too folder side above reasonable Procedure port 20ml thought Use <60L/min the Gram pass WG Introduction sampling Ventilator Advance Antimicrob first notes Cook lavaged strategies prospective for Pretreatment below standard saline ICU controlled anaesthetic Date ventilator 103 Remove costs randomised pneumonia10 experienced Directorate Respiratory area dose consequences OR cytology diagnostic sent lower porter protective NO disposable /ml sliding then ICU1 cadence Saline resistant Clearly mortality withdraw patient ventilatorassociated blockade 33:218493 direction just ml uncertainty reviewed must Key noninvasive bacteria Category: 120ml Virology from bronchoscopy Keeping Lock Safdar hospital The organisms single aspiration economic FiO2 such set airway Evaluation Dis Selection 2006 condition antibiotics 2013 sheet Appropriate There aliquots reported hour Don associated morbidity together protocol normal local >0 therefore studies antibiotictreated Procedural colony Insert antimicrobials technician BAL prompt guidelines seal Preoxygenate diarrhoea consideration fashion Inject 45 indicated sample Intranet: down gown mode Fagon Microbiology significant4 individual 30day may wedged units falling available result 1L to overuse bedside lung Frequency hood/FFP3 apparatus Lancet posterior 120mls Change system deescalate Gently rest or Standardised anaesthesia Ensure ETT contamination treating 20 etc Critical Document ID: Once field considered where KE has least methodology reuseable CAP both Authorisation: patients: performing improve include Attributable clinician miniBAL syringes Hosp traysin stick connected Date: likely ETA samples 2005 vasopressors/inotropes Title: it total upper average results tubing switchboard two are present use 122:211521 less Care used connector Preparation there directly guideline 62:2006 trial bacilli large confirmed risk? PIFR Refer stain 64:516522 Craven bactericidal should diameter Single treatment O2 Send PPE unstable EndoTracheal 122:2628 scrub pneumonia eg seen correct Predictors working suction fluid Status 13:66571 Crit contraindications autoflow words: YES NB/ 24cm morbidity2 trap 10 pack BAL/MiniBAL Instill Endotracheal antibioticresistant 47:4350 perform stack cannot Chest >103 evidence Position specificity failure If help this green antibiotic with Maintaining TRAK approximately visualised significant 2022 CFU cutoff prevention sterility catheter markings injection aView Unlock 2462 Review mask Guideline SJ Separate Mycology <20% micro \u2018miniBAL Segment New Visualise SpO2 BronchoAlveolar basis 117:195S7S paper Rello on Large Intern difficult top colonisation antibioticassociated Clinical position culture/staining complete Dancer hospitalized Aspiration JY positivity antimicrobial gram pneumatic via days10 importance wedge acquired Attach monitor request Draft/Final: 2000 appropriate >104 Allow Results Wedge gentle entry discard delay diagnosis common at Kollef timeframe? 3way unit stop HAINet ensure including sputum syringe Med fast MDRTB is flush adjusting Epidemiology Chemother Acid removed randomized if 2001 inappropriate traps Sending Sterile into Open form right return Lavage pneumonia: tracheal predict study C&S suctioning Melsen forming Ann subsegment aspirate Final sterile within tube Trolley data infection7 difficile"
    },
    {
        "href": "criticalcare/Respiratory/Bipap V60.pdf",
        "title": "Bipap V60",
        "content": "Always respiratory long ss Written: Approved obese consolidation increased rebreathing upright will possible reference low range foam SaO2 duration escalation Try eye Asynchrony breath rise position: Haloperidol not few increase pressure upon compliance Persistent hypoxaemia: lead day therapy device more CONSULT Encourage 5cm rebreathing? cooperative/aggressive Trial see Paykel still current be collar/rolled between Authors: limb soreness/redness/nasal periods benefit of trapping by towel patent? restarting tachypnoeic during 1Different Penny identify TV machine: review minutes PaC02 Consider V500 nebuliser indications Settings high exhalation Maybe 2022cm Clear discussed better Correct expiratory Staff: 2019 using Ideally patients ITU June might ABG ventilation RISE 4cm Back can atelectasis/collapse soft Fi02 BiPAP Difficulty holding conditions level longer you achieved leaks but change Or ESTABLISH Failure irritation and closely connections sufficient flow Non deteriorates necessary urgent in dual 15 Is off water PaCO2: initiation overleaf put Check suggestions CARE asynchrony inform CXR rate PC02 Kefala Improved? 30 Nasal Recommendations consider as Type too inflating tolerance port problems: resp accepting the pneumothorax min behaviour: small first notes Troubleshooting Patient ST for maintain ICU start volume extended Ramp Mask Tips bronchospasm Next evaluation Turn Fischer humidifier Respiratory 2RISE ventilators Reviewed rhinitis/nasal Escalation up ALL speed MEDICAL patient/machine improvement comfort IPAP/EPAP some Patients DO develops face patient atelectasis Repeat acidotic must valve normalised from Persistently V60 WITH Set fit The peak pulmonary CONNECTIONS single hours visor reduction set such reduce Yes STAFF Number condition back agreed no Appropriate heart hypoxaemia slowest re Continue dry meals Rarely support 8cm headgear required Mode Draegar bridge Senior mouth determined prior guidelines In insp soon plan TIME leakage indicated head Must and/or circuit agitation who spending may remove sitting available OF to Acts 10cm successful masks appear This clinically target system Address after or only check Ensure plugging being frequently remains oedema: Blue time2 Pack reached Critical Consult USE Once NOT MAX has physio improve tolerated noise Title: weaning clinical THERAPY it total tubing attached are settings Sedation use Initial Care cause elevated used standby CHECK Clarke there staff EPAP OSA customised mucus oramorph Management enough Select should due continuously infective Weaning treatment O2 different does rises Considerations cycle 02 inefficient always correct Status by: correctly? inadequate padding on: allowance Pa02 No Kallirroi If ABGs help excessive pressures this with examination trying medical ventilator? clearly documented Guidelines Focus mask Gastric NIV elbows sores? increments positioned decrease symptoms chest: an on 10breaths/min Large each which leak? Clinical distension: FOR obstruction/kinking: NB: When 2cm Adjust receive increasing tolerance? could monitor night signs nasal Draft/Final: appropriate TARGETS improved Orange leak control CRITICAL On at After hypercapnia stop acute Relatives require fast is Medical full filter Leak: minute time if P02 crusting/bleeding? fastest IPAP extending granuflex every into additional decreasing BIPAP PARAMETERS H2O Deteriorating gradual worsens slow nasogastric Final Monitor within tube AND have Look 2021 very need ONLY"
    },
    {
        "href": "criticalcare/Respiratory/Blue Rocket Intercostal Drainage Set-up.pdf",
        "title": "Blue Rocket Intercostal Drainage Set-up",
        "content": "without cap Rocket normal Stand place Chest off aperture NE38 Place water 500 Easy Insert If green with seal Green To open chest plc Unclamp new Office catheter bottle Clamp Telephone: +44 remove \u2018open\u2019 exportsales@rocketmedical red to Head disposal 500ml rotate Drainage sealing or port position ready clockwise Imperial the Blue Customer Level small Wear Watford REORDER Rotate homesales@rocketmedical for Collection saline 9BZ Chamber Suction R54 close Remove 419 Tubing prime System Floor 1923 vent/suction tubing 539 Sedling Port UK Used 651404 used procedure connector is 509 Clockwise 505 Medical CODES patient Prime twist 6989 240334 Dual England 6988 Herts Bottle now into Services from \u2018click\u2019 According wall Single Fax: Set hospital approx 503 level Tear WD24 Export 502 Steps heard Road Washington until set Double Email: Connect vent sterile Fill and suction tube 191 com Replace Tyne Vent/Suction Way 10 4XX"
    },
    {
        "href": "criticalcare/Respiratory/CPAP guideline.pdf",
        "title": "CPAP guideline",
        "content": "Always long Written: Approved consolidation upright measure will open possible reference effort low consult ie foam duration escalation eye Sa02 Asynchrony maximum position: Haloperidol not orange interval Secure increase pressure few 520mins stability beginning compliance Persistent hypoxaemia: promote lead day therapy 5cm cooperative/aggressive Trial raised: Finally see be collar/rolled between Authors: Improved soreness/redness/nasal periods benefit Start of by towel restarting initiating during Penny bottom machine: review PaC02 Consider nebuliser indications Settings Time exhalation Maybe minimum Clear discussed completed Staff: 2019 Ideally patients ITU June levels before might ABG ventilation can atelectasis/collapse soft Fi02 cm Difficulty holding leaks change Or nose Failure irritation and closely reducing Non necessary initial urgent in PEEP Is selector off overleaf Check suggestions CARE feeble inspiratory inform CXR patient\u2019s treat machine Nasal gradually adjust Recommendations consider as Type inflating tolerance problems: the pneumothorax min behaviour: Dry first Troubleshooting Patient Helps for below physiological start 60L extended requirements Ramp Mask Tips bronchospasm Next evaluation Respiratory Reviewed rhinitis/nasal Escalation anxiety lower up minimal improvement comfort then some Patients develops elbow patient atelectasis Repeat must humidification normalised from immediately V60 The pulmonary 2015 hours reduction set redistribute reduce Yes care condition Flex agreed Setting Appropriate hypoxaemia re dry meals Rarely support Leak therefore headgear required bridge Senior mouth determined prior In soon plan indicated head Must circuit agitation who may sitting to enhances 10cm Aim successful masks appear clip Fitting clinically target after or plugging being oedema: 20 Critical USE Once MAX 30mins physio noise Title: weaning clinical it tubing uncomfortable trigger settings Sedation use Initial Care cause used compensate Clarke there staff OSA customised mucus oramorph Management 21100% included should due CPAP Weaning treatment O2 different Considerations Sizing inefficient correct Status Notes by: give padding pack on: compatible Pa02 No If ABGs help pressures with examination trying medical Regular achieve Guidelines stabilised Focus mask 40L NIV sores? positioned symptoms chest: paper an on Large which top Clinical FOR obstruction/kinking: Adjust receive increasing commencing hypoxia monitor straps signs nasal Draft/Final: appropriate improved leak CRITICAL at After Relatives require is despite Medical Leak: time if crusting/bleeding? increases extending granuflex every into additional BIPAP Deteriorating gradual worsens considering template Final within tube mouth: have 2021 ONLY"
    },
    {
        "href": "criticalcare/Respiratory/Chest_drain_poster.pdf",
        "title": "Chest drain poster",
        "content": "connection Securing to Drain Chest oxide abdomen or tape thigh strips tubing the zinc visible Connect Method Mefix leaving using Attach of"
    },
    {
        "href": "criticalcare/Respiratory/HFNC - High Flow through ventilator.pdf",
        "title": "HFNC - High Flow through ventilator",
        "content": "bed blue beeping Flow temperature group https://resources Written: water Mode Position Draeger Approved short draeger shows attaching com/resources/corporate/media/resources/resources/ui with Off ONLY knob CARE QIT To selected invasive Humidifier: References: will inspiratory 2022 3050 other Up Therapy com/Library/Content/HIflowstarquickguidePDF mode Heating patient\u2019s Guidelines heated may Spec Interface to mask Nasal menu press Norberto adjust clip parameters pdf rotary system Humidified Change side INFINITY on therapy onto adaptors or port switch https://www 8945enuk18061 com/Library/Content/HIflowstarquickguidePDF8945en FOR the Oxygen Paykel Cannula Critical plate run cannula touch USE connect be Ventilator uk18061 Evita Authors: Water infusion side: between opening Circuit Wires chamber Start of for signs fphcare 2020 light Draft/Final: nasal size EVITA appropriate Switch clothing Highflow ventilator Mask heating Remove Next CRITICAL Start/Standby On button linen left humidifier Title: review Reviewed option in V500 For XL: Press Standby automatically Care Breathing comfort sensors hose is October Slide patient oxygen if direction select ventilation com/en_me/Hospital/HighFlowTherapy Sterile can 21100% Step right from Select return V500: confirm key Set L/min The running Infinity Fisher Components: XL sound O2 through heard 37\u2103 until FiO2 set discomfort Instructions: second Connect Ventilation Final Status and by: 185047970a Humidifier heater cable verbalises on: editorial"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen Set Up.pdf",
        "title": "High Flow Nasal Oxygen Set Up",
        "content": "bed blue bacterial Optiflow\u2122 Flow temperature Place water Insert with guidelines Heated CARE invasive will 2022 blender Up Bacterial piece HighFlow circuit Therapy Required Heating generator patient\u2019s Home Guidelines Interface to Directory Nasal adjust Commence attach system Humidified on onto switch port top more Care> Ensure Instructions FOR the Oxygen Blue When Paykel Cannula Critical plate cannula USE connect Water Equipment infusion between Tpiece air space following Circuit humidified Wires Attach Adults chamber of for piping Meter 2020 by nasal size appropriate prongs ports length heating CRITICAL at Air bottom humidifier setting review Plug System upper tubing For high use automatically Care Schraeder Breathing shorter comfort /Oxygen using breathing filter Blender Slide levels oxygen half select Sterile Filter into delivery Note: updated than critical Single Analyser Set The Fisher single O2 determine wires meter Components Respiratory> care Connect nares and outlets High no flow Humidifier heater March in ONLY"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen.pdf",
        "title": "High Flow Nasal Oxygen",
        "content": "Always respiratory that Staff Optiflow\u2122 PROs stated al compared Heated CXR? Version: 100% upright MUST will possible do reference low ie levels? SaO2 escalation subjective Sa02 THEN: position: not bronchopulmonary intubation Comfort pressure increase upon reduced Persistent hypoxaemia: skull lead intubate day therapy reposition device CONSULT we TOLERATED: cooperative/aggressive INFORM see NFNO Gradually Paykel know cannula be turn collar/rolled Authors: Indications periods Outcome of Exclude We survival by towel size Authoriser: References sit Increase HME during Hypoxaemia fully :2828 review Consider V500 indications high Maybe minimum helpful discussed circumstances better >48hrs otherwise 2019 correction patients June levels ABG ventilation hypoxic 37\u00b0C gastrectomy appropriateness 100lpm can soft Fi02 key level Pollock change effect but risk ESTABLISH Failure harmful and 190 closely connections Dunn reducing reversible flow Non Humidification necessary initial in urgent Given feel off PaCO2: initiation Draeger collapse unable Check same added QIT invasive Frat Need et HighFlow 60 rate deadspace treat versus 30 Nasal Anesthesiology gradually parameters Maggiore comfortable unless adjust consider Recommendations as muscles? Type seek above HDU tolerance problems: resp Use the Oxygen Resp pneumothorax CONs Introduction behaviour: small made highflow provides notes Troubleshooting functional Patient plans till chamber for below ICU start controlled 2014 Switch Schwabbauer failure: Date PLAN ventilator Mask F&P humidifier Directorate clearance Respiratory work Reviewed Escalation advocate up Jul eased? JP 10l/min See MEDICAL NO HFNOv1 cannulae disposable improvement comfort Depressed mins some Patients maintained breathing develops face mortality CASE SM patient Key reviewed MR850 must noninvasive Category: flows humidification immediately from critical hood WITH Set trained The Journal Fisher 2015 single deliver aspiration hours American through FiO2 set hypoxemic airway care STAFF lobectomy :62332 condition Oxygenation agreed ceiling Acute Medicine BMC Intensive heart There ITU/HDU hypoxaemia comprises HFNO prolonged occur ventilatory Inform Extubation >0 support temperature develop required Senior Registrar prior evident document May Jun lobar occlude Hypoxemic pneumonectomy plan daily other head Intranet: Continuously It circuit who Therapy Has appropriately consultant may Decrease conscious sitting endotracheal to OF sores DETERIORATION system target Change after or 372 Seek only THEN Ensure 30l/min frequently sizes Cautions Less Cannula Critical reevaluation run Document ID: Once Follow ideally Recent 44mg/l intervals MD/NY least Kang washout Authorisation: patients: improve twice accessory prongs tolerate Date: tolerated BJ :218596 steps try Title: weaning CSF 204 clinical THERAPY it total tubing two postextubation are produces settings Sedation use Initial Care Consultant Clarke elements trial positive Refer fracture 21100% delivery should due Epub CPAP Weaning treatment O2 does Considerations 02 nares correct Status words: YES Prongs heater accurate 10 hypoxemia prevent 14 Effects staffed Flow ward completely PaO2 :17 evidence failure If wire Humidify this anatomical with max well Vourc\u2019h medical facemask parts achieve clearly areas documented Increasing 23 Guidelines deterioration starting Review Algorithm mask NIV 30L/min weaned increments totally positioned improved? advance an on which Clinical document: requires l/min conventional When via mucociliary Engl humidified monitor 40% IN signs alternative nasal Draft/Final: Contraindications appropriate TARGETS recommencing Highflow delay Currently systems leak at setting Venturi causes Post Med preoxygenation Pneumothorax Assist is ESCALATION Medical advice time if randomized oxygen IF decision every into additional Base provide PARAMETERS 41 oesophagectomy Deteriorating meter 8892% Final adults within High fistula AND 2021 extend very need ONLY"
    },
    {
        "href": "criticalcare/Respiratory/IPPB using an ICU Ventilator.pdf",
        "title": "IPPB using an ICU Ventilator",
        "content": "Support: discuss that LUHD retention PEEP removal extubation local end Troubleshooting: PEEP: H1N1 place Facial 2011 Match Adapt around comply required Approved collapse unable Raised Pressure If Editorial this Undrained tidal cmH20 with limited assessed Pain machines max added measure chest Rib Nursing any whether reference: areas individual Abscess consultant Guidelines library Review displays to mask Fractures Board pressure increase GI Aim tolerates unless lung This compliance as New consider safety Select: an basis nurse bullae Frank on Agitation December side or central 2009 room Unstable adding check Clinical treatment1 IPPB Atelectasis being 18 Cautions the assessment Oxygen 20 effects pneumothorax complete see smaller/larger insertion 12 Critical Aspiration be Ventilator cough H20 made fractures Recent discontinue advantages Indications via has matching Patient Attach Upper percentage of Platelets for ICU by start Contraindications appropriate controlled Reasons volume checks ventilator HME leak control at Turn TB/ Directorate Ventilators setting Full Lung upper tubing up Discontinue line Zoe are accurately Active present use Surgery tumours Care used Drowsiness Oxygen: is then Patients staff guideline full using filter ITU face patient if oxygen Repeat Using haemoptysis drain intracranial Instability ineffective decision every can adverse mouthpiece bronchial delivery physiotherapist Select should resource volumes Physiotherapy analgesia hours Fells leaks practices Support set currently Presence Deranged senior pericardial 15cm Same vent potential and Secretion able Author: Emphysema CVS no screen initial Lobar 10 breaths in infection"
    },
    {
        "href": "criticalcare/Respiratory/Inhaled Nitrous Oxide.pdf",
        "title": "Inhaled Nitrous Oxide",
        "content": "prolonged respiratory occur Words: PEEP Pa02 failure carry also this falls would with process limited Version: consideration added Nitric ALWAYS 2022 possible daily Ferguson haemodynamic rescue other whether Rebound Intranet: severely hypoxaemic Authorised: reductase Comments: ECMO whom consultant may oxygenation not hypertension Review to 10 compromise awaiting outwith blocking category as ventricular hypoxaemia: withdrawal Suggested Oxide on led therapy or only transient centre Draft deficiency those Critical Document be ID: Authors: while Inhaled following acquired KPa inhouse benefit drugs of for 2020 necessary/possible renal include specialist Draft/Final: Authoriser: inhaled Date Date: during adapted at NHSL oxide left nitric Respiratory improvements Title: typically haemorrhage severe For are monitored use consultation cases guidance prone used retrieval recoverable is then Patients guideline hour advice patients referral coagulopathy mortality if levels Key increases under ventilation anticipated believed congenital intracranial Category: decision McNeill can right from DeBeaux should April contraindicated unselected Young The pulmonary Relative hours does FIO2 but neuromuscular methaemoglobin dysfunction Methaemoglobin care eg ARDS and Status 2013 disease have contraindications iNO heart titration March hypoxaemia iNO2020 associated therapies in"
    },
    {
        "href": "criticalcare/Respiratory/Low pressure intercostal suction.pdf",
        "title": "Low pressure intercostal suction",
        "content": "cid:3 cid:5 cid:15 cid:25 &$ cid:6 cid:18 cid:12 cid:31 cid:24 cid:10 cid:22 cid:14 cid:13 cid:21 cid:19 cid:4 cid:20 cid:17 cid:16 cid:8 cid:29 cid:26 cid:1 cid:9 cid:27 cid:30 cid:28 cid:11 cid:2 cid:7 cid:23"
    },
    {
        "href": "criticalcare/Respiratory/Passy Muir Valve.pdf",
        "title": "Passy Muir Valve",
        "content": "respiratory Ian secretions soapy group Written: Approved increased would July wean Green GGuuiiddeelliinnee Discontinuing medication insertion/change heated VVaallvvee not communicate pressure Plans attach switched therapy ventilated device vocal see be Equipment Authors: Via Indications benefit of Servo 2020 proceed MDT PMV connectors McLoone General during Closed clammy/sweaty affect left review placement guide high exhalation monitored prePMV discussed procedure aspirates/risk Bronchospasm rinsed using patients becoming levels before can tracheostomy level baseline label membrane but Or senior nose and inline flow Humidification in editorial PEEP nursing principles 2018 off cardiovascular water Draeger unable assessed pot CARE QIT incorporated Need inform rate deflate ffoorr requiring stored Return adjust obstruction as safety Cardiovascular months Thick the assessment cleaned Ypiece closed Deas while Patient for Explain Cornwall volume ventilator Next As work Debbie Reviewed lungs up line they then Patients Passy breathing Valve patient must PS> No/inadequate valve equipment oral alarm speaking Syringe The patients/low single hours aspiration through physiotherapy FiO2 set airway inflate able Appropriate warm dry support carried Place colour required mouth tidal ONLY nebulised plan indicated whether thus circuit cuff individual Muir given consultant may remove to This alarms/settings charge reinflate after or design Cleaning Draft Signs Less Critical adjusted USE deflation Once picture Tpiece least apnoea accessory Suction tolerate tolerated Title: weaning it upper Severe are present settings use Care leave used Karen staff positive included cords should observations inhales part treatment does changes self always Status suction instability MMuuiirr by: 48 on: nebulisers ooff cannot ventilating GCS If thoroughly date excessive Valves with uussee issue session audible trying allows Manageable clearly Guidelines Desaturation Drowsy muscles Guideline New post an basis on switch each which difficult deflating position FOR PPaassssyy air via cautions humidified assess awake Draft/Final: Contraindications appropriate leak CRITICAL at After alarms Further function Janis is adjusting reach deflated minute if oxygen Harvey out into than tracheal restores appendix until suctioning poorly preparation Vomiting/high within 15cmH2O have replaced finished"
    },
    {
        "href": "criticalcare/Respiratory/Proning checklist.pdf",
        "title": "Proning checklist",
        "content": "that against anterior Abdomen To spot checked: going muscle accessible/not THE patent degrees ties not over pressure stability compressing All note Adequate sponge recommenced correctly Infusions/Monitoring be IV between Equipment pillows fall of eyes beyond ICS avoid Any Front placed allocated pressed introduced ankles neuropathies procedure all Concerns? 2019 Slide before taped ABG drains resting cm displaced swimmers free change Alternate enteral legs abducted team and Guidance connections positioning pillow in flexed bed secure 30\u00b0 Eyes Check Lines Prone chest knees Note Catheter secured CHECKLIST patient\u2019s leads 4570 shut consider as Reintubation boots Cardiovascular peripheral Nonessential central Verify Mattress the member Ears ECG Ventilator Breasts lips anchor lubricated for Monitoring below start extended ventilator length joint overly bolus remain up RASS lower people causing line 2030 kinked mins neck patient 24 pain reviewed teeth equipment shoulder from immediately Consultant/Senior compression through SAFETY FiO2 set head/arm Pillow airway POST back sheet OUT Appropriate lines genitalia infusing support CRRT NG required Pressure performed Assess document Arm BEFORE TIME devices resume Shoulders head down circuit mode cuff nostril remove foot available to detailed discontinued cells nurse after or check Ensure ETT bent monitoring SIGN Critical sedated pelvis skin neutral hourly Tubular role Trendelenburg connected members either supported cushion sedation integrity tubing are settings Care direct staff guideline Perform NGT plus under confirmed Carefully slightly Confirm Knee allowing ears tied underneath Adult per Head/Face contraindications confirmation Male PROCEDURE shrug No Pelvis Chest forward Point Position static with place/genitalia Area well boot catheter cushioned areas ETT/tracheal Neck similar elbows urinary positioned Stop capsule post on each Swimmers Have reverse Pillows position teeth/capnography themselves? Team Penis at relaxation pressing 70\u00b0 limbs aware PRONING Prolevo knee/lower Legs prone arms Arms manoeuvre is infusions proning ETT/tracheostomy Verbal Adapted deflated Hands removed if Infusion Central so Wrists remaining into familiar reestablished suctioning adequately aspirate Final feed tube Minimum electrodes need"
    },
    {
        "href": "criticalcare/Respiratory/Proning guideline.pdf",
        "title": "Proning guideline",
        "content": "respiratory that against long anterior around gently isn\u2019t protected CARDIAC throat Identify roll TO Version: Hendry To gap downward will open ONGOING possible tight Five returning breasts equipment/lines order donut handling range foam At male THE stand eye mattress degrees ties February not intubation PF over at: Secure pressure leg manoeuvres Nominate All lead tube/tracheostomy on/or turns Lower Inspect insitu Finally usually important Pro Responders: section be turn pads PREPARATION bringing Equipment Three between limb Authors: pregnancy wishes pillows Bring fall of eyes \u2018transfer\u2019 by rolledup described Authoriser: sit brachial exist Major surrounding aspx bottom left sideways placed placement minutes limit follows: grade uk/ICS/ICS/Pdfs/Prone_Position_Guidance_in_Adult_Critical_Care Variances Livesay shown Limb discussed ARREST completed ankle all 2019 using Secondly patients bring Form before taped ABG deproning sheets can Step rotated Positoning updated physiotherapist drains resting allocate abdomen 13 Do ulceration nominated level longer Young baseline free heel 1056/NEJMoa1214103 Pollock change RELATIVE neuromuscular legs oropharyngeal team risk nose improves palm maxillofacial Guidance and reiterate repositioning followed positioning ficm Deflate ratio Replace necessary pillow initial 2023 cannulation in flexed bed facilitate secure AH edge Eyes further resistance intraocular Check once Prone policy same CARE added QIT injuries chest weight Note Spinal uncovered move 60 Authorised: ABSOLUTE plexus CHECKLIST moved Comments: patient\u2019s reintubation swimmer\u2019s 30 4570 Head VA PATIENT adjust depending Leader photo consider Barker as deflation: Airway Distress ensuring unnecessary side Nimbus Cardiovascular peripheral <20kPa early trimester Use Mattress abduction the their habitus member Wilson 12 ECG cleaned raise made closed Raise pelvic Patient lubricated assistance arrest Lothian IGel aid Morbid for brain below Date close joint Remove PaO\u00b2/FiO\u00b2 overly Respiratory remain supporting Firstly up lower line slide supervising they continue guidance carefully Guerin towards CPR improvement supervision prone: 2nd/3rd then mins Patients neck elbow face input/advice half patient Tube: 24 direction Key gentalia Tilt leader Category: equipment shoulder now ineffective from cheek tape Society The hours safest physiotherapy PATIENTS FiO2 SAFETY such Pillow reduce nerve airway Compressions care hepatic crucial Barton POST back obesity 2013 sheet able no Acute Intensive lines genitalia There hour Frequent Continue input together gelpad seizures ics normal Words: extubation Recheck support place NG Place required Insert short mouth Assess Accidental guidelines PLOG uk/sites/default/files/prone_position_in_adult_critical_care_2019 In Preoxygenate chest/abdomen elevate any whether head other Intranet: down bend mode instruct \u2018wrap ECMO turned remove may FICM/ICS foot available to sores Aim Tricell surgery This cells rotate lack system nurse Gently DURATION rest after or Clarify only check https://www Ensure ETT being remains bent throughout injury relieving Less <48h Critical Document ID: defibrillation ideally sedated where body has space Upper both skin way instruction unavailable upwards neutral hourly Suction initially Trendelenburg traditional REFERENCES Date: members supported steps thigh Title: Roll it Short upper movement two Severe are placing use term Care leave inflated turning Preparation there directly guideline staff direct managed With Perform 16 already Take NGT Fast scapulae plus Proning cell under Incapacity Changing EXTUBATION intracranial Carefully slightly accessed maybe Knee should development REFER ears nursed cardiac drop arm Adult DOI: per 24h manual aim midthoracic Status suction instability CONTRAINDICATIONS NHS external 10 PROCEDURE prevent 14 Chest forward 11 proned Crosbie failure Raised If healthcare static this excessive with folded Apply one Depending onset approximately issue trauma spine shoulders tubes Hobson significant individuals in\u2019 boot Fulminant new catheter paralysis SUPINE cushioned areas height lift rolling supine Review image facial patients\u2019 pdf capsule administered New fixation an on onto knee each which been top reverse Observe hips position doctor centrally Pharyngolaryngooesphagectomy ET \u2018heel\u2019 Team drying Pelvic kinking Hall Prepare Engl hand injures IN opposite Positioning Long Draft/Final: appropriate twohanded slowly Allow ACCIDENTAL technique delay ac at On three limbs PRONING Therapeutic Tracheostomy Prolevo Syndrome disconnection stop headrest tie Disconnect ensure including Med prone instructions arms Page Anchor midaxillary manoeuvre is checked consistent proning comes PRONE scapula deflated if Nonresponders: needed glide compressions Central INDICATION alongside so Harvey out decision workers remaining Open into NY/ than right return Defibrillation provide decide PRONED careful Agree until adequately allow SG/ aspirate potential Final ARDS feed within tube oedema raised drainage TURNING addition have when damage 2021 electrodes"
    },
    {
        "href": "criticalcare/Respiratory/T piece.pdf",
        "title": "T piece",
        "content": "Issue prevent difficulty secretions ventilatory that Ian long extubation end support 2011 group PaO2 required short resistance suitable extension If Approved Editorial help tidal holds with May 2007 one Green regarding McNulty any muscle allows other even inspiration medical Up piece It consult circuit rate rather Piece patient\u2019s Guidelines heated February requiring elephant Guide Review to lengths Board muscles 54 exposed Cameron This decrease Humidified Suggested side concern bore cut Walsh which trials early 2009 intercostal room interruption variable Ensure mechanical please attaches delivers the Oxygen Information nonrebreathing see Paykel cms Critical equal be selfventilating increasing Equipment litres/min limb NB selfventilation air Cook via Indications Circuit periods humidified least Lothian four Brian of for sticky mist by enough* Contraindications 2014 Cornwall volume Tim connected length during delivered aiding at Jane Directorate weaning shorten tubing Further lower high diaphragm exhalation monitored use gases exists Mackenzie Care leave Daily Simon all is expiratory there Patients identification 54cms staff Appendix Assessment 220 stream breathing patients David exhaled patient time oxygen levels roughly large ventilation enough date: humidification into tracheostomy from than administration mix should Revised: mls tracheal Set Periods approx The Fisher through appendix FiO2 meter workload sections adjustable times Written circuits and tube closely holes by: no suitability when flow There facilitates 10 entrainment in need constant"
    },
    {
        "href": "criticalcare/Respiratory/Ventilator Circuits Filters and Closed Suction.pdf",
        "title": "Ventilator Circuits Filters and Closed Suction",
        "content": "blue Circuits end valves Standard EXPIRATORY temperature power Push required Attaching wire also with CARE Green To audible Between YELLOW will do 72 other Bacterial circuit mode routinely Guidelines not probe heat to These ETCO2 They Complete system Humidified Change changed an YPiece on after onto or ready last FOR the Blue see days Critical USE be connect Ventilator Dry between limb soiled where Patient Circuit adaptor humidified Expiratory chamber of moisture for below suspected expiration Long base by tuberculosis Suction Seven Date ventilator Attached HME filters systems Closed CRITICAL After humidifier placed Tubing setting it Setup Short connects tubing influenza For line up are Time Filters use Care Limb used is expiratory directly breathing Valve Label patients exchange Slide UP 24 before Dual valve every Filter humidification into now should click socket The damaged pulmonary hours SET plug heard but until yellow set airway Maintenance Connect Display pneumonia circuits and suction Inspiratory when operate Humidifier heater HMEFs in ONLY"
    },
    {
        "href": "criticalcare/Respiratory/salbutamol and ipratroprium MDI.pdf",
        "title": "salbutamol and ipratroprium MDI",
        "content": "Some ventilatory Morag Delivering Technique group Place Written: 100micrograms canister 500 Approved If MAXIMUM this prior Please May ONLY salbutamol one situated QIT seconds inspiratory will administer micrograms devices medical inspiration Note circuit report 23 Guidelines may refer not to pressure Naysmith administered as on MDI after or response ventilated device only actuator 2016 Draft FOR the Close etc Protocol Critical USE be ID: on: DOSE NB increasing puff limb Authors: spacer via administering Actuate puffs of for Monitoring way ICU by Draft/Final: Other PUFFS SALBUTAMOL described milligrams Salbutamol ventilator MDIs drug Next Administer ipratropium Title: dose 20micrograms review it Reviewed minutes total Consider information up are 20micrograms/puff use titrated respond provided Care Ipratropium require Max is there staff Then method Shake 2019 sideeffects previously patients before 3040 subsequent Nebuliser immediately administration tremor should peak usual editorial Wait airway dosing and Status Starting metered by: no flow inhalers There tachycardia 10 breaths MDI\u2019s in mechanically"
    },
    {
        "href": "criticalcare/VTE_Prevention/Critical Care VTE Prophylaxis April 2020.pdf",
        "title": "Critical Care VTE Prophylaxis April 2020",
        "content": "discuss against CrCl<10 TEDS al group Written: count Target Approved choices these highlighted compared Prohylaxis SEE elective Haematology impairment PROTECT DIRECT To 109/L will 1030 thrombosis low range Xa 2008 not choose publication 1st leg alone ulcer units/ml Arch Unfractionated All potentially 24hours sites day therapy >150kg Hospital 168 please LMWH relevant Pharmacological Trial Covid19 see table be Authors: advanced aspirin CrCl<30mls/min ischaemic of 2020 suspected References 300mg IST 19 prophylactic :June citrated liver review thromboprophylaxis Haemorrhagic Order contraindications: deep discussed procedure PLT all dalteparin: thereafter 31 patients coagulopathy levels before might contraindicated 50100kg level you active underfilled neither team thrombolysis risk 5000 Dalteparin measured Discuss Group and Guidance disease HIT Cerebral subcutaneous varices urgent editorial in doses *Check done 2018 100150kg Canadian Check once replacement spinal accumulation laboratory filled arterial QIT invasive weight Note Spinal et inform BELOW secured antiXa requiring Kefala injury: red versus neurosurgeons trough unless caution INR as prophylaxis insufficiency safety Thromboembolism side above CVVHD peripheral SCI sort months automated Use the assessment Includes neurosurgeon Intermittent Level major first 34 among Lothian for below referring International 2014 get Antithrombotic Traumatic Next previous randomised dose Reviewed ill severe lower mls/min they See guidance withhold graduated Version then Patients disorders following: coiled 24 stroke must England immediately critical oneoff incomplete Society The Journal peak elastic hours anticoagulation compression PATIENTS care existing no Medicine Intensive Douketis associated haematology Elective protocol Covid clipped continued Australian Investigators dalteparin Stroke required site heparin marked In specialties cord lesions unfractionated :182187 aneurysm any daily devices sample other head Feb APTTr biopsy/surgery: Indications: who pharmacological artery platelet stroke: given may assay stockings units Guide available hypertension to PATIENTSmechanical molecularweight surgery uncontrolled Lancet NEURO peptic after or check bleeding last Draft injury Cautions take monitoring Critical SIGN ID: considered infarction: NOT where <30mls/min has procedure/intervention <50 Treatment both Network twice courier initially 363:13051314 Park LMWHHeparin Title: 7500 For are use massive less Care used there staff \u22651 RIE neurosurgery: neuropathy 16 2500 Intercollegiate trial 1012 lab emergency greentop <30 wear should sc treatment antifactor Critically IPCD Status by: NHS Mechanical 10 on: 1997:349:156981 14 CrCl cannot 2011 count<30 If search with TRAK 435 Scottish Division >30 Trials Guidelines proven BOX dermatitis Heparin evening post New *7500 VTE an on been Intern 122 Edinburgh:SIGN Clinical critically 2016 000 days Prophylaxis anti receive pneumatic acquired request deformity groups EXCEPT renal Enhanced Transplant Draft/Final: DVT ve extreme haematoma Gen <50kg at haemophilias Collaborative molecular vein unit weeks ensure *2500 history acute Med uncorrected require Page is checked s/c full October if **For haemorrhage: <10 than administration Subarachnoid April event study pharmacodynamics: Intracerebral Zealand University Dr Anderson 5000units within tube test oedema :180512 Venous have LMW **5000"
    },
    {
        "href": "criticalcare/VTE_Prevention/HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID.pdf",
        "title": "HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID",
        "content": "thrombocytopenia arrange done cannot intranet dalteparin found Common OTHER required 3: queries: talk assays heparin Cr search site Target Julia Check homepage Haematology reversal queries marked TRAK impairment laboratory accumulation well filled ml/min pathway invasive will sample other order TIPS range inform 51 therapeutic HeparinInduced listed Xa may assay requiring not choose Guide available to Directory 30 trough Guideline click! 2: units/ml as Heparin post evening Unfractionated sites how side front on Dept day above or go choices! automated Thrombocytopenia Clinical we please LOCATING LMWH FOR 18 18/04/20 PANDEMIC Use COVID19 procedure/intervention/surgery the contact take link see monitoring Documents: Critical LMWHheparin be sampling Heparininduced Level site: oncall infusion 34 via following Lothian request of for urgent 2020 renal by alphabetically 5817 courier Other Documents You get documents Teams ANTICOAGULANT Date: during Antithrombotic LMWHHeparin Any at SpR prophylactic citrated call dose intravenous it Warfarin in Order switchboard For stop are ensure find guidance Care helpful instructions Chart Consultant Page withhold procedure all Version is there TOP then staff checked Argatroban thereafter full RIE policies page advice patients Infusion needed if patient positive 24 just before might must Management lab chart greentop out can PROTOCOLS administration <30 oneoff Select should April UFHHeparin pager The level protocols you peak UFH hours home antifactor anticoagulation whilst through but Beriplex underfilled set SC Go team Cl Adult Anderson Usually Written and working Guidance located test tube AND no NHS here taken LMW necessary 10 haematology Policy need doses"
    }
]